
<html lang="en"     class="pb-page"  data-request-id="90aa5bf6-1cd8-4662-b1ac-2dae5b5e9ed6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.9b01085;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-21;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Benzyl Phenylsemicarbazides: A Chemistry-Driven Approach Leading to G Protein-Biased Dopamine D4 Receptor Agonists with High Subtype Selectivity" /></meta><meta name="dc.Creator" content="Anna S.  Pirzer" /></meta><meta name="dc.Creator" content="Roman  Lasch" /></meta><meta name="dc.Creator" content="Heike  Friedrich" /></meta><meta name="dc.Creator" content="Harald  Hübner" /></meta><meta name="dc.Creator" content="Peter  Gmeiner" /></meta><meta name="dc.Creator" content="Markus R.  Heinrich" /></meta><meta name="dc.Description" content="Many subtype-selective dopamine receptor ligands developed for the D2–D4 family incorporate a 1-arylpiperazine-derived primary recognition motif, which is connected to a lipophilic moiety occupying..." /></meta><meta name="Description" content="Many subtype-selective dopamine receptor ligands developed for the D2–D4 family incorporate a 1-arylpiperazine-derived primary recognition motif, which is connected to a lipophilic moiety occupying..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 15, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01085" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01085" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01085" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01085" /></link>
        
    
    

<title>Benzyl Phenylsemicarbazides: A Chemistry-Driven Approach Leading to G Protein-Biased Dopamine D4 Receptor Agonists with High Subtype Selectivity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01085" /></meta><meta property="og:title" content="Benzyl Phenylsemicarbazides: A Chemistry-Driven Approach Leading to G Protein-Biased Dopamine D4 Receptor Agonists with High Subtype Selectivity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0015.jpeg" /></meta><meta property="og:description" content="Many subtype-selective dopamine receptor ligands developed for the D2–D4 family incorporate a 1-arylpiperazine-derived primary recognition motif, which is connected to a lipophilic moiety occupying an extended binding pocket (EBP) of the receptor via an aliphatic linker of variable lengths. The evaluation of a novel group of dopamine receptor ligands now showed that highly subtype-selective ligands [up to Ki(D4.4) = 0.25 nM, D2L/D4.4 = 320, D3/D4.4 = 710 for APH199 (17)] can be obtained by choosing a relatively large and conformationally flexible 1-benzyl-1-phenylsemicarbazide substructure to fill the EBP. The novel chemotype APH199 (17) was found to act as a full agonist at the D4 receptor showing significant bias toward G protein activation over β-arrestin recruitment in comparison to quinpirole." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01085"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01085">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01085&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01085&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01085&amp;href=/doi/10.1021/acs.jmedchem.9b01085" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9658-9679</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01035" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01091" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Benzyl Phenylsemicarbazides: A Chemistry-Driven Approach Leading to G Protein-Biased Dopamine D<sub>4</sub> Receptor Agonists with High Subtype Selectivity</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Anna S. Pirzer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anna S. Pirzer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anna+S.++Pirzer">Anna S. Pirzer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Roman Lasch</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roman Lasch</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roman++Lasch">Roman Lasch</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Heike Friedrich</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Heike Friedrich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Heike++Friedrich">Heike Friedrich</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Harald Hübner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Harald Hübner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Harald++H%C3%BCbner">Harald Hübner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter Gmeiner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter Gmeiner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Gmeiner">Peter Gmeiner</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4127-197X" title="Orcid link">http://orcid.org/0000-0002-4127-197X</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Markus R. Heinrich</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Markus R. Heinrich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#9af7fbe8f1efe9b4f2fff3f4e8f3f9f2dafcfbefb4feff"><span class="__cf_email__" data-cfemail="c5a8a4b7aeb0b6ebada0acabb7aca6ad85a3a4b0eba1a0">[email protected]</span></a>. Phone: +49-9131-85-65670.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Markus+R.++Heinrich">Markus R. Heinrich</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7113-2025" title="Orcid link">http://orcid.org/0000-0001-7113-2025</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01085&amp;href=/doi/10.1021%2Facs.jmedchem.9b01085" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9658–9679</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 15, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 July 2019</li><li><span class="item_label"><b>Published</b> online</span>15 October 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 November 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01085" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01085</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9658%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAnna%2BS.%2BPirzer%252C%2BRoman%2BLasch%252C%2BHeike%2BFriedrich%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D21%26contentID%3Dacs.jmedchem.9b01085%26title%3DBenzyl%2BPhenylsemicarbazides%253A%2BA%2BChemistry-Driven%2BApproach%2BLeading%2Bto%2BG%2BProtein-Biased%2BDopamine%2BD4%2BReceptor%2BAgonists%2Bwith%2BHigh%2BSubtype%2BSelectivity%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9679%26publicationDate%3DNovember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01085"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">820</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01085" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Benzyl Phenylsemicarbazides: A Chemistry-Driven Approach Leading to G Protein-Biased Dopamine D4 Receptor Agonists with High Subtype Selectivity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;S. Pirzer&quot;},{&quot;first_name&quot;:&quot;Roman&quot;,&quot;last_name&quot;:&quot;Lasch&quot;},{&quot;first_name&quot;:&quot;Heike&quot;,&quot;last_name&quot;:&quot;Friedrich&quot;},{&quot;first_name&quot;:&quot;Harald&quot;,&quot;last_name&quot;:&quot;Hübner&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Gmeiner&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;R. Heinrich&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;9658-9679&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01085&quot;},&quot;abstract&quot;:&quot;Many subtype-selective dopamine receptor ligands developed for the D2–D4 family incorporate a 1-arylpiperazine-derived primary recognition motif, which is connected to a lipophilic moiety occupying an extended binding pocket (EBP) of the receptor via an aliphatic linker of variable lengths. The evaluation of a novel group of dopamine receptor ligands now showed that highly subtype-selective ligands [up to Ki(D4.4) = 0.25 nM, D2L/D4.4 = 320, D3/D4.4 = 710 for APH199 (17)] can be obtained by choosing a relatively large and conformationally flexible 1-benzyl-1-phenylsemicarbazide substructure to fill the EBP. The novel chemotype APH199 (17) was found to act as a full agonist at the D4 receptor showing significant bias toward G protein activation over β-arrestin recruitment in comparison to quinpirole.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01085&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01085" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01085&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01085" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01085&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01085" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01085&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01085&amp;href=/doi/10.1021/acs.jmedchem.9b01085" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01085" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01085" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01085%26sid%3Dliteratum%253Aachs%26pmid%3D31613617%26genre%3Darticle%26aulast%3DPirzer%26date%3D2019%26atitle%3DBenzyl%2BPhenylsemicarbazides%253A%2BA%2BChemistry-Driven%2BApproach%2BLeading%2Bto%2BG%2BProtein-Biased%2BDopamine%2BD4%2BReceptor%2BAgonists%2Bwith%2BHigh%2BSubtype%2BSelectivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D21%26spage%3D9658%26epage%3D9679%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/jmcmar.2019.62.issue-21/20191114/jmcmar.2019.62.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Many subtype-selective dopamine receptor ligands developed for the D<sub>2</sub>–D<sub>4</sub> family incorporate a 1-arylpiperazine-derived primary recognition motif, which is connected to a lipophilic moiety occupying an extended binding pocket (EBP) of the receptor via an aliphatic linker of variable lengths. The evaluation of a novel group of dopamine receptor ligands now showed that highly subtype-selective ligands [up to <i>K</i><sub>i</sub>(D<sub>4.4</sub>) = 0.25 nM, D<sub>2L</sub>/D<sub>4.4</sub> = 320, D<sub>3</sub>/D<sub>4.4</sub> = 710 for APH199 (<b>17</b>)] can be obtained by choosing a relatively large and conformationally flexible 1-benzyl-1-phenylsemicarbazide substructure to fill the EBP. The novel chemotype APH199 (<b>17</b>) was found to act as a full agonist at the D<sub>4</sub> receptor showing significant bias toward G protein activation over β-arrestin recruitment in comparison to quinpirole.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35284" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35284" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Dopamine is one of the most prevalent catecholamines in the human brain and affects many processes in the central nervous system.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> A variety of disorders can be associated to imbalances in the dopamine neurotransmitter system and, thus, dopamine receptors play a crucial role as drug targets in medicinal chemistry. The family of the human dopamine receptors refers to the rhodopsin like G protein-coupled receptors (GPCRs) and can be divided into the D<sub>1</sub>-like subgroup, consisting of the D<sub>1</sub> and the D<sub>5</sub> receptor, and the D<sub>2</sub>-like subgroup, consisting of the D<sub>2</sub>, D<sub>3</sub>, and the D<sub>4</sub> receptor, respectively.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2−4)</a></div><div class="NLM_p">When the D<sub>4</sub> receptor was cloned and identified for the first time in 1991, and the preferential affinity of the atypical antipsychotic clozapine to this subtype was observed, efforts were undertaken to design and develop D<sub>4</sub> receptor antagonists as new drugs for the treatment of schizophrenia.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5−7)</a> A few years later in 1997, the initial enthusiasm to discover improved antipsychotic drugs with potentially less side effects faded because of a multicenter study revealing that the D<sub>4</sub> selective receptor antagonist L-745870 was ineffective in the treatment of schizophrenia.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">Nevertheless, subtype-selective D<sub>4</sub> receptor ligands are still developed and investigated with the aim to provide better treatment options for addictive disorders associated with cocaine,<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> morphine,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> amphetamine,<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16">(12−16)</a> heroin,<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16">(12−16)</a> and nicotine,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> eating disorders like anorexia nervosa,<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18−20)</a> as well as attention deficit disorder.<a onclick="showRef(event, 'ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24">(21−24)</a> Moreover, D<sub>4</sub>-selective compounds have been discussed as potential drugs with regard to erectile dysfunction<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25−27)</a> or cognitive deficits.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> A very recent publication by Keck et al.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> further highlights the importance of D<sub>4</sub>-subtype selective ligands (<i>K</i><sub>i</sub> up to 4.3 nM and >100-fold selectivity over D<sub>2</sub>-like receptors).</div><div class="NLM_p">The continuous interest in highly subtype and also functionally selective ligands for the D<sub>4</sub> subtype becomes obvious from a very recent and so far unique approach, in which 138 million library molecules were docked against the D<sub>4</sub> receptor.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> From 589 selected hits, 549 molecules were successfully synthesized, and further optimization of the docking hit ZINC621433143 in terms of stereochemistry led to the full agonist ZINC621433144 (<i>K</i><sub>i</sub> = 180 pM).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> This compound did not only show high subtype selectivity toward D<sub>4</sub>, but was also functionally selective with a 17-fold preference toward G<sub>i</sub> signaling versus β-arrestin recruitment, compared to the classic agonist quinpirole.</div><div class="NLM_p">Previous studies showed that D<sub>4</sub> selectivity can be achieved by connecting a 1-arylpiperazine recognition element, which represents a substitute for the endogenous dopamine, to a lipophilic appendage via a short methylene (C<sub>1</sub>) linker unit.<a onclick="showRef(event, 'ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33 ref34">(31−34)</a> This structure-subtype selectivity relationship is nicely supported by the D<sub>4</sub> receptor antagonists <b>1a</b> and <b>1b</b> developed by Kulagowski,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> displaying sub-nanomolar affinity and high subtype selectivity (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Highly subtype-selective dopamine D<sub>4</sub> receptor ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Structurally related antagonists of <b>1a</b> and <b>1b</b>, in which the 7-azaindole substructure was replaced by an indole, a 7a-azaindole (pyrazolopyridine) or an azulene unit, showed similar D<sub>4</sub> binding affinity and subtype selectivity, thereby strengthening the suitability of the overall structural design.<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36−38)</a> The D<sub>4</sub>-selective agonist PD168077 (<b>2</b>) developed by Glase<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and the docking hit ZINC621433144 (<b>3</b>)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> are no longer in accordance with the structural requirements mentioned above. The length of the linker units has been discussed earlier,<a onclick="showRef(event, 'ref38 ref40 ref41 ref42 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref38 ref40 ref41 ref42 ref43 ref44 ref45">(38,40−45)</a> and elongated alkyl chains can be found in the D<sub>4</sub>-selective ligands <b>4</b> and <b>5</b>, recently developed by Sampson<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and Wang.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The new chemotype <b>5</b>, in which the quinolone moiety acts as a primary recognition motif and the phenoxy unit represents the lipophilic appendage, was developed using data from the previously determined D<sub>4</sub> crystal structure (co-crystallized with nemonapride) in combination with virtual screening. Taking the D<sub>4</sub> crystal structure as a basis, the detailed docking results from the study by Wang<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> clearly support that new chemotypes with longer alkyl linker units can be well tolerated by the D<sub>4</sub> subtype.</div><div class="NLM_p">Seeking for a new chemotype that may confer atypical biological effects such as ligand bias, we found it challenging to investigate if the combination of an elongated linker unit and a comparably large, but flexible lipophilic appendage—such as in the general structure <b>6</b>—might also be a suitable approach to induce strong D<sub>4</sub> subtype selectivity. Encouraged by the remarkable functional selectivity of the atypical chemotype ZINC621433144 (<b>3</b>)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (17-fold preference toward G<sub>i</sub> vs β-arrestin), we thought to investigate the effect of our newly developed chemotype on the downstream signaling pathways, thereby aiming to get further insights into the structural determinants for functional selectivity, which are so far poorly understood.</div><div class="NLM_p last">Using a chemistry-based approach, and exploiting a newly developed reductive alkylation method,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> we now show that the extended binding pocket (EBP) of the dopamine D<sub>4</sub> receptor can indeed tolerate a sterically demanding benzyl phenylsemicarbazide substructure, a crucial element of our newly developed ligands of type <b>6</b>. Our study comprises 36 novel ligands, which we evaluated for their affinity to the dopamine D<sub>4.4</sub> receptor and their subtype selectivity in comparison to the other D<sub>2</sub>-like receptors, D<sub>2L</sub>, D<sub>2S</sub>, and D<sub>3</sub>. The most promising ligands were further studied in functional assays and characterized for their selectivity over a small set of related GPCRs. Modeling studies finally pointed to new key interactions, thereby showing that the EBP in the dopamine D<sub>2–4</sub> receptor family can be a valuable starting point for future developments with regard to ligands displaying both high subtype and functional selectivity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73712" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73712" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis</h3><div class="NLM_p">The synthesis of the target compounds started from the commercially available 1-arylpiperazines <b>7a–e</b> which were alkylated with <i>N</i>-phthalyl-protected bromoalkyl amines <b>8a–c</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Deprotection with hydrazine provided the free amines <b>10a–i</b>, which were subsequently coupled to various phenylazocarboxylic acid <i>tert</i>-butyl esters <b>11a–f</b> to give the azocarboxamides <b>12a–n</b>. The final reductive N-alkylation of <b>12a–n</b> with benzyl and allyl bromides <b>13a–i</b> was carried out according to a protocol recently developed in our group,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> thereby completing the straightforward synthesis of the semicarbazide target compounds <b>14–47</b>. Remarkably, the presence of zinc changes the selectivity of the final alkylation, as one would otherwise expect a selective functionalization at the tertiary aliphatic amino group in the piperazine subunit of <b>12</b>. However, and especially for the lower yielding alkylation reactions, we can currently not exclude that alkylation at the tertiary aliphatic amine also occurs to a significant extent.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Target Compounds <b>12a–c</b> and <b>14–47</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) arylpiperazine hydrochloride <b>7a–e</b> (1.0 equiv), bromoalkylphthalimide <b>8a–c</b> (2.0 equiv), K<sub>2</sub>CO<sub>3</sub> (4.0 equiv), acetone, reflux, 20 h 40–100%; (ii) N<sub>2</sub>H<sub>4</sub> (10.0 equiv), ethanol, reflux, 1 h, 65–88%; (iii) <i>tert</i>-butyl phenylazocarboxylate <b>11a–f</b> (1.1 equiv), K<sub>2</sub>CO<sub>3</sub> (4.0 equiv), ethanol, argon atmosphere, 40 °C, 24–99%; (iv) benzyl- or allyl bromide <b>13a–i</b> (2.5–5.0 equiv), zinc powder (2.5–10 equiv), THF, NH<sub>4</sub>Cl, 30 s, 18–99%.</p></p></figure><div class="NLM_p last">Notably, compounds that include comparably substituted semicarbazide substructures as the D<sub>4</sub> ligands prepared within this work, have, among others, previously appeared in studies focusing on MAP kinase inhibitors,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> inhibitors of integrin binding,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> and blood coagulation.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Compared to semicarbazides bearing only one substituent on the β-nitrogen atom of the hydrazine subunit, the β,β-disubstituted derivatives presented herein cannot be directly oxidized to their corresponding azo compounds and do thus show a high chemical stability, which was also observed during their preparation. No decomposition occurred even after storing the semicarbazide ligands in solution and at ambient temperature over several weeks.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Ligand Binding</h3><div class="NLM_p">Radioligand competition binding assays were performed to determine binding affinities and the selectivity profiles of <b>12c</b><a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and the new dopamine receptor ligands <b>12a</b>, <b>12b</b> and <b>14–47</b> in comparison to the previously described compounds L-745870 (<b>1a</b>) and PD168077 (<b>2</b>). The binding data were generated by measuring the ligands’ ability to compete with [<sup>3</sup>H]spiperone for the in-house available cloned human dopamine receptor subtypes D<sub>2L</sub>, D<sub>2S</sub>, D<sub>3</sub>, and D<sub>4.4</sub> stably expressed in CHO cells (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<named-content content-type="anchor" rid="tbl2" type="simple"></named-content><named-content content-type="anchor" rid="tbl3" type="simple"></named-content><named-content content-type="anchor" rid="tbl4" type="simple"></named-content><a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). As the <i>K</i><sub>i</sub> values were derived from binding experiments that have been analyzed as monophasic curves, the selectivity profiles may be inferred when applying different binding conditions, that is, using an agonist radioligand or varying the ratio between receptor and G protein in the membranes.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Radioligand Binding Data of Compounds <b>1a</b>, <b>2</b>, <b>12a–c</b>, and <b>14–16</b> to the Subtypes of the Dopamine D<sub>2</sub> Receptor Family</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0009.gif" alt="" id="GRAPHIC-d7e691-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="±"><i>K</i><sub>i</sub> (nM ± SEM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">selectivity<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center"><i>n</i>=</th><th class="colsep0 rowsep0" align="center" char="±">D<sub>2L</sub></th><th class="colsep0 rowsep0" align="center" char="±">D<sub>2S</sub></th><th class="colsep0 rowsep0" align="center" char="±">D<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char="±">D<sub>4.4</sub></th><th class="colsep0 rowsep0" align="center" char=".">D<sub>2L</sub>/D<sub>4.4</sub></th><th class="colsep0 rowsep0" align="center" char=".">D<sub>2S</sub>/D<sub>4.4</sub></th><th class="colsep0 rowsep0" align="center" char=".">D<sub>3</sub>/D<sub>4.4</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">L-745870 (<b>1a</b>)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">47000 ± 5200</td><td class="colsep0 rowsep0" align="char" char="±">33000 ± 3600</td><td class="colsep0 rowsep0" align="char" char="±">65000 ± 12000</td><td class="colsep0 rowsep0" align="char" char="±">0.70 ± 0.046</td><td class="colsep0 rowsep0" align="char" char=".">67 000</td><td class="colsep0 rowsep0" align="char" char=".">47 000</td><td class="colsep0 rowsep0" align="char" char=".">93 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PD168077 (<b>2</b>)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">2300 ± 470</td><td class="colsep0 rowsep0" align="char" char="±">1100 ± 100</td><td class="colsep0 rowsep0" align="char" char="±">4700 ± 1700</td><td class="colsep0 rowsep0" align="char" char="±">2.3 ± 0.56</td><td class="colsep0 rowsep0" align="char" char=".">1000</td><td class="colsep0 rowsep0" align="char" char=".">480</td><td class="colsep0 rowsep0" align="char" char=".">2000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char="±">270 ± 26</td><td class="colsep0 rowsep0" align="char" char="±">140 ± 26</td><td class="colsep0 rowsep0" align="char" char="±">120 ± 30</td><td class="colsep0 rowsep0" align="char" char="±">36 ± 5.4</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="char" char="±">110 ± 21</td><td class="colsep0 rowsep0" align="char" char="±">51 ± 2.0</td><td class="colsep0 rowsep0" align="char" char="±">140 ± 37</td><td class="colsep0 rowsep0" align="char" char="±">20 ± 3.0</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="char" char="±">38 ± 4.6</td><td class="colsep0 rowsep0" align="char" char="±">34 ± 3.0</td><td class="colsep0 rowsep0" align="char" char="±">3.1 ± 0.38</td><td class="colsep0 rowsep0" align="char" char="±">94 ± 13</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">0.033</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 35</td><td class="colsep0 rowsep0" align="char" char="±">71 ± 25</td><td class="colsep0 rowsep0" align="char" char="±">700 ± 220</td><td class="colsep0 rowsep0" align="char" char="±">9.0 ± 0.41</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">7.9</td><td class="colsep0 rowsep0" align="char" char=".">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="char" char="±">6.6 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">4.3 ± 0.76</td><td class="colsep0 rowsep0" align="char" char="±">25 ± 6.0</td><td class="colsep0 rowsep0" align="char" char="±">0.55 ± 0.087</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">7.8</td><td class="colsep0 rowsep0" align="char" char=".">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="char" char="±">160 ± 21</td><td class="colsep0 rowsep0" align="char" char="±">94 ± 19</td><td class="colsep0 rowsep0" align="char" char="±">76 ± 5.2</td><td class="colsep0 rowsep0" align="char" char="±">4.4 ± 0.95</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">17</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Values are reported as mean (nM ± SEM) of three to five individual experiments each done in triplicate and analyzing the data applying a monophasic curve fitting.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Subtype selectivity for D<sub>4.4</sub> over D<sub>2L</sub>, D<sub>2S</sub>, or D<sub>3</sub> (=D<sub><i>x</i></sub>) was determined by calculating the ratio of <i>K</i><sub>i</sub> D<sub><i>X</i></sub>/<i>K</i><sub>i</sub> D<sub>4.4</sub>.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">The <i>K</i><sub>i</sub> values determined for <b>12c</b> are similar to those previously reported in ref <a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a>.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Data of Compounds <b>15</b> and <b>17–36</b> with Varying Substitution Pattern in Ring <b>A</b> and <b>B</b> to the Subtypes of the Dopamine D<sub>2</sub> Receptor Family</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0010.gif" alt="" id="GRAPHIC-d7e1139-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="±"><i>K</i><sub>i</sub> (nM ± SEM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">selectivity<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup>=</th><th class="colsep0 rowsep0" align="center">R<sup>2</sup>=</th><th class="colsep0 rowsep0" align="center" char="±">D<sub>2L</sub></th><th class="colsep0 rowsep0" align="center" char="±">D<sub>2S</sub></th><th class="colsep0 rowsep0" align="center" char="±">D<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char="±">D<sub>4.4</sub></th><th class="colsep0 rowsep0" align="center" char=".">D<sub>2L</sub>/D<sub>4.4</sub></th><th class="colsep0 rowsep0" align="center" char=".">D<sub>2S</sub>/D<sub>4.4</sub></th><th class="colsep0 rowsep0" align="center" char=".">D<sub>3</sub>/D<sub>4.4</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RLH676 (<b>15</b>)</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">6.6 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">4.3 ± 0.76</td><td class="colsep0 rowsep0" align="char" char="±">25 ± 6.0</td><td class="colsep0 rowsep0" align="char" char="±">0.55 ± 0.087</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">7.8</td><td class="colsep0 rowsep0" align="char" char=".">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">APH199 (<b>17</b>)</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">77 ± 14</td><td class="colsep0 rowsep0" align="char" char="±">73 ± 17</td><td class="colsep0 rowsep0" align="char" char="±">170 ± 13</td><td class="colsep0 rowsep0" align="char" char="±">0.25 ± 0.054</td><td class="colsep0 rowsep0" align="char" char=".">320</td><td class="colsep0 rowsep0" align="char" char=".">300</td><td class="colsep0 rowsep0" align="char" char=".">710</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">APH212 (<b>18</b>)</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char="±">140 ± 31</td><td class="colsep0 rowsep0" align="char" char="±">110 ± 18</td><td class="colsep0 rowsep0" align="char" char="±">310 ± 28</td><td class="colsep0 rowsep0" align="char" char="±">0.55 ± 0.088</td><td class="colsep0 rowsep0" align="char" char=".">250</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="char" char=".">560</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="char" char="±">92 ± 14</td><td class="colsep0 rowsep0" align="char" char="±">47 ± 10</td><td class="colsep0 rowsep0" align="char" char="±">160 ± 25</td><td class="colsep0 rowsep0" align="char" char="±">3.6 ± 0.27</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="char" char="±">73 ± 9.4</td><td class="colsep0 rowsep0" align="char" char="±">46 ± 12</td><td class="colsep0 rowsep0" align="char" char="±">88 ± 16</td><td class="colsep0 rowsep0" align="char" char="±">3.8 ± 0.52</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char="±">77 ± 8.4</td><td class="colsep0 rowsep0" align="char" char="±">30 ± 3.0</td><td class="colsep0 rowsep0" align="char" char="±">85 ± 19</td><td class="colsep0 rowsep0" align="char" char="±">4.6 ± 0.59</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="char" char="±">110 ± 12</td><td class="colsep0 rowsep0" align="char" char="±">62 ± 7.2</td><td class="colsep0 rowsep0" align="char" char="±">150 ± 15</td><td class="colsep0 rowsep0" align="char" char="±">5.9 ± 1.1</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="char" char="±">210 ± 36</td><td class="colsep0 rowsep0" align="char" char="±">120 ± 11</td><td class="colsep0 rowsep0" align="char" char="±">640 ± 190</td><td class="colsep0 rowsep0" align="char" char="±">15 ± 2.9</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">8.0</td><td class="colsep0 rowsep0" align="char" char=".">43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">4-Ph</td><td class="colsep0 rowsep0" align="char" char="±">140 ± 42</td><td class="colsep0 rowsep0" align="char" char="±">42 ± 12</td><td class="colsep0 rowsep0" align="char" char="±">110 ± 28</td><td class="colsep0 rowsep0" align="char" char="±">5.9 ± 2.1</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">32 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">23 ± 3.5</td><td class="colsep0 rowsep0" align="char" char="±">130 ± 43</td><td class="colsep0 rowsep0" align="char" char="±">2.9 ± 0.87</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">7.9</td><td class="colsep0 rowsep0" align="char" char=".">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="char" char="±">41 ± 3.2</td><td class="colsep0 rowsep0" align="char" char="±">26 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">95 ± 18</td><td class="colsep0 rowsep0" align="char" char="±">2.6 ± 0.21</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">2,4-Cl<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">35 ± 4.8</td><td class="colsep0 rowsep0" align="char" char="±">24 ± 3.0</td><td class="colsep0 rowsep0" align="char" char="±">61 ± 14</td><td class="colsep0 rowsep0" align="char" char="±">15 ± 7.1</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">2,4-Cl<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="char" char="±">150 ± 27</td><td class="colsep0 rowsep0" align="char" char="±">94 ± 13</td><td class="colsep0 rowsep0" align="char" char="±">280 ± 58</td><td class="colsep0 rowsep0" align="char" char="±">12 ± 2.0</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">7.8</td><td class="colsep0 rowsep0" align="char" char=".">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">4-Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">55 ± 15</td><td class="colsep0 rowsep0" align="char" char="±">34 ± 2.4</td><td class="colsep0 rowsep0" align="char" char="±">130 ± 27</td><td class="colsep0 rowsep0" align="char" char="±">3.4 ± 0.60</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">4-Br</td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="char" char="±">45 ± 6.4</td><td class="colsep0 rowsep0" align="char" char="±">22 ± 2.2</td><td class="colsep0 rowsep0" align="char" char="±">92 ± 9.1</td><td class="colsep0 rowsep0" align="char" char="±">3.3 ± 0.74</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td><td class="colsep0 rowsep0" align="char" char=".">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">45 ± 2.0</td><td class="colsep0 rowsep0" align="char" char="±">19 ± 4.4</td><td class="colsep0 rowsep0" align="char" char="±">120 ± 10</td><td class="colsep0 rowsep0" align="char" char="±">1.7 ± 0.50</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="char" char="±">42 ± 12</td><td class="colsep0 rowsep0" align="char" char="±">19 ± 4.6</td><td class="colsep0 rowsep0" align="char" char="±">76 ± 11</td><td class="colsep0 rowsep0" align="char" char="±">2.6 ± 0.19</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">7.3</td><td class="colsep0 rowsep0" align="char" char=".">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="char" char="±">59 ± 4.8</td><td class="colsep0 rowsep0" align="char" char="±">35 ± 7.2</td><td class="colsep0 rowsep0" align="char" char="±">86 ± 30</td><td class="colsep0 rowsep0" align="char" char="±">6.2 ± 1.5</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char="±">160 ± 11</td><td class="colsep0 rowsep0" align="char" char="±">110 ± 7.3</td><td class="colsep0 rowsep0" align="char" char="±">400 ± 100</td><td class="colsep0 rowsep0" align="char" char="±">2.9 ± 0.77</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="char" char=".">140</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="char" char="±">150 ± 15</td><td class="colsep0 rowsep0" align="char" char="±">110 ± 15</td><td class="colsep0 rowsep0" align="char" char="±">320 ± 120</td><td class="colsep0 rowsep0" align="char" char="±">33 ± 3.8</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">9.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="char" char="±">250 ± 0</td><td class="colsep0 rowsep0" align="char" char="±">110 ± 32</td><td class="colsep0 rowsep0" align="char" char="±">220 ± 32</td><td class="colsep0 rowsep0" align="char" char="±">16 ± 3.4</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Values are reported as mean (nM ± SEM) of three to seven individual experiments each done in triplicate and analyzing the data applying a monophasic curve fitting.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Subtype selectivity for D<sub>4.4</sub> over D<sub>2L</sub>, D<sub>2S</sub> or D<sub>3</sub> (=D<sub><i>x</i></sub>) was determined by calculating the ratio of <i>K</i><sub>i</sub> D<sub><i>X</i></sub>/<i>K</i><sub>i</sub> D<sub>4.4</sub>.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Binding Data for the Methoxyphenyl Substituted Compounds <b>31</b>, <b>37</b>, and <b>38</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0011.gif" alt="" id="GRAPHIC-d7e2099-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center"><i>K</i><sub>i</sub> (nM ± SEM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="3" align="center">selectivity<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">compound</td><td class="colsep0 rowsep0" align="left">R=</td><td class="colsep0 rowsep0" align="left">D<sub>2L</sub></td><td class="colsep0 rowsep0" align="left">D<sub>2S</sub></td><td class="colsep0 rowsep0" align="left">D<sub>3</sub></td><td class="colsep0 rowsep0" align="left">D<sub>4.4</sub></td><td class="colsep0 rowsep0" align="left">D<sub>2L</sub>/D<sub>4.4</sub></td><td class="colsep0 rowsep0" align="left">D<sub>2S</sub>/D<sub>4.4</sub></td><td class="colsep0 rowsep0" align="left">D<sub>3</sub>/D<sub>4.4</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">45 ± 2.0</td><td class="colsep0 rowsep0" align="left">19 ± 4.4</td><td class="colsep0 rowsep0" align="left">120 ± 10</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.50</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">180 ± 43</td><td class="colsep0 rowsep0" align="left">340 ± 74</td><td class="colsep0 rowsep0" align="left">660 ± 29</td><td class="colsep0 rowsep0" align="left">61 ± 2.3</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">210 ± 32</td><td class="colsep0 rowsep0" align="left">300 ± 28</td><td class="colsep0 rowsep0" align="left">860 ± 73</td><td class="colsep0 rowsep0" align="left">64 ± 8.2</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="left">13</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Values are reported as mean (nM ± SEM) of three to seven individual experiments each done in triplicate and analyzing the data applying a monophasic curve fitting.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Subtype selectivity for D<sub>4.4</sub> over D<sub>2L</sub>, D<sub>2S</sub>, or D<sub>3</sub> (=D<sub><i>x</i></sub>) was determined by calculating the ratio of <i>K</i><sub>i</sub> D<sub><i>X</i></sub>/<i>K</i><sub>i</sub> D<sub>4.4</sub>.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Binding Data for Compounds <b>17</b>, <b>18</b>, and <b>39–44</b> Constituting Different Structural Variations of the Phenylpiperazine Moiety</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0012.gif" alt="" id="GRAPHIC-d7e2344-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="±"><i>K</i><sub>i</sub> (nM ± SEM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">selectivity<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R=</th><th class="colsep0 rowsep0" align="center">X=</th><th class="colsep0 rowsep0" align="center" char="±">D<sub>2L</sub></th><th class="colsep0 rowsep0" align="center" char="±">D<sub>2S</sub></th><th class="colsep0 rowsep0" align="center" char="±">D<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char="±">D<sub>4.4</sub></th><th class="colsep0 rowsep0" align="center" char=".">D<sub>2L</sub>/D<sub>4.4</sub></th><th class="colsep0 rowsep0" align="center" char=".">D<sub>2S</sub>/D<sub>4.4</sub></th><th class="colsep0 rowsep0" align="center" char=".">D<sub>3</sub>/D<sub>4.4</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">APH199 (<b>17</b>)</td><td class="colsep0 rowsep0" align="left">2-OMe</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char="±">77 ± 14</td><td class="colsep0 rowsep0" align="char" char="±">73 ± 17</td><td class="colsep0 rowsep0" align="char" char="±">170 ± 13</td><td class="colsep0 rowsep0" align="char" char="±">0.25 ± 0.054</td><td class="colsep0 rowsep0" align="char" char=".">320</td><td class="colsep0 rowsep0" align="char" char=".">300</td><td class="colsep0 rowsep0" align="char" char=".">710</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char="±">640 ± 120</td><td class="colsep0 rowsep0" align="char" char="±">410 ± 52</td><td class="colsep0 rowsep0" align="char" char="±">1100 ± 320</td><td class="colsep0 rowsep0" align="char" char="±">9.7 ± 5.2</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">42</td><td class="colsep0 rowsep0" align="char" char=".">110</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">4-Br</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char="±">730 ± 100</td><td class="colsep0 rowsep0" align="char" char="±">520 ± 67</td><td class="colsep0 rowsep0" align="char" char="±">1500 ± 310</td><td class="colsep0 rowsep0" align="char" char="±">14 ± 7.0</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="char" char=".">110</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char="±">580 ± 140</td><td class="colsep0 rowsep0" align="char" char="±">440 ± 96</td><td class="colsep0 rowsep0" align="char" char="±">2000 ± 480</td><td class="colsep0 rowsep0" align="char" char="±">18 ± 5.8</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">110</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">APH212 (<b>18</b>)</td><td class="colsep0 rowsep0" align="left">2-OMe</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char="±">140 ± 31</td><td class="colsep0 rowsep0" align="char" char="±">110 ± 18</td><td class="colsep0 rowsep0" align="char" char="±">310 ± 28</td><td class="colsep0 rowsep0" align="char" char="±">0.55 ± 0.088</td><td class="colsep0 rowsep0" align="char" char=".">250</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="char" char=".">560</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char="±">500 ± 46</td><td class="colsep0 rowsep0" align="char" char="±">380 ± 35</td><td class="colsep0 rowsep0" align="char" char="±">850 ± 100</td><td class="colsep0 rowsep0" align="char" char="±">17 ± 7.1</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">4-Br</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char="±">790 ± 76</td><td class="colsep0 rowsep0" align="char" char="±">620 ± 52</td><td class="colsep0 rowsep0" align="char" char="±">1400 ± 120</td><td class="colsep0 rowsep0" align="char" char="±">46 ± 20</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char="±">430 ± 110</td><td class="colsep0 rowsep0" align="char" char="±">310 ± 47</td><td class="colsep0 rowsep0" align="char" char="±">1900 ± 100</td><td class="colsep0 rowsep0" align="char" char="±">19 ± 4.9</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Values are reported as mean (nM ± SEM) of three to four individual experiments each done in triplicate and analyzing the data applying a monophasic curve fitting.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Subtype selectivity for D<sub>4.4</sub> over D<sub>2L</sub>, D<sub>2S</sub> or D<sub>3</sub> (=D<sub><i>x</i></sub>) was determined by calculating the ratio of <i>K</i><sub>i</sub> D<sub><i>X</i></sub>/<i>K</i><sub>i</sub> D<sub>4.4</sub>.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Binding Data of Compounds <b>40</b> and <b>45–47</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0013.gif" alt="" id="GRAPHIC-d7e2792-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="±"><i>K</i><sub>i</sub> (nM ± SEM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">selectivity<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center"><i>n</i>=</th><th class="colsep0 rowsep0" align="center" char="±">D<sub>2L</sub></th><th class="colsep0 rowsep0" align="center" char="±">D<sub>2S</sub></th><th class="colsep0 rowsep0" align="center" char="±">D<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char="±">D<sub>4.4</sub></th><th class="colsep0 rowsep0" align="center" char=".">D<sub>2L</sub>/D<sub>4.4</sub></th><th class="colsep0 rowsep0" align="center" char=".">D<sub>2S</sub>/D<sub>4.4</sub></th><th class="colsep0 rowsep0" align="center" char=".">D<sub>3</sub>/D<sub>4.4</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="char" char="±">730 ± 100</td><td class="colsep0 rowsep0" align="char" char="±">520 ± 67</td><td class="colsep0 rowsep0" align="char" char="±">1500 ± 310</td><td class="colsep0 rowsep0" align="char" char="±">14 ± 7.0</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="char" char=".">110</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char="±">390 ± 92</td><td class="colsep0 rowsep0" align="char" char="±">430 ± 46</td><td class="colsep0 rowsep0" align="char" char="±">1800 ± 310</td><td class="colsep0 rowsep0" align="char" char="±">28 ± 3.8</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="char" char="±">690 ± 160</td><td class="colsep0 rowsep0" align="char" char="±">670 ± 17</td><td class="colsep0 rowsep0" align="char" char="±">1300 ± 340</td><td class="colsep0 rowsep0" align="char" char="±">21 ± 5.2</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char="±">490 ± 150</td><td class="colsep0 rowsep0" align="char" char="±">510 ± 39</td><td class="colsep0 rowsep0" align="char" char="±">1800 ± 290</td><td class="colsep0 rowsep0" align="char" char="±">44 ± 13</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">38</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Values are reported as means (nM ± SEM) of three to four individual experiments each done in triplicate and analyzing the data applying a monophasic curve fitting.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Subtype selectivity for D<sub>4.4</sub> over D<sub>2L</sub>, D<sub>2S</sub> or D<sub>3</sub> (=D<sub><i>x</i></sub>) was determined by calculating the ratio of <i>K</i><sub>i</sub> D<sub><i>X</i></sub>/<i>K</i><sub>i</sub> D<sub>4.4</sub>.</p></div></div></div><div class="NLM_p">Already, the first series of semicarbazide ligands <b>14–16</b> revealed a modified binding profile compared to the azocarboxamide analogues <b>12a–c</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). While the azocarboxamides <b>12a–c</b> were found to be at least roughly in agreement with the established rule that short linker units (<b>12a</b>, <i>n</i> = 1; <b>12b</b>, <i>n</i> = 2) favor binding to the D<sub>4</sub> subtype, while longer linkers such as C<sub>4</sub> (<b>12c</b>, <i>n</i> = 3) shift the affinity toward D<sub>3</sub>,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> the evaluation of the semicarbazides <b>14–16</b> revealed a remarkable preference for the D<sub>4</sub> subtype independent of the linker length. As the best combination of affinity [<i>K</i><sub>i</sub>(D<sub>4.4</sub>) = 0.55 nM] and selectivity (D<sub>2L</sub>/D<sub>4.4</sub> = 12, D<sub>3</sub>/D<sub>4.4</sub> = 45) was determined for RLH676 (<b>15</b>) at a linker length of three carbon atoms (<i>n</i> = 2), the study was continued with this lead structure.</div><div class="NLM_p"><a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> summarizes the results obtained upon variation of the substituents on the two aromatic moieties <b>A</b> and <b>B</b> of the benzyl phenylsemicarbazide unit. Compared to RLH676 (<b>15</b>), the subtype selectivity toward D<sub>4</sub> could be strongly increased by shifting the fluorine atom from the 4-position of ring <b>A</b> to the 4-position of ring <b>B</b>, as in APH212 (<b>18</b>), and even slightly more by leaving both ring systems <b>A</b> and <b>B</b> unsubstituted, as in compound APH199 (<b>17</b>). Almost all other substitution patterns, as they are present in ligands <b>19–36</b>, lead to a reduced D<sub>4</sub> affinity and subtype selectivity. Regarding the trends in D<sub>4</sub> binding affinity for the less potent ligands, most compounds show <i>K</i><sub>i</sub> values in a quite narrow range from 2 to 6 nM, indicating that a variety of substitution patterns is also quite well tolerated. Only unfavorable patterns such as 2,4-dichloro substitution on ring <b>A</b> (compounds <b>27</b> and <b>28</b>) and/or 4-cyano and 3-methoxy substitution on ring <b>B</b> (compounds <b>23</b>, <b>28</b>, <b>35</b>, and <b>36</b>) resulted in <i>K</i><sub>i</sub> values higher than 10 nM. Notably, a good subtype selectivity (D<sub>2L</sub>/D<sub>4.4</sub> = 55, D<sub>3</sub>/D<sub>4.4</sub> = 140) was also observed for ligand <b>34</b>, although this was not due to subnanomolar binding to D<sub>4</sub> [<i>K</i><sub>i</sub>(D<sub>4.4</sub>) = 2.9 nM], but due to a much reduced affinity to the D<sub>2</sub> and D<sub>3</sub> subtypes.</div><div class="NLM_p">Having seen that the combination of an unsubstituted phenyl and an unsubstituted benzyl group on the semicarbazide, as present in compound APH199 (<b>17</b>), provides high affinity and subtype selectivity for the D<sub>4</sub> receptor, we replaced the benzyl moiety by a smaller allyl or 2-methallyl unit to evaluate the effect of decreased size (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). With compound <b>31</b> serving as a reference for this modification, it became apparent that allylation as well as 2-methallylation only lead to ligands <b>37</b> and <b>38</b> with significantly reduced D<sub>4</sub> affinity and subtype selectivity. Thus, a certain size of the two units attached to the semicarbazide appears to be necessary to successfully differentiate between the D<sub>2</sub>–D<sub>4</sub> subtypes.</div><div class="NLM_p">In the next stage, we turned to the variation of the recognition motif, which was so far represented by a 1-(2-methoxyphenyl)piperazine. Based on the highly potent and subtype-selective D<sub>4</sub> receptor ligands reported so far (cf. <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), the 2-methoxyphenyl unit was exchanged for a 4-chlorophenyl, 4-bromophenyl, or a pyrimidin-2-yl substructure. The results obtained in comparison to the so far most APH199 (<b>17</b>) and APH212 (<b>18</b>) are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>.</div><div class="NLM_p">For both series, either starting from the benzyl semicarbazide APH199 (<b>17</b>) or the 4-fluorobenzyl semicarbazide APH212 (<b>18</b>), these variations resulted in an at least 31-fold loss of D<sub>4</sub> binding affinity for compounds <b>39–44</b> combined with a remarkable decrease of selectivity toward the other subtypes D<sub>2L</sub>, D<sub>2S</sub>, and D<sub>3</sub>. To answer the question whether the increased size of a 4-bromo or 4-iodo-substituted phenyl ring in the 1-arylpiperazine recognition motif could possibly be counterbalanced by a shorter linker length (cf. ligand <b>1b</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), we finally prepared the semicarbazides <b>45–47</b> (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). In comparison to 4-bromo derivative <b>40</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>), the exchange of the 4-bromo for a 4-iodo substituent as well as the shortening of linker length from three to two methylene units independently led to less binding affinity of the ligands <b>45–47</b> to the D<sub>4</sub> subtype.</div><div class="NLM_p">The biological evaluation of the ligands <b>17</b> and <b>18</b>, possessing the most favorable binding profile for the D<sub>4</sub> subtype, toward receptors of the D<sub>1</sub> family as well as other non-dopaminergic receptors demonstrated that significantly lower binding affinities (higher <i>K</i><sub>i</sub> values) are found for most other receptors (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Binding Data of Compounds <b>17</b> and <b>18</b> to Receptors of the D<sub>1</sub> Family As Well As Other Non-Dopaminergic Receptors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0014.gif" alt="" id="GRAPHIC-d7e3396-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="7" align="center" char="±"><i>K</i><sub>i</sub> (nM ± SD)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="±">D<sub>1</sub></th><th class="colsep0 rowsep0" align="center" char="±">D<sub>5</sub></th><th class="colsep0 rowsep0" align="center" char="±">α<sub>1A</sub></th><th class="colsep0 rowsep0" align="center" char="±">α<sub>2</sub></th><th class="colsep0 rowsep0" align="center">β<sub>1</sub></th><th class="colsep0 rowsep0" align="center" char="±">β<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char="±">δ-OR</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">APH199 (<b>17</b>)</td><td class="colsep0 rowsep0" align="char" char="±">200 ± 120</td><td class="colsep0 rowsep0" align="char" char="±">340 ± 21</td><td class="colsep0 rowsep0" align="char" char="±">1.7 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">400 ± 57</td><td class="colsep0 rowsep0" align="left">13000 ± 3500</td><td class="colsep0 rowsep0" align="char" char="±">1800 ± 350</td><td class="colsep0 rowsep0" align="char" char="±">10000 ± 7100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">APH212 (<b>18</b>)</td><td class="colsep0 rowsep0" align="char" char="±">360 ± 99</td><td class="colsep0 rowsep0" align="char" char="±">1000 ± 91</td><td class="colsep0 rowsep0" align="char" char="±">1.6 ± 0.42</td><td class="colsep0 rowsep0" align="char" char="±">860 ± 110</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="char" char="±">4500 ± 420</td><td class="colsep0 rowsep0" align="char" char="±">19000 ± 5600</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="7" align="center" char="±"><i>K</i><sub>i</sub> (nM ± SD)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="±">κ-OR</th><th class="colsep0 rowsep0" align="center" char="±">μ-OR</th><th class="colsep0 rowsep0" align="center" char="±">5-HT<sub>1A</sub></th><th class="colsep0 rowsep0" align="center" char="±">5-HT<sub>2A</sub></th><th class="colsep0 rowsep0" align="center" char="±">M<sub>1</sub></th><th class="colsep0 rowsep0" align="center" char="±">M<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char="±">M<sub>3</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">APH199 (<b>17</b>)</td><td class="colsep0 rowsep0" align="char" char="±">3900 ± 1700</td><td class="colsep0 rowsep0" align="char" char="±">2000 ± 850</td><td class="colsep0 rowsep0" align="char" char="±">17 ± 2.1</td><td class="colsep0 rowsep0" align="char" char="±">65 ± 2.1</td><td class="colsep0 rowsep0" align="char" char="±">25000 ± 14000</td><td class="colsep0 rowsep0" align="char" char="±">14000 ± 11000</td><td class="colsep0 rowsep0" align="char" char="±">25000 ± 4900</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">APH212 (<b>18</b>)</td><td class="colsep0 rowsep0" align="char" char="±">4300 ± 1600</td><td class="colsep0 rowsep0" align="char" char="±">2300 ± 920</td><td class="colsep0 rowsep0" align="char" char="±">34 ± 12</td><td class="colsep0 rowsep0" align="char" char="±">130 ± 7.1</td><td class="colsep0 rowsep0" align="char" char="±">15000 ± 0</td><td class="colsep0 rowsep0" align="char" char="±">17000 ± 710</td><td class="colsep0 rowsep0" align="char" char="±">37000 ± 9200</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Values are reported as mean values in (nM ± SD) derived from two individual experiments each done in triplicate.</p></div></div></div><div class="NLM_p">The only exception was observed for the α<sub>1A</sub> subtype to which both ligands <b>17</b> and <b>18</b> showed a comparably strong binding with <i>K</i><sub>i</sub> values of 1.7 ± 0.14 and 1.6 ± 0.42 nM, respectively, which corresponds to selectivity ratios of 7.1 and 2.9 over the D<sub>4</sub> subtype. Functional assays at the α<sub>1A</sub> receptor led to the observation that <b>17</b> and <b>18</b> both behave as neutral antagonists (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01085/suppl_file/jm9b01085_si_001.pdf" class="ext-link">Supporting Information</a> for dose–response curves). These assays were performed for G<sub>αq</sub> mediated signaling (IP-One assay) and β-arrestin recruitment (PathHunter assay).</div><div class="NLM_p">Functional assays to determine agonistic or antagonistic properties at the D<sub>4</sub> subtype were conducted for the most promising ligands RLH676 (<b>15</b>), APH199 (<b>17</b>), and APH212 (<b>18</b>) using quinpirole as a reference compound. The results summarized in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a> show that all three compounds behave as almost full agonists with bias toward the G protein over the β-arrestin signaling pathway.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Dose–response curves for the most potent compounds <b>15</b>, <b>17</b>, <b>18</b>, and the reference quinpirole measuring G protein or arrestin-mediated D<sub>4</sub> receptor signaling. (A) IP-One assay measuring G protein-mediated signaling in HEK cells co-expressing the D<sub>4</sub>R and the G protein hybrid Gα<sub>qi</sub>. (B) Arrestin recruitment measuring partial agonist properties as well as partial antagonism of 300 nM quinpirole employing the PathHunter complementation assay in HEK cells expressing D<sub>4</sub>R-PKA and (EA)-β-arrestin-2. Both graphs show pooled curves from six individual experiments each done in duplicates (agonist effect), antagonist properties are displayed as mean curves derived from three to four experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Key Data from Functional Assays Using Quinpirole As a Reference Compound</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IP-One-D<sub>4</sub> + Gα<sub>qi</sub><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center">arrestin-D<sub>4</sub>-PKA<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">maximal activation (% ± SEM)<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">EC<sub>50</sub> (nM ± SEM)</th><th class="colsep0 rowsep0" align="center">maximal activation (% ± SEM)<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">EC<sub>50</sub> (nM ± SEM)<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">bias factor 10<sup>ΔΔlog(τ/KA)</sup></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">quinpirole</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="char" char="±">2.2 ± 0.2</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="char" char="±">83 ± 0.7</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RLH676 (<b>15</b>)</td><td class="colsep0 rowsep0" align="left">88 ± 4</td><td class="colsep0 rowsep0" align="char" char="±">1.8 ± 0.39</td><td class="colsep0 rowsep0" align="left">22 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">340 ± 150</td><td class="colsep0 rowsep0" align="char" char=".">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">APH199 (<b>17</b>)</td><td class="colsep0 rowsep0" align="left">89 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">8.7 ± 4.2</td><td class="colsep0 rowsep0" align="left">16 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">250 ± 150</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">APH212 (<b>18</b>)</td><td class="colsep0 rowsep0" align="left">86 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">41 ± 15</td><td class="colsep0 rowsep0" align="left">17 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">500 ± 110</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">An IP-One assay with HEK293T cells transiently co-transfected with D<sub>4</sub>R and the G protein hybrid Gα<sub>qi</sub> was applied for the determination of G protein-mediated signaling of the test compounds at D<sub>4</sub>R.</p></div><div class="footnote" id="t7fn2"><sup><sup>b</sup></sup><p class="last">Measuring of arrestin recruitment was performed using the PathHunter complementation assay with HEK293T cells stably expressing (EA)-β-arrestin and the transiently transfected D<sub>4</sub>R-PKA construct.</p></div><div class="footnote" id="t7fn3"><sup><sup>c</sup></sup><p class="last">Maximum activation in % ± SEM relative to the reference quinpirole derived from six individual experiments each done in duplicate.</p></div><div class="footnote" id="t7fn4"><sup><sup>d</sup></sup><p class="last">EC<sub>50</sub> value ± SEM from six individual experiments each done in duplicate.</p></div></div></div><div class="NLM_p">Regarding signaling via the G protein pathway, a strong activation was determined for the three novel semicarbazides RLH676 (<b>15</b>), APH199 (<b>17</b>), and APH212 (<b>18</b>), which reach 86–89% of the maximum effect attainable by quinpirole. The functional assay on β-arrestin recruitment, in contrast, revealed that <b>15</b>, <b>17</b>, and <b>18</b> do by far not reach the same level of activation as quinpirole and act as weak partial agonists (16–22% relative to quinpirole). In the presence of an agonist (300 nM of quinpirole), <b>15</b>, <b>17</b>, and <b>18</b> dose-dependently inhibit this effect with the best potency observed for <b>15</b> (for <b>15</b>: IC<sub>50</sub> = 49 ± 19 nM, for <b>17</b>: IC<sub>50</sub> = 450 ± 140 nM, for <b>18</b>: IC<sub>50</sub> = 620 ± 220 nM) and displayed a partial antagonist effect (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B).</div><div class="NLM_p last">The fact that the control compound quinpirole shows an approximately 38-fold higher affinity for the G protein assay versus the β-arrestin assay, with EC<sub>50</sub> values of 2.2 versus 83 nM, is most likely due to an amplification of the G protein response by the spare receptor phenomenon,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> rather than that the control compound quinpirole exhibits a significant bias. Comparing the EC<sub>50</sub> (affinity) ratio of 38 [EC<sub>50</sub>(β-arr.)/EC<sub>50</sub>(G<sub>i</sub>)] for quinpirole with the ratios calculated in the same way for the semicarbazides <b>15</b>, <b>17</b>, and <b>18</b>, which leads to values of 189, 29, and 12, respectively, shows that only RLH676 (<b>15</b>) displays an affinity- and efficacy-wise bias toward the G protein. For APH199 (<b>17</b>) and APH212 (<b>18</b>), a lower affinity-wise bias (EC<sub>50</sub> ratios of 29 and 12 vs 38 for quinpirole) was determined, so that the overall bias seen in the signaling of <b>17</b> and <b>18</b> is primarily driven by a loss of efficacy at stimulating the β-arrestin pathway—not a loss of affinity. These considerations are supported by the bias factors calculated for <b>15</b>, <b>17</b>, and <b>18</b> according to the operational model by Black and Leff,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> thereby following recently published procedures.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55,56)</a> From these calculations, a comparably high bias factor of 26 was obtained for RLH676 (<b>15</b>), while lower values of 4.9 and 1.8 were determined for <b>17</b> and <b>18</b>, respectively. From literature, functional data are available for the recently developed D<sub>4</sub>-selective ligand 621433134 (<b>3</b>) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which was also evaluated using quinpirole as reference, and for which a G protein over β-arrestin bias factor of 17 was calculated.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Studies on Metabolic Stability</h3><div class="NLM_p">The metabolic stability of semicarbazide APH199 (<b>17</b>) was studied using male rat liver microsomes and imipramine under previously established conditions.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> The reliability of the assay could be confirmed, as product patterns similar to those reported for imipramine in literature were obtained after comparable incubation times with N-demethylation and hydroxylation occurring as main metabolic pathways.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The results obtained for APH199 (<b>17</b>) in comparison with imipramine are summarized in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Oxidative metabolism of APH199 (<b>17</b>) and imipramine upon exposure to male rat liver microsomes. Results from LC–MS analysis are depicted in percentage of non-metabolized APH199 (<b>17</b>) and imipramine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, APH199 (<b>17</b>) was found to be more stable than imipramine under the assay conditions, whereas imipramine is typically classified as a moderately stable positive control for phase I metabolism.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> After 120 min incubation time, analysis of the reaction mixture by LC–ESI–MS showed approximately 50% hydroxylation of <b>17</b> (detected as [M + O + H]<sup>+</sup>: <i>m</i>/<i>z</i> = 490), approximately 20% of O-demethylated <b>17</b> (detected as [M – CH<sub>2</sub> + H]<sup>+</sup>: <i>m</i>/<i>z</i> = 460), approximately 20% of N-debenzylated <b>17</b> (detected as [M – C<sub>7</sub>H<sub>6</sub> + H]<sup>+</sup>: <i>m</i>/<i>z</i> = 384), and approximately 10% of unchanged APH199 (<b>17</b>) (detected as [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> = 474). These results suggest that <b>17</b> should possess sufficient metabolic stability to be considered for in vivo testing in the future. Furthermore, no warnings in the PAINS screening were obtained for the metabolites of APH199 (<b>17</b>) resulting from O-demethylation and N-debenzylation. The hydroxylated metabolite could not be screened because the actual position of the hydroxy group is so far unknown.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Docking</h3><div class="NLM_p">Docking studies<a onclick="showRef(event, 'ref59 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref59 ref60 ref61">(59−61)</a> were performed to get insights into the binding poses of the novel semicarbazide ligands, especially the possible interactions in the EBP. Moreover, explanations for subtype selectivity can be derived. Advantageously, crystal structures are available for the dopamine receptor subtypes D<sub>2</sub>, D<sub>3</sub>, and D<sub>4</sub>, which were recently co-crystalized with the antagonists risperidone,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> eticlopride,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> and nemonapride,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> respectively.</div><div class="NLM_p">The EBP (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, left) in the D<sub>4</sub> subtype is mainly surrounded by amino acids bearing nonpolar side chains with the exception of Arg186, whereas the hydrophilic guanidine moiety is however not orientated toward the lipophilic benzyl unit of the ligand <b>17</b>. From the comparably long distance between the benzyl unit of <b>17</b> and the guanidine side chain of Arg186, which is around 5.2 Å, only a very weak cation-aryl interaction could possibly occur.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Lipophilic amino acids that are in vicinity to the phenyl moiety of APH199 (<b>17</b>) are Val87, Leu90, Phe91, and Leu111 (highlighted in pink). A lipophilic residue, which is closely located to the benzyl moiety on the semicarbazide is the side chain of Val184, and Trp101 might act as a further boundary element for the EBP.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Calculated binding pose of ligand APH199 (<b>17</b>) (green) to the dopamine D<sub>4</sub> receptor (PDB-D<sub>4</sub>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WIU">5WIU</a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> View from the extracellular side on the phenyl and benzyl units occupying the EBP (left) and view on the semicarbazide unit (center).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Key interactions of the polar residues of ligand <b>17</b> are shown in the center of <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. The protonated tertiary aliphatic amine forms a salt bridge with Asp115 from TM3 and the carbonyl unit of the semicarbazide is engaged in a hydrogen bond with Thr434 from TM7. Because of these two anchor groups, we assume that the C<sub>3</sub> alkyl spacer present in <b>17</b> provides the necessary flexibility so that both interactions to Asp115 and Thr434 can effectively occur, while the large lipophilic benzyl phenylsemicarbazide of <b>17</b> is at the same time correctly directed into the EBP. The fixation of the 3-methoxyphenyl unit of the 1-arylpiperazine recognition element by Val116 from TM3 and Phe411 from TM6 has earlier been observed for the corresponding recognition element of nemonapride in its co-crystal with the D<sub>4</sub> receptor.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Insights into the effects that are responsible for the subtype selectivity of the D<sub>4</sub> ligand <b>17</b> over the subtypes D<sub>2</sub> and D<sub>3</sub> are given in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Subtype selectivity of ligand <b>17</b> (green). Docking into the D<sub>4</sub> subtype (left) compared with an overlay of the D<sub>2</sub> (purple) and D<sub>3</sub> (turquoise) subtype (right) (PDB-D<sub>4</sub>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WIU">5WIU</a>; PDB-D<sub>2</sub>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CM4">6CM4</a>; PDB-D<sub>3</sub>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBL">3PBL</a>).<a onclick="showRef(event, 'ref47 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref47 ref62 ref63">(47,62,63)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">From the computational results depicted in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, one can conclude that the EBP is likely to play a key role in the context of subtype selectivity of the novel semicarbazide ligands. As nicely shown by Wang,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> an EBP is available in all three subtypes D<sub>2</sub>, D<sub>3</sub>, and D<sub>4</sub>, but its orientation within the overall seven transmembrane structure changes significantly. An important amino acid, which leads to this reorientation, is Leu111 from TM3 in D<sub>4</sub>, which is exchanged for a much bulkier Phe110 in the D<sub>2</sub> subtype and for a Phe106 in the D<sub>3</sub> subtype (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, right). Although the EBP of the D<sub>2</sub> and D<sub>3</sub> subtypes is on the other hand larger at the original position of Phe91 in D<sub>4</sub>, as this amino acid is replaced by either Val91 in D<sub>2</sub> or Val86 in D<sub>3</sub>, the semicarbazide ligand <b>17</b> appears to be unable to follow this reorientation as the polar key interactions shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> (center) only allow a favorable placement of the bulky benzyl phenylsemicarbazide unit in the EBP of the D<sub>4</sub> subtype. Therefore, if no simple reorientation is possible for ligand <b>17</b> in the other subtypes, the phenyl moiety on the semicarbazide is likely to lead to a significant steric clash with Phe110 in D<sub>2</sub> and Phe106 in D<sub>3</sub>, thereby explaining the observed subtype selectivity. Moreover, the importance of the key interactions (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, center) also provides an explanation for the reduced influence of the chain length connecting the recognition element and the lipophilic appendage (cf. <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) in the semicarbazide ligands. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, all three semicarbazides <b>14–16</b> displayed a remarkable selectivity toward D<sub>4</sub>, although the length of the alkyl linker was varied from two to three, and finally four methylene units. In contrast, the key interactions of the novel semicarbazide ligands with Asp115 and Thr434 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, center) are significantly disturbed when a more bulky nitrile group is placed on the benzyl moiety of the semicarbazide, such as in ligand <b>23</b>, because either the salt bridge to Asp115 can then no longer be formed or the size of the EBP in the D<sub>4</sub> subtype will become insufficient to host the enlarged benzyl phenylsemicarbazide.</div><div class="NLM_p">Finally, the docking study was extended to the known D<sub>4</sub> selective ligands <b>1b</b> and 9-6-24 (<b>5</b>) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Because these computational experiments led to a similar docking pose for 9-6-24 (<b>5</b>) as previously determined by Wang et al.,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> the obtained results can serve as a control for the reliability of our docking studies.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Docking of the known D<sub>4</sub> selective ligands <b>1b</b> and 9-6-24 (<b>5</b>) into the D<sub>4</sub> subtype (PDB-D<sub>4</sub>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WIU">5WIU</a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, both ligands <b>1b</b> and <b>5</b> only partially occupy the EBP available in the D<sub>4</sub> subtype, whereas the lipophilic 4-iodophenyl group of ligand <b>1b</b> points to TM6 and TM7 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, left) and the phenoxy unit in ligand <b>5</b> is oriented toward TM2 and TM3 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, right). Notably, the alternative orientation of ligand <b>1b</b>, in which the 4-iodophenylpiperazine acts as a recognition element and the 7-azaindole moiety occupies the EBP, would lead to a much larger distance between the protonated piperazine nitrogen and Asp115 (5.7 Å) and can thus be considered as much less likely (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01085/suppl_file/jm9b01085_si_001.pdf" class="ext-link">Supporting Information</a>). All three ligands <b>1b</b>, 9-6-24 (<b>5</b>), and APH199 (<b>17</b>) show a similar key interaction of their protonated amine to Asp115 from TM3 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, center), but only <b>5</b> and <b>17</b> display a second polar interaction of their lipophilic appendages directed to the EBP. Whereas this second polar interaction of the semicarbazide APH199 (<b>17</b>) is an <i>intermolecular</i> one (semicarbazide carbonyl to Thr434 in the D<sub>4</sub> subtype, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, center) the favorable placement of the phenoxy unit of 9-6-24 (<b>5</b>) in the EBP is secured by an <i>intramolecular</i> interaction of the ether oxygen atom to a hydrogen atom on the protonated secondary amine. Besides these favorable polar key interactions, the novel semicarbazide ligands nevertheless demonstrate that high subtype selectivities for the D<sub>4</sub> subtype over D<sub>2</sub> and D<sub>3</sub> can also be achieved by compounds fully occupying the EBP of D<sub>4</sub> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, left).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, it has been shown that 1-arylpiperazines that are linked to a novel 1-benzyl-1-phenylsemicarbazide motif can display high affinity and subtype selectivity toward the dopamine D<sub>4</sub> receptor in combination with a significant bias toward G protein activation. Taking advantage of a recently developed Barbier-type reaction, which is applicable for the reductive alkylation of phenylazocarboxamides, a series of 34 new semicarbazide ligands could be prepared via a straightforward synthetic sequence. The resulting compounds were subsequently evaluated in competition binding assays toward the three subtypes of the D<sub>2</sub> family, and structure–activity relationships as summarized in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> were observed.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Summary of structure–activity relationships and structure-functional selectivity relationships for the novel semicarbazide ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">According to docking studies, the favorable binding profile of the most promising ligand APH199 (<b>17</b>) [<i>K</i><sub>i</sub>(D<sub>4.4</sub>) = 0.25 nM, D<sub>2L</sub>/D<sub>4.4</sub> = 320, D<sub>3</sub>/D<sub>4.4</sub> = 710] results from two main factors. First, a comparably strong fixation of the ligand in the D<sub>4</sub> receptor is likely to be achieved via a salt bridge linking the protonated piperazine to Asp115 combined with a hydrogen bond between Thr434 and the carbonyl oxygen of the novel semicarbazide substructure. Second, the particular combination of a phenyl and benzyl substituent on the semicarbazide unit leads to a full occupation of the EBP and, because of an insufficient flexibility of the 1-benzyl-1-phenylsemicarbazide in the subtypes D<sub>2</sub> and D<sub>3</sub>, also to a clash with the bulkier side chains of Phe110 (in D<sub>2</sub>) and Phe106 (in D<sub>3</sub>), which can serve as a plausible explanation for subtype selectivity. These results demonstrate that the full occupation of the EBP in the dopamine receptor subtype D<sub>4</sub> by ligands bearing bulky lipophilic appendages can offer a valuable starting point for future developments toward G protein-biased D<sub>4</sub>-selective agonists, which has so far not been exploited. To date, little is known about G protein-biased D<sub>4</sub>-selective agonists besides the recently published ligand 621433134 (<b>3</b>) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) and the semicarbazides developed within this work. Within the D<sub>2</sub> receptor family, most examples for biased ligands have so far been reported for the D<sub>2</sub> subtype.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> For research groups interested in the pharmacology of the newly developed semicarbazide ligands, we would be happy to provide samples within a future collaboration.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06727" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06727" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Synthesis</h3><div class="NLM_p last">Solvents and reagents are obtained from commercial sources and used as received. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra are recorded on Bruker AVANCE 600 (<sup>1</sup>H: 600 MHz; <sup>13</sup>C: 151 MHz) and Bruker AVANCE 400 (<sup>1</sup>H: 400 MHz; <sup>13</sup>C: 101 MHz) spectrometers. For <sup>1</sup>H NMR spectra, CDCl<sub>3</sub> is used as solvent referenced to TMS (0 ppm): CHCl<sub>3</sub> (7.26 ppm), (CD<sub>3</sub>)<sub>2</sub>SO (2.5 ppm), CD<sub>3</sub>OD (3.31 ppm). Chemical shifts are reported in parts per million (ppm). Coupling constants are in hertz (Hz). The following abbreviations are used for the description of signals: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br s (broad singlet). <sup>13</sup>C NMR (DEPTQ) spectra are recorded in CDCl<sub>3</sub> using CDCl<sub>3</sub> (77.16 ppm) and in (CD<sub>3</sub>)<sub>2</sub>SO using (CD<sub>3</sub>)<sub>2</sub>SO (39.52 ppm) as standard, respectively. Chemical shifts are given in parts per million (ppm). Mass spectra are recorded using electron spray ionization (ESI) and atomospheric pressure photoionization (APPI) and a sector field mass analyzer for HRMS measurements. Analytical TLC is carried out on Merck silica gel plates using short wave (254 nm) UV light to visualize components. Silica gel (Kieselgel 60, 40–63 mm, Merck) is used for flash column chromatography. Infrared spectra were recorded on a JASCO FT/IR-4100 spectrometer using a NaCl crystal (25 mm × 4 mm) purchased at Sigma-Aldrich. The bands were classified according to their intensity as strong (s), middle (m), and weak (w). The purity of the substances was determined using an analytical HPLC (10:90 → 100:0 methanol/water + 0.1% formic acid over 18 min, Eclipse XDB-C8; 5 μm; 4.6 × 150 mm). The purity of all target compounds <b>12a–c</b> and <b>14–47</b> was determined as >95%.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Synthesis and Characterization of Compounds</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Procedure 1: Alkylation of Phenylpiperazine (GP 1)</h4><div class="NLM_p">A suspension of the phenylpiperazine hydrochloride <b>7</b> (4.00 mmol, 915 mg), bromoalkylphthalimide <b>8</b> (8.00 mmol), and potassium carbonate (16.0 mmol, 2.21 g) was refluxed in dry acetone (25 mL) for 20 h. After completion of the reaction, the mixture was cooled to room temperature and filtered, and the solid was washed with acetone (10 mL). The organic solvent was removed under reduced pressure, and the crude product <b>9</b> was purified by flash chromatography.</div><div id="sec4_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> 2-(2-(4-(2-Methoxyphenyl)piperazin-1-yl)ethyl)isoindoline-1,3-dione (<b>9a</b>)</h5><div class="NLM_p last">Compound <b>9a</b> was prepared from 1-(2-methoxyphenyl)piperazine-hydrochloride (<b>7a</b>) (4.00 mmol, 915 mg), <i>N</i>-(2-bromethyl)phthalimide (<b>8a</b>) (8.00 mmol, 2.03 g), and potassium carbonate (16.0 mmol, 2.21 g) in acetone (25 mL) according to GP 1. Purification by column chromatography (hexane/ethyl acetate = 3:1 → 2:1) gave <b>9a</b> (3.11 mmol, 1.13 g, 78%) as a slightly yellow solid. <i>R</i><sub>f</sub>: 0.2 (hexane/ethyl acetate = 3:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 2.69–2.81 (m, 6H), 3.04 (m, 4H), 3.85 (s, 3H), 3.87–3.93 (m, 2H), 6.82–7.01 (m, 4H), 7.67–7.74 (m, 2H), 7.82–7.87 (m, 2H); <sup>13</sup>C NMR (151 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 35.2 (CH<sub>2</sub>), 50.6 (2 × CH<sub>2</sub>), 53.3 (2 × CH<sub>2</sub>), 55.3 (CH<sub>3</sub>), 55.8 (CH<sub>2</sub>), 111.1 (CH), 118.2 (CH), 121.0 (CH), 122.8 (CH), 123.1 (2 × CH), 132.2 (2 × C<sub>q</sub>), 133.8 (2 × CH), 141.3 (C<sub>q</sub>), 152.2 (C<sub>q</sub>), 168.3 (2 × C<sub>q</sub>).</div></div><div id="sec4_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> 2-(3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)isoindoline-1,3-dione (<b>9b</b>)</h5><div class="NLM_p last">Compound <b>9b</b> was prepared from 1-(2-methoxyphenyl)piperazine-hydrochloride (<b>7a</b>) (4.00 mmol, 915 mg), <i>N</i>-(2-brompropyl)phthalimide (<b>8b</b>) (8.00 mmol, 2.14 g), and potassium carbonate (16.0 mmol, 2.21 g) in acetone (25 mL) according to GP 1. Purification by column chromatography (hexane/ethyl acetate = 3:1) gave <b>9b</b> (3.40 mmol, 1.29 g, 85%) as a slightly yellow solid. <i>R</i><sub>f</sub>: 0.2 (hexane/ethyl acetate = 3:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.91 (p, <i>J</i> = 6.9 Hz, 2H), 2.49 (t, <i>J</i> = 6.9 Hz, 2H), 2.50–2.68 (m, 4H), 2.18–2.79 (m, 4H), 3.79 (t, <i>J</i> = 6.9 Hz, 2H), 3.82 (s, 3H), 6.82 (ddd, <i>J</i> = 1.5 Hz, <i>J</i> = 8.0 Hz, <i>J</i> = 9.5 Hz, 2H), 6.88 (td, <i>J</i> = 1.5 Hz, <i>J</i> = 7.6 Hz, 1H), 6.96 (td, <i>J</i> = 1.5 Hz, <i>J</i> = 7.6 Hz, 1H), 7.67–7.71 (m, 2H), 7.82–7.85 (m, 2H); <sup>13</sup>C NMR (151 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 25.2 (CH<sub>2</sub>), 36.7 (CH<sub>2</sub>), 50.4 (CH<sub>2</sub>), 53.3 (2 × CH<sub>2</sub>), 55.3 (CH<sub>3</sub>), 56.1 (2 × CH<sub>2</sub>), 111.1 (CH), 118.1 (CH), 120.9 (CH), 122.8 (CH), 123.1 (2 × CH), 132.3 (2 × C<sub>q</sub>), 133.8 (2 × CH), 141.3 (C<sub>q</sub>), 152.2 (C<sub>q</sub>), 168.5 (2 × C<sub>q</sub>).</div></div><div id="sec4_2_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> 2-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)isoindoline-1,3-dione (<b>9c</b>)</h5><div class="NLM_p last">Compound <b>9c</b> was prepared from 1-(2-methoxyphenyl)piperazine-hydrochloride (<b>7a</b>) (4.00 mmol, 915 mg), <i>N</i>-(2-bromobutyl)phthalimide (<b>8c</b>) (8.00 mmol, 2.26 g), and potassium carbonate (16.0 mmol, 2.21 g) in acetone (25 mL) according to GP 1. Purification by column chromatography (hexane/ethyl acetate = 3:1) gave <b>9c</b> (2.57 mmol, 1.01 g, 64%) as a slightly yellow solid. <i>R</i><sub>f</sub>: 0.2 (hexane/ethyl acetate = 1:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.60 (br s, 2H), 1.74 (td, <i>J</i> = 7.2 Hz, <i>J</i> = 14.9 Hz, 2H), 2.31–3.36 (m, 10H), 3.73 (t, <i>J</i> = 7.2 Hz, 2H), 3.86 (s, 3H), 6.85 (dd, <i>J</i> = 1.2 Hz, <i>J</i> = 8.3 Hz, 1H), 6.90–6.95 (m, 2H), 6.98–7.01 (m, 1H), 7.70–7.73 (m, 2H), 7.83–7.86 (m, 2H); <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ (ppm) 24.2 (CH<sub>2</sub>), 26.7 (CH<sub>2</sub>), 37.9 (CH<sub>2</sub>), 50.6 (2 × CH<sub>2</sub>), 53.5 (2 × CH<sub>2</sub>), 55.4 (CH<sub>3</sub>), 58.1 (CH<sub>2</sub>), 111.2 (CH), 118.2 (CH), 121.0 (CH), 122.9 (CH), 123.2 (2 × CH), 132.2 (2 × C<sub>q</sub>), 133.9 (2 × CH), 141.4 (C<sub>q</sub>), 152.3 (C<sub>q</sub>), 168.4 (2 × C<sub>q</sub>).</div></div><div id="sec4_2_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> 2-(3-(4-(4-Chlorophenyl)piperazin-1-yl)propyl)isoindoline-1,3-dione (<b>9d</b>)</h5><div class="NLM_p last">Compound <b>9d</b> was prepared from 1-(4-chlorophenyl)piperazine-hydrochloride (<b>7a</b>) (5.00 mmol, 1.35 g), <i>N</i>-(2-brompropyl)phthalimide (<b>8b</b>) (10.0 mmol, 2.68 g), and potassium carbonate (20.0 mmol, 2.76 g) in acetone (60 mL) according to GP 1. Purification by column chromatography (methylene chloride/methanol = 50:1) gave <b>9d</b> (2.85 mmol, 1.09 g, 57%) as a white solid. <i>R</i><sub>f</sub>: 0.4 (methylene chloride/methanol = 50:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.84 (dp, <i>J</i> = 7.1 Hz, <i>J</i> = 13.8 Hz, 2H), 2.32–2.51 (m, 6H), 2.90 (dd, <i>J</i> = 7.5 Hz, <i>J</i> = 12.6 Hz, 4H), 3.70 (t, <i>J</i> = 6.9 Hz, 2H), 6.62–6.70 (m, 2H), 7.03–7.12 (m, 2H), 7.55–7.62 (m, 2H), 7.69–7.77 (m, 2H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 25.3 (CH<sub>2</sub>), 36.7 (CH<sub>2</sub>), 49.1 (2 × CH<sub>2</sub>), 53.1 (2 × CH<sub>2</sub>), 56.1 (CH<sub>2</sub>), 117.3 (2 × CH), 123.3 (2 × CH), 124.6 (C<sub>q</sub>), 129.0 (2 × CH), 132.4 (2 × C<sub>q</sub>), 134.0 (2 × CH), 149.9 (C<sub>q</sub>), 168.6 (2 × C<sub>q</sub>). The analytical data obtained is in agreement with those reported in literature.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div></div><div id="sec4_2_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> 2-(3-(4-(4-Bromophenyl)piperazin-1-yl)propyl)isoindoline-1,3-dione (<b>9e</b>)</h5><div class="NLM_p last">Compound <b>9e</b> was prepared from 1-(4-bromophenyl)piperazine-hydrochloride (<b>7c</b>) (1.25 mmol, 302 mg), <i>N</i>-(2-bromopropyl)phthalimide (<b>8b</b>) (2.50 mmol, 670 mg), and potassium carbonate (5.00 mmol, 691 mg) in acetone (3.1 mL) according to GP 1. Purification by column chromatography (methylene chloride/methanol = 50:1) gave <b>9e</b> (1.01 mmol, 434 mg, 81%) as a slightly yellow solid. <i>R</i><sub>f</sub>: 0.3 (chloroform/methanol = 50:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.91 (dp, <i>J</i> = 6.9 Hz, <i>J</i> = 13.7 Hz, 2H), 2.40–2.61 (m, 6H), 2.99 (dd, <i>J</i> = 7.5 Hz, <i>J</i> = 12.4 Hz, 4H), 3.75–3.84 (m, 2H), 6.64–6.74 (m, 2H), 7.24–7.33 (m, 2H), 7.62–7.74 (m, 2H), 7.78–7.88 (m, 2H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 25.2 (CH<sub>2</sub>), 36.6 (CH<sub>2</sub>), 48.8 (2 × CH<sub>2</sub>), 52.9 (2 × CH<sub>2</sub>), 56.0 (CH<sub>2</sub>), 111.6 (C<sub>q</sub>), 117.5 (2 × CH), 123.1 (2 × CH), 131.8 (2 × CH), 132.3 (2 × C<sub>q</sub>), 133.9 (2 × CH), 150.3 (C<sub>q</sub>), 168.5 (2 × C<sub>q</sub>).</div></div><div id="sec4_2_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> 2-(3-(4-(Pyrimidin-2-yl)piperazin-1-yl)propyl)isoindoline-1,3-dione (<b>9f</b>)</h5><div class="NLM_p last">Compound <b>9f</b> was prepared from 2-(piperazine-1-yl)pyrimidine-hydrochloride (<b>7d</b>) (1.42 mmol, 432 μL), <i>N</i>-(2-bromopropyl)phthalimide (<b>8b</b>) (2.84 mmol, 761 mg), and potassium carbonate (5.68 mmol, 785 mg) in acetone (9 mL) according to GP 1. Purification by column chromatography (ethyl acetate + 3% NH<sub>3</sub>) gave <b>9f</b> (1.42 mmol, 499 mg, 100%) as a slightly yellow solid. <i>R</i><sub>f</sub>: 0.54 (ethyl acetate + 3% NH<sub>3</sub>) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.85–1.95 (m, 2H), 2.32–2.53 (m, 6H), 3.66 (br s, 4H), 3.79 (t, <i>J</i> = 6.9 Hz, 2H), 6.45 (t, <i>J</i> = 4.7 Hz, 1H), 7.67–7.72 (m, 2H), 7.81–7.86 (m, 2H), 8.26 (d, <i>J</i> = 4.7 Hz, 2H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 25.3 (CH<sub>2</sub>), 36.8 (CH<sub>2</sub>), 43.5 (CH<sub>2</sub>), 53.1 (2 × CH<sub>2</sub>), 56.3 (2 × CH<sub>2</sub>), 109.9 (CH), 123.3 (2 × CH), 132.4 (2 × C<sub>q</sub>), 134.0 (2 × CH), 157.8 (2 × CH), 161.6 (C<sub>q</sub>), 168.6 (2 × C<sub>q</sub>).</div></div><div id="sec4_2_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 2-(2-(4-(4-Bromophenyl)piperazin-1-yl)ethyl)isoindoline-1,3-dione (<b>9g</b>)</h5><div class="NLM_p last">Compound <b>9g</b> was prepared from 1-(4-bromophenyl)piperazine-hydrochloride (<b>7c</b>) (1.24 mmol, 300 mg), <i>N</i>-(2-bromoethyl)phthalimide (<b>8a</b>) (2.49 mmol, 670 mg), and potassium carbonate (4.98 mmol, 688 mg) in acetone (3.1 mL) according to GP 1. Purification by column chromatography (methylene chloride/methanol = 50:1) gave <b>9g</b> (0.501 mmol, 208 mg, 40%) as a white solid. <i>R</i><sub>f</sub>: 0.2 (methylene chloride/methanol = 50:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 2.64–2.72 (m, 6H), 3.06–3.12 (m, 4H), 3.86 (t, <i>J</i> = 6.5 Hz, 2H), 6.72–6.78 (m, 2H), 7.28–7.33 (m, 2H), 7.69–7.74 (m, 2H), 7.82–7.86 (m, 2H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 35.3 (CH<sub>2</sub>), 48.9 (2 × CH), 52.9 (2 × CH<sub>2</sub>), 55.7 (CH<sub>2</sub>), 111.7 (C<sub>q</sub>), 117.6 (2 × CH), 123.3 (2 × CH), 131.9 (2 × CH), 132.3 (2 × C<sub>q</sub>), 134.0 (2 × CH), 150.4 (C<sub>q</sub>), 168.5 (2 × C<sub>q</sub>).</div></div><div id="sec4_2_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 2-(3-(4-(4-Iodophenyl)piperazin-1-yl)propyl)isoindoline-1,3-dione (<b>9h</b>)</h5><div class="NLM_p last">A suspension of 1-(4-iodophenyl)piperazine-hydrochloride (<b>7e</b>) (0.826 mmol, 268 mg) and potassium carbonate (1.65 mmol, 228 mg) in DMF (5 mL) was heated at 80 °C for 10 min. <i>N</i>-(2-Bromopropyl)phthalimide (<b>8b</b>) (0.909 mmol, 244 mg) was added to the mixture, and the reaction was stirred at the same temperature for 6 h. After cooling to room temperature, the solvent was evaporated, and the residue was partitioned between water (50 mL) and ethyl acetate (50 mL). The aqueous phase was further extracted with ethyl acetate (3 × 30 mL). The combined organic layers were dried over sodium sulfate and evaporated to dryness. The product <b>9h</b> (0.735 mmol, 339 mg, 48%) was obtained as a white solid by crystallization from ethyl acetate.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a><i>R</i><sub>f</sub>: 0.5 (methylene chloride/methanol = 50:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.90 (p, <i>J</i> = 6.8 Hz, 2H), 2.48 (t, <i>J</i> = 6.9 Hz, 2H), 2.50–2.55 (m, 4H), 2.97–3.04 (m, 4H), 3.79 (t, <i>J</i> = 6.9 Hz, 2H), 6.58–6.64 (m, 2H), 7.44–7.50 (m, 2H), 7.69 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 5.5 Hz, 2H), 7.83 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 5.5 Hz, 2H); <sup>13</sup>C NMR (151 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 25.2 (CH<sub>2</sub>), 36.7 (CH<sub>2</sub>), 48.6 (2 × CH<sub>2</sub>), 52.9 (2 × CH<sub>2</sub>), 56.1 (CH<sub>2</sub>), 81.4 (C<sub>q</sub>), 118.1 (2 × CH), 123.2 (2 × CH), 132.4 (2 × C<sub>q</sub>), 134.0 (2 × CH), 137.8 (2 × CH), 150.9 (C<sub>q</sub>), 168.6 (2 × C<sub>q</sub>).</div></div><div id="sec4_2_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 2-(2-(4-(4-Iodophenyl)piperazin-1-yl)ethyl)isoindoline-1,3-dione (<b>9i</b>)</h5><div class="NLM_p last">A suspension of 1-(4-iodophenyl)piperazine-hydrochloride (<b>7e</b>) (1.54 mmol, 500 mg) and potassium carbonate (3.08 mmol, 426 mg) in DMF (10 mL) was heated at 80 °C for 10 min. <i>N</i>-(2-Bromoethyl)phthalimide (<b>8a</b>) (1.69 mmol, 429 mg) was added to the mixture, and the reaction was stirred at the same temperature for 6 h. After cooling to room temperature, the solvent was evaporated, and the residue was partitioned between water (50 mL) and ethyl acetate (50 mL). The aqueous phase was further extracted with ethyl acetate (3 × 30 mL). The combined organic layers were dried over sodium sulfate and evaporated to dryness. The product <b>9i</b> (0.517 mmol, 246 mg, 63%) was obtained as a white solid by crystallization from ethyl acetate. <i>R</i><sub>f</sub>: 0.5 (methylene chloride/methanol = 50:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 2.61–2.76 (m, 6H), 3.04–3.16 (m, 4H), 3.87 (t, <i>J</i> = 6.4 Hz, 2H), 6.62–6.68 (m, 2H), 7.45–7.52 (m, 2H), 7.71 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 5.5 Hz, 2H), 7.84 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 5.5 Hz, 2H); <sup>13</sup>C NMR (151 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 35.2 (CH<sub>2</sub>), 48.7 (CH<sub>2</sub>), 52.9 (2 × CH<sub>2</sub>), 55.7 (2 × CH<sub>2</sub>), 81.4 (C<sub>q</sub>), 118.1 (2 × CH), 123.4 (2 × CH), 132.3 (2 × C<sub>q</sub>), 134.0 (2 × CH), 137.9 (2 × CH), 150.9 (C<sub>q</sub>), 168.5 (2 × C<sub>q</sub>).</div></div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> General Procedure 2: Deprotection of the Alkylamines (GP 2)</h4><div class="NLM_p">A solution of the phthalimide <b>9</b> (3.00 mmol, from GP 1) in ethanol (25 mL) was refluxed with hydrazine hydrate (30.0 mmol) for 1 h. Upon completion of the reaction, hydrochloric acid (5 mL, 2 M) was added, and the solution was let to come to room temperature while stirring. After removing the solvents under reduced pressure, the obtained solid was dissolved with a sodium hydroxide solution (2 M) and was extracted with dichloromethane (6 × 15 mL). The combined organic phases were washed with brine (20 mL) and dried over sodium sulfate. The drying agent was separated by filtration, and the solvents were removed under vacuum. The amine <b>10</b> could be used without further purification.</div><div id="sec4_2_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> 2-(4-(2-Methoxyphenyl)piperazin-1-yl)ethan-1-amine (<b>10a</b>)</h5><div class="NLM_p last">Compound <b>10a</b> was prepared from <b>9a</b> (3.11 mmol, 1.13 g, from GP 1) and hydrazine hydrate (31.1 mmol, 1.60 mL) according to GP 2. <b>10a</b> (2.68 mmol, 631 mg, 86%) is obtained as a pure colorless oil. <i>R</i><sub>f</sub>: 0.2 (hexane/ethyl acetate = 3:1) [UV]; <sup>1</sup>H NMR (600 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ (ppm) 2.37 (t, <i>J</i> = 6.5 Hz,2H), 2.50–2.56 (m, 4H), 2.68 (t, <i>J</i> = 6.5 Hz, 2H), 2.87–3.06 (m, 4H), 3.76 (s, 3H), 6.84–6.88 (m, 2H), 6.90–6.95 (m, 2H); <sup>13</sup>C NMR (151 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ (ppm) 38.2 (CH<sub>2</sub>), 50.1 (2 × CH<sub>2</sub>), 53.1 (2 × CH<sub>2</sub>), 55.3 (CH<sub>3</sub>), 60.1 (CH<sub>2</sub>), 111.9 (CH), 117.9 (CH), 120.83 (CH), 122.3 (CH), 141.3 (C<sub>q</sub>), 152.0 (C<sub>q</sub>). The analytical data obtained are in agreement with those reported in literature.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div></div><div id="sec4_2_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 3-(4-(2-Methoxyphenyl)piperazin-1-yl)propan-1-amine (<b>10b</b>)</h5><div class="NLM_p last">Compound <b>10c</b> was prepared from <b>9b</b> (3.40 mmol, 1.29 g, from GP 1) and hydrazine hydrate (34.0 mmol, 1.80 mL) according to GP 2. <b>10b</b> (3.00 mmol, 750 mg, 88%) is obtained as a pure colorless oil. <i>R</i><sub>f</sub>: 0.2 (hexane/ethyl acetate = 3:1) [UV]; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) 1.58 (br s, 2H), 1.64–1.74 (m, 2H), 2.44–2.52 (m, 2H), 2.59–2.74 (m, 4H), 2.79 (t, <i>J</i> = 6.8 Hz, 2H), 3.10 (br s, 4H), 3.86 (s, 3H), 6.86 (dd, <i>J</i> = 1.3 Hz, <i>J</i> = 8.0 Hz, 1H), 6.90–6.96 (m, 2H), 6.97–7.02 (m, 1H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ (ppm) 30.4 (CH<sub>2</sub>), 40.9 (CH<sub>2</sub>), 50.7 (2 × CH<sub>2</sub>), 53.5 (2 × CH<sub>2</sub>), 56.6 (CH<sub>3</sub>), 56.6 (CH<sub>2</sub>), 111.1 (CH), 118.2 (CH), 121.0 (CH), 122.9 (CH), 141.3 (C<sub>q</sub>), 152.2 (C<sub>q</sub>). The analytical data obtained are in agreement with those reported in literature.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div></div><div id="sec4_2_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 4-(4-(2-Methoxyphenyl)piperazin-1-yl)butan-1-amine (<b>10c</b>)</h5><div class="NLM_p last">Compound <b>10c</b> was prepared from <b>9c</b> (2.57 mmol, 1.01 g, from GP 1) and hydrazine hydrate (25.7 mmol, 1.30 mL) according to GP 2. <b>10c</b> (1.68 mmol, 443 mg, 65%) is obtained as a pure colorless oil. <i>R</i><sub>f</sub>: 0.2 (hexane/ethyl acetate = 3:1) [UV]; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ (ppm) 1.46–1.63 (m, 4H), 2.42–2.45 (m, 2H), 2.60–2.76 (m, 6H), 3.06 (br s, 4H), 3.85 (s, 3H), 6.87–7.03 (m, 4H); <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ (ppm) 24.3 (CH<sub>2</sub>), 31.4 (CH<sub>2</sub>) 41.9 (CH<sub>2</sub>), 50.6 (2 × CH<sub>2</sub>), 53.4 (2 × CH<sub>2</sub>), 55.3 (CH<sub>3</sub>), 58.5 (CH<sub>2</sub>), 111.1 (CH), 118.2 (CH), 121.0 (CH), 122.9 (CH), 141.3 (C<sub>q</sub>), 152.2 (C<sub>q</sub>). The analytical data obtained are in agreement with those reported in literature.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div></div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Synthesis of Phenylazocarboxylates <b>11a–f</b></h4><div class="NLM_p last"><i>tert</i>-Butyl-2-(4-fluorophenyl)azocarboxylate (<b>11a</b>),<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a><i>tert</i>-butyl-2-phenylazocarboxylate (<b>11b</b>),<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a><i>tert</i>-butyl-2-(4-chlorophenyl)azocarboxylate (<b>11c</b>),<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a><i>tert</i>-butyl-2-(2,4-dichlorophenyl) azocarboxylate (<b>11d</b>),<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> and <i>tert</i>-butyl-2-(4-bromophenyl)azocarboxylate (<b>11e</b>)<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> were prepared as previously reported. <i>tert</i>-Butyl-2-(4-methoxyphenyl)azocarboxylate (<b>11f</b>) was prepared according to the known procedure,<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> but has not yet been reported. <i>tert</i>-Butyl-2-(4-methoxyphenyl)azocarboxylate (<b>11f</b>).<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a><sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.91–7.95 (m, 2H), 6.97–7.01 (m, 2H), 3.90 (s, 3H), 1.66 (s, 9H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 164.3 (C<sub>q</sub>), 161.3 (C<sub>q</sub>), 146.1 (C<sub>q</sub>), 126.3 (2 × CH), 114.5 (2 × CH), 84.5 (C<sub>q</sub>), 55.7 (CH<sub>3</sub>), 28.0 (3 × CH<sub>3</sub>); HRMS (EI): calcd for C<sub>12</sub>H<sub>16</sub>N<sub>2</sub>O<sub>3</sub> [M]<sup>+</sup>, 236.1161; found, 236.1163.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> General Procedure 3: Synthesis of Phenylazocarboxamides <b>12</b> (GP 3)</h4><div class="NLM_p">The phenylazocarboxylate <b>11</b> (2.20 mmol), the amine <b>10</b> (2.00 mmol, from GP 2), and potassium carbonate (8.00 mmol) were dissolved in dry ethanol (4.5 mL) in a flame-dried Schlenk flask under an argon atmosphere. The mixture was stirred at 40 °C, and the reaction course was monitored by TLC. Once the reaction was completed, water (5 mL) was added, and the product was extracted with ethyl acetate (3 × 15 mL). The combined organic phases were washed with brine (2 × 10 mL) and dried over sodium sulfate. The drying agent was separated by filtration, and the solvents were removed under vacuum. The crude product <b>12</b> was purified by flash chromatography or recrystallized from hot ethyl acetate.</div><div id="sec4_2_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 2-(4-Fluorophenyl)-<i>N</i>-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)diazene-1-carboxamide (<b>12a</b>)</h5><div class="NLM_p last">Compound <b>12a</b> was prepared from 4-fluorophenylazocarboxylate <b>11a</b> (2.93 mmol, 657 mg) and <b>10a</b> (2.68 mmol, 636 mg, from GP 2) according to GP 3. Recrystallization from hot ethyl acetate 100% gave <b>12a</b> (2.56 mmol, 985 mg, 96%) as an orange solid. <i>R</i><sub>f</sub>: 0.3 (ethyl acetate = 100%) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 2.63–2.89 (m, 6H), 3.02–3.30 (m, 4H), 3.61–3.70 (m, 2H), 3.87 (s, 3H), 6.84–7.04 (m, 4H), 7.21 (dd, <i>J</i><sub>HF</sub> = 8.1 Hz, <i>J</i><sub>HF</sub> = 9.0 Hz, 2H), 8.01 (dd, <i>J</i><sub>HF</sub> = 5.2 Hz, <i>J</i><sub>HF</sub> = 9.0 Hz, 2H); <sup>13</sup>C NMR (91 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 37.1 (CH<sub>2</sub>), 50.5 (2 × CH<sub>2</sub>), 53.2 (2 × CH<sub>2</sub>), 55.4 (CH<sub>3</sub>), 56.5 (CH<sub>2</sub>), 111.3 (CH), 116.5 (d, <i>J</i><sub>CF</sub> = 23.1 Hz, 2 × CH), 118.2 (CH), 121.0 (CH), 123.1 (CH), 126.4 (d, <i>J</i><sub>CF</sub> = 9.5 Hz, 2 × CH), 141.0 (C<sub>q</sub>), 147.8 (d, <i>J</i><sub>CF</sub> = 3.1 Hz, C<sub>q</sub>), 152.3 (C<sub>q</sub>), 160.5 (C<sub>q</sub>), 166.0 (<i>J</i><sub>CF</sub> = 256.1 Hz, C<sub>q</sub>); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 15.5 min, purity: 96%.</div></div><div id="sec4_2_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 2-(4-Fluorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12b</b>)</h5><div class="NLM_p last">Compound <b>12b</b> was prepared from 4-fluorophenylazocarboxylate <b>11a</b> (3.30 mmol, 740 mg) and <b>10b</b> (3.00 mmol, 750 mg, from GP 2) according to GP 3. Recrystallization from hot ethyl acetate 100% gave <b>12b</b> (1.93 mmol, 774 mg, 65%) as an orange solid. <i>R</i><sub>f</sub>: 0.3 (ethyl acetate = 100%) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.80–1.92 (m, 2H), 2.59–2.89 (m, 6H), 3.09 (br s, 4H), 3.66 (dd, <i>J</i> = 5.4 Hz, <i>J</i> = 11.4 Hz, 2H), 3.86 (s, 3H), 6.78 (dd, <i>J</i> = 1.4 Hz, <i>J</i> = 7.8 Hz, 1H), 6.84–6.94 (m, 2H), 7.03 (tt, <i>J</i> = 3.4 Hz, <i>J</i> = 6.7 Hz, 1H), 7.08–7.17 (m, 2H), 7.93–8.02 (m, 2H), 8.73 (br s, 1NH); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 24.4 (CH<sub>2</sub>), 41.6 (2 × CH<sub>2</sub>), 50.9 (CH<sub>2</sub>), 53.4 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 58.1 (CH<sub>2</sub>), 111.3 (CH), 116.5 (d, <i>J</i><sub>CF</sub> = 23.1 Hz, 2 × CH), 118.1 (CH), 121.0 (CH), 123.3 (CH), 126.3 (d, <i>J</i><sub>CF</sub> = 9.5 Hz, 2 × CH), 141.1 (C<sub>q</sub>), 147.9 (d, <i>J</i><sub>CF</sub> = 3.0 Hz, C<sub>q</sub>), 152.3 (C<sub>q</sub>), 160.9 (C<sub>q</sub>), 165.9 (d, <i>J</i><sub>CF</sub> = 255.7 Hz, C<sub>q</sub>); HRMS (ESI): calcd for C<sub>21</sub>H<sub>27</sub>FN<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 400.2143; found, 400.2149; HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 15.3 min, purity: 99%.</div></div><div id="sec4_2_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 2-(4-Fluorophenyl)-<i>N</i>-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)diazene-1-carboxamide (<b>12c</b>)</h5><div class="NLM_p last">Compound <b>12c</b> was prepared from 4-fluorophenylazocarboxylate <b>11a</b> (1.85 mmol, 415 mg) and <b>10c</b> (1.68 mmol, 443 mg, aus from GP 2) according to GP 3. Recrystallization from hot ethyl acetate 100% gave <b>12c</b> (1.62 mmol, 669 mg, 87%) as an orange solid. <i>R</i><sub>f</sub>: 0.2 (chloroform/methanol = 20:1) [UV]; <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>): δ (ppm) 1.73–1.89 (m, 2H), 1.94–2.10 (m, 2H), 3.13–3.23 (m, 2H), 3.29 (br s, 2H), 3.47–3.62 (m, 6H), 3.68 (br s, 2H), 3.88 (s, 3H), 5.34 (br s, 1NH), 6.90–7.00 (m, 2H), 7.07 (dt, <i>J</i> = 3.3 Hz, <i>J</i> = 6.6 Hz, 1H), 7.11–7.17 (m, 1H), 7.18–7.25 (m, 2H), 8.01 (br s, 2H); <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ (ppm) 20.9 (CH<sub>2</sub>), 26.5 (CH<sub>2</sub>), 39.4 (CH<sub>2</sub>), 48.0 (2 × CH<sub>2</sub>), 52.2 (2 × CH<sub>2</sub>), 55.7 (CH<sub>3</sub>), 56.9 (CH<sub>2</sub>), 111.9 (2 × CH), 116.7 (d, <i>J</i><sub>CF</sub> = 23.1 Hz, 2 × CH), 119.8 (C<sub>q</sub>), 121.6 (2 × CH), 126.0 (C<sub>q</sub>), 126.7 (d, <i>J</i><sub>CF</sub> = 7.7 Hz, C<sub>q</sub>), 137.3 (C<sub>q</sub>), 152.4 (2 × CH), 166.3 (d, <i>J</i><sub>CF</sub> = 256.6 Hz, C<sub>q</sub>); MS (ESI) <i>m</i>/<i>z</i> (%): 414 [MH<sup>+</sup>]. The analytical data obtained are in agreement with those reported in literature.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div></div><div id="sec4_2_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> <i>N</i>-(3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)-2-phenyldiazene-1-carboxamide (<b>12d</b>)</h5><div class="NLM_p last">Compound <b>12d</b> was prepared from the phenylazocarboxylate <b>11b</b> (1.56 mmol, 321 mg) and <b>10b</b> (1.42 mmol, 355 mg, from GP 2) according to GP 3. Purification by column chromatography (chloroform/methanol = 20:1) gave <b>12d</b> (1.21 mmol, 460 mg, 85%) as a brown oil. <i>R</i><sub>f</sub>: 0.5 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.79–1.89 (m, 2H), 2.59–2.77 (m, 6H), 3.06 (s, 4H), 3.59–3.67 (m, 2H), 3.83 (d, <i>J</i> = 3.4 Hz, 3H), 6.76 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 7.7 Hz, 1H), 6.81–6.88 (m, 2H), 6.95–7.03 (m, 1H), 7.39–7.46 (m, 2H), 7.48–7.55 (m, 1H), 7.88–7.95 (m, 2H), 8.65 (br s, 1NH); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 24.5 (CH<sub>2</sub>), 41.6 (CH<sub>2</sub>), 50.8 (2 × CH<sub>2</sub>), 53.5 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 58.1 (CH<sub>2</sub>), 111.3 (CH), 118.3 (CH), 121.0 (CH), 123.2 (CH), 124.0 (2 × CH), 129.4 (2 × CH), 133.4 (CH), 141.2 (C<sub>q</sub>), 151.3 (C<sub>q</sub>), 152.4 (C<sub>q</sub>), 161.2 (C<sub>q</sub>).</div></div><div id="sec4_2_4_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 2-(4-Chlorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12e</b>)</h5><div class="NLM_p last">Compound <b>12e</b> was prepared from 4-chlorophenylazocarboxylate <b>11c</b> (0.662 mmol, 149 mg) and <b>10b</b> (0.602 mmol, 150 mg, from GP 2) according to GP 3. Purification by column chromatography (chloroform/methanol = 10:1) gave <b>12e</b> (0.469 mmol, 196 mg, 78%) as a red oil. <i>R</i><sub>f</sub>: 0.8 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) 1.83–1.89 (m, 2H), 2.59–2.85 (m, 6H), 3.06 (br s, 4H), 3.63–3.68 (m, 2H), 3.86 (s, 3H), 6.75 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 7.8 Hz, 1H), 6.85–6.92 (m, 2H), 7.03 (td, <i>J</i> = 1.6 Hz, <i>J</i> = 7.8 Hz, 1H), 7.39–7.42 (m, 2H), 7.85–7.89 (m, 2H), 8.78 (br s, 1NH); <sup>13</sup>C NMR (151 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 24.4 (2 × CH<sub>2</sub>), 41.7 (CH<sub>2</sub>), 50.9 (CH<sub>2</sub>), 53.4 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 58.1 (CH<sub>2</sub>), 111.4 (CH), 118.09 (CH), 121.0 (CH), 123.3 (CH), 125.2 (2 × CH), 129.8 (2 × CH), 139.6 (C<sub>q</sub>), 141.1 (C<sub>q</sub>), 149.7 (C<sub>q</sub>), 152.4 (C<sub>q</sub>), 161.0 (C<sub>q</sub>).</div></div><div id="sec4_2_4_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 2-(2,4-Dichlorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12f</b>)</h5><div class="NLM_p last">Compound <b>12f</b> was prepared from 2,4-dichlorophenylazocarboxylate <b>11d</b> (1.32 mmol, 342 mg) and <b>10b</b> (1.20 mmol, 300 mg, from GP 2) according to GP 3. Purification by column chromatography (chloroform/methanol = 10:1) gave <b>12f</b> (0.910 mmol, 409 mg, 76%) as an orange brown oil. <i>R</i><sub>f</sub>: 0.8 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) 1.84–1.93 (m, 2H), 2.61–2.80 (m, 6H), 3.02 (br s, 4H), 3.65 (dd, <i>J</i> = 5.6 Hz, <i>J</i> = 11.7 Hz, 2H), 3.86 (s, 3H), 6.68 (dd, <i>J</i> = 1.4 Hz, <i>J</i> = 8.1 Hz, 1H), 6.83–6.89 (m, 2H), 6.98–7.04 (m, 1H), 7.24–7.27 (m, 1H), 7.59 (dd, <i>J</i> = 3.2 Hz, <i>J</i> = 5.4 Hz, 2H), 8.41 (br s, 1NH); <sup>13</sup>C NMR (151 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 24.6 (2 × CH<sub>2</sub>), 41.2 (CH<sub>2</sub>), 50.8 (CH<sub>2</sub>), 53.4 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 57.7 (CH<sub>2</sub>), 111.3 (CH), 118.1 (CH), 118.6 (CH), 121.0 (CH), 123.3 (CH), 128.1 (CH), 131.0 (CH), 137.9 (C<sub>q</sub>), 140.0 (C<sub>q</sub>), 141.1 (C<sub>q</sub>), 146.2 (C<sub>q</sub>), 152.4 (C<sub>q</sub>), 161.1 (C<sub>q</sub>).</div></div><div id="sec4_2_4_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 2-(4-Bromophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12g</b>)</h5><div class="NLM_p last">Compound <b>12g</b> was prepared from 4-bromophenylazocarboxylate <b>11e</b> (0.660 mmol, 178 mg) and <b>10b</b> (0.60 mmol, 150 mg, from GP 2) according to GP 3. Purification by column chromatography (chloroform/methanol = 10:1) gave <b>12g</b> (0.505 mmol, 232 mg, 84%) as a slightly orange solid. <i>R</i><sub>f</sub>: 0.7 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) 1.83–1.90 (m, 2H), 2.62–2.82 (m, 6H), 3.06 (s, 4H), 3.62–3.68 (m, 2H), 3.86 (s, 3H), 6.74 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 7.8 Hz, 1H), 6.84–6.92 (m, 2H), 7.04 (td, <i>J</i> = 1.5 Hz, <i>J</i> = 7.8 Hz, 1H), 7.55–7.60 (m, 2H), 7.76–7.82 (m, 2H), 8.78 (br s, 1NH); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 24.4 (2 × CH<sub>2</sub>), 41.7 (CH<sub>2</sub>), 50.8 (CH<sub>2</sub>), 53.4 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 58.1 (CH<sub>2</sub>), 111.4 (CH), 118.1 (CH), 121.0 (CH), 123.4 (CH), 125.3 (2 × CH), 128.3 (C<sub>q</sub>), 132.8 (2 × CH), 141.0 (C<sub>q</sub>), 150.1 (C<sub>q</sub>), 152.3 (C<sub>q</sub>), 161.0 (C<sub>q</sub>).</div></div><div id="sec4_2_4_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 2-(4-Methoxyphenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12h</b>)</h5><div class="NLM_p last">Compound <b>12h</b> was prepared from 4-methoxyphenylazocarboxylate <b>11f</b> (1.69 mmol, 400 mg) and <b>10b</b> (1.53 mmol, 382 mg, from GP 2) according to GP 3. Purification by column chromatography (ethyl acetate 100%) gave <b>12h</b> (1.29 mmol, 532 mg, 84%) as an orange solid. <i>R</i><sub>f</sub>: 0.4 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.81–1.89 (m, 2H), 2.66 (dd, <i>J</i> = 10.1 Hz, 16.0 Hz, 6H), 3.09 (s, 4H), 3.63 (dd, <i>J</i> = 5.5 Hz, 11.6 Hz, 2H), 3.86 (s, 3H), 3.88 (s, 3H), 6.81 (dd, <i>J</i> = 1.6 Hz, 7.8 Hz, 1H), 6.87 (ddd, <i>J</i> = 1.4 Hz, <i>J</i> = 5.2 Hz, <i>J</i> = 8.0 Hz, 2H), 6.89–6.95 (m, 2H), 6.98–7.05 (m, 1H), 7.91–7.97 (m, 2H), 8.51 (br s, 1NH); <sup>13</sup>C NMR (151 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 24.8 (2 × CH<sub>2</sub>), 41.4 (CH<sub>2</sub>), 50.8 (CH<sub>2</sub>), 53.5 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 55.8 (CH<sub>3</sub>), 58.1 (CH<sub>2</sub>), 111.4 (CH), 114.6 (2 × CH), 118.3 (CH), 121.0 (CH), 123.2 (CH), 126.4 (2 × CH), 141.3 (C<sub>q</sub>), 145.7 (C<sub>q</sub>), 152.4 (C<sub>q</sub>), 161.5 (C<sub>q</sub>), 164.1 (C<sub>q</sub>).</div></div><div id="sec4_2_4_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> <i>N</i>-(3-(4-(4-Chlorophenyl)-1l4-piperazin-1-yl)propyl)-2-phenyldiazene-1-carboxamide (<b>12i</b>)</h5><div class="NLM_p last">Compound <b>12i</b> was prepared from the phenylazocarboxylate <b>11b</b> (0.360 mmol, 74.9 mg) and <b>10d</b> (0.330 mmol, 83.6 mg, from GP 2) according to GP 3. Purification by column chromatography (chloroform/methanol = 30:1) gave <b>12i</b> (0.302 mmol, 117 mg, 84%) as a red solid. <i>R</i><sub>f</sub>: 0.3 (chloroform/methanol = 30:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.77–1.92 (m, 2H), 2.63 (dd, <i>J</i> = 4.9 Hz, <i>J</i> = 10.4 Hz, 6H), 3.06–3.19 (m, 4H), 3.62 (dd, <i>J</i> = 5.6 Hz, <i>J</i> = 11.5 Hz, 2H), 6.70–6.83 (m, 2H), 7.14–7.23 (m, 2H), 7.31–7.43 (m, 2H), 7.45–7.56 (m, 1H), 7.80–7.88 (m, 2H), 8.40 (br s, 1NH); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 24.7 (CH<sub>2</sub>), 41.1 (CH<sub>2</sub>), 49.1 (2 × CH<sub>2</sub>), 52.9 (2 × CH<sub>2</sub>), 57.6 (CH<sub>2</sub>), 117.3 (2 × CH), 123.7 (2 × CH), 124.6 (C<sub>q</sub>), 128.9 (2 × CH), 129.2 (2 × CH), 133.4 (CH), 149.8 (C<sub>q</sub>), 151.0 (C<sub>q</sub>), 160.9 (C<sub>q</sub>).</div></div><div id="sec4_2_4_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> <i>N</i>-(3-(4-(4-Bromophenyl)piperazin-1-yl)propyl)-2-phenyldiazene-1-carboxamide (<b>12j</b>)</h5><div class="NLM_p last">Compound <b>12j</b> was prepared from the phenylazocarboxylate <b>11b</b> (0.857 mmol, 177 mg) and <b>10e</b> (0.779 mmol, 232 mg, from GP 2) according to GP 3. Purification by column chromatography (methylene chloride/methanol = 20:1) gave <b>12j</b> (0.599 mmol, 258 mg, 77%) as an orange solid. <i>R</i><sub>f</sub>: 0.3 (methylene chloride/methanol = 20:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.80–1.91 (m, 2H), 2.58–2.66 (m, 6H), 3.10–3.18 (m, 4H), 3.63 (dd, <i>J</i> = 5.6 Hz, <i>J</i> = 11.7 Hz, 2H), 6.69–6.75 (m, 2H), 7.29–7.40 (m, 4H), 7.47–7.55 (m, 1H), 7.80–7.87 (m, 2H), 8.38 (br s, 1NH); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 24.8 (CH<sub>2</sub>), 41.2 (CH<sub>2</sub>), 49.1 (2 × CH<sub>2</sub>), 53.0 (2 × CH<sub>2</sub>), 57.7 (CH<sub>2</sub>), 112.0 (C<sub>q</sub>), 117.7 (2 × CH), 123.8 (2 × CH), 129.3 (2 × CH), 131.9 (2 × CH), 133.5 (CH), 150.3 (Cq), 151.1 (C<sub>q</sub>), 160.9 (C<sub>q</sub>).</div></div><div id="sec4_2_4_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 2-Phenyl-<i>N</i>-(3-(4-(pyrimidin-2-yl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12k</b>)</h5><div class="NLM_p last">Compound <b>12k</b> was prepared from the phenylazocarboxylate <b>11b</b> (1.88 mmol, 388 mg) and <b>10f</b> (1.71 mmol, 378 mg, from GP 2) according to GP 3. Purification by column chromatography (chloroform/methanol = 15:1 + 3% NH<sub>3</sub>) gave <b>12k</b> (1.70 mmol, 601 mg, 99%) as an orange oil. <i>R</i><sub>f</sub>: 0.5 (chloroform/methanol = 15:1 + 3% NH<sub>3</sub>) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.77–1.88 (m, 2H), 2.52 (dt, <i>J</i> = 5.6 Hz, <i>J</i> = 10.1 Hz, 6H), 3.58 (dd, <i>J</i> = 5.8, <i>J</i> = 11.9 Hz, 2H), 3.73–3.84 (m, 4H), 6.43–6.47 (m, 1H), 7.34–7.42 (m, 2H), 7.42–7.49 (m, 1H), 7.81–7.86 (m, 2H), 8.18 (t, <i>J</i> = 8.8 Hz, 1NH), 8.23–8.27 (m, 2H); <sup>13</sup>C NMR (151 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 24.9 (CH<sub>2</sub>), 40.9 (CH<sub>2</sub>), 43.7 (2 × CH<sub>2</sub>), 53.0 (2 × CH<sub>2</sub>), 57.5 (CH<sub>2</sub>), 110.0 (CH), 123.7 (2 × CH), 129.2 (2 × CH), 133.3 (CH), 151.1 (C<sub>q</sub>), 157.6 (2 × CH), 161.0 (C<sub>q</sub>), 161.6 (C<sub>q</sub>).</div></div><div id="sec4_2_4_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> <i>N</i>-(2-(4-(4-Bromophenyl)piperazin-1-yl)ethyl)-2-phenyldiazene-1-carboxamide (<b>12l</b>)</h5><div class="NLM_p last">Compound <b>12l</b> was prepared from the phenylazocarboxylate <b>11b</b> (1.78 mmol, 367 mg, 5 equiv) and <b>10g</b> (0.356 mmol, 101 mg, from GP 2) according to GP 3. In contrast to GP 3, 5 equivalents of <b>11b</b> were needed to get comparable yields. Purification by column chromatography (methylene chloride/methanol = 20:1) gave <b>12l</b> (0.301 mmol, 139 mg, 85%) as an orange solid. <i>R</i><sub>f</sub>: 0.3 (methylene chloride/methanol = 20:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 2.66–2.76 (m, 6H), 3.17–3.24 (m, 4H), 3.66 (dd, <i>J</i> = 5.6 Hz, <i>J</i> = 11.6 Hz, 2H), 6.76–6.82 (m, 2H), 7.04 (br s, 1NH), 7.32–7.37 (m, 2H), 7.49–7.61 (m, 3H), 7.93–7.98 (m, 2H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 37.2 (CH<sub>2</sub>), 49.0 (2 × CH<sub>2</sub>), 52.8 (2 × CH<sub>2</sub>), 56.5 (CH<sub>2</sub>), 112.1 (C<sub>q</sub>), 117.8 (2 × CH), 124.1 (2 × CH), 129.4 (2 × CH), 132.0 (2 × CH), 133.7 (CH), 150.2 (C<sub>q</sub>), 151.2 (C<sub>q</sub>), 160.8 (C<sub>q</sub>).</div></div><div id="sec4_2_4_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> <i>N</i>-(3-(4-(4-Iodophenyl)piperazin-1-yl)propyl)-2-phenyldiazene-1-carboxamide (<b>12m</b>)</h5><div class="NLM_p last">Compound <b>12m</b> was prepared from the phenylazocarboxylate <b>11b</b> (2.16 mmol, 446 mg, 5 equiv) and <b>10h</b> (0.432 mmol, 149 mg, from GP 2) according to GP 3. In contrast to GP 3, 5 equivalents of <b>11b</b> were necessary. Also, ethyl acetate (3 mL) was needed here instead of ethanol because of low solubility of <b>10h</b>. Purification by column chromatography (hexane/ethyl acetate = 1:15 + 3% NH<sub>3</sub>) gave <b>12m</b> (0.105 mmol, 50.3 mg, 24%) as an orange solid. <i>R</i><sub>f</sub>: 0.3 (hexane/ethyl acetate = 1:15 + 3% NH<sub>3</sub>) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.84–1.99 (m, 2H), 2.63–2.77 (m, 6H), 3.14–3.27 (m, 4H), 3.65 (dd, <i>J</i> = 5.6 Hz, <i>J</i> = 11.7 Hz, 2H), 6.60–6.66 (m, 2H), 7.38 (dd, <i>J</i> = 6.1 Hz, <i>J</i> = 13.6 Hz, 2H), 7.48–7.57 (m, 3H), 7.83–7.89 (m, 2H), 8.29 (br s, 1NH); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 24.8 (2 × CH<sub>2</sub>), 41.0 (CH<sub>2</sub>), 48.8 (CH<sub>2</sub>), 52.9 (2 × CH<sub>2</sub>), 57.6 (CH<sub>2</sub>), 118.4 (2 × CH), 123.9 (2 × CH), 129.4 (2 × CH), 133.6 (CH), 138.0 (2 × CH), 151.2 (C<sub>q</sub>), 161.0 (C<sub>q</sub>). Two C<sub>q</sub> signals are missing because of the signal noise ratio.</div></div><div id="sec4_2_4_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> <i>N</i>-(2-(4-(4-Iodophenyl)piperazin-1-yl)ethyl)-2-phenyldiazene-1-carboxamide (<b>12n</b>)</h5><div class="NLM_p last">Compound <b>12n</b> was prepared from the phenylazocarboxylate <b>11b</b> (4.48 mmol, 924 mg, 5 equiv) and <b>10i</b> (0.897 mmol, 297 mg, from GP 2) according to GP 3. In contrast to GP 3, 5 equivalents of <b>11b</b> were necessary. Also, ethyl acetate (4.5 mL) was needed here instead of ethanol because of low solubility of <b>10i</b>. Purification by column chromatography (hexane/ethyl acetate = 1:15 + 3% NH<sub>3</sub>) gave <b>12n</b> (0.359 mmol, 166 mg, 40%) as an orange solid. <i>R</i><sub>f</sub>: 0.5 (hexane/ethyl acetate + 3% NH<sub>3</sub> = 1:15) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 2.67–2.82 (m, 6H), 3.20–3.27 (m, 4H), 3.61–3.73 (m, 2H), 6.66–6.72 (m, 2H), 7.11 (br s, 1NH), 7.49–7.62 (m, 5H), 7.93–7.98 (m, 2H); <sup>13</sup>C NMR (151 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 37.1 (CH<sub>2</sub>), 48.6 (2 × CH<sub>2</sub>), 52.8 (2 × CH<sub>2</sub>), 56.6 (CH<sub>2</sub>), 81.9 (Cq), 118.3 (2 × CH), 124.1 (2 × CH), 129.4 (2 × CH), 133.7 (CH), 138.0 (2 × CH), 150.7 (C<sub>q</sub>), 151.3 (C<sub>q</sub>), 160.9 (C<sub>q</sub>).</div></div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> General Procedure 4: Reductive N-alkylation of Phenylazocarboxamides (GP 4)</h4><div class="NLM_p">To a solution of the phenylcarboxamide <b>12</b> (0.15 mmol, from GP 3) and benzyl (or allyl) bromide <b>13</b> (0.375–0.750 mmol) in tetrahydrofuran (2.0 mL), a saturated aqueous solution of ammonium chloride (0.5 mL) and zinc powder (0.375–1.50 mmol) was added under vigorous stirring. After completion of the reaction, as monitored by TLC, and decoloration of the mixture, water and hydrochloric acid (1.0 mL, 1 M) were added, and the aqueous phase was washed with diethyl ether (3 × 10 mL). Subsequently, a solution of sodium hydroxide (4.0 mL, 1 M) was added to the aqueous phase, which was then extracted with dichloromethane (4 × 10 mL). The combined organic phases were washed with brine (10 mL) and dried over sodium sulfate. The drying agent was separated by filtration, and the solvents were removed under vacuum. The crude product was purified by flash chromatography and additionally by preparative HPLC, when needed.</div><div id="sec4_2_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 2-Benzyl-2-(4-fluorophenyl)-<i>N</i>-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)hydrazine-1-carboxamide (<b>14</b>)</h5><div class="NLM_p last">Compound <b>14</b> was prepared from 2-(4-fluorophenyl)-<i>N</i>-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)azocarboxamide <b>12a</b> (130 μmol, 50.0 mg) and benzyl bromide (<b>13a</b>) (325 μmol, 39.0 μL) according to GP 4. Purification by column chromatography (dichloromethane/ethyl acetate = 1:1) gave <b>14</b> (94.0 μmol, 44.9 mg, 72%) as a colorless oil. <i>R</i><sub>f</sub>: 0.1 (methylene chloride/ethyl acetate = 1:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 2.39–2.85 (m, 6H), 2.87–3.19 (m, 4H), 3.19–3.47 (m, 2H), 3.86 (s, 3H), 4.38–4.75 (m, 2H), 5.99 (br s, 1NH), 6.33 (br s, 1NH), 6.83–7.06 (m, 8H), 7.20–7.35 (m, 5H); <sup>13</sup>C NMR (91 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 36.1 (CH<sub>2</sub>), 50.2 (2 × CH<sub>2</sub>), 53.0 (2 × CH<sub>2</sub>), 55.3 (CH<sub>3</sub>), 56.9 (CH<sub>2</sub>), 59.7 (CH<sub>2</sub>), 111.2 (CH), 115.9 (d, <i>J</i><sub>CF</sub> = 22.5 Hz, 2 × CH), 116.8 (d, <i>J</i><sub>CF</sub> = 7.7 Hz, 2 × CH), 118.2 (CH), 121.0 (CH), 123.1 (CH), 128.0 (CH), 128.6 (2 × CH), 128.7 (2 × CH), 135.2 (C<sub>q</sub>), 140.9 (C<sub>q</sub>), 145.6 (d, <i>J</i><sub>CF</sub> = 2.4 Hz, C<sub>q</sub>), 152.2 (C<sub>q</sub>), 158.0 (d, <i>J</i><sub>CF</sub> = 240.6 Hz, C<sub>q</sub>), 158.0 (C<sub>q</sub>); HRMS (ESI): calcd for C<sub>27</sub>H<sub>33</sub>FN<sub>5</sub>O<sub>2</sub> [M + H<sup>+</sup>], 478.2613; found, 478.2606; HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 18.0 min, purity: 98%.</div></div><div id="sec4_2_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> 2-Benzyl-2-(4-fluorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>15</b>)</h5><div class="NLM_p last">Compound <b>15</b> was prepared from 2-(4-fluorophenyl)-<i>N</i>-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)azocarboxamide (<b>12b</b>) (150 μmol, 60.0 mg) and benzyl bromide (<b>13a</b>) (450 μmol, 53.5 μL) according to GP 4. Purification by column chromatography (dichloromethane/ethyl acetate = 1:1) gave <b>15</b> (126 μmol, 61.7 mg, 84%) as a colorless oil. <i>R</i><sub>f</sub>: 0.3 (chloroform/methanol = 20:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.58–1.76 (m, 2H), 2.33–2.73 (m, 6H), 2.78–3.10 (m, 4H), 3.14–3.42 (m, 2H), 3.87 (s, 3H), 4.39–4.75 (m, 2H), 5.89 (br s, 1NH), 6.41 (br s, 1NH), 6.82 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.4 Hz, 1H), 6.87 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.2 Hz, 1H), 6.91–7.05 (m, 6H), 7.18–7.24 (m, 2H), 7.29–7.35 (3H); <sup>13</sup>C NMR (91 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 25.9 (CH<sub>2</sub>), 39.2 (CH<sub>2</sub>), 50.1 (2 × CH<sub>2</sub>), 53.5 (2 × CH<sub>2</sub>), 55.3 (CH<sub>3</sub>), 57.1 (CH<sub>2</sub>), 58.8 (CH<sub>2</sub>), 111.2 (CH), 115.9 (d, <i>J</i><sub>CF</sub> = 22.5 Hz, 2 × CH), 116.4 (d, <i>J</i><sub>CF</sub> = 8.7 Hz, 2 × CH), 116.5 (CH), 118.2 (CH), 120.9 (CH), 123.0 (CH), 128.1 (2 × CH), 128.8 (2 × CH), 134.7 (C<sub>q</sub>), 140.9 (C<sub>q</sub>), 145.6 (d, <i>J</i><sub>CF</sub> = 2.2 Hz, C<sub>q</sub>), 152.1 (C<sub>q</sub>), 157.9 (d, <i>J</i><sub>CF</sub> = 240.5 Hz, C<sub>q</sub>), 158.1 (C<sub>q</sub>); HRMS (ESI): calcd for C<sub>28</sub>H<sub>35</sub>FN<sub>5</sub>O<sub>2</sub> [M + H<sup>+</sup>], 492.2769; found, 492.2769; HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 18.2 min, purity: 97%.</div></div><div id="sec4_2_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> 2-Benzyl-2-(4-fluorophenyl)-<i>N</i>-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)hydrazine-1-carboxamide (<b>16</b>)</h5><div class="NLM_p last">Compound <b>16</b> was prepared from 2-(4-fluorophenyl)-<i>N</i>-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)azocarboxamide (<b>12c</b>) (121 μmol, 50.0 mg) and benzyl bromide (<b>13a</b>) (303 μmol, 51.5 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 20:1) gave <b>16</b> (118 μmol, 60.0 mg, 97%) as a colorless oil. An analytical sample was purified using preparative HPLC (5:95 → 70:30 acetonitrile/water + 0.1% formic acid over 18 min, flow rate: 10 mL/min, ZORBAX Eclipse XDB-C8) to yield the desired product <b>16</b>. <i>R</i><sub>f</sub>: 0.1 (chloroform/methanol = 20:1) [UV]; <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ (ppm) 1.26–1.37 (m, 2H), 1.43–1.59 (m, 2H), 2.82–3.02 (m, 4H), 3.04–3.19 (m, 4H), 3.47 (t, <i>J</i> = 11.8 Hz, 4H), 3.80 (s, 3H), 4.53 (br s, 2H), 6.54 (br s, 1NH), 6.87–7.13 (m, 8H), 7.23–7.36 (m, 3H), 7.38–7.44 (m, 2H), 8.12 (br s, 1NH); <sup>13</sup>C NMR (91 MHz, DEPTQ, (CD<sub>3</sub>)<sub>2</sub>SO): δ (ppm) 20.4 (CH<sub>2</sub>), 27.0 (CH<sub>2</sub>), 38.1 (CH<sub>2</sub>), 47.1 (2 × CH<sub>2</sub>), 51.2 (2 × CH<sub>2</sub>), 55.2 (CH<sub>2</sub>), 55.4 (CH<sub>3</sub>), 58.1 (CH<sub>2</sub>), 112.0 (CH), 115.2 (d, <i>J</i><sub>CF</sub> = 22.2 Hz, 2 × CH), 118.3 (CH), 120.9 (CH), 123.6 (CH), 127.1 (CH), 128.2 (2 × CH), 128.6 (2 × CH), 137.3 (C<sub>q</sub>), 139.3 (C<sub>q</sub>), 146.8 (d, <i>J</i><sub>CF</sub> = 1.8 Hz, C<sub>q</sub>), 151.8 (C<sub>q</sub>), 156.3 (d, <i>J</i><sub>CF</sub> = 235.3 Hz, C<sub>q</sub>), 158.0 (C<sub>q</sub>). Two CH-signals are missing. HRMS (ESI): calcd for C<sub>29</sub>H<sub>37</sub>FN<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 506.2926; found, 506.2924. HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 15.6 min, purity: 99%.</div></div><div id="sec4_2_5_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> 2-Benzyl-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)-2-phenylhydrazine-1-carboxamide (<b>17</b>)</h5><div class="NLM_p last">Compound <b>17</b> was prepared from <i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)-2-phenyldiazene-1-carboxamide (<b>12d</b>) (217 μmol, 82.6 mg) and benzyl bromide (<b>13a</b>) (1.09 mmol, 129 μL) according to GP 4. Purification by preparative HPLC (5:95 → 95:5 methanol/water + 0.1% formic acid over 18 min, flow rate: 10 mL/min, ZORBAX Eclipse XDB-C8) gave the desired product <b>17</b> (93.3 μmol, 44.2 mg, 43%) as a yellow oil. <i>R</i><sub>f</sub>: 0.3 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.78–1.93 (m, 2H), 2.70–2.88 (m, 2H), 3.07 (br s, 4H), 3.23 (br s, 6H), 3.87 (s, 3H), 4.59 (m, 2H), 6.24 (br s, 1NH), 6.40 (br s, 1NH), 6.83–7.00 (m, 4H), 7.01–7.10 (m, 3H), 7.23–7.39 (m, 7H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) 24.9 (2 × CH<sub>2</sub>), 37.3 (CH<sub>2</sub>), 48.1 (2 × CH<sub>2</sub>), 52.4 (CH<sub>2</sub>), 54.9 (CH<sub>2</sub>), 55.6 (CH<sub>3</sub>), 58.7 (CH<sub>2</sub>), 111.3 (CH), 115.1 (CH), 118.8 (CH), 121.2 (CH), 121.5 (CH), 124.2 (2 × CH), 128.1 (CH), 128.9 (2 × CH), 129.0 (2 × CH), 129.6 (2 × CH), 135.5 (C<sub>q</sub>), 139.5 (C<sub>q</sub>), 149.2 (C<sub>q</sub>), 152.1 (C<sub>q</sub>), 158.8 (C<sub>q</sub>); HRMS (ESI): calcd for C<sub>28</sub>H<sub>36</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 474.2864; found, 474.2864; IR (NaCl) ν (cm<sup>–1</sup>): 2929 (m), 2832 (m), 1670 (s), 1597 (s), 1500 (s), 1454 (s), 1356 (m), 1243 (s), 1027 (m), 751 (s), 695 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 17.0 min, purity: 99%.</div></div><div id="sec4_2_5_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> 2-(4-Fluorobenzyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)-2-phenylhydrazine-1-carboxamide (<b>18</b>)</h5><div class="NLM_p last">Compound <b>18</b> was prepared from <i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)-2-phenyldiazene-1-carboxamide (<b>12d</b>) (197 μmol, 75.0 mg) and 1-(bromomethyl)-4-fluorobenzene (<b>13b</b>) (983 μmol, 123 μL) according to GP 4. Purification by preparative HPLC (5:95 → 95:5 methanol/water + 0.1% formic acid over 18 min, flow rate: 10 mL/min, ZORBAX Eclipse XDB-C8) gave the desired product <b>18</b> (87.5 μmol, 43 mg, 44%) as a yellow oil. <i>R</i><sub>f</sub>: 0.6 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.75–1.93 (m, 2H), 2.79 (br s, 2H), 3.05 (s, 4H), 3.15–3.37 (m, 6H), 3.86 (s, 3H), 4.56 (d, <i>J</i> = 23.2 Hz, 2H), 6.28 (br s, 1NH), 6.48 (br s, 1NH), 6.86–7.08 (m, 9H), 7.22–7.34 (m, 4H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 24.9 (CH<sub>2</sub>), 37.3 (CH<sub>2</sub>), 48.0 (2 × CH), 52.3 (2 × CH<sub>2</sub>), 54.9 (CH<sub>3</sub>), 55.5 (CH<sub>2</sub>), 57.9 (CH<sub>2</sub>), 111.3 (CH), 115.2 (CH), 115.6 (d, <i>J</i><sub>CF</sub> = 21.4 Hz, 2 × CH), 118.7 (CH), 121.2 (2 × CH), 121.6 (CH), 124.1 (CH), 129.6 (2 × CH), 130.8 (d, <i>J</i><sub>CF</sub> = 8.1 Hz, 2 × CH), 131.3 (C<sub>q</sub>), 139.6 (C<sub>q</sub>), 149.1 (C<sub>q</sub>), 152.1 (C<sub>q</sub>), 158.7 (C<sub>q</sub>), 162.5 (C<sub>q</sub>, d, <i>J</i><sub>CF</sub> = 246.4 Hz); HRMS (ESI): calcd for C<sub>28</sub>H<sub>35</sub>FN<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 492.2769; found, 492.2770; IR (NaCl) ν (cm<sup>–1</sup>): 3420 (s), 2943 (w), 2820 (w), 1647 (s), 1597 (s), 1500 (s), 1351 (m), 1241 (m), 1027 (m), 751 (s); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 17.1 min, purity: 99%.</div></div><div id="sec4_2_5_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> 2-(2-Fluorobenzyl)-2-(4-fluorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl) Hydrazine-1-carboxamide (<b>19</b>)</h5><div class="NLM_p last">Compound <b>19</b> was prepared from 2-(4-fluorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12b</b>) (175 μmol, 70.0 mg) and 1-(bromomethyl)-2-fluorobenzene (<b>13c</b>) (825 μmol, 100 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 20:1) gave <b>19</b> (84.6 μmol, 43.1 mg, 48%) as a brown oil. <i>R</i><sub>f</sub>: 0.3 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.63 (br s, 2H), 2.42 (br s, 2H), 2.62 (br s, 4H), 2.99 (br s, 4H), 3.06–3.33 (m, 2H), 3.85 (s, <i>J</i> = 4.1 Hz, 3H), 4.41 (d, <i>J</i> = 14.0 Hz, 1H), 4.70 (d, <i>J</i> = 11.7 Hz, 1H), 5.93 (br s, 1NH), 6.29 (br s, 1NH), 6.79–7.14 (m, 9H), 7.20–7.34 (m, 3H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.1 (2 × CH<sub>2</sub>), 39.1 (CH<sub>2</sub>), 50.2 (CH<sub>2</sub>), 53.4 (CH<sub>2</sub>, d, <i>J</i><sub>CF</sub> = 1.9 Hz), 53.6 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 56.9 (CH<sub>2</sub>), 111.3 (CH), 115.7 (CH), 116.1 (d, <i>J</i><sub>CF</sub> = 22.5 Hz, 2 × CH), 116.8 (d, <i>J</i><sub>CF</sub> = 7.7 Hz, 2 × CH), 118.4 (CH), 121.1 (CH), 122.4 (d, <i>J</i><sub>CF</sub> = 14.8 Hz, C<sub>q</sub>), 123.2 (CH), 124.4 (d, <i>J</i><sub>CF</sub> = 3.6 Hz, CH), 130.2 (d, <i>J</i><sub>CF</sub> = 8.3 Hz, CH), 131.5 (d, <i>J</i><sub>CF</sub> = 4.0 Hz, CH), 141.1 (C<sub>q</sub>), 145.7 (d, <i>J</i><sub>CF</sub> = 2.3 Hz, C<sub>q</sub>), 152.3 (C<sub>q</sub>), 158.2 (d, <i>J</i><sub>CF</sub> = 240.7 Hz, C<sub>q</sub>), 158.4 (C<sub>q</sub>), 161.5 (d, <i>J</i><sub>CF</sub> = 246.7 Hz, C<sub>q</sub>); HRMS (ESI): calcd for C<sub>28</sub>H<sub>34</sub>F<sub>2</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 510.2675; found, 510.2679; IR (NaCl) ν (cm<sup>–1</sup>): 2924 (s), 2854 (s), 1685 (w), 1676 (w), 1507 (w), 1458 (m), 1377 (w), 1241 (w), 1230 (w), 753 (w); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 17.1 nm, purity: 95%.</div></div><div id="sec4_2_5_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> 2-(3-Fluorobenzyl)-2-(4-fluorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>20</b>)</h5><div class="NLM_p last">Compound <b>20</b> was prepared from 2-(4-fluorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12b</b>) (184 μmol, 73.6 mg) and 1-(bromomethyl)-2-fluorobenzene (<b>13d</b>) (920 μmol, 113 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 20:1) gave <b>20</b> (83.6 μmol, 42.6 mg, 45%) as a yellow oil. <i>R</i><sub>f</sub>: 0.4 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.67 (br s, 2H), 2.43 (br s, 2H), 2.58 (br s, 4H), 2.93 (br s, 4H), 3.28 (d, <i>J</i> = 50.4 Hz, 2H), 3.85 (s, 3H), 4.54 (d, <i>J</i> = 34.4 Hz, 2H), 5.86 (br s, 1NH), 6.46 (br s, 1NH), 6.78 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 7.8 Hz, 1H), 6.86 (dd, <i>J</i> = 1.4 Hz, <i>J</i> = 8.0 Hz, 1H), 6.89–7.05 (m, 8H), 7.25–7.32 (m, 2H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.0 (2 × CH<sub>2</sub>), 39.7 (CH<sub>2</sub>), 50.4 (CH<sub>2</sub>), 53.7 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 57.4 (CH<sub>2</sub>), 58.6 (CH<sub>2</sub>), 111.3 (CH), 115.3 (d, <i>J</i><sub>CF</sub> = 21.0 Hz, CH), 115.8 (d, <i>J</i><sub>CF</sub> = 21.5 Hz, CH), 116.2 (d, <i>J</i><sub>CF</sub> = 22.5 Hz, 2 × CH), 116.5 (d, <i>J</i><sub>CF</sub> = 7.7 Hz, 2 × CH), 118.3 (CH), 121.0 (CH), 123.1 (CH), 124.6 (d, <i>J</i><sub>CF</sub> = 2.9 Hz, CH), 130.5 (d, <i>J</i><sub>CF</sub> = 8.2 Hz, CH), 137.6 (d, <i>J</i><sub>CF</sub> = 6.7 Hz, C<sub>q</sub>), 141.1 (C<sub>q</sub>), 145.5 (d, <i>J</i><sub>CF</sub> = 2.3 Hz, C<sub>q</sub>), 152.3 (C<sub>q</sub>), 158.1 (d, <i>J</i><sub>CF</sub> = 240.8 Hz, C<sub>q</sub>), 158.1 (C<sub>q</sub>), 163.0 (d, <i>J</i><sub>CF</sub> = 247.3 Hz, C<sub>q</sub>); HRMS (ESI): calcd for C<sub>28</sub>H<sub>34</sub>F<sub>2</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 510.2675; found, 510.2677; IR (NaCl) ν (cm<sup>–1</sup>): 2941 (m), 2819 (m), 2360 (m), 2342 (w), 1672 (s), 1506 (s), 1451 (m), 1241 (s), 1144 (m), 749 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 17.0 min, purity: 97%.</div></div><div id="sec4_2_5_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> 2-(4-Fluorobenzyl)-2-(4-fluorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>21</b>)</h5><div class="NLM_p last">Compound <b>21</b> was prepared from 2-(4-fluorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12b</b>) (180 μmol, 72.0 mg) and 1-(bromomethyl)-4-fluorobenzene (<b>13b</b>) (900 μmol, 112 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 20:1) gave <b>21</b> (97.5 μmol, 49.7 mg, 54%) as a yellow oil. <i>R</i><sub>f</sub>: 0.3 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.56–1.72 (m, 2H), 2.35–2.47 (m, 2H), 2.56 (br s, 4H), 2.94 (br s, 4H), 3.25 (d, <i>J</i> = 45.3 Hz, 2H), 3.85 (s, 3H), 4.38–4.66 (m, 2H), 5.86 (br s, 1NH), 6.38 (br s, 1NH), 6.80 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 7.8 Hz, 1H), 6.86 (dd, <i>J</i> = 1.4 Hz, <i>J</i> = 8.0 Hz, 1H), 6.89–7.07 (m, 8H), 7.15–7.23 (m, 2H); <sup>13</sup>C NMR (151 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.2 (2 × CH<sub>2</sub>), 39.6 (CH<sub>2</sub>), 50.5 (CH<sub>2</sub>), 53.7 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 57.4 (CH<sub>2</sub>), 58.3 (CH<sub>2</sub>), 111.4 (CH), 115.8 (d, <i>J</i><sub>CF</sub> = 21.5 Hz, 2 × CH), 116.2 (d, <i>J</i><sub>CF</sub> = 22.4 Hz, 2 × CH), 116.7 (d, <i>J</i><sub>CF</sub> = 7.7 Hz, 2 × CH), 118.3 (CH), 121.0 (CH), 123.1 (CH), 130.5 (d, <i>J</i><sub>CF</sub> = 3.1 Hz, C<sub>q</sub>), 130.9 (d, <i>J</i><sub>CF</sub> = 8.1 Hz, 2 × CH), 145.6 (d, <i>J</i><sub>CF</sub> = 2.3 Hz, C<sub>q</sub>), 141.2 (C<sub>q</sub>), 152.3 (C<sub>q</sub>), 158.1 (C<sub>q</sub>), 158.1 (d, <i>J</i><sub>CF</sub> = 240.8 Hz, C<sub>q</sub>), 162.7 (d, <i>J</i><sub>CF</sub> = 247.2 Hz, C<sub>q</sub>); HRMS (ESI): calcd for C<sub>28</sub>H<sub>34</sub>F<sub>2</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>,510.2675; found, 510.2675; IR (NaCl) ν (cm<sup>–1</sup>): 2941 (w), 2818 (w), 2360 (s), 1670 (m), 1507 (s), 1240 (m), 1227 (m), 827 (w), 750 (m), 668 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 16.6 min, purity: 96%.</div></div><div id="sec4_2_5_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> 2-(4-Fluorophenyl)-2-(3-methoxybenzyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>22</b>)</h5><div class="NLM_p last">Compound <b>22</b> was prepared from 2-(4-fluorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12b</b>) (174 μmol, 69.4 mg) and 1-(bromomethyl)-3-methoxybenzene (<b>13e</b>) (870 μmol, 122 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 15:1) gave <b>22</b> (136 μmol, 71.0 mg, 78%) as a brownish-yellow oil. <i>R</i><sub>f</sub>: 0.5 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.58–1.75 (m, 2H), 2.41 (dd, <i>J</i> = 6.0, 10.6 Hz, 2H), 2.56 (br s, <i>J</i> = 38.0 Hz, 4H), 2.94 (br s, <i>J</i> = 69.0 Hz, 4H), 3.13–3.38 (m, 2H), 3.73 (s, 3H), 3.85 (s, 3H), 4.43 (d, <i>J</i> = 14.6 Hz, 1H), 4.62 (d, <i>J</i> = 14.7 Hz, 1H), 5.96 (br s, 1H), 6.42 (br s, 1H), 6.70–7.04 (m, 11H), 7.18–7.25 (m, 1H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.2 (2 × CH<sub>2</sub>), 39.6 (CH<sub>2</sub>), 50.5 (CH<sub>2</sub>), 53.7 (2 × CH<sub>2</sub>), 55.3 (CH<sub>3</sub>), 55.5 (CH<sub>3</sub>), 57.4 (CH<sub>2</sub>), 58.9 (CH<sub>2</sub>), 111.3 (CH), 113.3 (CH), 114.7 (CH), 116.1 (d, <i>J</i><sub>CF</sub> = 22.5 Hz, 2 × CH), 116.5 (d, <i>J</i><sub>CF</sub> = 7.7 Hz, 2 × CH), 118.3 (CH), 121.0 (CH), 121.0 (CH), 123.0 (CH), 130.0 (CH), 136.4 (C<sub>q</sub>), 141.2 (C<sub>q</sub>), 145.7 (d, <i>J</i><sub>CF</sub> = 2.3 Hz, C<sub>q</sub>), 152.3 (C<sub>q</sub>), 157.9 (d, <i>J</i><sub>CF</sub> = 240.3 Hz, C<sub>q</sub>), 158.2 (C<sub>q</sub>), 159.94 (C<sub>q</sub>); HRMS (ESI): calcd for C<sub>29</sub>H<sub>37</sub>FN<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 522.2875; found, 522.2874; IR (NaCl) ν (cm<sup>–1</sup>): 2941 (w), 2819 (w), 1674 (m), 1586 (w), 1506 (s), 1456 (m), 1241 (s), 1146 (m), 748 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 16.9 min, purity: 98%.</div></div><div id="sec4_2_5_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> 2-(4-Cyanobenzyl)-2-(4-fluorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>23</b>)</h5><div class="NLM_p last">Compound <b>23</b> was prepared from 2-(4-fluorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12b</b>) (87.6 μmol, 35.0 mg) and 4-(bromomethyl)benzonitrile (<b>13f</b>) (876 μmol, 172 mg) according to GP 4. Purification by column chromatography (chloroform/methanol = 20:1 → 10:1) gave <b>23</b> (86.9 μmol, 44.9 mg, 99%) as a slightly yellow oil. <i>R</i><sub>f</sub>: 0.6 (chloroform/methanol = 10:1) [UV]; ]; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) 1.66 (br s, 2H), 2.43 (br s, 2H), 2.58 (br s, 4H), 2.94 (br s, 4H), 3.26 (d, <i>J</i> = 84.4 Hz, 2H), 3.85 (s, <i>J</i> = 6.8 Hz, 3H), 4.60 (d, <i>J</i> = 34.1 Hz, 2H), 6.41 (br s, 2NH), 6.78 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 7.8 Hz, 1H), 6.86 (dd, <i>J</i> = 1.2 Hz, <i>J</i> = 8.1 Hz, 1H), 6.90–6.97 (m, 5H), 7.01 (td, <i>J</i> = 1.5 Hz, <i>J</i> = 7.8 Hz, 1H), 7.36 (d, <i>J</i> = 8.2 Hz, 2H), 7.60 (d, <i>J</i> = 8.2 Hz, 2H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.0 (CH<sub>2</sub>), 39.5 (CH<sub>2</sub>), 50.3 (CH<sub>2</sub>), 53.7 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 57.3 (CH<sub>2</sub>), 58.7 (2 × CH<sub>2</sub>), 111.3 (CH), 112.0 (C<sub>q</sub>), 116.3 (d, <i>J</i><sub>CF</sub> = 22.6 Hz, 2 × CH), 116.4 (d, <i>J</i><sub>CF</sub> = 8.1 Hz, 2 × CH), 118.2 (CH), 118.5 (C<sub>q</sub>), 121.0 (CH), 123.1 (CH), 129.5 (2 × CH), 132.5 (2 × CH), 140.8 (C<sub>q</sub>), 141.0 (C<sub>q</sub>), 145.3 (d, <i>J</i><sub>CF</sub> = 2.1 Hz, C<sub>q</sub>), 152.2 (C<sub>q</sub>), 158.1 (C<sub>q</sub>), 158.1 (d, <i>J</i><sub>CF</sub> = 241.2 Hz, C<sub>q</sub>); HRMS (ESI): calcd for C<sub>29</sub>H<sub>33</sub>FN<sub>6</sub>O<sub>2</sub> [M<sup>+</sup>], 517.2722; found, 517.2709; IR (NaCl) ν (cm<sup>–1</sup>): 2941 (w), 2819 (w), 2228 (w), 1673 (m), 1532 (m), 1505 (s), 1241 (s), 1027 (w), 827 (w), 736 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 17.2 min, purity: 100%.</div></div><div id="sec4_2_5_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> 2-([1,1′-Biphenyl]-4-ylmethyl)-2-(4-fluorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>24</b>)</h5><div class="NLM_p last">Compound <b>24</b> was prepared from 2-(4-fluorophenyl)-<i>N</i>-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)azocarboxamide (<b>12b</b>) (100 μmol, 40.0 mg) and 4-(bromomethyl)-1,1′-biphenyl (<b>13g</b>) (300 μmol, 74.1 mg) according to GP 4. Purification by column chromatography (dichloromethane/ethyl acetate = 1:1) gave <b>24</b> (25.9 μmol, 14.7 mg, 26%) as a colorless oil. <i>R</i><sub>f</sub>: 0.1 (ethyl acetate = 100%) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.57–1.92 (m, 2H), 2.35–3.41 (m, 12H), 3.85 (s, 3H), 4.42–4.77 (m, 2H), 5.97 (br s, 1NH), 6.50 (br s, 1NH), 6.78–7.09 (m, 8H), 7.28–7.37 (m, 3H), 7.39–7.45 (m, 2H), 7.52–7.61 (m, 4H); <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ (ppm) 25.7 (CH<sub>2</sub>), 38.7 (CH<sub>2</sub>), 49.6 (2 × CH<sub>2</sub>), 53.3 (2 × CH<sub>2</sub>), 55.3 (CH<sub>3</sub>), 56.8 (CH<sub>2</sub>), 58.8 (CH<sub>2</sub>), 111.2 (CH), 116.0 (d, <i>J</i><sub>CF</sub> = 22.5 Hz, 2 × CH), 116.7 (d, <i>J</i><sub>CF</sub> = 7.3 Hz, 2 × CH), 118.3 (CH), 120.9 (CH), 123.2 (CH), 127.0 (2 × CH), 127.4 (2 × CH), 127.5 (CH), 128.8 (2 × CH), 129.4 (2 × CH), 133.7 (C<sub>q</sub>), 140.4 (C<sub>q</sub>), 141.0 (C<sub>q</sub>), 145.6 (d, <i>J</i><sub>CF</sub> = 2.2 Hz, C<sub>q</sub>), 152.1 (C<sub>q</sub>), 158.0 (C<sub>q</sub>), 158.0 (d, <i>J</i><sub>CF</sub> = 240.6 Hz, C<sub>q</sub>), one C<sub>q</sub>-signal is missing; HRMS (ESI): calcd for C<sub>34</sub>H<sub>39</sub>FN<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 568.3082; found, 568.3082; HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 16.6 min, purity: 96%.</div></div><div id="sec4_2_5_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> 2-Benzyl-2-(4-chlorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>25</b>)</h5><div class="NLM_p last">Compound <b>25</b> was prepared from 2-(4-chlorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12e</b>) (194 μmol, 80.8 mg) and benzyl bromide (<b>13a</b>) (582 μmol, 69.1 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 10:1) gave <b>25</b> (112 μmol, 57.0 mg, 58%) as a light yellow oil. <i>R</i><sub>f</sub>: 0.6 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) 1.63 (tt, <i>J</i> = 17.7 Hz, <i>J</i> = 35.2 Hz, 2H), 2.42 (dd, <i>J</i> = 6.4 Hz, <i>J</i> = 15.5 Hz, 2H), 2.56 (br s, <i>J</i> = 58.6 Hz, 4H), 2.92 (br s, <i>J</i> = 78.2 Hz, 4H), 3.13–3.22 (m, 1H), 3.29–3.39 (m, 1H), 3.85 (s, <i>J</i> = 6.3 Hz, 3H), 4.47 (d, <i>J</i> = 15.0 Hz, 1H), 4.68 (d, <i>J</i> = 15.0 Hz, 1H), 6.08 (br s, 1NH), 6.43 (br s, 1NH), 6.77 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 7.8 Hz, 1H), 6.86 (dd, <i>J</i> = 1.4 Hz, <i>J</i> = 8.0 Hz, 1H), 6.92–6.97 (m, 3H), 6.99–7.03 (m, 1H), 7.15–7.18 (m, 2H), 7.20 (dt, <i>J</i> = 3.5 Hz, <i>J</i> = 5.5 Hz, 2H), 7.27–7.32 (m, 3H); <sup>13</sup>C NMR (151 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.0 (2 × CH<sub>2</sub>), 39.7 (CH<sub>2</sub>), 50.4 (CH<sub>2</sub>), 53.7 (2 × CH<sub>2</sub>), 55.4 (CH<sub>3</sub>), 57.5 (CH<sub>2</sub>), 58.0 (CH<sub>2</sub>), 111.3 (CH), 116.1 (2 × CH), 118.3 (CH), 121.0 (CH), 123.0 (CH), 126,1 (C<sub>q</sub>), 128.2 (CH), 128.8 (2 × CH), 128.9 (2 × CH), 129.5 (2 × CH), 134.8 (C<sub>q</sub>), 141.1 (C<sub>q</sub>), 148.1 (C<sub>q</sub>), 152.2 (C<sub>q</sub>), 158.1 (C<sub>q</sub>); HRMS (ESI): calcd for C<sub>28</sub>H<sub>35</sub>ClN<sub>5</sub>O<sub>2</sub> [M<sup>+</sup>], 508.2474; found, 508.2484; IR (NaCl) ν (cm<sup>–1</sup>): 3418 (m), 3212 (m), 3063 (m), 2940 (s), 2819 (s), 2361 (w), 1875 (w), 1674 (s), 1595 (s), 1532 (s), 1499 (s), 1454 (s), 1241 (s); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 17.3 min, purity: 98%.</div></div><div id="sec4_2_5_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> 2-(4-Chlorophenyl)-2-(2-fluorobenzyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>26</b>)</h5><div class="NLM_p last">Compound <b>26</b> was prepared from 2-(4-chlorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12e</b>) (144 μmol, 60.0 mg) and 1-(bromomethyl)-2-fluorobenzene (<b>13c</b>) (720 μmol, 86.9 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 10:1) gave <b>26</b> (110 μmol, 58.1 mg, 76%) as a yellow oil. <i>R</i><sub>f</sub>: 0.3 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.47–1.67 (m, 2H), 2.37 (dd, <i>J</i> = 6.2 Hz, <i>J</i> = 10.7 Hz, 2H), 2.53 (br s, 4H), 2.89 (br s, 4H), 2.99–3.36 (m, 2H), 3.83 (s, 3H), 4.46 (d, <i>J</i> = 14.7 Hz, 1H), 4.70 (d, <i>J</i> = 14.6 Hz, 1H), 5.96 (br s, 1NH), 6.31 (br s, 1NH), 6.76 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 7.8 Hz, 1H), 6.84 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 7.9 Hz, 1H), 6.89–7.02 (m, 4H), 7.02–7.10 (m, 2H), 7.14–7.22 (m, 3H), 7.25–7.32 (m, 1H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.0 (2 × CH<sub>2</sub>), 39.6 (CH<sub>2</sub>), 50.4 (CH<sub>2</sub>), 52.3 (d, <i>J</i><sub>CF</sub> = 2.3 Hz, CH<sub>2</sub>), 53.7 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 57.4 (CH<sub>2</sub>), 111.3 (CH), 115.9 (d, <i>J</i><sub>CF</sub> = 21.7 Hz, CH), 116.2 (2 × CH), 118.4 (CH), 121.1 (CH), 122.1 (d, <i>J</i><sub>CF</sub> = 15.0 Hz, C<sub>q</sub>), 123.0 (CH), 124.5 (d, <i>J</i><sub>CF</sub> = 3.6 Hz, CH), 126.6 (C<sub>q</sub>), 129.5 (2 × CH), 130.3 (d, <i>J</i><sub>CF</sub> = 8.3 Hz, CH), 131.1 (d, <i>J</i><sub>CF</sub> = 4.0 Hz, CH), 141.2 (C<sub>q</sub>), 148.0 (C<sub>q</sub>), 152.3 (C<sub>q</sub>), 158.1 (C<sub>q</sub>), 161.4 (d, <i>J</i><sub>CF</sub> = 246.7 Hz, C<sub>q</sub>); HRMS (ESI): calcd for C<sub>28</sub>H<sub>34</sub>ClFN<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 526.2380; found, 526.2381; IR (NaCl) ν (cm<sup>–1</sup>): 2940 (m), 2819 (m), 1674 (m), 1595 (s), 1532 (m), 1499 (s), 1456 (m), 1240 (s), 756 (m), 753 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 17.6 min, purity: 100%.</div></div><div id="sec4_2_5_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> 2-Benzyl-2-(2,4-dichlorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>27</b>)</h5><div class="NLM_p last">Compound <b>27</b> was prepared from 2-(2,4-dichlorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12f</b>) (165 μmol, 74.1 mg) and benzyl bromide (<b>13a</b>) (495 μmol, 58.8 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 20:1 → 10:1) gave <b>27</b> (77.8 μmol, 42.2 mg, 47%) as a brown oil. <i>R</i><sub>f</sub>: 0.5 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) 1.57–1.68 (m, H), 2.39 (m, 2H), 2.67 (br s, 4H), 3.13 (m, 6H), 3.86 (s, 3H), 4.20 (d, <i>J</i> = 52.1 Hz, 2H), 6.03 (t, <i>J</i> = 5.8 Hz, 1NH), 6.86 (d, <i>J</i> = 7.7 Hz, 1H), 6.89–6.97 (m, 2H), 6.97–7.05 (m, 1H), 7.13–7.20 (m, 2H), 7.22–7.36 (m, 6H), 7.43 (d, <i>J</i> = 2.0 Hz, 1NH); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 27.0 (CH<sub>2</sub>), 37.8 (2 × CH<sub>2</sub>), 50.3 (CH<sub>2</sub>), 53.4 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 55.7 (CH<sub>2</sub>), 62.2 (CH<sub>2</sub>), 111.3 (CH), 118.4 (CH), 121.1 (CH), 123.2 (CH), 124.7 (CH), 128.2 (CH), 128.4 (CH), 128.5 (C<sub>q</sub>), 128.6 (2 × CH), 130.0 (CH), 130.2 (2 × CH), 131.3 (C<sub>q</sub>), 134.4 (C<sub>q</sub>), 141.1 (C<sub>q</sub>), 146.0 (C<sub>q</sub>), 152.3 (C<sub>q</sub>), 158.2 (C<sub>q</sub>); HRMS (ESI): calcd for C<sub>28</sub>H<sub>34</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>2</sub> [M<sup>+</sup>], 542.2084; found, 542.2072; IR (NaCl) ν (cm<sup>–1</sup>): 3407 (w), 3206 (w), 3088 (w), 2904 (m), 2817 (m), 2360 (w), 2341 (w), 1674 (s), 1535 (s), 1500 (s), 1241 (s), 746 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 17.7 min; 97%.</div></div><div id="sec4_2_5_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> 2-(4-Cyanobenzyl)-2-(2,4-dichlorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>28</b>)</h5><div class="NLM_p last">Compound <b>28</b> was prepared from 2-(2,4-dichlorophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12f</b>) (258 μmol, 116 mg) and 4-(bromomethyl)benzonitrile (<b>13f</b>) (2.58 mmol, 506 mg) according to GP 4. Purification by column chromatography (chloroform/methanol = 10:1) gave <b>28</b> (131 μmol, 74.3 mg, 51%) as a yellow oil. <i>R</i><sub>f</sub>: 0.5 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) 1.56–1.67 (m, 2H), 2.39 (br s, 2H), 2.67 (br s, 4H), 3.03–3.22 (m, 6H), 3.87 (s, 3H), 4.28 (br s, 2H), 5.98 (br s, 1NH), 6.85–6.89 (m, 1H), 6.91–6.95 (m, 2H), 6.98–7.04 (m, 1H), 7.22 (dd, <i>J</i> = 2.3 Hz, <i>J</i> = 8.7 Hz, 1H), 7.25–7.27 (m, 1H), 7.44 (d, <i>J</i> = 2.3 Hz, 1H), 7.46 (d, <i>J</i> = 8.2 Hz, 2H), 7.60 (d, <i>J</i> = 8.3 Hz, 2H), 7.75 (br s, 1NH); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ (ppm) 27.0 (CH<sub>2</sub>), 29.6 (CH<sub>2</sub>), 37.8 (2 × CH<sub>2</sub>), 50.3 (CH<sub>2</sub>), 53.5 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 55.70 (CH<sub>2</sub>), 61.8 (C<sub>q</sub>), 111.3 (CH), 112.3 (C<sub>q</sub>), 118.4 (CH), 118.6 (C<sub>q</sub>), 121.1 (CH), 123.2 (CH), 124.5 (CH), 128.5 (CH), 128.6 (C<sub>q</sub>), 130.2 (CH), 130.7 (2 × CH), 132.0 (C<sub>q</sub>), 132.3 (2 × CH), 140.4 (C<sub>q</sub>), 145.6 (C<sub>q</sub>), 152. (C<sub>q</sub>), 158.2 (C<sub>q</sub>); HRMS (ESI): calcd for C<sub>29</sub>H<sub>32</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 567.2037; found, 567.2029; IR (NaCl) ν (cm<sup>–1</sup>): 3408 (w), 3207 (w), 3090 (w), 2938 (m), 2819 (m), 2228 (m), 1674 (s), 1501 (s), 1241 (s), 749 (m), 736 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 18.0 min; purity: 97%.</div></div><div id="sec4_2_5_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> 2-Benzyl-2-(4-bromophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>29</b>)</h5><div class="NLM_p last">Compound <b>29</b> was prepared from 2-(4-bromophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12g</b>) (275 μmol, 126 mg) and benzyl bromide (<b>13a</b>) (825 μmol, 97.9 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 10:1) gave <b>29</b> (115 mmol, 63.5 mg, 42%) as a lightly yellow oil. <i>R</i><sub>f</sub>: 0.6 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) 1.58–1.70 (m, 2H), 2.42 (dt, <i>J</i> = 6.4 Hz, <i>J</i> = 9.6 Hz, 2H), 2.55 (br s, 4H), 2.91 (br s, 4H), 3.11–3.23 (m, 1H), 3.29–3.40 (m, 1H), 3.85 (s, 3H), 4.47 (d, <i>J</i> = 15.0 Hz, 1H), 4.68 (d, <i>J</i> = 15.0 Hz, 1H), 6.10 (br s, 1NH), 6.44 (br s, 1NH), 6.77 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 7.8 Hz, 1H), 6.85 (dt, <i>J</i> = 4.1 Hz, <i>J</i> = 8.1 Hz, 1H), 6.88–6.92 (m, 2H), 6.95 (td, <i>J</i> = 1.4, <i>J</i> = 7.6 Hz, 1H), 7.00 (tt, <i>J</i> = 3.0 Hz, <i>J</i> = 6.1 Hz, 1H), 7.20 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 7.6 Hz, 2H), 7.27–7.33 (m, 5H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 25.9 (2 × CH<sub>2</sub>), 39.8 (CH<sub>2</sub>), 50.4 (CH<sub>2</sub>), 53.7 (2 × CH<sub>2</sub>), 55.4 (CH<sub>3</sub>), 57.6 (CH<sub>2</sub>), 57.8 (CH<sub>2</sub>), 111.3 (C<sub>q</sub>), 113.4 (C<sub>q</sub>), 116.4 (2 × CH), 118.3 (CH), 121.01 (CH), 123.0 (CH), 128.2 (CH), 128.7 (2 × CH), 128.9 (2 × CH), 132.4 (2 × CH), 134.8 (C<sub>q</sub>), 141.1 (C<sub>q</sub>), 148.6 (C<sub>q</sub>), 152.2 (C<sub>q</sub>), 158.1 (C<sub>q</sub>); HRMS (ESI): calcd for C<sub>28</sub>H<sub>35</sub>BrN<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 552.1969; found, 552.1970; IR (NaCl) ν (cm<sup>–1</sup>): 2923 (m), 2852 (m), 2818 (m), 2362 (w), 1670 (m), 1591 (m), 1528 (m), 1500 (s), 1490 (s), 1453 (m), 1240 (s); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 17.2 min, purity: 98%.</div></div><div id="sec4_2_5_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> 2-(4-Bromophenyl)-2-(2-fluorobenzyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>30</b>)</h5><div class="NLM_p last">Compound <b>30</b> was prepared from 2-(4-bromophenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12g</b>) (140 μmol, 64.6 mg) and 1-(bromomethyl)-2-fluorobenzene (<b>13c</b>) (700 μmol, 84.4 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 20:1 → 10:1) gave <b>30</b> (128 μmol, 73.0 mg, 91%) as a brownish-yellow oil. <i>R</i><sub>f</sub>: 0.4 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.60 (dq, <i>J</i> = 6.4 Hz, <i>J</i> = 12.7 Hz, 2H), 2.39 (dd, <i>J</i> = 6.3 Hz, <i>J</i> = 11.0 Hz, 2H), 2.55 (br s, 4H), 2.90 (br s, 4H), 3.02–3.35 (m, 2H), 3.85 (s, 3H), 4.47 (d, <i>J</i> = 14.7 Hz, 1H), 4.72 (d, <i>J</i> = 14.7 Hz, 1H), 6.12 (br s, 1NH), 6.34 (br s, 1NH), 6.77 (dt, <i>J</i> = 3.3 Hz, <i>J</i> = 6.6 Hz, 1H), 6.85 (dt, <i>J</i> = 3.5 Hz, <i>J</i> = 7.1 Hz, 1H), 6.89–6.94 (m, 2H), 6.95–7.03 (m, 2H), 7.04–7.12 (m, 2H), 7.21 (td, <i>J</i> = 1.8 Hz, <i>J</i> = 7.7 Hz, 1H), 7.27–7.35 (m, 3H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 25.9 (2 × CH<sub>2</sub>), 39.6 (CH<sub>2</sub>), 50.3 (CH<sub>2</sub>), 52.1 (CH<sub>2</sub>), 53.7 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 57.4 (CH<sub>2</sub>), 111.3 (CH), 113.8 (C<sub>q</sub>), 115.9 (d, <i>J</i><sub>CF</sub> = 21.7 Hz, CH), 116.5 (2 × CH), 118.3 (CH), 121.0 (CH), 122.1 (d, <i>J</i><sub>CF</sub> = 14.8 Hz, C<sub>q</sub>), 123.0 (CH), 124.5 (d, <i>J</i><sub>CF</sub> = 3.5 Hz, CH), 130.2 (d, <i>J</i><sub>CF</sub> = 8.3 Hz, CH), 131.1 (d, <i>J</i><sub>CF</sub> = 4.0 Hz, CH), 132.4 (2 × CH), 141.1 (C<sub>q</sub>), 148.4 (C<sub>q</sub>), 152.2 (C<sub>q</sub>), 158.2 (C<sub>q</sub>), 161.3 (d, <i>J</i><sub>CF</sub> = 246.7 Hz, C<sub>q</sub>); HRMS (ESI): calcd for C<sub>28</sub>H<sub>34</sub>BrFN<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 570.1874; found, 570.1872; IR (NaCl) ν (cm<sup>–1</sup>): 2940 (m), 2817 (m), 1670 (m), 1527 (m), 1499 (s), 1490 (s), 1456 (m), 1240 (s), 821 (w); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 17.7 min, purity: 97%.</div></div><div id="sec4_2_5_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> 2-Benzyl-2-(4-methoxyphenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>31</b>)</h5><div class="NLM_p last">Compound <b>31</b> was prepared from 2-(4-methoxyphenyl)-<i>N</i>-(2-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)azocarboxamide (<b>12h</b>) (146 μmol, 60.0 mg) and benzyl bromide (<b>13a</b>) (438 μmol, 52.0 μL) according to GP 4. Purification by column chromatography (dichloromethane/ethyl acetate = 1:1) gave <b>31</b> (127 μmol, 63.9 mg, 87%) as a colorless oil. <i>R</i><sub>f</sub>: 0.1 (chloroform/methanol = 20:1) [UV]; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) 1.64 (br s, 2H), 2.41 (br s, 2H), 2.59 (br s, 4H), 2.98 (br s, 4H), 3.24 (d, <i>J</i> = 61.1 Hz, 2H), 3.75 (s, 3H), 3.85 (s, 3H), 4.50 (d, <i>J</i> = 47.5 Hz, 2H), 5.75 (br s, 1H), 6.36 (br s, 1H), 6.79–6.82 (m, 2H), 6.84 (ddd, <i>J</i> = 1.4 Hz, <i>J</i> = 7.9 Hz, <i>J</i> = 13.5 Hz, 2H), 6.91–6.94 (m, 1H), 6,96–6.98 (m, 2H), 6.99–7.02 (m, 1H), 7.19–7.23 (m, 2H), 7.27–7.32 (m, 3H); <sup>13</sup>C NMR (91 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 25.7 (CH<sub>2</sub>), 38.6 (CH<sub>2</sub>), 49.4 (2 × CH<sub>2</sub>), 53.3 (2 × CH<sub>2</sub>), 55.4 (CH<sub>3</sub>), 55.5 (CH<sub>3</sub>), 56.6 (CH<sub>2</sub>), 59.6 (CH<sub>2</sub>), 111.2 (2 × CH), 114.6 (2 × CH), 117.0 (CH), 118.4 (CH), 121.0 (CH), 123.4 (CH), 128.0 (CH), 128.6 (2 × CH), 129.1 (2 × CH), 135.0 (C<sub>q</sub>), 143.1 (C<sub>q</sub>), 152.1 (C<sub>q</sub>), 154.7 (C<sub>q</sub>), 158.2 (C<sub>q</sub>), One C<sub>q</sub>-signal is missing; HRMS (ESI): calcd for C<sub>29</sub>H<sub>38</sub>N<sub>5</sub>O<sub>3</sub> [M + H<sup>+</sup>], 504.2969; found, 504.2972; HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 17.0 min, purity: 95%.</div></div><div id="sec4_2_5_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> 2-(2-Fluorobenzyl)-2-(4-methoxyphenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>32</b>)</h5><div class="NLM_p last">Compound <b>32</b> was prepared from 2-(4-methoxyphenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12h</b>) (180 μmol, 74.1 mg) and 1-(bromomethyl)-2-fluorobenzene (<b>13c</b>) (900 μmol, 108 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 20:1 → 10:1) gave <b>32</b> (82.0 μmol, 42.8 mg, 46%) as a yellow oil. <i>R</i><sub>f</sub>: 0.4 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.64 (br s, 2H), 2.42 (br s, 2H), 2.63 (br s, 4H), 3.02 (br s, 4H), 3.08–3.33 (m, 2H), 3.75 (s, 3H), 3.85 (s, <i>J</i> = 5.0 Hz, 3H), 4.34 (d, <i>J</i> = 13.4 Hz, 1H), 4.68 (d, <i>J</i> = 13.7 Hz, 1H), 5.83 (br s, 1NH), 6.27 (br s, 1NH), 6.79–6.88 (m, 4H), 6.89–6.96 (m, 1H), 6.97–7.06 (m, 3H), 7.09 (ddd, <i>J</i> = 1.9 Hz, <i>J</i> = 5.3 Hz, <i>J</i> = 9.8 Hz, 2H), 7.21–7.33 (m, 2H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.2 (2 × CH<sub>2</sub>), 38.9 (CH<sub>2</sub>), 50.2 (CH<sub>2</sub>), 53.6 (2 × CH<sub>2</sub>), 53.8 (CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 55.7 (CH<sub>3</sub>), 56.9 (CH<sub>2</sub>), 111.3 (CH), 114.8 (2 × CH), 115.8 (d, <i>J</i><sub>CF</sub> = 21.8 Hz, CH), 117.1 (2 × CH), 118.5 (CH), 121.1 (CH), 122.7 (d, <i>J</i><sub>CF</sub> = 14.7 Hz, C<sub>q</sub>), 123.2 (CH), 124.4 (d, <i>J</i><sub>CF</sub> = 3.6 Hz, CH), 130.1 (d, <i>J</i><sub>CF</sub> = 8.3 Hz, CH), 131.6 (d, <i>J</i><sub>CF</sub> = 4.1 Hz, CH), 143.3 (C<sub>q</sub>), 152.3 (C<sub>q</sub>), 155.1 (C<sub>q</sub>), 158.4 (2 × C<sub>q</sub>), 161.5 (C<sub>q</sub>, d, <i>J</i><sub>CF</sub> = 246.8 Hz); HRMS (ESI): calcd for C<sub>29</sub>H<sub>37</sub>FN<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 522.2875; found, 522.2879; IR (NaCl) ν (cm<sup>–1</sup>): 2943 (w), 2817 (w), 1670 (m), 1501 (s), 1464 (m), 1241 (s), 1181 (w), 1144 (w), 1029 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 16.9 min, purity: 96%.</div></div><div id="sec4_2_5_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> 2-(3-Fluorobenzyl)-2-(4-methoxyphenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>33</b>)</h5><div class="NLM_p last">Compound <b>33</b> was prepared from 2-(4-methoxyphenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12h</b>) (210 μmol, 86.4 mg) and 1-(bromomethyl)-2-fluorobenzene (<b>13d</b>) (1.05 mmol, 129 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 20:1) gave <b>33</b> (68.9 μmol, 35.9 mg, 33%) as a yellow oil. <i>R</i><sub>f</sub>: 0.5 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.64 (d, <i>J</i> = 3.5 Hz, 2H), 2.33–2.47 (m, 2H), 2.56 (br s, 4H), 2.94 (br s, 4H), 3.25 (d, <i>J</i> = 43.8 Hz, 2H), 3.75 (s, 3H), 3.85 (s, 3H), 4.48 (d, <i>J</i> = 3.8 Hz, 2H), 5.96 (br s, 1NH), 6.41 (br s, 1NH), 6.76–6.88 (m, 4H), 6.88–7.04 (m, 7H), 7.20–7.32 (m, 1H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.2 (2 × CH<sub>2</sub>), 39.5 (CH<sub>2</sub>), 50.5 (CH<sub>2</sub>), 53.7 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 55.7 (CH<sub>3</sub>), 57.3 (CH<sub>2</sub>), 59.1 (CH<sub>2</sub>), 111.3 (CH), 114.9 (2 × CH), 115.0 (d, <i>J</i><sub>CF</sub> = 21.1 Hz, CH), 115.9 (d, <i>J</i><sub>CF</sub> = 21.4 Hz, CH), 116.8 (2 × CH), 118.3 (CH), 121.0 (CH), 123.0 (CH), 124.7 (d, <i>J</i><sub>CF</sub> = 2.9 Hz, CH), 130.3 (d, <i>J</i><sub>CF</sub> = 8.2 Hz, CH), 138.0 (d, <i>J</i><sub>CF</sub> = 6.8 Hz, C<sub>q</sub>), 141.3 (C<sub>q</sub>), 143.1 (C<sub>q</sub>), 152.3 (C<sub>q</sub>), 154.9 (C<sub>q</sub>), 158.3 (C<sub>q</sub>), 162.9 (d, <i>J</i><sub>CF</sub> = 246.9 Hz, C<sub>q</sub>); HRMS (ESI): calcd for C<sub>29</sub>H<sub>37</sub>FN<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 522.2875; found, 522.2872; IR (NaCl) ν (cm<sup>–1</sup>): 2939 (w), 2817 (w), 2360 (s), 2332 (s), 1671 (m), 1507 (s), 1502 (s), 1465 (m), 1029 (w), 750 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 16.9 nm, purity: 98%.</div></div><div id="sec4_2_5_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> 2-(4-Fluorobenzyl)-2-(4-methoxyphenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>34</b>)</h5><div class="NLM_p last">Compound <b>34</b> was prepared from 2-(4-methoxyphenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12h</b>) (122 μmol, 50.0 mg) and 1-(bromomethyl)-4-fluorobenzene (<b>13b</b>) (610 μmol, 76.0 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 20:1) gave <b>34</b> (90.7 μmol, 47.3 mg, 74%) as a yellow oil. <i>R</i><sub>f</sub>: 0.6 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) 1.66 (br s, 2H), 2.44 (br s, 2H), 2.60 (br s, <i>J</i> = 7.2 Hz, 4H), 3.00 (br s, 4H), 3.14–3.37 (m, 2H), 3.75 (s, 3H), 3.85 (s, 3H), 4.34–4.55 (m, 2H), 5.74 (br s, 1NH), 6.37 (br s, 1NH), 6.79–6.83 (m, 2H), 6.83–6.88 (m, 2H), 6.92 (td, <i>J</i> = 1.4 Hz, <i>J</i> = 7.6 Hz, 1H), 6.95–7.04 (m, 5H), 7.15–7.22 (m, 2H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.21 (2 × CH<sub>2</sub>), 39.17 (CH<sub>2</sub>), 50.29 (CH<sub>2</sub>), 53.64 (2 × CH<sub>2</sub>), 55.49 (CH<sub>3</sub>), 55.69 (CH<sub>3</sub>), 57.14 (CH<sub>2</sub>), 58.90 (CH<sub>2</sub>), 111.32 (CH), 114.83 (2 × CH), 115.67 (d, <i>J</i><sub>CF</sub> = 21.4 Hz, 2 × CH), 117.15 (CH), 118.40 (CH), 121.06 (2 × CH), 123.13 (CH), 130.85 (d, <i>J</i><sub>CF</sub> = 3.2 Hz, C<sub>q</sub>), 131.05 (d, <i>J</i><sub>CF</sub> = 8.1 Hz, 2 × CH), 143.02 (C<sub>q</sub>), 152.31 (C<sub>q</sub>), 154.96 (C<sub>q</sub>), 158.26 (2 × C<sub>q</sub>), 162.61 (d, <i>J</i><sub>CF</sub> = 246.9 Hz, C<sub>q</sub>); HRMS (ESI): calcd for C<sub>29</sub>H<sub>37</sub>FN<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 522.2875; found, 522.2871; IR (NaCl) ν (cm<sup>–1</sup>): 2938 (w), 2832 (w), 2818 (w), 2359 (m), 2342 (w), 1675 (m), 1508 (s), 1464 (m), 1242 (s), 1029 (w); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 16.6 min, purity: 99%.</div></div><div id="sec4_2_5_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> 2-(3-Methoxybenzyl)-2-(4-methoxyphenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>35</b>)</h5><div class="NLM_p last">Compound <b>35</b> was prepared from 2-(4-methoxyphenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12h</b>) (171 μmol, 70.3 mg) and 1-(bromomethyl)-3-methoxybenzene (<b>13e</b>) (855 μmol, 120 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 15:1) gave <b>35</b> (81.1 μmol, 43.3 mg, 47%) as a yellow oil. <i>R</i><sub>f</sub>: 0.4 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.52–1.72 (m, 2H), 2.42 (br s, 2H), 2.62 (br s, 4H), 2.97 (br s, 4H), 3.25 (d, <i>J</i> = 29.3 Hz, 2H), 3.74 (s, 3H), 3.75 (s, 3H), 3.85 (s, 3H), 4.48 (d, <i>J</i> = 41.6 Hz, 2H), 5.82 (br s, 1NH), 6.39 (br s, 1NH), 6.71–7.05 (m, 11H), 7.21 (t, <i>J</i> = 7.9 Hz, 1H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.3 (2 × CH<sub>2</sub>), 39.3 (CH<sub>2</sub>), 50.5 (CH<sub>2</sub>), 53.7 (2 × CH<sub>2</sub>), 55.3 (CH<sub>3</sub>), 55.5 (CH<sub>3</sub>), 55.7 (CH<sub>3</sub>), 57.2 (CH<sub>2</sub>), 59.4 (CH<sub>2</sub>), 111.3 (CH), 113.3 (CH), 114.8 (2 × CH), 114.9 (CH), 116.8 (2 × CH), 118.4 (CH), 121.0 (CH), 121.3 (CH), 123.0 (CH), 129.8 (CH), 136.7 (C<sub>q</sub>), 141.3 (C<sub>q</sub>), 143.3 (C<sub>q</sub>), 152.3 (C<sub>q</sub>), 154.8 (C<sub>q</sub>), 158.4 (C<sub>q</sub>), 159.9 (C<sub>q</sub>); HRMS (ESI): calcd for C<sub>30</sub>H<sub>40</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 534.3075; found, 534.3071; IR (NaCl) ν (cm<sup>–1</sup>): 2939 (w), 2832 (w), 2360 (m), 2342 (m), 1671 (m), 1508 (s), 1455 (m), 1242 (s), 1029 (m), 750 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 19.9 nm, purity: 97%.</div></div><div id="sec4_2_5_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> 2-(4-Cyanobenzyl)-2-(4-methoxyphenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>36</b>)</h5><div class="NLM_p last">Compound <b>36</b> was prepared from 2-(4-methoxyphenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12h</b>) (146 μmol, 60.0 mg) and 4-(bromomethyl)benzonitrile (<b>13f</b>) (1.46 mmol, 286 mg) according to GP 4. Purification by column chromatography (chloroform/methanol = 20:1 → 10:1) gave <b>36</b> (0.046 mmol, 24.5 mg, 32%) as a yellow oil. <i>R</i><sub>f</sub>: 0.38 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.68 (br s, 2H), 2.46 (br s, 2H), 2.63 (br s, 4H), 2.99 (br s, 4H), 3.25 (d, <i>J</i> = 32.4 Hz, 2H), 3.75 (s, 3H), 3.85 (s, 3H), 4.55 (br s, 2H), 5.99 (br s, 1NH), 6.45 (br s, 1NH), 6.79–6.88 (m, 4H), 6.89–6.97 (m, 3H), 7.01 (ddd, <i>J</i> = 1.6 Hz, <i>J</i> = 6.3 Hz, <i>J</i> = 7.8 Hz, 1H), 7.36 (d, <i>J</i> = 8.3 Hz, 2H), 7.60 (d, <i>J</i> = 8.3 Hz, 2H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.0 (CH<sub>2</sub>), 39.2 (CH<sub>2</sub>), 50.2 (CH<sub>2</sub>), 53.6 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 55.7 (CH<sub>3</sub>), 57.1 (CH<sub>2</sub>), 59.3 (2 × CH<sub>2</sub>), 111.3 (CH), 112.0 (C<sub>q</sub>), 114.9 (2 × CH), 116.9 (CH), 118.4 (CH), 118.6 (C<sub>q</sub>), 121.0 (CH), 123.2 (2 × CH), 129.7 (2 × CH), 132.5 (2 × CH), 140.9 (2 × C<sub>q</sub>), 142.7 (C<sub>q</sub>), 152.3 (C<sub>q</sub>), 155.1 (C<sub>q</sub>), 158.2 (C<sub>q</sub>); HRMS (ESI): calcd for C<sub>30</sub>H<sub>37</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 529.2922; found, 529.2905; IR (NaCl) ν (cm<sup>–1</sup>): 2939 (m), 2832 (m), 2228 (m) 1671 (s), 1530 (s), 1508 (s), 1464 (m), 1453 (m), 1243 (s), 1028 (m), 826 (m), 750 (m), 735 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 16.3, purity: 98%.</div></div><div id="sec4_2_5_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> 2-Allyl-2-(4-methoxyphenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>37</b>)</h5><div class="NLM_p last">Compound <b>37</b> was prepared from 2-(4-methoxyphenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12h</b>) (122 μmol, 50.0 mg) and 3-iodoprop-1-ene (<b>13h</b>) (610 μmol, 55.4 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 20:1 → 10:1) gave <b>37</b> (44.5 μmol, 20.2 mg, 37%) as a lightly yellow oil. <i>R</i><sub>f</sub>: 0.3 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.74 (p, <i>J</i> = 6.4 Hz, 2H), 2.50 (t, <i>J</i> = 6.5 Hz, 2H), 2.61 (br s, 4H), 2.93 (br s, <i>J</i> = 62.3 Hz, 4H), 3.31–3.42 (m, 2H), 3.75 (s, 3H), 3.84 (s, 3H), 5.03–5.11 (m, 1H), 5.21–5.26 (m, 1H), 5.39 (br s, 1H), 5.78 (ddt, <i>J</i> = 6.5 Hz, <i>J</i> = 10.1 Hz, <i>J</i> = 16.6 Hz, 1H), 6.68–6.72 (m, 2H), 6.72–6.76 (m, 1H), 6.77–6.82 (m, 2H), 6.82–6.85 (m, 1H), 6.89 (td, <i>J</i> = 1.5 Hz, <i>J</i> = 7.6 Hz, 1H), 6.99 (tt, <i>J</i> = 2.7 Hz, <i>J</i> = 11.7 Hz, 1H), 7.03 (t, <i>J</i> = 5.3 Hz, 1H), two protons are missing likely due to rotation effects; <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.3 (2 × CH<sub>2</sub>), 40.2 (CH<sub>2</sub>), 50.3 (CH<sub>2</sub>), 53.7 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 55.7 (CH<sub>3</sub>), 57.7 (CH<sub>2</sub>), 111.2 (CH), 115.0 (2 × CH), 116.2 (2 × CH), 118.4 (CH), 119.6 (CH<sub>2</sub>), 121.0 (CH), 123.0 (CH), 132.4 (CH), 138.9 (C<sub>q</sub>), 141.2 (C<sub>q</sub>), 152.3 (C<sub>q</sub>), 155.1 (C<sub>q</sub>), 159.1 (C<sub>q</sub>), one C atom is missing, possibly because of rotation effects; HRMS (ESI): calcd for C<sub>25</sub>H<sub>36</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 454.2813; found, 454.2805; IR (NaCl) ν (cm<sup>–1</sup>): 3410 (w), 3267 (w), 2939 (m), 2831 (m), 1653 (m), 1596 (w), 1529 (m), 1509 (s), 1501 (s), 1464 (m), 1453 (m), 1240 (s), 1030 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 16.0 min, purity: 99%.</div></div><div id="sec4_2_5_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> 2-(4-Methoxyphenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)-2-(2-methylallyl)hydrazine-1-carboxamide (<b>38</b>)</h5><div class="NLM_p last">Compound <b>38</b> was prepared from 2-(4-methoxyphenyl)-<i>N</i>-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>11h</b>) (122 μmol, 50.0 mg) and 3-bromo-2-methylprop-1-ene (<b>13i</b>) (610 μmol, 61.5 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 20:1) gave <b>38</b> (30.2 μmol, 14.1 mg, 25%) as a light yellow oil. <i>R</i><sub>f</sub>: 0.6 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ (ppm) 1.71 (s, 3H), 1.77 (br s, 2H), 2.52 (br s, 2H), 2.63 (br s, 4H), 2.96 (br s, 4H), 3.33–3.43 (m, 2H), 3.75 (s, 3H), 3.84 (s, 3H), 4.68 (br s, 1H), 4.93 (br s, 1H), 5.34 (br s, 1H), 6.68–6.72 (m, 2H), 6.76–6.81 (m, 3H), 6.84 (dd, <i>J</i> = 1.2 Hz, <i>J</i> = 8.0 Hz, 1H), 6.88–6.92 (m, 1H), 6.95–7.02 (m, 2H), two protons are missing, likely because of rotation effects; <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ (ppm) 20.5 (CH<sub>3</sub>), 26.4 (2 × CH<sub>2</sub>), 29.8 (CH<sub>2</sub>), 39.9 (CH<sub>2</sub>), 50.1 (CH<sub>2</sub>), 53.6 (2 × CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 55.7 (CH<sub>3</sub>), 57.4 (CH<sub>2</sub>), 111.2 (CH), 113.98 (2 × C<sub>q</sub>), 115.0 (2 × CH), 116.2 (2 × CH), 118.5 (CH), 121.0 (CH), 123.2 (CH), 138.8 (C<sub>q</sub>), 140.4 (C<sub>q</sub>), 152.3 (C<sub>q</sub>), 155.1 (C<sub>q</sub>), 159.2 (C<sub>q</sub>); HRMS (ESI): calcd for C<sub>26</sub>H<sub>38</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 468.2969; found, 468.2956; IR (NaCl) ν (cm<sup>–1</sup>): 3277 (w), 2919 (m), 2831 (m), 1653 (m), 1528 (m), 1509 (s), 1501 (s), 1464 (m), 1240 (s), 1029 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 16.6 min, purity: 99%.</div></div><div id="sec4_2_5_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> 2-Benzyl-<i>N</i>-(3-(4-(4-chlorophenyl)piperazin-1-yl)propyl)-2-phenylhydrazine-1-carboxamide (<b>39</b>)</h5><div class="NLM_p last">Compound <b>39</b> was prepared from <i>N</i>-(3-(4-(4-chlorophenyl)piperazin-1-yl)propyl)-2-phenyldiazene-1-carboxamide (<b>12i</b>) (143 μmol, 55.0 mg) and benzyl bromide (<b>13a</b>) (715 μmol, 84.7 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 100:5) gave <b>39</b> (62.1 μmol, 29.7 mg, 43%) as a colorless oil. An analytical sample was purified using preparative HPLC (5:95 → 95:5 acetonitrile/water + 0.1% formic acid over 18 min, flow rate: 10 mL/min, ZORBAX Eclipse XDB-C8) to yield the desired product <b>39</b>. <i>R</i><sub>f</sub>: 0.3 (chloroform/methanol = 20:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.56–1.68 (m, 2H), 2.36 (td, <i>J</i> = 3.6 Hz, <i>J</i> = 6.5 Hz, 2H), 2.42–2.54 (m, 4H), 2.86–3.05 (m, 4H), 3.12–3.38 (m, 2H), 4.49 (d, <i>J</i> = 14.9 Hz, 1H), 4.68 (d, <i>J</i> = 14.9 Hz, 1H), 5.94 (br s, 1NH), 6.33 (t, <i>J</i> = 5.2 Hz, 1NH), 6.71–6.78 (m, 2H), 6.87–6.94 (m, 1H), 6.97–7.03 (m, 2H), 7.16–7.25 (m, 6H), 7.25–7.33 (m, 3H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.1 (CH<sub>2</sub>), 39.4 (CH<sub>2</sub>), 48.8 (2 × CH<sub>2</sub>), 53.3 (2 × CH<sub>2</sub>), 57.2 (CH<sub>2</sub>), 58.1 (CH<sub>2</sub>), 114.7 (2 × CH), 117.3 (2 × CH), 121.2 (CH), 124.6 (C<sub>q</sub>), 128.1 (CH), 128.9 (d, <i>J</i> = 2.9 Hz, 4 × CH), 129.0 (2 × CH), 129.6 (2 × CH), 135.2 (C<sub>q</sub>), 149.3 (C<sub>q</sub>), 149.8 (C<sub>q</sub>), 158.3 (C<sub>q</sub>); HRMS (APPI): calcd for C<sub>27</sub>H<sub>33</sub>ClN<sub>5</sub>O [M + H<sup>+</sup>], 478.2368; found, 478.2372;; IR (NaCl) ν (cm<sup>–1</sup>): 2925 (w), 2821 (w), 2359 (w), 1675 (m), 1597 (m), 1496 (s), 1236 (m), 1146 (w), 818 (w), 753 (w); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 17.6 min, purity: 99%.</div></div><div id="sec4_2_5_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> 2-Benzyl-<i>N</i>-(3-(4-(4-bromophenyl)piperazin-1-yl)propyl)-2-phenylhydrazine-1-carboxamide (<b>40</b>)</h5><div class="NLM_p last">Compound <b>40</b> was prepared from <i>N</i>-(3-(4-(4-bromophenyl)piperazin-1-yl)propyl)-2-phenyldiazene-1-carboxamide (<b>12j</b>) (171 μmol, 73.7 mg) and benzyl bromide (<b>13a</b>) (855 μmol, 102 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 100:3 → 100:5) gave <b>40</b> (124 μmol, 64.6 mg, 73%) as a light yellow oil. An analytical sample was purified using preparative HPLC (5:95 → 95:5 acetonitrile/water + 0.1% formic acid over 18 min, flow rate: 10 mL/min, ZORBAX Eclipse XDB-C8) to yield the desired product <b>40</b>. <i>R</i><sub>f</sub>: 0.3 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.63 (m, 2H), 2.39 (m, 2H), 2.60–2.44 (m, 4H), 2.88–3.08 (m, 4H), 3.13–3.42 (m, 2H), 4.49 (d, <i>J</i> = 14.9 Hz, 1H), 4.69 (d, <i>J</i> = 15.0 Hz, 1H), 5.95 (br s, 1NH), 6.33 (br s, 1NH), 6.67–6.73 (m, 2H), 6.88–6.93 (m, 1H), 6.98–7.03 (m, 2H), 7.18–7.25 (m, 4H), 7.27–7.37 (m, 5H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.1 (CH<sub>2</sub>), 39.3 (CH<sub>2</sub>), 48.6 (2 × CH<sub>2</sub>), 53.1 (2 × CH<sub>2</sub>), 57.1 (CH<sub>2</sub>), 58.1 (CH<sub>2</sub>), 111.9 (C<sub>q</sub>), 114.7 (2 × CH), 117.7 (2 × CH), 121.2 (CH), 128.1 (CH), 128.9 (4 × CH), 129.6 (2 × CH), 131.9 (2 × CH), 135.2 (C<sub>q</sub>), 149.3 (C<sub>q</sub>), 150.2 (C<sub>q</sub>), 158.3 (C<sub>q</sub>); HRMS (ESI): calcd for C<sub>27</sub>H<sub>34</sub>BrN<sub>5</sub>O [M + H]<sup>+</sup>, 522.1863; found, 522.1866; IR (NaCl) ν (cm<sup>–1</sup>): 2925 (w), 2822 (w), 1674 (s), 1533 (m), 1495 (s), 1455 (m), 1237 (s), 814 (m), 752 (m), 695 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 17.5 min, purity: 100%.</div></div><div id="sec4_2_5_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> 2-Benzyl-2-phenyl-<i>N</i>-(3-(4-(pyrimidin-2-yl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>41</b>)</h5><div class="NLM_p last">Compound <b>41</b> was prepared from 2-phenyl-<i>N</i>-(3-(4-(pyrimidin-2-yl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12k</b>) (200 μmol, 70.0 mg) and benzyl bromide (<b>13a</b>) (1.00 mmol, 119 μL) according to GP 4. Purification by column chromatography using preparative HPLC (5:95 → 95:5 acetonitrile/water + 0.1% formic acid over 30 min, flow rate: 10 mL/min, ZORBAX Eclipse XDB-C8) gave the desired product <b>41</b> (40.6 μmol, 18.1 mg, 20%) as a slightly orange oil. <i>R</i><sub>f</sub>: 0.4 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.72 (p, <i>J</i> = 6.7 Hz, 2H), 2.51 (t, <i>J</i> = 7.1 Hz, 2H), 2.57–2.73 (m, 4H), 3.13–3.30 (m, 2H), 3.72–3.94 (m, 4H), 4.54 (d, <i>J</i> = 14.7 Hz, 1H), 4.68 (d, <i>J</i> = 14.8 Hz, 1H), 6.24 (br s, 2NH), 6.54 (t, <i>J</i> = 4.7 Hz, 1H), 6.93 (t, <i>J</i> = 7.3 Hz, 1H), 7.04 (dd, <i>J</i> = 0.9 Hz, <i>J</i> = 8.7 Hz, 2H), 7.21–7.37 (m, 7H), 8.30–8.36 (m, 2H); <sup>13</sup>C NMR (151 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 25.6 (CH<sub>2</sub>), 38.3 (CH<sub>2</sub>), 42.5 (2 × CH<sub>2</sub>), 52.5 (2 × CH<sub>2</sub>), 55.9 (CH<sub>2</sub>), 58.6 (CH<sub>2</sub>), 110.6 (CH), 114.9 (CH), 121.5 (CH), 128.1 (CH), 128.9 (2 × CH), 129.0 (2 × CH), 129.6 (2 × CH), 135.5 (C<sub>q</sub>), 149.3 (C<sub>q</sub>), 157.9 (2 × CH), 158.6 (C<sub>q</sub>), 161.5 (C<sub>q</sub>), 166.3 (CH); HRMS (ESI): calcd for C<sub>25</sub>H<sub>32</sub>N<sub>7</sub>O [M + H]<sup>+</sup>, 446.2663; found, 446.2663; IR (NaCl) ν (cm<sup>–1</sup>): 2939 (w), 2360 (m), 2342 (m), 1675 (m), 1585 (s), 1546 (s), 1497 (s), 1360 (m), 1260 (m), 984 (m), 751 (m), 702 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 15.6 min, purity: 96%.</div></div><div id="sec4_2_5_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> <i>N</i>-(3-(4-(4-Chlorophenyl)piperazin-1-yl)propyl)-2-(4-fluorobenzyl)-2-phenylhydrazine-1-carboxamide (<b>42</b>)</h5><div class="NLM_p last">Compound <b>42</b> was prepared from <i>N</i>-(3-(4-(4-chlorophenyl)piperazin-1-yl)propyl)-2-phenyldiazene-1-carboxamide (<b>12i</b>) (123 μmol, 47.6 mg) and 1-(bromomethyl)-4-fluorobenzene (<b>13b</b>) (615 μmol, 76.5 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 100:3 → 100:5) gave <b>42</b> (94.8 μmol, 47.0 mg, 77%) as a slightly yellow oil. An analytical sample was purified using preparative HPLC (5:95 → 95:5 acetonitrile/water + 0.1% formic acid over 18 min, flow rate: 10 mL/min, ZORBAX Eclipse XDB-C8) to yield the desired product <b>42</b>. <i>R</i><sub>f</sub>: 0.4 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.66 (br s, 2H), 2.42 (m, 6H), 3.01 (m, 4H), 3.13–3.40 (m, 2H), 4.47 (d, <i>J</i> = 14.7 Hz, 1H), 4.64 (d, <i>J</i> = 14.8 Hz, 1H), 5.84 (br s, 1NH), 6.35 (br s, 1NH), 6.72–6.79 (m, 2H), 6.89–7.03 (m, 5H), 7.17–7.25 (m, 6H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.1 (CH<sub>2</sub>), 39.3 (CH<sub>2</sub>), 48.7 (2 × CH<sub>2</sub>), 53.2 (2 × CH<sub>2</sub>), 57.0 (CH<sub>2</sub>), 57.5 (CH<sub>2</sub>), 114.9 (2 × CH), 115.8 (d, <i>J</i><sub>CF</sub> = 21.4 Hz, 2 × CH), 117.3 (2 × CH), 121.5 (CH), 124.6 (C<sub>q</sub>), 129.0 (2 × CH), 129.7 (2 × CH), 130.8 (d, <i>J</i><sub>CF</sub> = 8.1 Hz, 2 × CH), 131.0 (d, <i>J</i><sub>CF</sub> = 3.3 Hz, C<sub>q</sub>), 149.1 (C<sub>q</sub>), 149.8 (C<sub>q</sub>), 158.3 (C<sub>q</sub>), 162.6 (d, <i>J</i><sub>CF</sub> = 246.9 Hz, C<sub>q</sub>); HRMS (ESI): calcd for C<sub>27</sub>H<sub>31</sub>ClFN<sub>5</sub>O [M + H]<sup>+</sup>, 496.2274; found, 496.2290; IR (NaCl) ν (cm<sup>–1</sup>): 2923 (w), 2823 (w), 1670 (m), 1598 (m), 1509 (m), 1496 (s), 1223 (m), 818 (m), 753 (w), 692 (w); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 17.7 min, purity: 100%.</div></div><div id="sec4_2_5_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80"> <i>N</i>-(3-(4-(4-Bromophenyl)piperazin-1-yl)propyl)-2-(4-fluorobenzyl)-2-phenylhydrazine-1-carboxamide (<b>43</b>)</h5><div class="NLM_p last">Compound <b>43</b> was prepared from <i>N</i>-(3-(4-(4-bromophenyl)piperazin-1-yl)propyl)-2-phenyldiazene-1-carboxamide (<b>12j</b>) (159 μmol, 68.3 mg) and 1-(bromomethyl)-4-fluorobenzene (<b>13b</b>) (795 μmol, 98.9 μL) according to GP 4. Purification by column chromatography (chloroform/methanol = 100:3 → 100:5) gave <b>43</b> (37.6 μmol, 20.3 mg, 24%) as a colorless oil. An analytical sample was purified using preparative HPLC (5:95 → 95:5 acetonitrile/water + 0.1% formic acid over 18 min, flow rate: 10 mL/min, ZORBAX Eclipse XDB-C8) to yield the desired product <b>43</b>. <i>R</i><sub>f</sub>: 0.4 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.71–1.84 (m, 2H), 2.63–2.74 (m, 2H), 2.90 (br s, <i>J</i> = 3.8 Hz, 4H), 3.23 (br s, 6H), 4.55 (d, <i>J</i> = 10.5 Hz, 2H), 6.49 (br s, 1NH), 6.27 (br s, 1NH), 6.71–6.78 (m, 2H), 6.92–7.07 (m, 5H), 7.20–7.32 (m, 4H), 7.35–7.40 (m, 2H); <sup>13</sup>C NMR (151 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.2 (CH<sub>2</sub>), 39.5 (CH<sub>2</sub>), 48.7 (2 × CH<sub>2</sub>), 53.3 (2 × CH<sub>2</sub>), 57.2 (CH<sub>2</sub>), 57.5 (CH<sub>2</sub>), 111.8 (C<sub>q</sub>), 114.9 (2 × CH), 115.8 (d, <i>J</i><sub>CF</sub> = 21.5 Hz, 2 × CH), 117.7 (2 × CH), 121.5 (CH), 129.7 (2 × CH), 130.8 (d, <i>J</i><sub>CF</sub> = 8.1 Hz, 2 × CH), 131.0 (d, <i>J</i><sub>CF</sub> = 3.3 Hz, C<sub>q</sub>), 131.9 (2 × CH), 149.1 (C<sub>q</sub>), 150.3 (C<sub>q</sub>), 158.2 (C<sub>q</sub>), 162.6 (d, <i>J</i><sub>CF</sub> = 247.0 Hz, C<sub>q</sub>); HRMS (ESI): calcd for C<sub>27</sub>H<sub>32</sub>BrFN<sub>5</sub>O [M + H]<sup>+</sup>, 540.176877; found, 540.175954; IR (NaCl) ν (cm<sup>–1</sup>): 2925 (m), 2359 (m), 1663 (s), 1617 (m), 1508 (s), 1495 (s), 1235 (m), 817 (w), 752 (w), 720 (w); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 17.9 min, purity: 99%.</div></div><div id="sec4_2_5_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i81" class="anchor-spacer"></div><h5 class="article-section__title" id="_i81"> 2-(4-Fluorobenzyl)-2-phenyl-<i>N</i>-(3-(4-(pyrimidin-2-yl)piperazin-1-yl)propyl)hydrazine-1-carboxamide (<b>44</b>)</h5><div class="NLM_p last">Compound <b>44</b> was prepared from 2-phenyl-<i>N</i>-(3-(4-(pyrimidin-2-yl)piperazin-1-yl)propyl)diazene-1-carboxamide (<b>12k</b>) (200 μmol, 70.0 mg) and 1-(bromomethyl)-4-fluorobenzene (<b>13b</b>) (1.00 mmol, 125 μL) according to GP 4. Purification by column chromatography using preparative HPLC (5:95 → 95:5 acetonitrile/water + 0.1% formic acid over 30 min, flow rate: 10 mL/min, ZORBAX Eclipse XDB-C8) gave the desired product <b>44</b> (75.9 μmol, 35.2 mg, 38%) as a slightly yellow oil. <i>R</i><sub>f</sub>: 0.4 (chloroform/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.59–1.72 (m, 2H), 2.34–2.52 (m, 6H), 3.23 (ddd, <i>J</i> = 14.3 Hz, <i>J</i> = 20.1 Hz, <i>J</i> = 34.5 Hz, 2H), 3.68 (d, <i>J</i> = 29.2 Hz, 4H), 4.48 (d, <i>J</i> = 14.7 Hz, 1H), 4.67 (d, <i>J</i> = 14.7 Hz, 1H), 5.98 (br s, 1NH), 6.31 (br s, 1NH), 6.51 (t, <i>J</i> = 4.7 Hz, 1H), 6.86–7.07 (m, 4H), 7.17–7.29 (m, 5H),8.30 (t, <i>J</i> = 6.1 Hz, 2H); <sup>13</sup>C NMR (151 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.1 (CH<sub>2</sub>), 43.3 (CH<sub>2</sub>), 53.1 (2 × CH<sub>2</sub>), 56.8 (CH<sub>2</sub>), 57.6 (CH<sub>2</sub>), 70.7 (2 × CH<sub>2</sub>), 110.2 (CH), 114.9 (2 × CH), 115.8 (d, <i>J</i><sub>CF</sub> = 21.4 Hz, 2 × CH), 121.5 (CH), 129.6 (2 × CH), 130.7 (d, <i>J</i><sub>CF</sub> = 8.1 Hz, 2 × CH), 131.1 (d, <i>J</i><sub>CF</sub> = 2.6 Hz, C<sub>q</sub>), 149.1 (C<sub>q</sub>), 157.8 (2 × CH), 158.2 (C<sub>q</sub>), 161.7 (C<sub>q</sub>), 162.6 (d, <i>J</i><sub>CF</sub> = 246.9 Hz, C<sub>q</sub>); HRMS (ESI): calcd for C<sub>25</sub>H<sub>31</sub>FN<sub>7</sub>O [M + H]<sup>+</sup>, 464.2569; found, 464.2572; IR (NaCl) ν (cm<sup>–1</sup>): 2927 (w), 1675 (m), 1585 (s), 1510 (s), 1447 (m), 1360 (s), 1260 (m), 1222 (m), 984 (m), 752 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 16.2 min, purity: 100%.</div></div><div id="sec4_2_5_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> 2-Benzyl-<i>N</i>-(2-(4-(4-bromophenyl)piperazin-1-yl)ethyl)-2-phenylhydrazine-1-carboxamide (<b>45</b>)</h5><div class="NLM_p last">Compound <b>45</b> was prepared from <i>N</i>-(2-(4-(4-bromophenyl)piperazin-1-yl)ethyl)-2-phenyldiazene-1-carboxamide (<b>12l</b>) (168 μmol, 70.0 mg) and benzyl bromide (<b>13a</b>) (840 μmol, 99.3 μL) according to GP 4. Purification by column chromatography (methylene chloride/methanol = 17:1) gave <b>45</b> (30.0 μmol, 15.5 mg, 18%) as a yellow oil. <i>R</i><sub>f</sub>: 0.4 (methylene chloride/methanol = 17:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 2.36–2.63 (m, 6H), 2.90–3.11 (m, 4H), 3.24–3.38 (m, 2H), 4.53 (d, <i>J</i> = 15.0 Hz, 1H), 4.70 (d, <i>J</i> = 15.0 Hz, 1H), 6.05 (br s, 1NH), 6.12 (br s, 1NH), 6.70–6.76 (m, 2H), 6.91–6.97 (m, 1H), 7.00–7.05 (m, 2H), 7.22–7.30 (m, 7H), 7.32–7.36 (m, 2H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 36.4 (CH<sub>2</sub>), 48.9 (2 × CH<sub>2</sub>), 52.7 (2 × CH<sub>2</sub>), 56.9 (CH<sub>2</sub>), 58.8 (CH<sub>2</sub>), 112.1 (C<sub>q</sub>), 114.9 (2 × CH), 117.8 (2 × CH), 121.4 (CH), 128.0 (CH), 128.6 (2 × CH), 128.9 (2 × CH), 129.5 (2 × CH), 132.0 (2 × CH), 135.7 (C<sub>q</sub>), 149.3 (C<sub>q</sub>), 150.2 (C<sub>q</sub>), 158.2 (C<sub>q</sub>); HRMS (APPI): calcd for C<sub>26</sub>H<sub>31</sub>BrN<sub>5</sub>O [M + H]<sup>+</sup>, 508.1706; found, 508.1711; IR (NaCl) ν (cm<sup>–1</sup>): 2942 (m), 2823 (m), 2239 (w), 1671 (s), 1494 (s), 1234 (s), 1150 (m), 911 (m), 811 (m), 733 (s); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 17.7 min, purity: 98%.</div></div><div id="sec4_2_5_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> 2-Benzyl-<i>N</i>-(3-(4-(4-iodophenyl)piperazin-1-yl)propyl)-2-phenylhydrazine-1-carboxamide (<b>46</b>)</h5><div class="NLM_p last">Compound <b>46</b> was prepared from <i>N</i>-(3-(4-(4-iodophenyl)piperazin-1-yl)propyl)-2-phenyldiazene-1-carboxamide (<b>12m</b>) (158 μmol, 75.4 mg) and benzyl bromide (<b>13a</b>) (790 μmol, 93.8 μL) according to GP 4. Purification by column chromatography (methylene chloride/methanol = 10:1) gave <b>46</b> (54.4 μmol, 31.0 mg, 34%) as a slightly yellow oil. An analytical sample was purified using preparative HPLC (5:95 → 95:5 acetonitrile/water + 0.1% formic acid over 18 min, flow rate: 10 mL/min, ZORBAX Eclipse XDB-C8) to yield the desired product <b>46</b>. <i>R</i><sub>f</sub>: 0.5 (methylene chloride/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.62–1.74 (m, 2H), 2.48 (dd, <i>J</i> = 6.4 Hz, <i>J</i> = 12.2 Hz, 2H), 2.59–2.71 (m, 4H), 3.00–3.36 (m, 6H), 4.51 (d, <i>J</i> = 14.8 Hz, 1H), 4.67 (d, <i>J</i> = 14.8 Hz, 1H), 6.14 (br s, 1NH), 6.29 (br s, 1NH), 6.55–6.67 (m, 2H), 6.92 (t, <i>J</i> = 7.3 Hz, 1H), 7.02 (d, <i>J</i> = 8.0 Hz, 2H), 7.20–7.35 (m, 7H), 7.48–7.58 (m, 2H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 26.0 (CH<sub>2</sub>), 39.2 (CH<sub>2</sub>), 48.2 (2 × CH<sub>2</sub>), 53.1 (2 × CH<sub>2</sub>), 57.0 (CH<sub>2</sub>), 58.1 (CH<sub>2</sub>), 81.7 (C<sub>q</sub>), 114.7 (2 × CH), 118.2 (2 × CH), 121.2 (CH), 128.1 (CH), 128.9 (4 × CH), 129.6 (2 × CH), 135.2 (C<sub>q</sub>), 137.8 (2 × CH), 149.3 (C<sub>q</sub>), 150.6 (C<sub>q</sub>), 158.3 (C<sub>q</sub>); HRMS (APPI): calcd for C<sub>27</sub>H<sub>33</sub>IN<sub>5</sub>O [M + H<sup>+</sup>], 570.1724; found, 570.1729; IR (NaCl) ν (cm<sup>–1</sup>): 2927 (m), 1671 (s), 1598 (s), 1588 (s), 1531 (s), 1494 (s), 1453 (s), 1244 (m), 755 (m), 697 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 17.3 min, purity: 100%.</div></div><div id="sec4_2_5_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i84" class="anchor-spacer"></div><h5 class="article-section__title" id="_i84"> 2-Benzyl-<i>N</i>-(2-(4-(4-iodophenyl)piperazin-1-yl)ethyl)-2-phenylhydrazine-1-carboxamide (<b>47</b>)</h5><div class="NLM_p last">Compound <b>47</b> was prepared from <i>N</i>-(2-(4-(4-iodophenyl)piperazin-1-yl)ethyl)-2-phenyldiazene-1-carboxamide (<b>12n</b>) (151 μmol, 70.0 mg) and benzyl bromide (<b>13a</b>) (755 μmol, 89.6 μL) according to GP 4. Purification by column chromatography (methylene chloride/methanol = 15:1 → 10:1) gave <b>47</b> (58.3 μmol, 32.4 mg, 39%) as a yellow oil. An analytical sample was purified using preparative HPLC (5:95 → 95:5 acetonitrile/water + 0.1% formic acid over 18 min, flow rate: 10 mL/min, ZORBAX Eclipse XDB-C8) to yield the desired product <b>47</b>. <i>R</i><sub>f</sub>: 0.4 (methylene chloride/methanol = 10:1) [UV]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 2.44 (dd, <i>J</i> = 5.8, 9.6 Hz, 2H), 2.49–2.61 (m, 4H), 2.91–3.11 (m, 4H), 3.23–3.37 (m, 2H), 4.53 (d, <i>J</i> = 14.9 Hz, 1H), 4.68 (d, <i>J</i> = 14.9 Hz, 1H), 6.09–6.17 (m, 2H), 6.59–6.67 (m, 2H), 6.94 (t, <i>J</i> = 7.3 Hz, 1H), 7.02 (d, <i>J</i> = 7.9 Hz, 2H), 7.19–7.37 (m, 7H), 7.46–7.56 (m, 2H); <sup>13</sup>C NMR (101 MHz, DEPTQ, CDCl<sub>3</sub>): δ (ppm) 36.4 (CH<sub>2</sub>), 48.6 (2 × CH<sub>2</sub>), 52.6 (2 × CH<sub>2</sub>), 56.9 (CH<sub>2</sub>), 58.8 (CH<sub>2</sub>), 81.7 (C<sub>q</sub>), 114.9 (2 × CH), 118.2 (2 × CH), 121.4 (CH), 128.0 (CH), 128.6 (2 × CH), 128.9 (2 × CH), 129.6 (2 × CH), 135.7 (C<sub>q</sub>), 137.9 (2 × CH), 149.26 (C<sub>q</sub>), 150.8 (C<sub>q</sub>), 158.2 (C<sub>q</sub>); HRMS (ESI): calcd for [M + H]<sup>+</sup>, 556.1574; found, 556.1578; IR (NaCl) ν (cm<sup>–1</sup>): 2849 (w), 2364 (w), 1676 (s), 1593 (s), 1536 (s), 1494 (s), 1453 (s), 1228 (m), 817 (m), 755 (m), 697 (m); HPLC: 254 nm, <i>t</i><sub>r</sub> (min) = 18.1 min, purity: 100%.</div></div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Receptor Binding Studies</h3><div class="NLM_p">Radioligand binding studies with the subtypes of the D<sub>2</sub> receptor family were performed as described previously.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> In brief, competition binding experiments were done using membranes of CHO cells stably expressing the human D<sub>2L</sub>, D<sub>2S</sub>,<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> D<sub>3</sub>,<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> or D<sub>4.4</sub><a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> receptor. Radioligand displacement assays were run in binding buffer (25 mM HEPES, 5 mM MgCl<sub>2</sub>, 1 mM EDTA, 0.006% BSA at a pH of 7.4) with [<sup>3</sup>H]spierone (specific activity = 79 Ci/mmol, PerkinElmer, Rodgau, Germany) at final concentrations of 0.20–0.30 nM. The assays were carried out at protein concentrations of 4–6 μg/assay tube, a <i>B</i><sub>max</sub> value of 1800 ± 120 fmol/μg, a <i>K</i><sub>D</sub> value of 0.11 ± 0.026 nM for D<sub>2L</sub>, of 1 μg protein/assay tube, <i>B</i><sub>max</sub> of 7800 ± 2100 fmol/μg, <i>K</i><sub>D</sub> of 0.083 ± 0.017 nM for D<sub>2S</sub>, of 2–4 μg protein/assay tube, <i>B</i><sub>max</sub> of 2900 ± 480 fmol/μg, <i>K</i><sub>D</sub> of 0.11 ± 0.021 nM for D<sub>3</sub>, and of 6–10 μg protein/assay tube, <i>B</i><sub>max</sub> of 1100 ± 110 fmol/μg, <i>K</i><sub>D</sub> of 0.19 ± 0.024 nM for D<sub>4.4</sub>, respectively. Unspecific binding was determined in the presence of 10 μM haloperidol, and protein concentration was established by the method of Lowry using bovine serum albumin as standard.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Competition binding experiments with GPCRs related to D<sub>2</sub>–D<sub>4</sub> were performed in an analogous manner with membranes from HEK293T cells transiently transfected with the corresponding cDNA by using the Mirus TransIT-293 transfection reagent (PeqLab, Erlangen, Germany) or a solution of polyethylenimine in PBS (PEI, linear 25 kDa, Polysciences, 1 mg/mL) as transfection reagent at a 3:1 PEI to cDNA ratio.<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79,80)</a> Binding to the dopamine receptors D<sub>1</sub> and D<sub>5</sub> was performed with the radioligand [<sup>3</sup>H]SCH23390 (60 Ci/mmol, Biotrend, Cologne, Germany) at a final concentration of 0.30 nM, <i>K</i><sub>D</sub> of 0.23 nM, <i>B</i><sub>max</sub> of 1200 fmol/mg, and 2 μg protein/well for D<sub>1</sub>, and of 0.50 nM, <i>K</i><sub>D</sub> of 0.50 nM, <i>B</i><sub>max</sub> of 1700 fmol/mg, and 6 μg protein/well for D<sub>5</sub>, respectively. Affinities to adrenergic receptors were determined applying [<sup>3</sup>H]prazosin (84 Ci/mmol, Biotrend) at 0.20 nM, <i>K</i><sub>D</sub> of 0.095 nM, <i>B</i><sub>max</sub> of 7500 fmol/mg, and 2 μg protein/well for α<sub>1A</sub>, [<sup>3</sup>H]RX821002 (57 Ci/mmol, PerkinElmer) at 0.30 nM, <i>K</i><sub>D</sub> of 0.29 nM, <i>B</i><sub>max</sub> of 900 fmol/mg, and 10 μg protein/well for α<sub>2A</sub>, [<sup>3</sup>H]CGP12177 (34 Ci/mmol, Biotrend) at 0.30 nM, <i>K</i><sub>D</sub> of 0.25 nM, <i>B</i><sub>max</sub> of 4000 fmol/mg, and 3 μg protein/well for β<sub>1</sub>, and [<sup>3</sup>H]CGP12177 (34 Ci/mmol, Biotrend) at 0.30 nM, <i>K</i><sub>D</sub> of 0.060 nM, <i>B</i><sub>max</sub> of 4000 fmol/mg, and 3 μg protein/well for β<sub>2</sub>, respectively. Opioid receptor binding was performed with the radioligand [<sup>3</sup>H]diprenorphine (31 Ci/mmol, PerkinElmer) at 0.30 nM and a <i>K</i><sub>D</sub> of 0.25 nM, <i>B</i><sub>max</sub> of 1700 fmol/mg and 8 μg protein/well for δOR, <i>K</i><sub>D</sub> of 0.13 nM, <i>B</i><sub>max</sub> of 6500 fmol/mg and 2 μg protein/well for κOR, and <i>K</i><sub>D</sub> of 0.095 nM, <i>B</i><sub>max</sub> of 4000 fmol/mg and 3 μg protein/well for μOR, respectively. Affnities to the muscarinic receptors M<sub>1</sub>, M<sub>2</sub>, and M<sub>3</sub> were determined with [<sup>3</sup>H]NMS (80 Ci/mmol, Biotrend) at 0.30 nM and a <i>K</i><sub>D</sub> of 0.12 nM, <i>B</i><sub>max</sub> of 2500 fmol/mg, and 2 μg protein/well for M<sub>1</sub>, <i>K</i><sub>D</sub> of 0.25 nM, <i>B</i><sub>max</sub> of 500 fmol/mg, and 10 μg protein/well for M<sub>2</sub>, and a <i>K</i><sub>D</sub> of 0.14 nM, <i>B</i><sub>max</sub> of 3500 fmol/mg, and 3 μg protein/well for M<sub>3</sub>, respectively. Serotonin receptor binding was measured with [<sup>3</sup>H]WAY100635 (80 Ci/mmol, Biotrend) at 0.20 nM, <i>K</i><sub>D</sub> of 0.10 nM, <i>B</i><sub>max</sub> of 3000 fmol/mg, and 2 μg protein/well for 5-HT<sub>1A</sub>, and [<sup>3</sup>H]ketanserin (47 Ci/mmol, Biotrend) at 0.30 nM, <i>K</i><sub>D</sub> of 0.17 nM, <i>B</i><sub>max</sub> of 1400 fmol/mg and 7 μg protein/well for 5-HT<sub>1A</sub>, respectively.</div><div class="NLM_p last">The resulting competition curves of the receptor binding experiments were analyzed by nonlinear regression using the algorithms in PRISM 6.0 (GraphPad Software, San Diego, CA). The data were initially fit using a sigmoid model to provide an IC<sub>50</sub> value, representing the concentration corresponding to 50% of maximal inhibition. IC<sub>50</sub> values were transformed to <i>K</i><sub>i</sub> values according to the equation of Cheng and Prusoff.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> Accumulation of Inositol Monophosphate (IP-One Assay)</h3><div class="NLM_p last">Determination of the activation of the dopamine D<sub>4</sub> receptor and the adrenergic α1A receptor was measured applying the IP-One HTRF assay (Cisbio, Codolet, France) according to the manufacturer’s protocol and as described previously.<a onclick="showRef(event, 'ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref82 ref83">(82,83)</a> In brief, HEK-293T cells were grown to a confluence of approx. 70% and transiently co-transfected with the cDNA of the human D4R (from the cDNA Resource Center, Bloomberg, PA) and of the hybrid G-protein Gα<sub>qi</sub> (Gα<sub>q</sub> protein with the last five amino acids at the C-terminus replaced by the corresponding sequence of Gα<sub>i</sub>; gift from The J. David Gladstone Institutes, San Francisco, CA) or transfected with α1AR (cDNA Resource Center, Bloomberg, PA) applying the Mirus TransIT-293 transfection reagent (PeqLab, Erlangen, Germany). After 1 day, cells were detached from the culture dish with Versene (Life Technologies, Darmstadt, Germany), seeded into black 384-well plates (10 000 cells/well) (Greiner Bio-One, Frickenhausen, Germany), and maintained for 24 h at 37 °C. Agonist properties were determined by incubating the test compounds (final range of concentration from 1 pM up to 10 μM) in duplicates for 90 min (D4R) or 60 min (α1AR) at 37 °C. Incubation was stopped by addition of the detection reagents (IP<sub>1</sub>-d2 conjugate and anti-IP<sub>1</sub>cryptate TB conjugate each dissolved in lysis buffer) for further 60 min at room temperature. Time-resolved fluorescence resonance energy transfer (HTRF) was measured using the Clariostar plate reader (BMG, Ortenberg, Germany).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> Arrestin Recruitment Assay (PathHunter Assay)</h3><div class="NLM_p last">Determination of β-arrestin-2 recruitment was performed applying the PathHunter assay (DiscoverX, Birmingham, U.K.) which is based on fragment complementation of β-galactosidase in HEK293 cells stably expressing (EA)-β-arrestin-2 and being transiently transfected with a receptor tagged to the PKA fragment as described.<a onclick="showRef(event, 'ref82 ref84'); return false;" href="javascript:void(0);" class="ref ref82 ref84">(82,84)</a> Cells were transfected with the D4-PKA or the ADRA1A-PK construct employing Mirus TransIT-293 (PeqLab, Erlangen, Germany) and incubated in DMEM/F12 medium (Life Technologies, Darmstadt, Germany) at 37 °C and 5% of CO<sub>2</sub>. After 24 h, cells were detached with Versene (Life Technologies) and transferred into 384-well plates (white plate, transparent bottom, Greiner Bio-One, Frickenhausen, Germany) at a density of 5000 cells/well using the medium CP7 Reagent (DiscoverX). After further 24 h of incubation, test compounds at concentrations from 10 pM to 100 μM dissolved in PBS were added to the cells at a final volume of 25 μL and incubated at 37 °C for 6 h. Antagonist properties at the D4R were determined by preincubation of the cells with the test compound (from 10 nM to 30 μM) for 30 min followed by addition of 300 nM quinpirole (EC<sub>80</sub>) and continuation of incubation for further 6 h. Determination of β-arrestin-2 recruitment was started by adding detection mix, incubation at room temperature for 60 min, and measuring chemoluminescence with a Clariostar plate reader (BMG, Ortenberg, Germany).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Data Analysis of Functional Experiments</h3><div class="NLM_p last">Data analysis of functional experiments was performed by normalizing the raw data relative to basal activity (0%) and the maximum effect of the reference agonist quinpirole (100%). Normalized curves from six individual experiments each done as duplicate were analyzed by nonlinear regression applying the algorithms in Prism 6.0 (GraphPad, San Diego, CA) to get dose–response curves representing average EC<sub>50</sub> and <i>E</i><sub>max</sub> value.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> Operational Model of Agonism</h3><div class="NLM_p last">Quantification of ligand bias was performed using the operational model by Black and Leff.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The calculations were carried out according to recently published protocols (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01085/suppl_file/jm9b01085_si_001.pdf" class="ext-link">Supporting Information</a> for details).<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55,56)</a></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> Metabolism Studies</h3><div class="NLM_p last">Metabolism experiments were performed as described previously in the publication by Hiller et al.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Pooled microsomes of the male rat liver (Sprague-Dawley) were purchased from Sigma-Aldrich and stored at −75 °C. NADPH was purchased from Carl and Roth and stored at −8 °C. The incubation reactions were performed in polyethylene caps (Eppendorf 1.5 mL) at 37 °C. The incubation mixture contained APH199 (<b>17</b>) (20 μM) or imipramine (20 μM), used as positive control, pooled rat liver microsomes (0.5 mg of microsomal protein/mL of incubation mixture), and Tris-MgCl<sub>2</sub> buffer (50 mM Tris and 5.0 mM MgCl<sub>2</sub>, pH 7.4). The final incubation volume was 0.5 mL. Microsomal reactions were started by adding 50 μL of enzyme cofactor solution NADPH (final concentration of 1 mM). After predetermined times of 0, 15, 30, 60, and 120 min, 100 μL samples were drawn from the incubation mixture and the reactions were terminated by adding 100 μL of ice-cold acetonitrile (containing internal standard <b>28</b>; final concentration of 25 μM). After removing precipitated proteins by centrifugation (15 000 rpm, 3 min), the supernatant was analyzed by HPLC/MS (binary solvent system, eluent methanol in 0.1% aqueous formic acid, 10–90% methanol in 15 min, 90% methanol for 4 min, 90–10% in 2 min). All incubations were performed in duplicate. Parallel control experiments were performed in the absence of cofactor NADPH solution to determine unspecific binding to matrix and in the absence of APH199 (<b>17</b>) or imipramine, respectively.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> Molecular Docking Studies</h3><div class="NLM_p last">All ligands for molecular modeling were built using the programs Avogadro (version 1.2.0)<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> and AutoDockTools (version 1.5.6).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> The ligands were protonated at the secondary amine group to receive the protonation state under the physiological pH value. The geometry of each ligand was optimized by energy minimization. For the docking studies, the crystal structures of the human dopamine D<sub>2</sub>, D<sub>3</sub>, and D<sub>4</sub> receptors were used in complex with antagonists risperidone (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CM4">6CM4</a>), eticlopride (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBL">3PBL</a>), and nemonapride (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WIU">5WIU</a>), respectively. The related PDB files were downloaded from the RCSB PDB webpage.<a onclick="showRef(event, 'ref47 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref47 ref62 ref63">(47,62,63)</a> Docking was performed using AutoDock Vina<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> while a search space of 20 × 20 × 20 Å was applied to cover the whole binding pocket, which was defined by the appropriate crystal ligand for each receptor sub type. In order to validate our methods, we reproduced the binding poses of risperidone, eticloprid, and nemonapride in the D<sub>2</sub>, D<sub>3</sub>, and the D<sub>4</sub> receptor, respectively. An exhaustiveness value of 8 was used with randomly selected starting positions. For each ligand, 20 conformations were received and analyzed manually. Considering the scoring function of AutoDock Vina and the presence of the salt bridge to Asp 115<sup>3.32</sup> (D<sub>4</sub> receptor), one plausible conformation was selected for each receptor ligand complex. Visualization of the receptor ligand complexes was accomplished with the PyMOL Molecular Graphics System, Version 1.3 (Schrödinger, LLC).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> PAINS Screening</h3><div class="NLM_p last">SMILES codes were determined for all target compounds using ChemDraw 16.0 (PerkinElmer), and screening for pan assay interference and aggregation liability was performed using the tools and standard filters<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> implemented in the ZINC 15 database.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> The screening (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01085/suppl_file/jm9b01085_si_001.pdf" class="ext-link">Supporting Information</a>) resulted in no detectable PAINS patterns for all semicarbazides <b>14–47</b> and led to warnings for <b>12a–c</b> because of the azo substructure incorporated in these ligands.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i93"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01085" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42338" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42338" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b01085" class="ext-link">10.1021/acs.jmedchem.9b01085</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional docking poses; <sup>1</sup>H and <sup>13</sup>C NMR spectra of all target compounds <b>12a–c</b>, <b>14–47</b> and HPLC purity analysis data; calculation of bias factors; and PAINS screening results (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01085/suppl_file/jm9b01085_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01085/suppl_file/jm9b01085_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Additional compound information such as the compound ID, the related SMILES code and the biological data based on the binding studies (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01085/suppl_file/jm9b01085_si_003.xlsx" class="ext-link">XLSX</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01085/suppl_file/jm9b01085_si_001.pdf">jm9b01085_si_001.pdf (10.58 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01085/suppl_file/jm9b01085_si_002.csv">jm9b01085_si_002.csv (8.66 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01085/suppl_file/jm9b01085_si_003.xlsx">jm9b01085_si_003.xlsx (15.97 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01085" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus R. Heinrich</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry and Pharmacy,
Medicinal Chemistry, Friedrich-Alexander-Universität
Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7113-2025" title="Orcid link">http://orcid.org/0000-0001-7113-2025</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8ae7ebf8e1fff9a4e2efe3e4f8e3e9e2caecebffa4eeef"><span class="__cf_email__" data-cfemail="3b565a49504e4815535e5255495258537b5d5a4e155f5e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna S. Pirzer</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry and Pharmacy,
Medicinal Chemistry, Friedrich-Alexander-Universität
Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roman Lasch</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry and Pharmacy,
Medicinal Chemistry, Friedrich-Alexander-Universität
Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heike Friedrich</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry and Pharmacy,
Medicinal Chemistry, Friedrich-Alexander-Universität
Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harald Hübner</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry and Pharmacy,
Medicinal Chemistry, Friedrich-Alexander-Universität
Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Gmeiner</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry and Pharmacy,
Medicinal Chemistry, Friedrich-Alexander-Universität
Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4127-197X" title="Orcid link">http://orcid.org/0000-0002-4127-197X</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.S.P. performed the research and modeling studies, designed, synthesized, analyzed the data, and wrote the manuscript. R.L. performed the research and synthesized. H.F. synthesized. H.H. conducted the biological assays, analyzed the data, wrote the manuscript. P.G. analyzed the data. M.R.H. designed the research, analyzed the data, and wrote the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10061" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10061" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors are very grateful for the financial support of this work by the Deutsche Forschungsgemeinschaft (DFG) (HE5413/3-3; GRK910/A1 and B3). A.S.P. would like to thank Maximilian Schmidt and Dr. Dorothée Weikert for helpful discussions related to docking studies and Nina Diesendorf, Azra Pezerovic, Leon Zähnle and Florian Steiger for experimental assistance.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">EBP</td><td class="NLM_def"><p class="first last">extended binding pocket</p></td></tr><tr><td class="NLM_term">TM</td><td class="NLM_def"><p class="first last">transmembrane domain</p></td></tr><tr><td class="NLM_term">OR</td><td class="NLM_def"><p class="first last">opioid receptor</p></td></tr><tr><td class="NLM_term">5-HT</td><td class="NLM_def"><p class="first last">5-hydroxytryptamine</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i97">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 86 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vallone, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picetti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrelli, E.</span></span> <span> </span><span class="NLM_article-title">Structure and function of dopamine receptors</span>. <i>Neurosci. Biobehav. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/s0149-7634(99)00063-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fs0149-7634%2899%2900063-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10654668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtVylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2000&pages=125-132&author=D.+Valloneauthor=R.+Picettiauthor=E.+Borrelli&title=Structure+and+function+of+dopamine+receptors&doi=10.1016%2Fs0149-7634%2899%2900063-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of dopamine receptors</span></div><div class="casAuthors">Vallone, D.; Picetti, R.; Borrelli, E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience and Biobehavioral Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">NBREDE</span>;
        ISSN:<span class="NLM_cas:issn">0149-7634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">This review with 87 refs. focuses on the pharmacol. and biochem. features shared by the dopamine receptors.  Dopamine (DA) is the most abundant catecholamine in the brain.  The involvement and importance of DA as a neurotransmitter in the regulation of different physiol. functions in the central nervous system (CNS) is well known.  Deregulation of the dopaminergic system was linked with Parkinson's disease, Tourette's syndrome, schizophrenia, attention deficit hyperactive disorder (ADHD), and generation of pituitary tumors.  The authors address their coupling to secondary messenger pathways and their physiol. function based upon studies using pharmacol. tools, specific brain lesions and, more recently, genetically modified animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoosy1SXDXa7Vg90H21EOLACvtfcHk0ljYl4uwcPJELQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtVylug%253D%253D&md5=0fa459e1055a9542eebfc06834ad7a72</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fs0149-7634%2899%2900063-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0149-7634%252899%252900063-9%26sid%3Dliteratum%253Aachs%26aulast%3DVallone%26aufirst%3DD.%26aulast%3DPicetti%26aufirst%3DR.%26aulast%3DBorrelli%26aufirst%3DE.%26atitle%3DStructure%2520and%2520function%2520of%2520dopamine%2520receptors%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2000%26volume%3D24%26spage%3D125%26epage%3D132%26doi%3D10.1016%2Fs0149-7634%2899%2900063-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Missale, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">Dopamine receptors: from structure to function</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1152/physrev.1998.78.1.189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1152%2Fphysrev.1998.78.1.189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=9457173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK1cXptlOjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1998&pages=189-225&author=C.+Missaleauthor=S.+R.+Nashauthor=S.+W.+Robinsonauthor=M.+Jaberauthor=M.+G.+Caron&title=Dopamine+receptors%3A+from+structure+to+function&doi=10.1152%2Fphysrev.1998.78.1.189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine receptors: from structure to function</span></div><div class="casAuthors">Missale, Cristina; Nash, S. Russel; Robinson, Susan W.; Jaber, Mohamed; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">189-225</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 481 refs.  The diverse physiol. actions of dopamine are mediated by at least five distinct G protein-coupled receptor subtypes.  Two D1-like receptor subtypes (D1 and D5) couple to the G protein Gs and activate adenylyl cyclase.  The other receptor subtypes belong to the D2-like subfamily (D2, D3, and D4) and are prototypic of G protein-coupled receptors that inhibit adenylyl cyclase and activate K+ channels.  The genes for the D1 and D5 receptors are intron-less, but pseudogenes of the D5 exist.  The D2 and D3 receptors vary in certain tissues and species as a result of alternative splicing, and the human D4 receptor gene exhibits extensive polymorphic variation.  In the central nervous system, dopamine receptors are widely expressed because they are involved in the control of locomotion, cognition, emotion, and affect as well as neuroendocrine secretion.  In the periphery, dopamine receptors are present more prominently in kidney, vasculature, and pituitary, where they affect mainly sodium homeostasis, vascular tone, and hormone secretion.  Numerous genetic linkage anal. studies have failed so far to reveal unequivocal evidence for the involvement of one of these receptors in the etiol. of various central nervous system disorders.  However, targeted deletion of several of these dopamine receptor genes in mice should provide valuable information about their physiol. functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaajNmBxnkYbVg90H21EOLACvtfcHk0lhHzDAKg1o0XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXptlOjtg%253D%253D&md5=a505d0e2c640ca205d4470ad69f607ff</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.1998.78.1.189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.1998.78.1.189%26sid%3Dliteratum%253Aachs%26aulast%3DMissale%26aufirst%3DC.%26aulast%3DNash%26aufirst%3DS.%2BR.%26aulast%3DRobinson%26aufirst%3DS.%2BW.%26aulast%3DJaber%26aufirst%3DM.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DDopamine%2520receptors%253A%2520from%2520structure%2520to%2520function%26jtitle%3DPhysiol.%2520Rev.%26date%3D1998%26volume%3D78%26spage%3D189%26epage%3D225%26doi%3D10.1152%2Fphysrev.1998.78.1.189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span> <span> </span><span class="NLM_article-title">The physiology, signaling, and pharmacology of dopamine receptors</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1124/pr.110.002642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1124%2Fpr.110.002642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=21303898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=182-217&author=J.-M.+Beaulieuauthor=R.+R.+Gainetdinov&title=The+physiology%2C+signaling%2C+and+pharmacology+of+dopamine+receptors&doi=10.1124%2Fpr.110.002642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The physiology, signaling, and pharmacology of dopamine receptors</span></div><div class="casAuthors">Beaulieu, Jean-Martin; Gainetdinov, Raul R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-217</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiol. functions of the catecholaminergic neurotransmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension.  Pharmacol. agents targeting dopaminergic neurotransmission have been clin. used in the management of several neurol. and psychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder, Huntington's disease, attention deficit hyperactivity disorder (ADHD1), and Tourette's syndrome.  Numerous advances have occurred in understanding the general structural, biochem., and functional properties of dopamine receptors that have led to the development of multiple pharmacol. active compds. that directly target dopamine receptors, such as antiparkinson drugs and antipsychotics.  Recent progress in understanding the complex biol. of dopamine receptor-related signal transduction mechanisms has revealed that, in addn. to their primary action on cAMP-mediated signaling, dopamine receptors can act through diverse signaling mechanisms that involve alternative G protein coupling or through G protein-independent mechanisms via interactions with ion channels or proteins that are characteristically implicated in receptor desensitization, such as β-arrestins.  One of the future directions in managing dopamine-related pathol. conditions may involve a transition from the approaches that directly affect receptor function to a precise targeting of postreceptor intracellular signaling modalities either directly or through ligand-biased signaling pharmacol.  In this comprehensive review, we discuss dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms.  In addn., we discuss the abnormalities of dopamine receptor expression, function, and signaling that are documented in human disorders and the current pharmacol. and emerging trends in the development of novel therapeutic agents that act at dopamine receptors and/or on related signaling events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplp84qmbSbA7Vg90H21EOLACvtfcHk0lhHzDAKg1o0XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D&md5=53e6841062c98abe60c732692109e498</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.002642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.002642%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.-M.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26atitle%3DThe%2520physiology%252C%2520signaling%252C%2520and%2520pharmacology%2520of%2520dopamine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D182%26epage%3D217%26doi%3D10.1124%2Fpr.110.002642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Löber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschammer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2010.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.tips.2010.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=21232805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A280%3ADC%252BC3M3ktVWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=148-157&author=S.+L%C3%B6berauthor=H.+H%C3%BCbnerauthor=N.+Tschammerauthor=P.+Gmeiner&title=Recent+advances+in+the+search+for+D3-+and+D4-selective+drugs%3A+probes%2C+models+and+candidates&doi=10.1016%2Fj.tips.2010.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates</span></div><div class="casAuthors">Lober Stefan; Hubner Harald; Tschammer Nuska; Gmeiner Peter</div><div class="citationInfo"><span class="NLM_cas:title">Trends in pharmacological sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">148-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dopamine D(2)-like receptors (including D(2), D(3) and D(4)) belong to the 'rhodopsin-like' family of G protein-coupled receptors (GPCRs), which represent the largest group of targets for bioactive molecules.  Due to their high sequence similarity, the design of subtype-selective ligands requires rational and effective strategies.  The general formula of 1,4-disubstituted aromatic piperidines and piperazines (1,4-DAPs) was extracted from classical dopaminergic drugs.  The biological properties of this compound family are encoded by an aromatic head group that controls intrinsic activity, an amine moiety and a lipophilic appendage.  D(3)- and D(4)-selective molecular probes and drug candidates were generated from the general formula of 1,4-DAP.  Formal structural rearrangement led to investigational drugs beyond the 1,4-DAP structure.  The very recent publication of the X-ray crystal structure of D(3) should facilitate efficient discovery of unprecedented chemotypes.  However, the development of D(3)-selective agonists, functionally selective ligands and the exploitation of homo- and heteromers remain challenging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJYDidIFGFwMjl5L8hwNX0fW6udTcc2eYqU4ct5cYcOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3ktVWnsg%253D%253D&md5=9b688525eaa75c6d965b634617c16d70</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2010.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2010.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DRecent%2520advances%2520in%2520the%2520search%2520for%2520D3-%2520and%2520D4-selective%2520drugs%253A%2520probes%252C%2520models%2520and%2520candidates%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D148%26epage%3D157%26doi%3D10.1016%2Fj.tips.2010.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Tol, H. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunzow, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunahara, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niznik, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Civelli, O.</span></span> <span> </span><span class="NLM_article-title">Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">610</span>– <span class="NLM_lpage">614</span>, <span class="refDoi"> DOI: 10.1038/350610a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1038%2F350610a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1840645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK38XhsV2n" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1991&pages=610-614&author=H.+H.+M.+Van%0ATolauthor=J.+R.+Bunzowauthor=H.-C.+Guanauthor=R.+K.+Sunaharaauthor=P.+Seemanauthor=H.+B.+Niznikauthor=O.+Civelli&title=Cloning+of+the+gene+for+a+human+dopamine+D4+receptor+with+high+affinity+for+the+antipsychotic+clozapine&doi=10.1038%2F350610a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine</span></div><div class="casAuthors">Van Tol, Hubert H. M.; Bunzow, James R.; Guan, Hong Chang; Sunahara, Roger K.; Seeman, Philip; Niznik, Hyman B.; Civelli, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">6319</span>),
    <span class="NLM_cas:pages">610-14</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The cloning of a gene that encodes a clozapine-sensitive dopamine receptor, D4 is reported.  The D4 receptor gene has high homol. to the human dopamine D2 and D3 receptor genes.  The pharmacol. characteristics of this receptor resemble those of the D2 and D3 receptors, but its affinity for clozapine is one order of magnitude higher.  Recognition and characterization of this clozapine neuroleptic site may prove useful in the design of new types of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpneU9aH4jnoLVg90H21EOLACvtfcHk0li8UZ2piYRaug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsV2n&md5=de5f7ade54d85f54181c53d15d6af169</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F350610a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F350610a0%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BTol%26aufirst%3DH.%2BH.%2BM.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DGuan%26aufirst%3DH.-C.%26aulast%3DSunahara%26aufirst%3DR.%2BK.%26aulast%3DSeeman%26aufirst%3DP.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DCloning%2520of%2520the%2520gene%2520for%2520a%2520human%2520dopamine%2520D4%2520receptor%2520with%2520high%2520affinity%2520for%2520the%2520antipsychotic%2520clozapine%26jtitle%3DNature%26date%3D1991%26volume%3D350%26spage%3D610%26epage%3D614%26doi%3D10.1038%2F350610a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seeman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tol, H. H. M.</span></span> <span> </span><span class="NLM_article-title">Atypical neuroleptics have low affinity for dopamine D<sub>2</sub> receptors or are selective for D<sub>4</sub> receptors</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/s0893-133x(96)00187-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fs0893-133x%2896%2900187-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=9015795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK2sXhtFemsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=93-110&author=P.+Seemanauthor=R.+Corbettauthor=H.+H.+M.+Van+Tol&title=Atypical+neuroleptics+have+low+affinity+for+dopamine+D2+receptors+or+are+selective+for+D4+receptors&doi=10.1016%2Fs0893-133x%2896%2900187-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors</span></div><div class="casAuthors">Seeman, Philip; Corbett, Roy; Van Tol, Hubert H. M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">93-110</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with over 150 refs.  This review examines the possible receptor basis of the atypical action of those atypical antipsychotic drugs that elicit low levels of Parkinsonism.  Such an examn. requires consistent and accurate dissocn. consts. for the antipsychotic drugs at the relevant dopamine and serotonin receptors.  It has long been known, however, that the dissocn. const. of a given antipsychotic drug at the dopamine D2 receptor varies between labs.  Although such variation depends on several factors, it has recently been recognized that the radioligand used to measure the competition between the antipsychotic drug and the radioligand is an important variable.  The present review summarizes information on this radioligand dependence.  In general, a radioligand of low soly. in the membrane (i.e., low tissue:buffer partition) results in a low value for the antipsychotic dissocn. const. when the drug competes with the radioligand.  Hence, by first obtaining the antipsychotic dissocn. consts. using different radioligands of different soly. in the membrane, one can then extrapolate the data to low or "zero" ligand soly.  The extrapolated value represents the radioligand-independent dissocn. const. of the antipsychotic.  These values are here given for dopamine D2 and D4 receptors, as well as for serotonin 5-HT2A receptors.  These values, moreover, agree with the dissocn. const. directly obtained with the radioactive antipsychotic itself.  For example, clozapine revealed a radioligand-independent value of 1.6 nM at the dopamine D4 receptor, agreeing with the value directly measured with [3H]-clozapine at D4.  However, because clozapine competes with endogenous dopamine, the in vivo concn. of clozapine (to occupy dopamine D4 receptors) can be derived to be about 13 nM, agreeing with the value of 12 to 20 nM in the plasma water or spinal fluid obsd. in treated patients.  The atypical neuroleptics remoxipride clozapine, perlapine, seroquel and melperone had low affinity for the dopamine D2 receptor (radioligand-independent dissocn. consts. of 30 to 90 nM).  Such low affinity make these latter five drugs readily displaceable gy high level of endogenous dopamine in the caudate or putamen.  Most typical neuroleptics have radioligand-independent values of 0.3 to 5 nM at dopamine D2 receptors, making them more resistant to displacement by endogenous dopamine.  Finally, a relation was found between the neuroleptic doses for rat catalepsy and the D2:D4 ratio of the radioligand-independent K values for these two receptors.  Thus, the atypical neuroleptics appear to fall into two groups, those that have a low affinity for dopamine D2 receptors and those that are selective for dopamine D4 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt31KrJf3jQrVg90H21EOLACvtfcHk0li8UZ2piYRaug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtFemsbo%253D&md5=6c9c980ce2a7bde593d57abbd87f09bf</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fs0893-133x%2896%2900187-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0893-133x%252896%252900187-x%26sid%3Dliteratum%253Aachs%26aulast%3DSeeman%26aufirst%3DP.%26aulast%3DCorbett%26aufirst%3DR.%26aulast%3DVan%2BTol%26aufirst%3DH.%2BH.%2BM.%26atitle%3DAtypical%2520neuroleptics%2520have%2520low%2520affinity%2520for%2520dopamine%2520D2%2520receptors%2520or%2520are%2520selective%2520for%2520D4%2520receptors%26jtitle%3DNeuropsychopharmacology%26date%3D1997%26volume%3D16%26spage%3D93%26epage%3D110%26doi%3D10.1016%2Fs0893-133x%2896%2900187-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarazi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeghiayan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldessarini, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kula, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumeyer, J. L.</span></span> <span> </span><span class="NLM_article-title">Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D<sub>2</sub>-like and striatolimbic D<sub>4</sub>-like dopamine receptors</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1016/s0893-133x(97)00046-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fs0893-133x%2897%2900046-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=9272485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK2sXls1Oqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=186-196&author=F.+Taraziauthor=S.+K.+Yeghiayanauthor=R.+J.+Baldessariniauthor=N.+S.+Kulaauthor=J.+L.+Neumeyer&title=Long-term+effects+of+S%28%2B%29N-n-propylnorapomorphine+compared+with+typical+and+atypical+antipsychotics%3A+differential+increases+of+cerebrocortical+D2-like+and+striatolimbic+D4-like+dopamine+receptors&doi=10.1016%2Fs0893-133x%2897%2900046-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors</span></div><div class="casAuthors">Tarazi, Frank I.; Yeghiayan, Sylva K.; Baldessarini, Ross J.; Kula, Nora S.; Neumeyer, John L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">186-196</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Changes in D2-like dopamine (DA) receptor binding in rat brain regions were compared by quant. in vitro receptor autoradiog. after 21-d treatment with a typical (fluphenazine), atypical (clozapine), or candidate atypical antipsychotic (S[+]-N-n-propylnorapomorphine, [+]-NPA).  Fluphenazine treatment significantly increased binding of the D2,3,4 radioligands [3H]nemonapride and [3H]spiperone in caudate-putamen (CPu: 22%, 32%), nucleus accumbens (ACC: 67%, 52%), olfactory tubercle (OT: 53%, 43%), and medial prefrontal cerebral cortex (MPC: 46%, 47%) but not dorsolateral frontal cortex (DFC).  D2-like binding in MPC was also increased by (+)-NPA (49%, 39%) and clozapine (60%, 40%), but not in DFC, CPu, ACC, or OT.  Binding of D2,3-selective [3H]raclopride increased less after fluphenazine in ACC (27%) and CPu (16%) than with the nonselective radioligands, and not after clozapine or (+)-NPA.  D3-selective binding of [3H]R(+)-7-OH-DPAT was not changed with any treatment or region including islands of Calleja.  Binding of [3H]nemonapride or [3H]spiperone under D4-selective conditions (with 300 nM S[-]-raclopride and other masking agents, at sites occluded by D4 ligand L-745,870), was increased by fluphenazine, (+)-NPA, clozapine in ACC (120%, 76%, 70%, resp.), in CPu (54%, 37%, 35%), but not in OT, DFC or MPC.  These results support the hypothesis that cerebrocortical D2-like and striatolimbic D4-like receptors contribute to antipsychotic actions of both typical and atypical drugs and encourage further consideration of S(+)aporphines as potential atypical antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMx9XZ42KSxLVg90H21EOLACvtfcHk0lhdgTWDR9kA6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXls1Oqsr4%253D&md5=d1790025d7ad2141c6318da40d39ad29</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fs0893-133x%2897%2900046-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0893-133x%252897%252900046-8%26sid%3Dliteratum%253Aachs%26aulast%3DTarazi%26aufirst%3DF.%26aulast%3DYeghiayan%26aufirst%3DS.%2BK.%26aulast%3DBaldessarini%26aufirst%3DR.%2BJ.%26aulast%3DKula%26aufirst%3DN.%2BS.%26aulast%3DNeumeyer%26aufirst%3DJ.%2BL.%26atitle%3DLong-term%2520effects%2520of%2520S%2528%252B%2529N-n-propylnorapomorphine%2520compared%2520with%2520typical%2520and%2520atypical%2520antipsychotics%253A%2520differential%2520increases%2520of%2520cerebrocortical%2520D2-like%2520and%2520striatolimbic%2520D4-like%2520dopamine%2520receptors%26jtitle%3DNeuropsychopharmacology%26date%3D1997%26volume%3D17%26spage%3D186%26epage%3D196%26doi%3D10.1016%2Fs0893-133x%2897%2900046-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Last, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reines, S. A.</span></span> <span> </span><span class="NLM_article-title">The effects of a selective D<sub>4</sub> dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia</span>. <i>Arch. Gen. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">567</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.1001/archpsyc.1997.01830180085011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1001%2Farchpsyc.1997.01830180085011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=9193198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK2sXksFWhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=567-572&author=M.+S.+Kramerauthor=B.+Lastauthor=A.+Getsonauthor=S.+A.+Reines&title=The+effects+of+a+selective+D4+dopamine+receptor+antagonist+%28L-745%2C870%29+in+acutely+psychotic+inpatients+with+schizophrenia&doi=10.1001%2Farchpsyc.1997.01830180085011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">the effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia</span></div><div class="casAuthors">Kramer, Mark S.; Last, Barbara; Getson, Albert; Reines, Scott A.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">567-572</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Based mainly on the selective antagonism of clozapine at D4 compared with D2 dopamine receptors, hopes have run high that a selective D4 dopamine receptor antagonist might improve the pharmacol. treatment of patients with schizophrenia.  We report, to our knowledge, the first multicenter study of the antipsychotic potential of a highly specific D4 dopamine receptor antagonist (ie, L-745,870) in patients with acute schizophrenia.  Thirty-eight acutely psychotic and neuroleptic responsive (by history) newly admitted inpatients with schizophrenia were randomized to 4 wk of double-blind treatment (2:1) with either L-745,870 (n = 26), 15 mg/d, or placebo (n = 12) after 3- to 5-day placebo run-in period.  Overall, a greater percentage of patients receiving L-745,870 compared with patients receiving placebo discontinued the study for insufficient therapeutic response (32% vs 16%).  At the end of 4 wk by last observation carried forward anal., the mean change from baseline to week 4 on the total Brief Psychiatric Rating Scale favored placebo (ie, -8 points [-15% change from baseline] vs -1 point [-2% change from baseline] from placebo vs L-745,870, P = 0.09).  Similar differences in favor of placebo in changes from baseline mean scores were obsd. for the not carried forward anal. on the total Brief Psychiatric Rating Scale (P < 0.03), for not carried forward and last observation carried forward analyses on the sum of selected pos. symptom items of the Brief Psychiatric Rating Scale, and for the Clin. Global Impression anal. (P = 0.03, last observation carried forward).  A greater percentage of patients receiving L-745,870 had scores indicative of some level of worsening (compared with baseline) on the total Brief Psychiatric Rating Scale and the Clin. Global Impressions' Severity of Illness Scale as well as pos. symptoms compared with those receiving placebo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOzPyP-d8vUrVg90H21EOLACvtfcHk0ljHZ0iu0dReHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksFWhsLk%253D&md5=1491ce3ea914e3cf85cf4025dd2bd2ba</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1997.01830180085011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1997.01830180085011%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DM.%2BS.%26aulast%3DLast%26aufirst%3DB.%26aulast%3DGetson%26aufirst%3DA.%26aulast%3DReines%26aufirst%3DS.%2BA.%26atitle%3DThe%2520effects%2520of%2520a%2520selective%2520D4%2520dopamine%2520receptor%2520antagonist%2520%2528L-745%252C870%2529%2520in%2520acutely%2520psychotic%2520inpatients%2520with%2520schizophrenia%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1997%26volume%3D54%26spage%3D567%26epage%3D572%26doi%3D10.1001%2Farchpsyc.1997.01830180085011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ukai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsunaga, H.</span></span> <span> </span><span class="NLM_article-title">Involvement of dopamine D<sub>3</sub> and D<sub>4</sub> receptors in the discriminative stimulus properties of cocaine in the rat</span>. <i>Methods Find. Exp. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">649</span>, <span class="refDoi"> DOI: 10.1358/mf.2005.27.9.939341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1358%2Fmf.2005.27.9.939341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=16357950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvV2htg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=645-649&author=M.+Ukaiauthor=H.+Mitsunaga&title=Involvement+of+dopamine+D3+and+D4+receptors+in+the+discriminative+stimulus+properties+of+cocaine+in+the+rat&doi=10.1358%2Fmf.2005.27.9.939341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of dopamine D3 and D4 receptors in the discriminative stimulus properties of cocaine in the rats</span></div><div class="casAuthors">Ukai, M.; Mitsunaga, H.</div><div class="citationInfo"><span class="NLM_cas:title">Methods and Findings in Experimental and Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">645-649</span>CODEN:
                <span class="NLM_cas:coden">MFEPDX</span>;
        ISSN:<span class="NLM_cas:issn">0379-0355</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">The present study was carried out to det. the involvement of dopamine receptor subtypes D3 and D4, in the discriminative stimulus effects of cocaine in the rats trained to discriminate 10 mg/kg of cocaine from vehicle.  The discriminative stimulus effects of cocaine (1-10 mg/kg) were dose-dependent.  The dopamine D2 receptor agonist bromocriptine (1.25-20 mg/kg) and the dopamine D3 receptor agonist R(+)-7-OH-DPAT (0.0001-03 mg/kg) produced cocaine (10 mg/kg)-like discriminative stimulus effects.  Both the dopamine D3 receptor antagonist GR103691 (1 mg/kg) and the dopamine D4 receptor antagonist L745870 (1 mg/kg) partially antagonized the discriminative stimulus effects of cocaine (10 mg/kg) and the cocaine (10 mg/kg)-like discriminative stimulus effects of R(+)-7-OH-DPAT (0.3 mg/kg).  L745870 (0.001 mg/kg) inhibited the antagonistic effects of GR103691 (1 mg/kg) on the discriminative stimulus effects of cocaine (10 mg/kg), whereas the drug (0.001 mg/kg) enhanced the antagonistic effects of GR103691 (1 mg/kg) on the cocaine (10 mg/kg)-like discriminative stimulus effects of R(+)-7-OH-DPAT (0.3 mg/kg).  GR103691 (1 mg/kg) in combination with L745870 (0.001 mg/kg) did not markedly affect the cocaine (10 mg/kg)-like discriminative stimulus effects of bromocriptine (20 mg/kg).  These results suggest that the discriminative stimulus effects of cocaine are different from the cocaine-like discriminative stimulus effects of bromocriptine or R(+)-7-OH-DPAT, in terms of dopamine D3 and D4 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNBl7L98oQv7Vg90H21EOLACvtfcHk0ljHZ0iu0dReHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvV2htg%253D%253D&md5=5050aaece272f8681109e673ce443981</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1358%2Fmf.2005.27.9.939341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fmf.2005.27.9.939341%26sid%3Dliteratum%253Aachs%26aulast%3DUkai%26aufirst%3DM.%26aulast%3DMitsunaga%26aufirst%3DH.%26atitle%3DInvolvement%2520of%2520dopamine%2520D3%2520and%2520D4%2520receptors%2520in%2520the%2520discriminative%2520stimulus%2520properties%2520of%2520cocaine%2520in%2520the%2520rat%26jtitle%3DMethods%2520Find.%2520Exp.%2520Clin.%2520Pharmacol.%26date%3D2005%26volume%3D27%26spage%3D645%26epage%3D649%26doi%3D10.1358%2Fmf.2005.27.9.939341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rheingold, C.</span></span> <span> </span><span class="NLM_article-title">Dopamine D Receptor Antagonists for the Treatment of Cocaine Use Disorders</span>. <i>CNS Neurol. Disord.: Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">707</span>– <span class="NLM_lpage">715</span>, <span class="refDoi"> DOI: 10.2174/1871527314666150529132723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.2174%2F1871527314666150529132723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=26022267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWls73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=707-715&author=J.+Bergmanauthor=C.+Rheingold&title=Dopamine+D+Receptor+Antagonists+for+the+Treatment+of+Cocaine+Use+Disorders&doi=10.2174%2F1871527314666150529132723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 Receptor Antagonists for the Treatment of Cocaine Use Disorders</span></div><div class="casAuthors">Bergman, Jack; Rheingold, Curtis G.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">707-715</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The identification of effective medications for the management of cocaine use disorders remains an unmet public health challenge.  In view of the prominent role of dopaminergic mechanisms in cocaine's abuse-related effects, research has focused on the development of subtype-selective dopamine D1-4 receptor antagonists.  Here, we briefly recap the current status of this research effort, with a focus on several aspects of D4 research that may be pertinent to the consideration of D4 ligands in the development of candidate medications.  Addnl., we present data from selfadministration studies in nonhuman primates showing that i.v. cocaine-maintained behavior is moderately, though non-significantly, decreased by doses of the D4-selective partial agonist Ro10-5824 and dramatically reduced by the D4- selective receptor antagonist NGD-94-1.  The effects of these D4 ligands on cocaine self-administration were consistent among subjects and occurred in the absence of comparable effects on food-maintained responding.  These data suggest that available D4 receptor antagonists should be investigated further as candidate medications for the management of cocaine use disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplh2B6VHhlkbVg90H21EOLACvtfcHk0ljHZ0iu0dReHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWls73E&md5=4ceaa55f00813312bdacb0a3d5a6f36e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F1871527314666150529132723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871527314666150529132723%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%26aulast%3DRheingold%26aufirst%3DC.%26atitle%3DDopamine%2520D%2520Receptor%2520Antagonists%2520for%2520the%2520Treatment%2520of%2520Cocaine%2520Use%2520Disorders%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2015%26volume%3D14%26spage%3D707%26epage%3D715%26doi%3D10.2174%2F1871527314666150529132723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mamiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ukai, M.</span></span> <span> </span><span class="NLM_article-title">Effects of L-745,870, a dopamine D<sub>4</sub> receptor antagonist, on naloxone-induced morphine dependence in mice</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>1025</i></span>,  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1196/annals.1316.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1196%2Fannals.1316.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=15542745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVSnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1025&publication_year=2004&pages=424-429&author=T.+Mamiyaauthor=T.+Matsumuraauthor=M.+Ukai&title=Effects+of+L-745%2C870%2C+a+dopamine+D4+receptor+antagonist%2C+on+naloxone-induced+morphine+dependence+in+mice&doi=10.1196%2Fannals.1316.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of L-745,870, a dopamine D4 receptor antagonist, on naloxone-induced morphine dependence in mice</span></div><div class="casAuthors">Mamiya, T.; Matsumura, T.; Ukai, M.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1025</span>
        (<span class="NLM_cas:issue">Current Status of Drug Dependence/Abuse Studies</span>),
    <span class="NLM_cas:pages">424-429</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">We examd. whether dopamine D4 receptor is involved in morphine dependence in mice.  Mice pretreated with morphine (10 mg/kg, s.c.) twice a day for 5 days showed withdrawal syndromes such as jumping, rearing, and forepaw tremors after the administration of naloxone (2 mg/kg, i.p.) on the sixth day.  Such mice exhibited significant elevation of cAMP levels in the thalamus compared with the control mice.  L-745,870 (1 mg/kg, i.p.), a selective dopamine D4 receptor antagonist, pretreated with morphine on the sixth day, significantly attenuated the severity of withdrawal syndromes and the increase in cAMP levels after the administration of naloxone.  These results suggest that (1) the elevation of cAMP levels is involved in the expression of morphine-induced withdrawal syndromes, and (2) dopamine D4 receptor antagonists-inhibit the expression of morphine-induced withdrawal syndromes accompanied with biochem. changes in mice.  Furthermore, dopamine D4 receptor antagonists may be useful drugs for attenuating the expression of morphine dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDlwunPK4wBbVg90H21EOLACvtfcHk0lg1L4z32I4-IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVSnsw%253D%253D&md5=d12f6f44acfaa192c0c1abf175bcc7c0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1196%2Fannals.1316.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1316.052%26sid%3Dliteratum%253Aachs%26aulast%3DMamiya%26aufirst%3DT.%26aulast%3DMatsumura%26aufirst%3DT.%26aulast%3DUkai%26aufirst%3DM.%26atitle%3DEffects%2520of%2520L-745%252C870%252C%2520a%2520dopamine%2520D4%2520receptor%2520antagonist%252C%2520on%2520naloxone-induced%2520morphine%2520dependence%2520in%2520mice%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2004%26volume%3D1025%26spage%3D424%26epage%3D429%26doi%3D10.1196%2Fannals.1316.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabeshima, T.</span></span> <span> </span><span class="NLM_article-title">Nefiracetam attenuates methamphetamine-induced discriminative stimulus effects in rats</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>1025</i></span>,  <span class="NLM_fpage">274</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1196/annals.1316.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1196%2Fannals.1316.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=15542727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVSjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1025&publication_year=2004&pages=274-278&author=Y.+Yanauthor=T.+Mizunoauthor=A.+Nittaauthor=K.+Yamadaauthor=T.+Nabeshima&title=Nefiracetam+attenuates+methamphetamine-induced+discriminative+stimulus+effects+in+rats&doi=10.1196%2Fannals.1316.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nefiracetam attenuates methamphetamine-induced discriminative stimulus effects in rats</span></div><div class="casAuthors">Yan, Yijin; Mizuno, Tomoko; Nitta, Atsumi; Yamada, Kiyofumi; Nabeshima, Toshitaka</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1025</span>
        (<span class="NLM_cas:issue">Current Status of Drug Dependence/Abuse Studies</span>),
    <span class="NLM_cas:pages">274-278</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">Nefiracetam has been reported to increase intracellular cAMP levels and enhance calcium channel current.  Since the cAMP cascade is involved in the development of drug dependence, we investigated whether nefiracetam attenuates the methamphetamine (MAP)-induced discriminative responses in rats.  Nefiracetam (50 mg/kg) inhibited MAP-induced discriminative responses.  Furthermore, rolipram, raclopride, and L-745870, all of which can enhance cAMP activity, disrupted MAP-paired lever press of rats.  Nifedipine and neomycin, which are blockers of voltage-sensitive calcium channels (VSCCs), decreased MAP-induced discriminative responses.  However, pretreatment of these VSCC blockers failed to affect the inhibitory effects of nefiracetam on MAP-induced discriminative responses.  Our findings suggested that nefiracetam inhibits MAP-induced discriminative responses, which may be at least partly assocd. with the changes in intracellular cAMP levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQhuG4Dp6v_7Vg90H21EOLACvtfcHk0lg1L4z32I4-IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVSjuw%253D%253D&md5=4027698285c63b4b8f1474f5b0e1d2f4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1196%2Fannals.1316.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1316.034%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DY.%26aulast%3DMizuno%26aufirst%3DT.%26aulast%3DNitta%26aufirst%3DA.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DNabeshima%26aufirst%3DT.%26atitle%3DNefiracetam%2520attenuates%2520methamphetamine-induced%2520discriminative%2520stimulus%2520effects%2520in%2520rats%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2004%26volume%3D1025%26spage%3D274%26epage%3D278%26doi%3D10.1196%2Fannals.1316.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ciano, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandy, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Foll, B.</span></span> <span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> receptors in psychostimulant addiction</span>. <i>Adv. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1016/b978-0-12-420118-7.00008-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fb978-0-12-420118-7.00008-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=24484981" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=301-321&author=P.+D.+Cianoauthor=D.+K.+Grandyauthor=B.+Le+Foll&title=Dopamine+D4+receptors+in+psychostimulant+addiction&doi=10.1016%2Fb978-0-12-420118-7.00008-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fb978-0-12-420118-7.00008-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fb978-0-12-420118-7.00008-1%26sid%3Dliteratum%253Aachs%26aulast%3DCiano%26aufirst%3DP.%2BD.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DLe%2BFoll%26aufirst%3DB.%26atitle%3DDopamine%2520D4%2520receptors%2520in%2520psychostimulant%2520addiction%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2014%26volume%3D69%26spage%3D301%26epage%3D321%26doi%3D10.1016%2Fb978-0-12-420118-7.00008-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suárez-Boomgaard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshitake, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roales-Buján, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valderrama-Carvajal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilbao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina-Luque, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Díaz-Cabiale, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craenenbroeck, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroto-Escuela, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez
de Fonseca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santín, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Calle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuxe, K.</span></span> <span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> receptor stimulation prevents nigrostriatal dopamine pathway activation by morphine: relevance for drug addiction</span>. <i>Addict. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1232</span>– <span class="NLM_lpage">1245</span>, <span class="refDoi"> DOI: 10.1111/adb.12407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1111%2Fadb.12407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=27212105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtl2gs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1232-1245&author=A.+Riveraauthor=B.+Gagoauthor=D.+Su%C3%A1rez-Boomgaardauthor=T.+Yoshitakeauthor=R.+Roales-Buj%C3%A1nauthor=A.+Valderrama-Carvajalauthor=A.+Bilbaoauthor=J.+Medina-Luqueauthor=Z.+D%C3%ADaz-Cabialeauthor=K.+V.+Craenenbroeckauthor=D.+O.+Borroto-Escuelaauthor=J.+Kehrauthor=F.+Rodr%C3%ADguez%0Ade+Fonsecaauthor=L.+Sant%C3%ADnauthor=A.+de+la+Calleauthor=K.+Fuxe&title=Dopamine+D4+receptor+stimulation+prevents+nigrostriatal+dopamine+pathway+activation+by+morphine%3A+relevance+for+drug+addiction&doi=10.1111%2Fadb.12407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 receptor stimulation prevents nigrostriatal dopamine pathway activation by morphine: relevance for drug addiction</span></div><div class="casAuthors">Rivera, Alicia; Gago, Belen; Suarez-Boomgaard, Diana; Yoshitake, Takashi; Roales-Bujan, Ruth; Valderrama-Carvajal, Alejandra; Bilbao, Ainhoa; Medina-Luque, Jose; Diaz-Cabiale, Zaida; Van Craenenbroeck, Kathleen; Borroto-Escuela, Dasiel O.; Kehr, Jan; Rodriguez de Fonseca, Fernando; Santin, Luis; de la Calle, Adelaida; Fuxe, Kjell</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1232-1245</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-1600</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Morphine is one of the most effective drugs used for pain management, but it is also highly addictive.  Morphine elicits acute and long-term adaptive changes at cellular and mol. level in the brain, which play a crit. role in the development of tolerance, dependence and addiction.  Previous studies indicated that the dopamine D4 receptor (D4R) activation counteracts morphine-induced adaptive changes of the μ opioid receptor (MOR) signaling in the striosomes of the caudate putamen (CPu), as well as the induction of several Fos family transcription factors.  Thus, it has been suggested that D4R could play an important role avoiding some of the addictive effects of morphine.  Here, using different drugs administration paradigms, it is detd. that the D4R agonist PD168,077 prevents morphine-induced activation of the nigrostriatal dopamine pathway and morphol. changes of substantia nigra pars compacta (SNc) dopamine neurons, leading to a restoration of dopamine levels and metab. in the CPu.  Results from receptor autoradiog. indicate that D4R activation modulates MOR function in the substantia nigra pars reticulata (SNr) and the striosomes of the CPu, suggesting that these regions are critically involved in the modulation of SNc dopamine neuronal function through a functional D4R/MOR interaction.  In addn., D4R activation counteracts the rewarding effects of morphine, as well as the development of hyperlocomotion and phys. dependence without any effect on its analgesic properties.  These results provide a novel role of D4R agonist as a pharmacol. strategy to prevent the adverse effects of morphine in the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomhjVo9ElQhLVg90H21EOLACvtfcHk0lgRwkSxz2qAZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtl2gs7fI&md5=a93bd2a424ae18405a96d9dcbb1dbecd</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fadb.12407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fadb.12407%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DA.%26aulast%3DGago%26aufirst%3DB.%26aulast%3DSu%25C3%25A1rez-Boomgaard%26aufirst%3DD.%26aulast%3DYoshitake%26aufirst%3DT.%26aulast%3DRoales-Buj%25C3%25A1n%26aufirst%3DR.%26aulast%3DValderrama-Carvajal%26aufirst%3DA.%26aulast%3DBilbao%26aufirst%3DA.%26aulast%3DMedina-Luque%26aufirst%3DJ.%26aulast%3DD%25C3%25ADaz-Cabiale%26aufirst%3DZ.%26aulast%3DCraenenbroeck%26aufirst%3DK.%2BV.%26aulast%3DBorroto-Escuela%26aufirst%3DD.%2BO.%26aulast%3DKehr%26aufirst%3DJ.%26aulast%3DRodr%25C3%25ADguez%2Bde%2BFonseca%26aufirst%3DF.%26aulast%3DSant%25C3%25ADn%26aufirst%3DL.%26aulast%3Dde%2Bla%2BCalle%26aufirst%3DA.%26aulast%3DFuxe%26aufirst%3DK.%26atitle%3DDopamine%2520D4%2520receptor%2520stimulation%2520prevents%2520nigrostriatal%2520dopamine%2520pathway%2520activation%2520by%2520morphine%253A%2520relevance%2520for%2520drug%2520addiction%26jtitle%3DAddict.%2520Biol.%26date%3D2017%26volume%3D22%26spage%3D1232%26epage%3D1245%26doi%3D10.1111%2Fadb.12407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, S.</span></span> <span> </span><span class="NLM_article-title">Dopamine receptor D<sub>4</sub> promoter hypermethylation increases the risk of drug addiction</span>. <i>Exp. Ther. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2128</span>– <span class="NLM_lpage">2133</span>, <span class="refDoi"> DOI: 10.3892/etm.2017.5615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.3892%2Fetm.2017.5615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=29434815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFSgtbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=2128-2133&author=H.+Jiauthor=X.+Xuauthor=G.+Liuauthor=H.+Liuauthor=Q.+Wangauthor=W.+Shenauthor=L.+Liauthor=X.+Xieauthor=H.+Huauthor=L.+Xuauthor=W.+Zhouauthor=S.+Duan&title=Dopamine+receptor+D4+promoter+hypermethylation+increases+the+risk+of+drug+addiction&doi=10.3892%2Fetm.2017.5615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine receptor D4 promoter hypermethylation increases the risk of drug addiction</span></div><div class="casAuthors">Ji, Huihui; Xu, Xuting; Liu, Guili; Liu, Huifen; Wang, Qinwen; Shen, Wenwen; Li, Longhui; Xie, Xiaohu; Hu, Haochang; Xu, Lei; Zhou, Wenhua; Duan, Shiwei</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Therapeutic Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">2128-2133</span>CODEN:
                <span class="NLM_cas:coden">ETMXA2</span>;
        ISSN:<span class="NLM_cas:issn">1792-1015</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Heroin and methylamphetamine (METH) are two addictive drugs that cause serious problems for society.  Dopamine receptor D4 (DRD4), a key receptor in the dopaminergic system, may facilitate the development of drug addiction.  The aim of the present study was to investigate the assocn. between the promoter methylation level of DRD4 gene and drug addiction.  Bisulfite pyrosequencing technol. was used to measure the methylation levels of DRD4 promoter in 60 drug addicts and 52 matched controls.  Significantly higher levels of DRD4 CpG1 and CpG4 methylation were detected in METH and heroin drug addicts compared with controls (P<0.05).  Male METH addicts exhibited significantly higher DRD4 CpG1, CpG2 and CpG4 methylation levels compared with sex-matched controls (P<0.05).  In heroin addicts, a pos. correlation was obsd. between depression-dejection and DRD4 CpG5 methylation (r = 0.537, P = 0.039) whereas there was a neg. correlation between drug usage frequency and CpG1 methylation (r = -0.632, P = 0.011).  In METH addicts, methylation levels were not significantly assocd. with depression-dejection and drug usage frequency.  In addn., luciferase assays demonstrated that the target sequence of the DRD4 promoter upregulates gene expression.  The results of the present study suggest that DNA methylation of DRD4 may be responsible for the patho-physiol. of drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonhACVhG-3nrVg90H21EOLACvtfcHk0ligRkiLpp3Zvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFSgtbvN&md5=c2f55480bff3823ff222f36288aad5c6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3892%2Fetm.2017.5615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fetm.2017.5615%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DDuan%26aufirst%3DS.%26atitle%3DDopamine%2520receptor%2520D4%2520promoter%2520hypermethylation%2520increases%2520the%2520risk%2520of%2520drug%2520addiction%26jtitle%3DExp.%2520Ther.%2520Med.%26date%3D2018%26volume%3D15%26spage%3D2128%26epage%3D2133%26doi%3D10.3892%2Fetm.2017.5615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Negrete-Díaz, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shumilov, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Real, M. Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina-Luque, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valderrama-Carvajal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Moreno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, A.</span></span> <span> </span><span class="NLM_article-title">Pharmacological activation of dopamine D<sub>4</sub> receptor modulates morphine-induced changes in the expression of GAD65/67 and GABA<sub>B</sub> receptors in the basal ganglia</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2019.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.neuropharm.2019.01.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=30682345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFGmtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2019&pages=22-29&author=J.+V.+Negrete-D%C3%ADazauthor=K.+Shumilovauthor=M.+%C3%81.+Realauthor=J.+Medina-Luqueauthor=A.+Valderrama-Carvajalauthor=G.+Floresauthor=A.+Rodr%C3%ADguez-Morenoauthor=A.+Rivera&title=Pharmacological+activation+of+dopamine+D4+receptor+modulates+morphine-induced+changes+in+the+expression+of+GAD65%2F67+and+GABAB+receptors+in+the+basal+ganglia&doi=10.1016%2Fj.neuropharm.2019.01.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological activation of dopamine D4 receptor modulates morphine-induced changes in the expression of GAD65/67 and GABAB receptors in the basal ganglia</span></div><div class="casAuthors">Negrete-Diaz, Jose Vicente; Shumilov, Kirill; Real, M. Angeles; Medina-Luque, Jose; Valderrama-Carvajal, Alejandra; Flores, Gonzalo; Rodriguez-Moreno, Antonio; Rivera, Alicia</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-29</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dopamine D4 receptor (D4R) stimulation, in a putative D4R/μ opioid heteroreceptor (MOR) complex, counteracts the mol., cellular and behavioral actions of morphine which are assocd. with morphine addiction, without any effect on its analgesic properties.  In the present work, we have evaluated the role of D4R in modulating the effects of a continuous treatment with morphine on the GABAergic system in the basal ganglia.  It has been demonstrated that the co-administration of a D4R agonist together with morphine leads to a restoration of GABA signaling by preventing drug-induced changes in GAD65/67 expression in the caudate putamen, globus palidus and substantia nigra.  Results from GABABR1 and GABABR2 expression suggest a role of D4R in modulation of the GABAB heteroreceptor complexes along the basal ganglia, esp. in the functional divisions of the caudate putamen.  These results provide a new proof of the functional interaction between D4R and MOR and we postulate this putative heteroreceptor complex as a key target for the development of a new strategy to prevent the addictive effects of morphine in the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMJ8ahLCSi6rVg90H21EOLACvtfcHk0ligRkiLpp3Zvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFGmtLc%253D&md5=ee391c642703584c792b58b29c6ff80b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2019.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2019.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DNegrete-D%25C3%25ADaz%26aufirst%3DJ.%2BV.%26aulast%3DShumilov%26aufirst%3DK.%26aulast%3DReal%26aufirst%3DM.%2B%25C3%2581.%26aulast%3DMedina-Luque%26aufirst%3DJ.%26aulast%3DValderrama-Carvajal%26aufirst%3DA.%26aulast%3DFlores%26aufirst%3DG.%26aulast%3DRodr%25C3%25ADguez-Moreno%26aufirst%3DA.%26aulast%3DRivera%26aufirst%3DA.%26atitle%3DPharmacological%2520activation%2520of%2520dopamine%2520D4%2520receptor%2520modulates%2520morphine-induced%2520changes%2520in%2520the%2520expression%2520of%2520GAD65%252F67%2520and%2520GABAB%2520receptors%2520in%2520the%2520basal%2520ganglia%26jtitle%3DNeuropharmacology%26date%3D2019%26volume%3D152%26spage%3D22%26epage%3D29%26doi%3D10.1016%2Fj.neuropharm.2019.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pushparaj, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Strat, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamaleddin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Justinova, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Foll, B.</span></span> <span> </span><span class="NLM_article-title">Blockade of dopamine D<sub>4</sub> receptors attenuates reinstatement of extinguished nicotine-seeking behavior in rats</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">696</span>, <span class="refDoi"> DOI: 10.1038/npp.2011.245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1038%2Fnpp.2011.245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=22030716" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2011&pages=685-696&author=Y.+Yanauthor=A.+Pushparajauthor=Y.+Le+Stratauthor=I.+Gamaleddinauthor=C.+Barnesauthor=Z.+Justinovaauthor=S.+R.+Goldbergauthor=B.+Le+Foll&title=Blockade+of+dopamine+D4+receptors+attenuates+reinstatement+of+extinguished+nicotine-seeking+behavior+in+rats&doi=10.1038%2Fnpp.2011.245"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.245%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DY.%26aulast%3DPushparaj%26aufirst%3DA.%26aulast%3DLe%2BStrat%26aufirst%3DY.%26aulast%3DGamaleddin%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DC.%26aulast%3DJustinova%26aufirst%3DZ.%26aulast%3DGoldberg%26aufirst%3DS.%2BR.%26aulast%3DLe%2BFoll%26aufirst%3DB.%26atitle%3DBlockade%2520of%2520dopamine%2520D4%2520receptors%2520attenuates%2520reinstatement%2520of%2520extinguished%2520nicotine-seeking%2520behavior%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2011%26volume%3D37%26spage%3D685%26epage%3D696%26doi%3D10.1038%2Fnpp.2011.245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bachner-Melman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zohar, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elizur, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemanov, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gritsenko, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebstein, R. P.</span></span> <span> </span><span class="NLM_article-title">Anorexia nervosa, perfectionism, and dopamine D<sub>4</sub> receptor (DRD4)</span>. <i>Am. J. Med. Genet., Part B</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">748</span>– <span class="NLM_lpage">756</span>, <span class="refDoi"> DOI: 10.1002/ajmg.b.30505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1002%2Fajmg.b.30505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFamsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2007&pages=748-756&author=R.+Bachner-Melmanauthor=E.+Lererauthor=A.+H.+Zoharauthor=I.+Kremerauthor=Y.+Elizurauthor=L.+Nemanovauthor=M.+Golanauthor=S.+Blankauthor=I.+Gritsenkoauthor=R.+P.+Ebstein&title=Anorexia+nervosa%2C+perfectionism%2C+and+dopamine+D4+receptor+%28DRD4%29&doi=10.1002%2Fajmg.b.30505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Anorexia nervosa, perfectionism, and dopamine D4 receptor (DRD4)</span></div><div class="casAuthors">Bachner-Melman, Rachel; Lerer, Elad; Zohar, Ada H.; Kremer, Ilana; Elizur, Yoel; Nemanov, Lubov; Golan, Moria; Blank, Shulamit; Gritsenko, Inga; Ebstein, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">144B</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">748-756</span>CODEN:
                <span class="NLM_cas:coden">AJMGC9</span>;
        ISSN:<span class="NLM_cas:issn">1552-4841</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The dopamine D4 receptor (DRD4), a well-characterized, polymorphic gene, is an attractive candidate for contributing risk to disordered eating and anorexia nervosa (AN).  We tested assocn. using UNPHASED for 5 DRD4 polymorphic loci, 3 promoter region SNPs (C-521T, C-616G, A-809G), the 120 bp promoter region tandem duplication and the exon III repeat, in 202 AN trios and 418 control families.  Since perfectionism characterizes AN, we tested these five loci for assocn. with the Child and Adolescent Perfectionism Scale (CAPS) in the AN and control groups.  Single locus anal. showed significant assocn. between the 'C' C-521T allele and AN.  Haplotype anal. also showed significant assocn., particularly a 4-locus haplotype (exon III&120 bp repeat&C-521T&A-809G).  Assocn. was also obsd. between DRD4 and CAPS scores both for AN and control subjects.  The insulin-like growth factor 2 (IGF2) and the arginine vasopressin 1a receptor (AVPR1a), previously shown to be assocd. with disordered eating, were also assocd. with CAPS scores.  Three genes assocd. with AN were also assocd. with perfectionism.  Personality traits are potential endophenotypes for understanding the etiol. of eating disorders and one of the several pathways to eating pathol. may be mediated by the impact of DNA sequences on perfectionism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU7UtVSmIpUbVg90H21EOLACvtfcHk0lg2m4VsdQEhgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFamsrrO&md5=75b47b7108110a6ef07cf6b1a672d330</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fajmg.b.30505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fajmg.b.30505%26sid%3Dliteratum%253Aachs%26aulast%3DBachner-Melman%26aufirst%3DR.%26aulast%3DLerer%26aufirst%3DE.%26aulast%3DZohar%26aufirst%3DA.%2BH.%26aulast%3DKremer%26aufirst%3DI.%26aulast%3DElizur%26aufirst%3DY.%26aulast%3DNemanov%26aufirst%3DL.%26aulast%3DGolan%26aufirst%3DM.%26aulast%3DBlank%26aufirst%3DS.%26aulast%3DGritsenko%26aufirst%3DI.%26aulast%3DEbstein%26aufirst%3DR.%2BP.%26atitle%3DAnorexia%2520nervosa%252C%2520perfectionism%252C%2520and%2520dopamine%2520D4%2520receptor%2520%2528DRD4%2529%26jtitle%3DAm.%2520J.%2520Med.%2520Genet.%252C%2520Part%2520B%26date%3D2007%26volume%3D144%26spage%3D748%26epage%3D756%26doi%3D10.1002%2Fajmg.b.30505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gervasini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordillo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Herráiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, J. A.</span></span> <span> </span><span class="NLM_article-title">Influence of dopamine polymorphisms on the risk for anorexia nervosa and associated psychopathological features</span>. <i>J. Clin. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">555</span>, <span class="refDoi"> DOI: 10.1097/jcp.0b013e3182970469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1097%2Fjcp.0b013e3182970469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=23775054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVGktrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=551-555&author=G.+Gervasiniauthor=I.+Gordilloauthor=A.+Garc%C3%ADa-Herr%C3%A1izauthor=I.+Floresauthor=M.+Jim%C3%A9nezauthor=M.+Mongeauthor=J.+A.+Carrillo&title=Influence+of+dopamine+polymorphisms+on+the+risk+for+anorexia+nervosa+and+associated+psychopathological+features&doi=10.1097%2Fjcp.0b013e3182970469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of Dopamine Polymorphisms on the Risk for Anorexia Nervosa and Associated Psychopathological Features</span></div><div class="casAuthors">Gervasini, Guillermo; Gordillo, Inmaculada; Garcia-Herraiz, Angustias; Flores, Isalud; Jimenez, Mercedes; Monge, Melchora; Carrillo, Juan Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">551-555</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Dopamine neuronal functions make polymorphisms in dopaminergic pathways good candidates for playing a relevant role in anorexia nervosa (AN) and related psychopathol. features.  We have analyzed the effect of 8 polymorphisms in genes coding for dopamine receptors (DRD2, DRD3, and DRD4), transporters (DAT1) and metabolizing enzymes (COMT) in 78 women with AN and 186 control subjects.  Assocd. psychopathol. characteristics in patients with AN were assessed by the Eating Disorders Inventory Test-2 and SCL-90R self-reported questionnaires.  The DRD4 variable no. of tandem repeats (VNTR) 7R/7R and DRD4 -616CC genotypes were significantly assocd. with a greater risk for AN (odds ratio, 3.83; confidence interval, 1.05-13.98; P = 0.04; and odds ratio, 1.74; confidence interval, 1.01-2.97; P = 0.03, resp.).  The anal. of physiol. parameters in the patients with AN revealed that the short allele of a 120-base pair tandem repeat in the promoter region of the DRD4 gene was assocd. with higher wt. (48.35 ± 6.79 vs 43.95 ± 5.78 kg; Bonferroni, P < 0.05), whereas the DRD4 -521TT genotype was assocd. with significantly higher body mass index (17.29 ± 2.25 vs 18.13 ± 2.41 kg/m; Bonferroni, P < 0.05).  The DRD4 C-616G and DAT1 VNTR polymorphisms correlated with several psychopathol. features in patients with AN.  Carriers of the mutant homozygous genotypes scored higher in all but one of the Eating Disorders Inventory Test-2 subscales.  After correction for multiple testing, differences in Asceticism scores between DAT1 VNTR genotypes, as well as differences in Drive for Thinness and Body Dissatisfaction between C-616G genotypes remained significant (P < 0.05).  The results show that certain genetic alterations in the dopamine pathways are able to modify the risk for AN as well as modulate psychopathol. features that are often coupled to this disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcDz_oQEKGy7Vg90H21EOLACvtfcHk0lg2m4VsdQEhgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVGktrzN&md5=6b60b589993020c31a1033cd790ba3ef</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1097%2Fjcp.0b013e3182970469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fjcp.0b013e3182970469%26sid%3Dliteratum%253Aachs%26aulast%3DGervasini%26aufirst%3DG.%26aulast%3DGordillo%26aufirst%3DI.%26aulast%3DGarc%25C3%25ADa-Herr%25C3%25A1iz%26aufirst%3DA.%26aulast%3DFlores%26aufirst%3DI.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DM.%26aulast%3DMonge%26aufirst%3DM.%26aulast%3DCarrillo%26aufirst%3DJ.%2BA.%26atitle%3DInfluence%2520of%2520dopamine%2520polymorphisms%2520on%2520the%2520risk%2520for%2520anorexia%2520nervosa%2520and%2520associated%2520psychopathological%2520features%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2013%26volume%3D33%26spage%3D551%26epage%3D555%26doi%3D10.1097%2Fjcp.0b013e3182970469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gervasini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamero-Villarroel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mota-Zamorano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Herráiz, A.</span></span> <span> </span><span class="NLM_article-title">Effect of dopamine receptor D<sub>4</sub> (DRD4) haplotypes on general psychopathology in patients with eating disorders</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>654</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.gene.2018.02.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.gene.2018.02.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=29455021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivVymtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=654&publication_year=2018&pages=43-48&author=G.+Gervasiniauthor=L.+M.+Gonz%C3%A1lezauthor=C.+Gamero-Villarroelauthor=S.+Mota-Zamoranoauthor=J.+A.+Carrilloauthor=I.+Floresauthor=A.+Garc%C3%ADa-Herr%C3%A1iz&title=Effect+of+dopamine+receptor+D4+%28DRD4%29+haplotypes+on+general+psychopathology+in+patients+with+eating+disorders&doi=10.1016%2Fj.gene.2018.02.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of dopamine receptor D4 (DRD4) haplotypes on general psychopathology in patients with eating disorders</span></div><div class="casAuthors">Gervasini, Guillermo; Gonzalez, Luz M.; Gamero-Villarroel, Carmen; Mota-Zamorano, Sonia; Carrillo, Juan Antonio; Flores, Isalud; Garcia-Herraiz, Angustias</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">654</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">43-48</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Among the many candidate genes analyzed in eating disorder (ED) patients, those involved in dopaminergic functions may be of special relevance, as dopamine is known to play a significant role in feeding behavior, the distortion of body image, hyperactivity and reward and reinforcement processes.  We aimed to det. the effect of functional polymorphisms and haplotypes in the Dopamine Receptor D4 (DRD4) gene on general psychopathol. symptoms in ED patients.  Two-hundred-and-seventy-three ED patients [199 with Anorexia Nervosa (AN) and 74 with Bulimia Nervosa (BN)] completed the SCL-90R inventory and were genotyped for four functional, clin. relevant DRD4 polymorphisms: three variants in the promoter region [120-bp tandem repeat (TR, long vs. short allele), C-616G and C-521T] and a variable no. of tandem repeats (VNTR) in exon 3 (7R vs. non-7R allele).  After correcting for multiple testing, none of the assayed polymorphisms were individually assocd. with SCL-90R results.  Four DRD4 haplotypes (*1-*4) were detected in the patients with a frequency>0.1.  In the BN group, haplotype *2 (non7R-TR long-C-C) was assocd. with higher scores in the three global SCL-90R indexes (GSI, PSDI and PST) after Bonferroni correction (p≤0.01 in all instances).  Furthermore, carriers of this haplotype displayed higher scores (worst symptomatol.) in Somatization, Obsessive-Compulsive, Anxiety, Phobic anxiety, Paranoid ideation and the test addnl. items (p-values for the differences between carriers vs. non-carriers ranging from 0.0001 to 0.0110).  Certain combinations of DRD4 variants may contribute to psychopathol. features in BN patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorYqAwTKTOWbVg90H21EOLACvtfcHk0lg4Rka_jYLajA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivVymtrs%253D&md5=4525c216cfce672ee4c4782633badc5f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.gene.2018.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gene.2018.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DGervasini%26aufirst%3DG.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DL.%2BM.%26aulast%3DGamero-Villarroel%26aufirst%3DC.%26aulast%3DMota-Zamorano%26aufirst%3DS.%26aulast%3DCarrillo%26aufirst%3DJ.%2BA.%26aulast%3DFlores%26aufirst%3DI.%26aulast%3DGarc%25C3%25ADa-Herr%25C3%25A1iz%26aufirst%3DA.%26atitle%3DEffect%2520of%2520dopamine%2520receptor%2520D4%2520%2528DRD4%2529%2520haplotypes%2520on%2520general%2520psychopathology%2520in%2520patients%2520with%2520eating%2520disorders%26jtitle%3DGene%26date%3D2018%26volume%3D654%26spage%3D43%26epage%3D48%26doi%3D10.1016%2Fj.gene.2018.02.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LaHoste, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigal, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glabe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. L.</span></span> <span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> receptor gene polymorphism is associated with attention deficit hyperactivity disorder</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=9118321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A280%3ADyaK2s3jtlartg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1996&pages=121-124&author=G.+J.+LaHosteauthor=J.+M.+Swansonauthor=S.+B.+Wigalauthor=C.+Glabeauthor=T.+Wigalauthor=N.+Kingauthor=J.+L.+Kennedy&title=Dopamine+D4+receptor+gene+polymorphism+is+associated+with+attention+deficit+hyperactivity+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder</span></div><div class="casAuthors">LaHoste G J; Swanson J M; Wigal S B; Glabe C; Wigal T; King N; Kennedy J L</div><div class="citationInfo"><span class="NLM_cas:title">Molecular psychiatry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-4</span>
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    </div><div class="casAbstract">Dopamine is believed to play a major role in the manifestation of attention deficit hyperactivity disorder (ADHD), which affects 3-6% of school-age children and shows evidence of familiarity.  The dopamine D4 receptor, which is preferentially distributed in cortical and limbic regions of the brain, is currently of major interest because of the high degree of functionally relevant variability in its gene (DRD4), and the association of this gene with Novelty Seeking behavior.  We examined the variability in the length of a region of DRD4 that contains a 48-bp repeat sequence in children with ADHD and controls matched for ethnicity.  ADHD children differed from controls in that the 7-fold repeat form of DRD4 occurred significantly more frequently than in the control sample.  This form of the receptor has previously been shown to mediate a blunted intracellular response to dopamine.  Although ADHD is likely to be multifactorial in its etiology and its heritability is likely to be polygenetic, the present findings suggest that polymorphic variation in the gene encoding the D4 dopamine receptor may be a contributing factor in the expression of symptoms associated with ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRN_l8s_261K2lSCSgBhwJFfW6udTcc2eZ_sz-23SL16bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s3jtlartg%253D%253D&md5=ce39ec8adf6503bb18524d566f891988</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaHoste%26aufirst%3DG.%2BJ.%26aulast%3DSwanson%26aufirst%3DJ.%2BM.%26aulast%3DWigal%26aufirst%3DS.%2BB.%26aulast%3DGlabe%26aufirst%3DC.%26aulast%3DWigal%26aufirst%3DT.%26aulast%3DKing%26aufirst%3DN.%26aulast%3DKennedy%26aufirst%3DJ.%2BL.%26atitle%3DDopamine%2520D4%2520receptor%2520gene%2520polymorphism%2520is%2520associated%2520with%2520attention%2520deficit%2520hyperactivity%2520disorder%26jtitle%3DMol.%2520Psychiatry%26date%3D1996%26volume%3D1%26spage%3D121%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smalley, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantwell, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGough, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del’Homme, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asarnow, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, S. F.</span></span> <span> </span><span class="NLM_article-title">Evidence that the dopamine D<sub>4</sub> receptor is a susceptibility gene in attention deficit hyperactivity disorder</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1038/sj.mp.4000457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1038%2Fsj.mp.4000457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=9774776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXls12ntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1998&pages=427-430&author=S.+L.+Smalleyauthor=J.+N.+Baileyauthor=C.+G.+Palmerauthor=D.+P.+Cantwellauthor=J.+J.+McGoughauthor=M.+A.+Del%E2%80%99Hommeauthor=J.+R.+Asarnowauthor=J.+A.+Woodwardauthor=C.+Ramseyauthor=S.+F.+Nelson&title=Evidence+that+the+dopamine+D4+receptor+is+a+susceptibility+gene+in+attention+deficit+hyperactivity+disorder&doi=10.1038%2Fsj.mp.4000457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder</span></div><div class="casAuthors">Smalley, S. L.; Bailey, J. N.; Palmer, C. G.; Cantwell, D. P.; McGough, J. J.; Del'Homme, M. A.; Asarnow, J. R.; Woodward, J. A.; Ramsey, C.; Nelson, S. F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">427-430</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">Attention deficit hyperactivity disorder (ADHD) is a common neurobehavioral problem afflicting 5-10% of children and adolescents and persisting into adulthood in 30-50% or more of cases.  Family, twin, and adoption studies suggest genetic factors contribute to ADHD and symptoms of inattention, impulsivity, and hyperactivity.  Because stimulant intervention is effective in reducing ADHD symptoms in about 70-80% of cases, mol. genetic investigations of genes involved in dopamine regulation are currently underway by many groups.  In a case control study of the dopamine D4 receptor gene (DRD4) and ADHD, La Hoste and colleagues (1996) found an increase of a 7-repeat variant of a 48-bp VNTR in exon 310 among ADHD subjects compared to controls.  Swanson and colleagues (1998) replicated this finding in a sample of 52 ADHD probands and their biol. parents using a haplotype relative risk anal.  Here, the authors describe linkage investigations of the VNTR and ADHD in affected sibling pair (ASP) families and singleton families using both the transmission disequil. test (TDT) and a mean test of identity-by-descent (IBD) sharing.  Using the TDT in the total sample, the 7 allele is differentially transmitted to ADHD children (P = 0.03) while the mean test revealed no evidence of increased IBD sharing among ASPs.  In the current sample, the 7 allele attributes a 1.5-fold risk for developing ADHD over non-carriers of the allele estd. under a model described by Risch and Merikangas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomy7yvc-tXBrVg90H21EOLACvtfcHk0lgo3xUzBu1fig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXls12ntr0%253D&md5=cee23ac900d1b77217b666acba5839d5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4000457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4000457%26sid%3Dliteratum%253Aachs%26aulast%3DSmalley%26aufirst%3DS.%2BL.%26aulast%3DBailey%26aufirst%3DJ.%2BN.%26aulast%3DPalmer%26aufirst%3DC.%2BG.%26aulast%3DCantwell%26aufirst%3DD.%2BP.%26aulast%3DMcGough%26aufirst%3DJ.%2BJ.%26aulast%3DDel%25E2%2580%2599Homme%26aufirst%3DM.%2BA.%26aulast%3DAsarnow%26aufirst%3DJ.%2BR.%26aulast%3DWoodward%26aufirst%3DJ.%2BA.%26aulast%3DRamsey%26aufirst%3DC.%26aulast%3DNelson%26aufirst%3DS.%2BF.%26atitle%3DEvidence%2520that%2520the%2520dopamine%2520D4%2520receptor%2520is%2520a%2520susceptibility%2520gene%2520in%2520attention%2520deficit%2520hyperactivity%2520disorder%26jtitle%3DMol.%2520Psychiatry%26date%3D1998%26volume%3D3%26spage%3D427%26epage%3D430%26doi%3D10.1038%2Fsj.mp.4000457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarazi, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldessarini, R. J.</span></span> <span> </span><span class="NLM_article-title">Role of dopamine D<sub>4</sub> receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">624</span>– <span class="NLM_lpage">632</span>, <span class="refDoi"> DOI: 10.1016/s0893-133x(01)00262-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fs0893-133x%2801%2900262-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=11682245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnslCjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2001&pages=624-632&author=K.+Zhangauthor=F.+I.+Taraziauthor=R.+J.+Baldessarini&title=Role+of+dopamine+D4+receptors+in+motor+hyperactivity+induced+by+neonatal+6-hydroxydopamine+lesions+in+rats&doi=10.1016%2Fs0893-133x%2801%2900262-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Dopamine D4 Receptors in Motor Hyperactivity Induced by Neonatal 6-Hydroxydopamine Lesions in Rats</span></div><div class="casAuthors">Zhang, Kehong; Tarazi, Frank I.; Baldessarini, Ross J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">624-632</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The role of dopamine D4 receptors in behavioral hyperactivity was investigated by assessing D4 receptor expression in brain regions and behavioral effects of D4 receptor-selective ligands in juvenile rats with neonatal 6-hydroxydopamine lesions, a lab. model for attention deficit-hyperactivity disorder (ADHD).  Autoradiog. anal. indicated that motor hyperactivity in lesioned rats was closely correlated with increases in D4 but not D2 receptor levels in caudate-putamen.  D4-selective antagonist CP-293,019 dose-dependently reversed lesion-induced hyperactivity, and D4-agonist CP-226,269 increased it.  These results indicate a physiol. role of dopamine D4 receptors in motor behavior, and may suggest much-needed innovative treatments for ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLwJLfQQgg3bVg90H21EOLACvtfcHk0lgo3xUzBu1fig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnslCjsLY%253D&md5=22ce93f3b654bee58d47552e6057bd1c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fs0893-133x%2801%2900262-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0893-133x%252801%252900262-7%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DTarazi%26aufirst%3DF.%2BI.%26aulast%3DBaldessarini%26aufirst%3DR.%2BJ.%26atitle%3DRole%2520of%2520dopamine%2520D4%2520receptors%2520in%2520motor%2520hyperactivity%2520induced%2520by%2520neonatal%25206-hydroxydopamine%2520lesions%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2001%26volume%3D25%26spage%3D624%26epage%3D632%26doi%3D10.1016%2Fs0893-133x%2801%2900262-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span> <span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> receptor gene associated with the frontal-striatal-cerebellar loop in children with ADHD: a resting-state fMRI study</span>. <i>Neurosci. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1007/s12264-018-0217-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1007%2Fs12264-018-0217-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=29564731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltlWjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2018&pages=497-506&author=A.+Qianauthor=X.+Wangauthor=H.+Liuauthor=J.+Taoauthor=J.+Zhouauthor=Q.+Yeauthor=J.+Liauthor=C.+Yangauthor=J.+Chengauthor=K.+Zhaoauthor=M.+Wang&title=Dopamine+D4+receptor+gene+associated+with+the+frontal-striatal-cerebellar+loop+in+children+with+ADHD%3A+a+resting-state+fMRI+study&doi=10.1007%2Fs12264-018-0217-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 Receptor Gene Associated with the Frontal-Striatal-Cerebellar Loop in Children with ADHD: A Resting-State fMRI Study</span></div><div class="casAuthors">Qian, Andan; Wang, Xin; Liu, Huiru; Tao, Jiejie; Zhou, Jiejie; Ye, Qiong; Li, Jiance; Yang, Chuang; Cheng, Jingliang; Zhao, Ke; Wang, Meihao</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Bulletin</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">497-506</span>CODEN:
                <span class="NLM_cas:coden">NBEUAS</span>;
        ISSN:<span class="NLM_cas:issn">1995-8218</span>.
    
            (<span class="NLM_cas:orgname">Shanghai Institutes for Biological Sciences</span>)
        </div><div class="casAbstract">Attention deficit hyperactivity disorder (ADHD) is a common childhood neuropsychiatric disorder that has been linked to the dopaminergic system.  This study aimed to investigate the effects of regulation of the dopamine D4 receptor (DRD4) on functional brain activity during the resting state in ADHD children using the methods of regional homogeneity (ReHo) and functional connectivity (FC).  Resting-state functional magnetic resonance imaging data were analyzed in 49 children with ADHD.  All participants were classified as either carriers of the DRD4 4-repeat/4-repeat (4R/4R) allele (n = 30) or the DRD4 2-repeat (2R) allele (n = 19).  The results showed that participants with the DRD4 2R allele had decreased ReHo bilaterally in the posterior lobes of the cerebellum, while ReHo was increased in the left angular gyrus.  Compared with participants carrying the DRD4 4R/4R allele, those with the DRD4 2R allele showed decreased FC to the left angular gyrus in the left striatum, right inferior frontal gyrus, and bilateral lobes of the cerebellum.  The increased FC regions included the left superior frontal gyrus, medial frontal gyrus, and rectus gyrus.  These data suggest that the DRD4 polymorphisms are assocd. with localized brain activity and specific functional connections, including abnormality in the frontal-striatal-cerebellar loop.  Our study not only enhances the understanding of the correlation between the cerebellar lobes and ADHD, but also provides an imaging basis for explaining the neural mechanisms underlying ADHD in children.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOihwD8Emw3bVg90H21EOLACvtfcHk0lg3mEFaZntDOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltlWjs78%253D&md5=09313b88aa334b4e91535e641d697f74</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2Fs12264-018-0217-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12264-018-0217-7%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DTao%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DM.%26atitle%3DDopamine%2520D4%2520receptor%2520gene%2520associated%2520with%2520the%2520frontal-striatal-cerebellar%2520loop%2520in%2520children%2520with%2520ADHD%253A%2520a%2520resting-state%2520fMRI%2520study%26jtitle%3DNeurosci.%2520Bull.%26date%3D2018%26volume%3D34%26spage%3D497%26epage%3D506%26doi%3D10.1007%2Fs12264-018-0217-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brioni, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreland, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedlund, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly-Roberts, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolasa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polakowski, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, K.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, J. P.</span></span> <span> </span><span class="NLM_article-title">Activation of dopamine D<sub>4</sub> receptors by ABT-724 induces penile erection in rats</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">6758</span>– <span class="NLM_lpage">6763</span>, <span class="refDoi"> DOI: 10.1073/pnas.0308292101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1073%2Fpnas.0308292101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=15087502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVyhs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=6758-6763&author=J.+D.+Brioniauthor=R.+B.+Morelandauthor=M.+Cowartauthor=G.+C.+Hsiehauthor=A.+O.+Stewartauthor=P.+Hedlundauthor=D.+L.+Donnelly-Robertsauthor=M.+Nakaneauthor=J.+J.+Lynchauthor=T.+Kolasaauthor=J.+S.+Polakowskiauthor=M.+A.+Osinskiauthor=K.+Marshauthor=K.-E.+Anderssonauthor=J.+P.+Sullivan&title=Activation+of+dopamine+D4+receptors+by+ABT-724+induces+penile+erection+in+rats&doi=10.1073%2Fpnas.0308292101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats</span></div><div class="casAuthors">Brioni, Jorge D.; Moreland, Robert B.; Cowart, Marlon; Hsieh, Gin C.; Stewart, Andrew O.; Hedlund, Petter; Donnelly-Roberts, Diana L.; Nakane, Masaki; Lynch, James J., III; Kolasa, Teodozyi; Polakowski, James S.; Osinski, Mark A.; Marsh, Kennan; Andersson, Karl-Erik; Sullivan, James P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6758-6763</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Apomorphine, a nonselective dopamine receptor agonist, facilitates penile erection and is effective in patients suffering from erectile dysfunction.  The specific dopamine receptor subtype(s) responsible for its erectogenic effect is not known.  Here we report that the dopamine D4 receptor plays a role in the regulation of penile function.  ABT-724 is a selective dopamine D4 receptor agonist that activates human dopamine D4 receptors with an EC50 of 12.4 nM and 61% efficacy, with no effect on dopamine D1, D2, D3, or D5 receptors.  ABT-724 dose-dependently facilitates penile erection when given s.c. to conscious rats, an effect that is blocked by haloperidol and clozapine but not by domperidone.  A proerectile effect is obsd. after intracerebroventricular but not intrathecal administration, suggesting a supraspinal site of action.  S.c. injections of ABT-724 increase intracavernosal pressure in awake freely moving rats.  In the presence of sildenafil, a potentiation of the proerectile effect of ABT-724 is obsd. in conscious rats.  The ability of ABT-724 to facilitate penile erection together with the favorable side-effect profile indicates that ABT-724 could be useful for the treatment of erectile dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_CPLyHqtzJ7Vg90H21EOLACvtfcHk0lg3mEFaZntDOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVyhs7g%253D&md5=b37690221970ae889a6589e9177cf321</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0308292101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0308292101%26sid%3Dliteratum%253Aachs%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DMoreland%26aufirst%3DR.%2BB.%26aulast%3DCowart%26aufirst%3DM.%26aulast%3DHsieh%26aufirst%3DG.%2BC.%26aulast%3DStewart%26aufirst%3DA.%2BO.%26aulast%3DHedlund%26aufirst%3DP.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DNakane%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DKolasa%26aufirst%3DT.%26aulast%3DPolakowski%26aufirst%3DJ.%2BS.%26aulast%3DOsinski%26aufirst%3DM.%2BA.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DAndersson%26aufirst%3DK.-E.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26atitle%3DActivation%2520of%2520dopamine%2520D4%2520receptors%2520by%2520ABT-724%2520induces%2520penile%2520erection%2520in%2520rats%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D6758%26epage%3D6763%26doi%3D10.1073%2Fpnas.0308292101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolasa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulenko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hakeem, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowart, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchic, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terranova, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kouhen, O. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly-Roberts, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namovic, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingsworth, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martino, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetter, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darbyshire, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gintant, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreland, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brioni, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. O.</span></span> <span> </span><span class="NLM_article-title">Discovery of 3-Methyl-N-(1-oxy-3′,4′,5′,6′-tetrahydro-2′H-[2,4′-bipyridine]-1′-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D<sub>4</sub> agonist for the treatment of erectile dysfunction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">7450</span>– <span class="NLM_lpage">7465</span>, <span class="refDoi"> DOI: 10.1021/jm060662k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060662k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFykurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7450-7465&author=M.+V.+Patelauthor=T.+Kolasaauthor=K.+Mortellauthor=M.+A.+Matulenkoauthor=A.+A.+Hakeemauthor=J.+J.+Rohdeauthor=S.+L.+Nelsonauthor=M.+D.+Cowartauthor=M.+Nakaneauthor=L.+N.+Millerauthor=M.+E.+Uchicauthor=M.+A.+Terranovaauthor=O.+F.+El-Kouhenauthor=D.+L.+Donnelly-Robertsauthor=M.+T.+Namovicauthor=P.+R.+Hollingsworthauthor=R.+Changauthor=B.+R.+Martinoauthor=J.+M.+Wetterauthor=K.+C.+Marshauthor=R.+Martinauthor=J.+F.+Darbyshireauthor=G.+Gintantauthor=G.+C.+Hsiehauthor=R.+B.+Morelandauthor=J.+P.+Sullivanauthor=J.+D.+Brioniauthor=A.+O.+Stewart&title=Discovery+of+3-Methyl-N-%281-oxy-3%E2%80%B2%2C4%E2%80%B2%2C5%E2%80%B2%2C6%E2%80%B2-tetrahydro-2%E2%80%B2H-%5B2%2C4%E2%80%B2-bipyridine%5D-1%E2%80%B2-ylmethyl%29benzamide+%28ABT-670%29%2C+an+orally+bioavailable+dopamine+D4+agonist+for+the+treatment+of+erectile+dysfunction&doi=10.1021%2Fjm060662k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3-Methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an Orally Bioavailable Dopamine D4 Agonist for the Treatment of Erectile Dysfunction</span></div><div class="casAuthors">Patel, Meena V.; Kolasa, Teodozyj; Mortell, Kathleen; Matulenko, Mark A.; Hakeem, Ahmed A.; Rohde, Jeffrey J.; Nelson, Sherry L.; Cowart, Marlon D.; Nakane, Masaki; Miller, Loan N.; Uchic, Marie E.; Terranova, Marc A.; El-Kouhen, Odile F.; Donnelly-Roberts, Diana L.; Namovic, Marian T.; Hollingsworth, Peter R.; Chang, Renjie; Martino, Brenda R.; Wetter, Jill M.; Marsh, Kennan C.; Martin, Ruth; Darbyshire, John F.; Gintant, Gary; Hsieh, Gin C.; Moreland, Robert B.; Sullivan, James P.; Brioni, Jorge D.; Stewart, Andrew O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">7450-7465</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The goal of this study was to identify a structurally distinct D4-selective agonist with superior oral bioavailability to our first-generation clin. candidate 1a (ABT-724) for the potential treatment of erectile dysfunction.  Arylpiperazines such as (heteroarylmethyl)piperazine 1a, benzamide 2, and acetamides such as 3a,b exhibit poor oral bioavailability.  Structure-activity relationship (SAR) studies with the arylpiperidine template provided potent partial agonists such as 4d and 5k that demonstrated no improvement in oral bioavailability.  Further optimization with the (N-oxy-2-pyridinyl)piperidine template led to the discovery of compd. 6b (ABT-670), which exhibited excellent oral bioavailability in rat, dog, and monkey (68%, 85%, and 91%, resp.) with comparable efficacy, safety, and tolerability to 1a.  The N-oxy-2-pyridinyl moiety not only provided the structural motif required for agonist function but also reduced metab. rates.  The SAR study leading to the discovery of 6b is described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3nDe7tEoJO7Vg90H21EOLACvtfcHk0lg31t1WUGlSng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFykurrM&md5=a036941dfd27f9a36e8e87aa177d8298</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm060662k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060662k%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%2BV.%26aulast%3DKolasa%26aufirst%3DT.%26aulast%3DMortell%26aufirst%3DK.%26aulast%3DMatulenko%26aufirst%3DM.%2BA.%26aulast%3DHakeem%26aufirst%3DA.%2BA.%26aulast%3DRohde%26aufirst%3DJ.%2BJ.%26aulast%3DNelson%26aufirst%3DS.%2BL.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26aulast%3DNakane%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DL.%2BN.%26aulast%3DUchic%26aufirst%3DM.%2BE.%26aulast%3DTerranova%26aufirst%3DM.%2BA.%26aulast%3DEl-Kouhen%26aufirst%3DO.%2BF.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DNamovic%26aufirst%3DM.%2BT.%26aulast%3DHollingsworth%26aufirst%3DP.%2BR.%26aulast%3DChang%26aufirst%3DR.%26aulast%3DMartino%26aufirst%3DB.%2BR.%26aulast%3DWetter%26aufirst%3DJ.%2BM.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DDarbyshire%26aufirst%3DJ.%2BF.%26aulast%3DGintant%26aufirst%3DG.%26aulast%3DHsieh%26aufirst%3DG.%2BC.%26aulast%3DMoreland%26aufirst%3DR.%2BB.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DStewart%26aufirst%3DA.%2BO.%26atitle%3DDiscovery%2520of%25203-Methyl-N-%25281-oxy-3%25E2%2580%25B2%252C4%25E2%2580%25B2%252C5%25E2%2580%25B2%252C6%25E2%2580%25B2-tetrahydro-2%25E2%2580%25B2H-%255B2%252C4%25E2%2580%25B2-bipyridine%255D-1%25E2%2580%25B2-ylmethyl%2529benzamide%2520%2528ABT-670%2529%252C%2520an%2520orally%2520bioavailable%2520dopamine%2520D4%2520agonist%2520for%2520the%2520treatment%2520of%2520erectile%2520dysfunction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7450%26epage%3D7465%26doi%3D10.1021%2Fjm060662k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corda, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melis, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piludu, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Löber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argiolas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgi, O.</span></span> <span> </span><span class="NLM_article-title">Dopamine agonist-induced penile erection and yawning: A comparative study in outbred Roman high- and low-avoidance rats</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/j.pbb.2013.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.pbb.2013.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=23664901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFOmsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2013&pages=59-66&author=F.+Sannaauthor=M.+G.+Cordaauthor=M.+R.+Melisauthor=M.+A.+Piluduauthor=S.+L%C3%B6berauthor=H.+H%C3%BCbnerauthor=P.+Gmeinerauthor=A.+Argiolasauthor=O.+Giorgi&title=Dopamine+agonist-induced+penile+erection+and+yawning%3A+A+comparative+study+in+outbred+Roman+high-+and+low-avoidance+rats&doi=10.1016%2Fj.pbb.2013.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine agonist-induced penile erection and yawning: A comparative study in outbred Roman high- and low-avoidance rats</span></div><div class="casAuthors">Sanna, Fabrizio; Corda, Maria Giuseppa; Melis, Maria Rosaria; Piludu, Maria Antonietta; Lober, Stefan; Hubner, Harald; Gmeiner, Peter; Argiolas, Antonio; Giorgi, Osvaldo</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-66</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The effects on penile erection and yawning of s.c. (SC) injections of the mixed dopamine D1/D2-like agonist apomorphine (0.02-0.2 mg/kg) were studied in outbred Roman high- (RHA) and low-avoidance (RLA) male rats, 2 lines selectively bred for their resp. rapid vs. poor acquisition of the active avoidance response in the shuttle-box, and compared with the effects obsd. in male Sprague-Dawley (SD) rats.  Apomorphine dose-response curves were bell-shaped in all rat lines/strains.  Notably, more penile erections and yawns were recorded mainly in the ascending part of these curves (e.g., apomorphine 0.02-0.08 mg/kg) in both RLA and RHA rats compared to SD rats, with RLA rats showing the higher response (esp. for yawning) with respect to RHA rats.  Similar results were found with PD-168,077 (0.02-0.2 mg/kg SC), a D4 receptor agonist, which induced penile erection but not yawning.  In all rat lines/strains, apomorphine responses were markedly reduced by the D2 antagonist L-741,626, but not by the D3 antagonist, SB277011A, whereas the D4 antagonists L-745,870 and FAUC213 elicited a partial, yet statistically significant, inhibitory effect.  In contrast, the pro-erectile effect of PD-168,077 was completely abolished by L-745,870 and FAUC213, as expected.  The present study confirms and extends previously reported differences in dopamine transmission between RLA and RHA rats and between the SD strain and the Roman lines.  Moreover, it confirms previous studies supporting the view that dopamine receptors of the D2 subtype play a predominant role in the pro-yawning and pro-erectile effect of apomorphine, and that the selective stimulation of D4 receptors induces penile erection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo27Y_IyA8S5LVg90H21EOLACvtfcHk0lj2ev5zMU1j8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFOmsrs%253D&md5=832f1e2297aa19e088faf9c41dcf6b2e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2013.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2013.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DF.%26aulast%3DCorda%26aufirst%3DM.%2BG.%26aulast%3DMelis%26aufirst%3DM.%2BR.%26aulast%3DPiludu%26aufirst%3DM.%2BA.%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DArgiolas%26aufirst%3DA.%26aulast%3DGiorgi%26aufirst%3DO.%26atitle%3DDopamine%2520agonist-induced%2520penile%2520erection%2520and%2520yawning%253A%2520A%2520comparative%2520study%2520in%2520outbred%2520Roman%2520high-%2520and%2520low-avoidance%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2013%26volume%3D109%26spage%3D59%26epage%3D66%26doi%3D10.1016%2Fj.pbb.2013.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sood, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idris, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neill, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A. M.</span></span> <span> </span><span class="NLM_article-title">PD168077, a D<sub>4</sub> receptor agonist, reverses object recognition deficits in rats: potential role for D<sub>4</sub> receptor mechanisms in improving cognitive dysfunction in schizophrenia</span>. <i>J. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">792</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1177/0269881110387840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1177%2F0269881110387840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=21088042" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=792-800&author=P.+Soodauthor=N.+F.+Idrisauthor=S.+Coleauthor=B.+Graysonauthor=J.+C.+Neillauthor=A.+M.+Young&title=PD168077%2C+a+D4+receptor+agonist%2C+reverses+object+recognition+deficits+in+rats%3A+potential+role+for+D4+receptor+mechanisms+in+improving+cognitive+dysfunction+in+schizophrenia&doi=10.1177%2F0269881110387840"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1177%2F0269881110387840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881110387840%26sid%3Dliteratum%253Aachs%26aulast%3DSood%26aufirst%3DP.%26aulast%3DIdris%26aufirst%3DN.%2BF.%26aulast%3DCole%26aufirst%3DS.%26aulast%3DGrayson%26aufirst%3DB.%26aulast%3DNeill%26aufirst%3DJ.%2BC.%26aulast%3DYoung%26aufirst%3DA.%2BM.%26atitle%3DPD168077%252C%2520a%2520D4%2520receptor%2520agonist%252C%2520reverses%2520object%2520recognition%2520deficits%2520in%2520rats%253A%2520potential%2520role%2520for%2520D4%2520receptor%2520mechanisms%2520in%2520improving%2520cognitive%2520dysfunction%2520in%2520schizophrenia%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2010%26volume%3D25%26spage%3D792%26epage%3D800%26doi%3D10.1177%2F0269881110387840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keck, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Free, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddaluna, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fountain, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stang, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhardt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenberger, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boateng, C. A.</span></span> <span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> receptor-selective compounds reveal structure–activity relationships that engender agonist efficacy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3722</span>– <span class="NLM_lpage">3740</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltFCiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3722-3740&author=T.+M.+Keckauthor=R.+B.+Freeauthor=M.+M.+Dayauthor=S.+L.+Brownauthor=M.+S.+Maddalunaauthor=G.+Fountainauthor=C.+Cooperauthor=B.+Fallonauthor=M.+Holmesauthor=C.+T.+Stangauthor=R.+Burkhardtauthor=A.+Bonifaziauthor=M.+P.+Ellenbergerauthor=A.+H.+Newmanauthor=D.+R.+Sibleyauthor=C.+Wuauthor=C.+A.+Boateng&title=Dopamine+D4+receptor-selective+compounds+reveal+structure%E2%80%93activity+relationships+that+engender+agonist+efficacy&doi=10.1021%2Facs.jmedchem.9b00231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 Receptor-Selective Compounds Reveal Structure-Activity Relationships that Engender Agonist Efficacy</span></div><div class="casAuthors">Keck, Thomas M.; Free, R. Benjamin; Day, Marilyn M.; Brown, Sonvia L.; Maddaluna, Michele S.; Fountain, Griffin; Cooper, Charles; Fallon, Brooke; Holmes, Matthew; Stang, Christopher T.; Burkhardt, Russell; Bonifazi, Alessandro; Ellenberger, Michael P.; Newman, Amy H.; Sibley, David R.; Wu, Chun; Boateng, Comfort A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3722-3740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D4 receptor (D4R) plays important roles in cognition, attention, and decision making.  Novel D4R-selective ligands have promise in medication development for neuropsychiatric conditions, including Alzheimer's disease and substance use disorders.  To identify new D4R-selective ligands, and to understand the mol. determinants of agonist efficacy at D4R, we report a series of eighteen novel ligands based on the classical D4R agonist A-412997 (1, 2-(4-(pyridin-2-yl)piperidin-1-yl)-N-(m-tolyl)acetamide).  Compds. were profiled using radioligand binding displacement assays, β-arrestin recruitment assays, cAMP inhibition assays, and mol. dynamics computational modeling.  We identified several novel D4R-selective (Ki ≤ 4.3 nM and >100-fold vs other D2-like receptors) compds. with diverse partial agonist and antagonist profiles, falling into three structural groups.  These compds. highlight receptor-ligand interactions that control efficacy at D2-like receptors and may provide insights into targeted drug discovery, leading to a better understanding of the role of D4Rs in neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmtBRYg7sp8rVg90H21EOLACvtfcHk0lj2ev5zMU1j8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltFCiuro%253D&md5=f3f03df2f50a91030295d32d6b692f1c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00231%26sid%3Dliteratum%253Aachs%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DFree%26aufirst%3DR.%2BB.%26aulast%3DDay%26aufirst%3DM.%2BM.%26aulast%3DBrown%26aufirst%3DS.%2BL.%26aulast%3DMaddaluna%26aufirst%3DM.%2BS.%26aulast%3DFountain%26aufirst%3DG.%26aulast%3DCooper%26aufirst%3DC.%26aulast%3DFallon%26aufirst%3DB.%26aulast%3DHolmes%26aufirst%3DM.%26aulast%3DStang%26aufirst%3DC.%2BT.%26aulast%3DBurkhardt%26aufirst%3DR.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DEllenberger%26aufirst%3DM.%2BP.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DBoateng%26aufirst%3DC.%2BA.%26atitle%3DDopamine%2520D4%2520receptor-selective%2520compounds%2520reveal%2520structure%25E2%2580%2593activity%2520relationships%2520that%2520engender%2520agonist%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3722%26epage%3D3740%26doi%3D10.1021%2Facs.jmedchem.9b00231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balius, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroz, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Meara, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Algaa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolmachova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolmachev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span> <span> </span><span class="NLM_article-title">Ultra-large library docking for discovering new chemotypes</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>566</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-0917-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1038%2Fs41586-019-0917-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=30728502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmt1yns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=566&publication_year=2019&pages=224-229&author=J.+Lyuauthor=S.+Wangauthor=T.+E.+Baliusauthor=I.+Singhauthor=A.+Levitauthor=Y.+S.+Morozauthor=M.+J.+O%E2%80%99Mearaauthor=T.+Cheauthor=E.+Algaaauthor=K.+Tolmachovaauthor=A.+A.+Tolmachevauthor=B.+K.+Shoichetauthor=B.+L.+Rothauthor=J.+J.+Irwin&title=Ultra-large+library+docking+for+discovering+new+chemotypes&doi=10.1038%2Fs41586-019-0917-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Ultra-large library docking for discovering new chemotypes</span></div><div class="casAuthors">Lyu, Jiankun; Wang, Sheng; Balius, Trent E.; Singh, Isha; Levit, Anat; Moroz, Yurii S.; O'Meara, Matthew J.; Che, Tao; Algaa, Enkhjargal; Tolmachova, Kateryna; Tolmachev, Andrey A.; Shoichet, Brian K.; Roth, Bryan L.; Irwin, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">566</span>
        (<span class="NLM_cas:issue">7743</span>),
    <span class="NLM_cas:pages">224-229</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Despite intense interest in expanding chem. space, libraries contg. hundreds-of-millions to billions of diverse mols. have remained inaccessible.  Here we investigate structure-based docking of 170 million make-on-demand compds. from 130 well-characterized reactions.  The resulting library is diverse, representing over 10.7 million scaffolds that are otherwise unavailable.  For each compd. in the library, docking against AmpC β-lactamase (AmpC) and the D4 dopamine receptor were simulated.  From the top-ranking mols., 44 and 549 compds. were synthesized and tested for interactions with AmpC and the D4 dopamine receptor, resp.  We found a phenolate inhibitor of AmpC, which revealed a group of inhibitors without known precedent.  This mol. was optimized to 77 nM, which places it among the most potent non-covalent AmpC inhibitors known.  Crystal structures of this and other AmpC inhibitors confirmed the docking predictions.  Against the D4 dopamine receptor, hit rates fell almost monotonically with docking score, and a hit-rate vs. score curve predicted that the library contained 453,000 ligands for the D4 dopamine receptor.  Of 81 new chemotypes discovered, 30 showed submicromolar activity, including a 180-pM subtype-selective agonist of the D4 dopamine receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc_Nuo9pc-Z7Vg90H21EOLACvtfcHk0ljoCKbfM2C8DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmt1yns70%253D&md5=589fb81ef11f9cbec645b9a3818648d1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-0917-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-0917-9%26sid%3Dliteratum%253Aachs%26aulast%3DLyu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DBalius%26aufirst%3DT.%2BE.%26aulast%3DSingh%26aufirst%3DI.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DMoroz%26aufirst%3DY.%2BS.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DM.%2BJ.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DAlgaa%26aufirst%3DE.%26aulast%3DTolmachova%26aufirst%3DK.%26aulast%3DTolmachev%26aufirst%3DA.%2BA.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26atitle%3DUltra-large%2520library%2520docking%2520for%2520discovering%2520new%2520chemotypes%26jtitle%3DNature%26date%3D2019%26volume%3D566%26spage%3D224%26epage%3D229%26doi%3D10.1038%2Fs41586-019-0917-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschammer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettinetti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Härterich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanig, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Dopamine D<sub>2</sub>, D<sub>3</sub>, and D<sub>4</sub> selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4923</span>– <span class="NLM_lpage">4935</span>, <span class="refDoi"> DOI: 10.1021/jm900690y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900690y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1ehtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4923-4935&author=K.+Ehrlichauthor=A.+G%C3%B6tzauthor=S.+Bollingerauthor=N.+Tschammerauthor=L.+Bettinettiauthor=S.+H%C3%A4rterichauthor=H.+H%C3%BCbnerauthor=H.+Lanigauthor=P.+Gmeiner&title=Dopamine+D2%2C+D3%2C+and+D4+selective+phenylpiperazines+as+molecular+probes+to+explore+the+origins+of+subtype+specific+receptor+binding&doi=10.1021%2Fjm900690y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D2, D3, and D4 Selective Phenylpiperazines as Molecular Probes To Explore the Origins of Subtype Specific Receptor Binding</span></div><div class="casAuthors">Ehrlich, Katharina; Gotz, Angela; Bollinger, Stefan; Tschammer, Nuska; Bettinetti, Laura; Harterich, Steffen; Hubner, Harald; Lanig, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4923-4935</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Assembling phenylpiperazines with 7a-azaindole via different spacer elements, we developed subtype selective dopamine receptor ligands, e.g. I, preferentially interacting with D4, D2, and D3, resp.  To complete this set, the methylthio analogs exceeding the affinity of methoxy derivs. by one order of magnitude and a structural intermediate II were synthesized.  These chem. similar but biol. divergent target compds. served as mol. probes for radioligand displacement expts., mutagenesis, and docking studies on homol. models based on the recent crystal structure of the β2-adrenergic receptor.  Specific interactions with the highly conserved amino acids Asp3.32 and His6.55 and less conserved residues at positions 2.61, 2.64, 3.28, and 3.29 were identified.  Inclusion of a carefully modeled extracellular loop 2 displayed two nonconserved residues in EL2 that differently contribute to ligand binding.  Obviously, subtype selectivity is caused by nonconserved but frequently mediated by conserved amino acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX2fsUqpFTIbVg90H21EOLACvtfcHk0lhQYEvXrchN6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1ehtLk%253D&md5=99880da2621063e269f8b7f765e09d55</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm900690y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900690y%26sid%3Dliteratum%253Aachs%26aulast%3DEhrlich%26aufirst%3DK.%26aulast%3DG%25C3%25B6tz%26aufirst%3DA.%26aulast%3DBollinger%26aufirst%3DS.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DBettinetti%26aufirst%3DL.%26aulast%3DH%25C3%25A4rterich%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DLanig%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDopamine%2520D2%252C%2520D3%252C%2520and%2520D4%2520selective%2520phenylpiperazines%2520as%2520molecular%2520probes%2520to%2520explore%2520the%2520origins%2520of%2520subtype%2520specific%2520receptor%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4923%26epage%3D4935%26doi%3D10.1021%2Fjm900690y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bettinetti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlotter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Interactive SAR studies:  rational discovery of super-potent and highly selective dopamine D<sub>3</sub> receptor antagonists and partial agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4594</span>– <span class="NLM_lpage">4597</span>, <span class="refDoi"> DOI: 10.1021/jm025558r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm025558r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms12rurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4594-4597&author=L.+Bettinettiauthor=K.+Schlotterauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Interactive+SAR+studies%3A%E2%80%89+rational+discovery+of+super-potent+and+highly+selective+dopamine+D3+receptor+antagonists+and+partial+agonists&doi=10.1021%2Fjm025558r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Interactive SAR Studies: Rational Discovery of Super-Potent and Highly Selective Dopamine D3 Receptor Antagonists and Partial Agonists</span></div><div class="casAuthors">Bettinetti, Laura; Schlotter, Karin; Huebner, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4594-4597</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Starting from dopamine receptor ligand BP897, an interactive drug discovery process leading to heterocyclic bioisosteres is demonstrated.  The four step strategy involved a careful optimization of geometric and electronic properties by systematic modification of the attachment points and heteroatoms, resp.  Efficacy tuning by modification of the Ph substituents led to both D3 partial agonists and full antagonists.  The benzothiophenes FAUC346 and FAUC365 revealed outstanding D3 affinity and subtype selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLmRgFhLa3yrVg90H21EOLACvtfcHk0lhQYEvXrchN6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms12rurg%253D&md5=c7ec92cd899fdcc79e918baf23ca826b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm025558r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm025558r%26sid%3Dliteratum%253Aachs%26aulast%3DBettinetti%26aufirst%3DL.%26aulast%3DSchlotter%26aufirst%3DK.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DInteractive%2520SAR%2520studies%253A%25E2%2580%2589%2520rational%2520discovery%2520of%2520super-potent%2520and%2520highly%2520selective%2520dopamine%2520D3%2520receptor%2520antagonists%2520and%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4594%26epage%3D4597%26doi%3D10.1021%2Fjm025558r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A.
H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cyriac, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deschamps, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span> <span> </span><span class="NLM_article-title">N-(4-(4-(2,3-Dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D<sub>3</sub> receptor antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2559</span>– <span class="NLM_lpage">2570</span>, <span class="refDoi"> DOI: 10.1021/jm900095y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900095y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktFGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2559-2570&author=A.%0AH.+Newmanauthor=P.+Cyriacauthor=J.+R.+Deschampsauthor=M.+Taylorauthor=R.+Kumarauthor=D.+Hoauthor=R.+R.+Luedtkeauthor=R.+R.+Luedtke&title=N-%284-%284-%282%2C3-Dichloro-+or+2-methoxyphenyl%29piperazin-1-yl%29butyl%29heterobiarylcarboxamides+with+functionalized+linking+chains+as+high+affinity+and+enantioselective+D3+receptor+antagonists&doi=10.1021%2Fjm900095y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">N-(4-(4-(2,3-Dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with Functionalized Linking Chains as High Affinity and Enantioselective D3 Receptor Antagonists</span></div><div class="casAuthors">Newman, Amy Hauck; Grundt, Peter; Cyriac, George; Deschamps, Jeffrey R.; Taylor, Michelle; Kumar, Rakesh; Ho, David; Luedtke, Robert R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2559-2570</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the present report, the D3 receptor pharmacophore is modified in the 2,3-diCl- and 2-OCH3-phenylpiperazine class of compds. with the goal to improve D3 receptor affinity and selectivity.  This extension of structure-activity relationships (SAR) has resulted in the identification of the first enantioselective D3 antagonists (R- and S-22) to be reported, wherein enantioselectivity is more pronounced at D3 than at D2, and that a binding region on the second extracellular loop (E2) may play a role in both enantioselectivity and D3 receptor selectivity.  Moreover, we have discovered some of the most D3-selective compds. reported to date that show high affinity (Ki = 1 nM) for D3 and ∼400-fold selectivity over the D2 receptor subtype.  Several of these analogs showed exquisite selectivity for D3 receptors over >60 other receptors, further underscoring their value as in vivo research tools.  These lead compds. also have appropriate phys. characteristics for in vivo exploration and therefore will be useful in detg. how intrinsic activity at D3 receptors tested in vitro is related to behaviors in animal models of addiction and other neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprbxvbF2dNX7Vg90H21EOLACvtfcHk0linvkTJupqOjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktFGrt7s%253D&md5=665731381e379cec45ef058cd6c45d0e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm900095y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900095y%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DCyriac%26aufirst%3DP.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DHo%26aufirst%3DD.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DN-%25284-%25284-%25282%252C3-Dichloro-%2520or%25202-methoxyphenyl%2529piperazin-1-yl%2529butyl%2529heterobiarylcarboxamides%2520with%2520functionalized%2520linking%2520chains%2520as%2520high%2520affinity%2520and%2520enantioselective%2520D3%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2559%26epage%3D2570%26doi%3D10.1021%2Fjm900095y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hackling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perachon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höltje, H.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermuth, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokoloff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">N-(ω-(4-(2-Methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D<sub>2</sub> and D<sub>3</sub> receptor ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3883</span>– <span class="NLM_lpage">3899</span>, <span class="refDoi"> DOI: 10.1021/jm030836n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030836n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVSjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3883-3899&author=A.+Hacklingauthor=R.+Ghoshauthor=S.+Perachonauthor=A.+Mannauthor=H.-D.+H%C3%B6ltjeauthor=C.+G.+Wermuthauthor=J.-C.+Schwartzauthor=W.+Sipplauthor=P.+Sokoloffauthor=H.+Stark&title=N-%28%CF%89-%284-%282-Methoxyphenyl%29piperazin-1-yl%29alkyl%29carboxamides+as+dopamine+D2+and+D3+receptor+ligands&doi=10.1021%2Fjm030836n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">N-(ω-(4-(2-Methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as Dopamine D2 and D3 Receptor Ligands</span></div><div class="casAuthors">Hackling, Anneke; Ghosh, Robin; Perachon, Sylvie; Mann, Andre; Hoeltje, Hans-Dieter; Wermuth, Camille G.; Schwartz, Jean-Charles; Sippl, Wolfgang; Sokoloff, Pierre; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3883-3899</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D3 receptor is recognized as a potential therapeutic target for the treatment of various neurol. and psychiatric disorders.  Targetting high affinity and D3 vs. D2 receptor-preferring ligands, the partial agonist BP 897 was taken as a lead structure.  Variations in the spacer and the aryl moiety led to N-alkylated 1-(2-methyoxyphenyl)piperazines with markedly improved affinity and selectivity.  Mol. modeling studies supported the structural development.  Pharmacophore models for dopamine D2 and D3 receptor ligands were developed from their potentially bioactive conformation and were compared in order to get insight into mol. properties of importance for D2/D3 receptor selectivity.  For the 72 compds. presented here, an extended and more linear conformation in the aliph. or aryl spacers turned out to be crucial for dopamine D3 receptor selectivity.  Structural diversity in the aryl moiety (benzamides, heteroarylamides, arylimides) had a major influence on (sub)nanomolar D3 receptor affinity, which was optimized with more rigid aryl acrylamide derivs.  Compd. 38 (ST 280, (E)-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)cinnamoylamide)displayeda most promising pharmacol. profile (Ki (hD3) = 0.5 nM; Ki (hD2L) = 76.4 nM; selectivity ratio of 153), and above that, compd. 38 offered the prospect of a novel radioligand as a pharmacol. tool for various D3 receptor-related in vitro and in vivo investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9JKRnXLo6ELVg90H21EOLACvtfcHk0linvkTJupqOjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVSjsr0%253D&md5=ced853199c82b9663d84a47365e680de</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm030836n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030836n%26sid%3Dliteratum%253Aachs%26aulast%3DHackling%26aufirst%3DA.%26aulast%3DGhosh%26aufirst%3DR.%26aulast%3DPerachon%26aufirst%3DS.%26aulast%3DMann%26aufirst%3DA.%26aulast%3DH%25C3%25B6ltje%26aufirst%3DH.-D.%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DSokoloff%26aufirst%3DP.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DN-%2528%25CF%2589-%25284-%25282-Methoxyphenyl%2529piperazin-1-yl%2529alkyl%2529carboxamides%2520as%2520dopamine%2520D2%2520and%2520D3%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3883%26epage%3D3899%26doi%3D10.1021%2Fjm030836n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kulagowski, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broughton, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mawer, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridgill, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emms, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragan, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine: an antagonist with high affinity and selectivity for the human dopamine D<sub>4</sub> receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1941</span>– <span class="NLM_lpage">1942</span>, <span class="refDoi"> DOI: 10.1021/jm9600712</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9600712" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK28XisFClu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1941-1942&author=J.+J.+Kulagowskiauthor=H.+B.+Broughtonauthor=N.+R.+Curtisauthor=I.+M.+Mawerauthor=M.+P.+Ridgillauthor=R.+Bakerauthor=F.+Emmsauthor=S.+B.+Freedmanauthor=R.+Marwoodauthor=S.+Patelauthor=S.+Patelauthor=C.+I.+Raganauthor=P.+D.+Leeson&title=3-%5B%5B4-%284-Chlorophenyl%29piperazin-1-yl%5Dmethyl%5D-1H-pyrrolo%5B2%2C3-b%5Dpyridine%3A+an+antagonist+with+high+affinity+and+selectivity+for+the+human+dopamine+D4+receptor&doi=10.1021%2Fjm9600712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine: An Antagonist with High Affinity and Selectivity for the Human Dopamine D4 Receptor</span></div><div class="casAuthors">Kulagowski, Janusz J.; Broughton, Howard B.; Curtis, Neil R.; Mawer, Ian M.; Ridgill, Mark P.; Baker, Raymond; Emms, Frances; Freedman, Stephen B.; Marwood, Rosemarie; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1941-2</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A topol. similarity search of the Merck sample collection using known dopamine agonists and antagonists as probe structures identified indole I as having modest binding selectivity for cloned human dopamine D4 receptors over D2 and D3 subtypes.  Optimization of the amino side chain and introduction of a nitrogen atom into the indole nucleus resulted in L-745,870 (II), having high D4 affinity (Ki 0.43 nM) with 2200 and >5000-fold selectivity over D2 and D3 receptors, resp.  Also identified in the course of this work was the piperidinol III which demonstrated the opposite selectivity, being 100-fold binding selective for the D2 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb-2eP0UEXCrVg90H21EOLACvtfcHk0ljCTTHR4P_5KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisFClu74%253D&md5=f67e836d1a4017fb08307cc1b9aabed9</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm9600712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9600712%26sid%3Dliteratum%253Aachs%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DBroughton%26aufirst%3DH.%2BB.%26aulast%3DCurtis%26aufirst%3DN.%2BR.%26aulast%3DMawer%26aufirst%3DI.%2BM.%26aulast%3DRidgill%26aufirst%3DM.%2BP.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DEmms%26aufirst%3DF.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DMarwood%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRagan%26aufirst%3DC.%2BI.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3D3-%255B%255B4-%25284-Chlorophenyl%2529piperazin-1-yl%255Dmethyl%255D-1H-pyrrolo%255B2%252C3-b%255Dpyridine%253A%2520an%2520antagonist%2520with%2520high%2520affinity%2520and%2520selectivity%2520for%2520the%2520human%2520dopamine%2520D4%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1941%26epage%3D1942%26doi%3D10.1021%2Fjm9600712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Löber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Rationally based efficacy tuning of selective dopamine D<sub>4</sub> receptor ligands leading to the complete antagonist 2-[4-(4-chlorophenyl)piperazin-1- ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 213)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">2691</span>– <span class="NLM_lpage">2694</span>, <span class="refDoi"> DOI: 10.1021/jm015522j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm015522j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A280%3ADC%252BD3MvltVaqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2691-2694&author=S.+L%C3%B6berauthor=H.+H%C3%BCbnerauthor=W.+Utzauthor=P.+Gmeiner&title=Rationally+based+efficacy+tuning+of+selective+dopamine+D4+receptor+ligands+leading+to+the+complete+antagonist+2-%5B4-%284-chlorophenyl%29piperazin-1-+ylmethyl%5Dpyrazolo%5B1%2C5-a%5Dpyridine+%28FAUC+213%29&doi=10.1021%2Fjm015522j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Rationally based efficacy tuning of selective dopamine d4 receptor ligands leading to the complete antagonist 2-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 213)</span></div><div class="casAuthors">Lober S; Hubner H; Utz W; Gmeiner P</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2691-4</span>
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Structure dependent efficacy studies in the field of selective D4 ligands led to the 2-aminomethyl substituted azaindole 2 (FAUC 213) that displayed strong D4 binding, high subtype selectivity, and complete antagonist properties in ligand-induced mitogenesis experiments.  According to our schematic molecular model, the intrinsic activity of the regioisomers investigated is controlled by the ability of the heterocyclic unit to interact with both elements of the D4 binding-site crevice, the aromatic microdomain in TM6, and a serine residue in TM5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTeUrGfCRgTjwpJitSxOdIlfW6udTcc2ebyGgp_t9X8Ybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MvltVaqtQ%253D%253D&md5=fff842f3c039a8eb23722e3dc080b387</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm015522j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm015522j%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DUtz%26aufirst%3DW.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DRationally%2520based%2520efficacy%2520tuning%2520of%2520selective%2520dopamine%2520D4%2520receptor%2520ligands%2520leading%2520to%2520the%2520complete%2520antagonist%25202-%255B4-%25284-chlorophenyl%2529piperazin-1-%2520ylmethyl%255Dpyrazolo%255B1%252C5-a%255Dpyridine%2520%2528FAUC%2520213%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2691%26epage%3D2694%26doi%3D10.1021%2Fjm015522j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Löber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschammer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melis, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argiolas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">The azulene framework as a novel arene bioisostere: design of potent dopamine D<sub>4</sub> receptor ligands inducing penile erection</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200800395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1002%2Fcmdc.200800395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=19185034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A280%3ADC%252BD1M3htVyjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=325-328&author=S.+L%C3%B6berauthor=N.+Tschammerauthor=H.+H%C3%BCbnerauthor=M.+R.+Melisauthor=A.+Argiolasauthor=P.+Gmeiner&title=The+azulene+framework+as+a+novel+arene+bioisostere%3A+design+of+potent+dopamine+D4+receptor+ligands+inducing+penile+erection&doi=10.1002%2Fcmdc.200800395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The azulene framework as a novel arene bioisostere: design of potent dopamine D4 receptor ligands inducing penile erection</span></div><div class="casAuthors">Lober Stefan; Tschammer Nuska; Hubner Harald; Melis Maria Rosaria; Argiolas Antonio; Gmeiner Peter</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">325-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Blue makes it happen: The non-uniform charge distribution of the blue colored azulene framework is highly suitable for the bioisosteric replacement of bicyclic heteroarene moieties.  Showing an analogous binding mode as heterocyclic dopamine D4 receptor-selective lead compounds, the induction of penile erection in rats over a greater range of doses indicates a putative advantage of the rationally developed azulene derivative 2 b over apomorphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1W2Z6Jw6xMGyYR5VtavbzfW6udTcc2ebyGgp_t9X8Ybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3htVyjtA%253D%253D&md5=c8e4a83af09476777109df320e6cb2b3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200800395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200800395%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DMelis%26aufirst%3DM.%2BR.%26aulast%3DArgiolas%26aufirst%3DA.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DThe%2520azulene%2520framework%2520as%2520a%2520novel%2520arene%2520bioisostere%253A%2520design%2520of%2520potent%2520dopamine%2520D4%2520receptor%2520ligands%2520inducing%2520penile%2520erection%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D325%26epage%3D328%26doi%3D10.1002%2Fcmdc.200800395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraxner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Cyanoindole derivatives as highly selective dopamine D<sub>4</sub> receptor partial agonists: solid-phase synthesis, binding assays, and functional experiments</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">4563</span>– <span class="NLM_lpage">4569</span>, <span class="refDoi"> DOI: 10.1021/jm0009989</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0009989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVamurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4563-4569&author=H.+H%C3%BCbnerauthor=J.+Kraxnerauthor=P.+Gmeiner&title=Cyanoindole+derivatives+as+highly+selective+dopamine+D4+receptor+partial+agonists%3A+solid-phase+synthesis%2C+binding+assays%2C+and+functional+experiments&doi=10.1021%2Fjm0009989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Cyanoindole Derivatives as Highly Selective Dopamine D4 Receptor Partial Agonists: Solid-Phase Synthesis, Binding Assays, and Functional Experiments</span></div><div class="casAuthors">Huebner, Harald; Kraxner, Johannes; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4563-4569</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Traceless linking of diethoxymethyl (DEM)-protected 5- and 6-cyanoindoles and subsequent incorporation of phenylpiperazine derivs. led to 2- and 3-piperazinylmethyl-substituted cyanoindoles.  Dopamine receptor binding studies on these products clearly indicated strong and selective recognition of the D4 subtype which is known as a promising target for the treatment of neuropsychiatric disorders.  The most interesting binding properties were obsd. for the 2-aminomethyl-5-cyanoindoles FAUC 299 and FAUC 316 (Ki = 0.52 and 1.0 nM, resp.) and a fluoro deriv. had extraordinary selectivity over D1, D2long, D2short, and D3 (>8600).  To det. ligand efficacy, mitogenesis expts. were performed indicating partial agonist effects for the test compds. (35% and 30%, when compared to the full agonist quinpirole).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSfyeNh-KUQLVg90H21EOLACvtfcHk0ljBtBQ5YWTrtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVamurc%253D&md5=31d091ddfbf43674ff5a991bd946ce81</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm0009989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0009989%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DKraxner%26aufirst%3DJ.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DCyanoindole%2520derivatives%2520as%2520highly%2520selective%2520dopamine%2520D4%2520receptor%2520partial%2520agonists%253A%2520solid-phase%2520synthesis%252C%2520binding%2520assays%252C%2520and%2520functional%2520experiments%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4563%26epage%3D4569%26doi%3D10.1021%2Fjm0009989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glase, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akunne, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgic, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffner, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manley, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugsley, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wise, L. D.</span></span> <span> </span><span class="NLM_article-title">Substituted [(4-phenylpiperazinyl)- methyl]benzamides: selective dopamine D<sub>4</sub> agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1771</span>– <span class="NLM_lpage">1772</span>, <span class="refDoi"> DOI: 10.1021/jm970021c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970021c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK2sXjtFyhurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1771-1772&author=S.+A.+Glaseauthor=H.+C.+Akunneauthor=L.+M.+Georgicauthor=T.+G.+Heffnerauthor=R.+G.+MacKenzieauthor=P.+J.+Manleyauthor=T.+A.+Pugsleyauthor=L.+D.+Wise&title=Substituted+%5B%284-phenylpiperazinyl%29-+methyl%5Dbenzamides%3A+selective+dopamine+D4+agonists&doi=10.1021%2Fjm970021c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted [(4-Phenylpiperazinyl)- methyl]benzamides: Selective Dopamine D4 Agonists</span></div><div class="casAuthors">Glase, Shelly A.; Akunne, Hyacinth C.; Georgic, Lynn M.; Heffner, Thomas G.; MacKenzie, Robert G.; Manley, Peter J.; Pugsley, Thomas A.; Wise, Lawrence D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1771-1772</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">4-Phenylpiperazinylmethyl benzamides were identified as having modest binding affinity and selectivity for the dopamine (DA) D4 receptors.  These compds. also showed partial agonist activity as demonstrated by activation of mitogenesis in D4-transfected CHO p-5 cells.  Optimization of these properties by substituent modification on the two aryl rings resulted in compd. I, an agonist with 8.7 nM affinity for the DA D4 receptor with >300-fold selectivity over D3 and >400-fold selectivity over D2.  The DA antagonists haloperidol and L-745870 were shown to block the agonist effect of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQmKuGFfqQNLVg90H21EOLACvtfcHk0ljBtBQ5YWTrtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtFyhurs%253D&md5=f5cee04dc26c4c57eb5ed1b6ad2d2385</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm970021c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970021c%26sid%3Dliteratum%253Aachs%26aulast%3DGlase%26aufirst%3DS.%2BA.%26aulast%3DAkunne%26aufirst%3DH.%2BC.%26aulast%3DGeorgic%26aufirst%3DL.%2BM.%26aulast%3DHeffner%26aufirst%3DT.%2BG.%26aulast%3DMacKenzie%26aufirst%3DR.%2BG.%26aulast%3DManley%26aufirst%3DP.%2BJ.%26aulast%3DPugsley%26aufirst%3DT.%2BA.%26aulast%3DWise%26aufirst%3DL.%2BD.%26atitle%3DSubstituted%2520%255B%25284-phenylpiperazinyl%2529-%2520methyl%255Dbenzamides%253A%2520selective%2520dopamine%2520D4%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1771%26epage%3D1772%26doi%3D10.1021%2Fjm970021c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raviña, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masaguer, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Areias, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selent, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D<sub>3</sub> receptor ligands</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1773</span>– <span class="NLM_lpage">1778</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.01.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.bmcl.2009.01.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=19217777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1773-1778&author=R.+Ortegaauthor=E.+Ravi%C3%B1aauthor=C.+F.+Masaguerauthor=F.+Areiasauthor=J.+Breaauthor=M.+I.+Lozaauthor=L.+L%C3%B3pezauthor=J.+Selentauthor=M.+Pastorauthor=F.+Sanz&title=Synthesis%2C+binding+affinity+and+SAR+of+new+benzolactam+derivatives+as+dopamine+D3+receptor+ligands&doi=10.1016%2Fj.bmcl.2009.01.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands</span></div><div class="casAuthors">Ortega, Raquel; Ravina, Enrique; Masaguer, Christian F.; Areias, Filipe; Brea, Jose; Loza, Maria I.; Lopez, Laura; Selent, Jana; Pastor, Manuel; Sanz, Ferran</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1773-1778</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of new benzolactam derivs. was synthesized and the derivs. were evaluated for their affinities at the dopamine D1, D2, and D3 receptors.  Some of these compds. showed high D2 and/or D3 affinity and selectivity over the D1 receptor.  The SAR study of these compds. revealed structural characteristics that decisively influenced their D2 and D3 affinities.  Structural models of the complexes between some of the most representative compds. of this series and the D2 and D3 receptors were obtained with the aim of rationalizing the obsd. exptl. results.  Moreover, selected compds. showed moderate binding affinity on 5-HT2A which could contribute to reducing the occurrence of extrapyramidal side effects as potential antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrYQNuzEqh47Vg90H21EOLACvtfcHk0ljBtBQ5YWTrtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSltLk%253D&md5=128aaff8165c04095fee2270f2459868</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.067%26sid%3Dliteratum%253Aachs%26aulast%3DOrtega%26aufirst%3DR.%26aulast%3DRavi%25C3%25B1a%26aufirst%3DE.%26aulast%3DMasaguer%26aufirst%3DC.%2BF.%26aulast%3DAreias%26aufirst%3DF.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DSelent%26aufirst%3DJ.%26aulast%3DPastor%26aufirst%3DM.%26aulast%3DSanz%26aufirst%3DF.%26atitle%3DSynthesis%252C%2520binding%2520affinity%2520and%2520SAR%2520of%2520new%2520benzolactam%2520derivatives%2520as%2520dopamine%2520D3%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1773%26epage%3D1778%26doi%3D10.1016%2Fj.bmcl.2009.01.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Löber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological investigations of dopaminergic partial agonists preferentially recognizing the D<sub>4</sub> receptor subtype</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2955</span>– <span class="NLM_lpage">2959</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.02.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.bmcl.2006.02.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=16563764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A280%3ADC%252BD283osFyjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2955-2959&author=S.+L%C3%B6berauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Synthesis+and+biological+investigations+of+dopaminergic+partial+agonists+preferentially+recognizing+the+D4+receptor+subtype&doi=10.1016%2Fj.bmcl.2006.02.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological investigations of dopaminergic partial agonists preferentially recognizing the D4 receptor subtype</span></div><div class="casAuthors">Lober Stefan; Hubner Harald; Gmeiner Peter</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2955-9</span>
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    </div><div class="casAbstract">Aminomethyl-substituted biaryls bearing a pyrazole or triazole moiety were synthesized and investigated for dopamine and serotonin receptor binding.  The N-arylpyrazoles 3b,f,g and 4 revealed Ki values in the subnanomolar range (0.28-0.70 nM) for the dopamine D4 receptor subtype.  Employing both mitogenesis and GTPgammaS assays, ligand efficacy was evaluated indicating partial agonist properties.  Interestingly, the tetrahydropyrimidine 4 (FAUC 2020) displayed significant intrinsic selectivity for D2(long) over D2(short).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQDBGjugch2s8-crCu0nI_sfW6udTcc2eZzf6V8ru6d8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD283osFyjuw%253D%253D&md5=34c01cba25a1234f964d85d04bfa1310</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.02.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.02.075%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520biological%2520investigations%2520of%2520dopaminergic%2520partial%2520agonists%2520preferentially%2520recognizing%2520the%2520D4%2520receptor%2520subtype%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2955%26epage%3D2959%26doi%3D10.1016%2Fj.bmcl.2006.02.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okuyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawashima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funakoshi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, S.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumagai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagamine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomisawa, K.</span></span> <span> </span><span class="NLM_article-title">A selective dopamine D<sub>4</sub> receptor antagonist, NRA0160: A preclinical neuropharmacological profile</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">2109</span>– <span class="NLM_lpage">2125</span>, <span class="refDoi"> DOI: 10.1016/s0024-3205(99)00476-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fs0024-3205%2899%2900476-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10579464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFegtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1999&pages=2109-2125&author=S.+Okuyamaauthor=N.+Kawashimaauthor=S.+Chakiauthor=R.+Yoshikawaauthor=T.+Funakoshiauthor=S.-i.+Ogawaauthor=Y.+Suzukiauthor=Y.+Ikedaauthor=T.+Kumagaiauthor=A.+Nakazatoauthor=M.+Nagamineauthor=K.+Tomisawa&title=A+selective+dopamine+D4+receptor+antagonist%2C+NRA0160%3A+A+preclinical+neuropharmacological+profile&doi=10.1016%2Fs0024-3205%2899%2900476-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A selective dopamine D4 receptor antagonist, NRA0160: A preclinical neuropharmacological profile</span></div><div class="casAuthors">Okuyama, Shigeru; Kawashima, Naoya; Chaki, Shigeyuki; Yoshikawa, Ryoko; Funakoshi, Takeo; Ogawa, Shin-Ichi; Suzuki, Yoshiko; Ikeda, Yoko; Kumagai, Toshihito; Nakazato, Atsuro; Nagamine, Masashi; Tomisawa, Kazuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2109-2125</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">NRA0160, 5-[2-(4-(3-fluorobenzylidene) piperidin-1-yl)ethyl]-4-(4-fluorophenyl)thiazole-2-carboxamide, has a high affinity for human cloned dopamine D4.2, D4.4 and D4.7 receptors, with Ki values of 0.5, 0.9 and 2.7 nM, resp.  NRA0160 is over 20,000-fold more potent at the dopamine D4.2 receptor compared with the human cloned dopamine D2L receptor.  NRA0160 has negligible affinity for the human cloned dopamine D3 receptor (Ki=39 nM), rat serotonin (5-HT)2A receptors (Ki=180 nM) and rat α1 adrenoceptor (Ki=237 nM).  NRA0160 and clozapine antagonized locomotor hyperactivity induced by methamphetamine (MAP) in mice.  NRA0160 and clozapine antagonized MAP-induced stereotyped behavior in mice, although their effects did not exceed 50% inhibition, even at the highest dose given.  NRA0160 and clozapine significantly induced catalepsy in rats, although their effects did not exceed 50% induction even at the highest dose given.  NRA0160 and clozapine significantly reversed the disruption of prepulse inhibition (PPI) in rats produced by apomorphine.  NRA0160 and clozapine significantly shortened the phencyclidine (PCP)-induced prolonged swimming latency in rats in a water maze task.  These findings suggest that NRA0160 may have unique antipsychotic activities without the liability of motor side effects typical of classical antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1yx7gnQ9hUrVg90H21EOLACvtfcHk0li6TiHdAhip_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFegtbs%253D&md5=d3377a91a770321c4aa5d443e3fe8080</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fs0024-3205%2899%2900476-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0024-3205%252899%252900476-2%26sid%3Dliteratum%253Aachs%26aulast%3DOkuyama%26aufirst%3DS.%26aulast%3DKawashima%26aufirst%3DN.%26aulast%3DChaki%26aufirst%3DS.%26aulast%3DYoshikawa%26aufirst%3DR.%26aulast%3DFunakoshi%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DS.-i.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DY.%26aulast%3DKumagai%26aufirst%3DT.%26aulast%3DNakazato%26aufirst%3DA.%26aulast%3DNagamine%26aufirst%3DM.%26aulast%3DTomisawa%26aufirst%3DK.%26atitle%3DA%2520selective%2520dopamine%2520D4%2520receptor%2520antagonist%252C%2520NRA0160%253A%2520A%2520preclinical%2520neuropharmacological%2520profile%26jtitle%3DLife%2520Sci.%26date%3D1999%26volume%3D65%26spage%3D2109%26epage%3D2125%26doi%3D10.1016%2Fs0024-3205%2899%2900476-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broughton, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emms, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragan, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">5-(4-Chlorophenyl)-4-methyl-3-(1-(2- phenylethyl)piperidin-4-yl)isoxazole: A Potent, Selective Antagonist at Human Cloned Dopamine D4 Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1943</span>– <span class="NLM_lpage">1945</span>, <span class="refDoi"> DOI: 10.1021/jm960072u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960072u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK28XisFClu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1943-1945&author=M.+Rowleyauthor=H.+B.+Broughtonauthor=I.+Collinsauthor=R.+Bakerauthor=F.+Emmsauthor=R.+Marwoodauthor=S.+Patelauthor=S.+Patelauthor=C.+I.+Raganauthor=S.+B.+Freedmanauthor=P.+D.+Leeson&title=5-%284-Chlorophenyl%29-4-methyl-3-%281-%282-+phenylethyl%29piperidin-4-yl%29isoxazole%3A+A+Potent%2C+Selective+Antagonist+at+Human+Cloned+Dopamine+D4+Receptors&doi=10.1021%2Fjm960072u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">5-(4-Chlorophenyl)-4-methyl-3-(1-(2- phenylethyl)piperidin-4-yl)isoxazole: A Potent, Selective Antagonist at Human Cloned Dopamine D4 Receptors</span></div><div class="casAuthors">Rowley, Michael; Broughton, Howard B.; Collins, Ian; Baker, Raymond; Emms, Frances; Marwood, Rosemarie; Patel, Shil; Patel, Smita; Ragan, C. Ian; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1943-5</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Based on the structure of the classical neuroleptic haloperidol, the Merck sample collection was screened using the topol. similarity probe method for compds. that might have affinity for human cloned dopamine D4 receptors, and in the hope that they might show selectivity over other subtypes.  This led to 5-(4-chlorophenyl)-3-(1-(4-chlorobenzyl)piperidin-4-yl)pyrazole with a Ki of 61 nM at D4, and 4-fold selectivity over D2.  A medicinal chem. program was initiated to improve the affinity and selectivity.  Alteration of the basic nitrogen substituent gave increased affinity, while changes to the pyrazole moiety improved selectivity.  The isoxazole 5-(4-chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole is an antagonist with high D4 affinity and selectivity over the other human cloned dopamine receptor subtypes (Ki: hD4 3.5 nM, hD2 > 1700 nM, hD3 770 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLxE0hed6E4LVg90H21EOLACvtfcHk0lhyynwy7N994A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisFClu78%253D&md5=3521fcd79cb3b3ca262337f2c9dbf3d1</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm960072u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960072u%26sid%3Dliteratum%253Aachs%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DBroughton%26aufirst%3DH.%2BB.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DEmms%26aufirst%3DF.%26aulast%3DMarwood%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRagan%26aufirst%3DC.%2BI.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3D5-%25284-Chlorophenyl%2529-4-methyl-3-%25281-%25282-%2520phenylethyl%2529piperidin-4-yl%2529isoxazole%253A%2520A%2520Potent%252C%2520Selective%2520Antagonist%2520at%2520Human%2520Cloned%2520Dopamine%2520D4%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1943%26epage%3D1945%26doi%3D10.1021%2Fjm960072u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Löber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschammer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of dopamine D4 receptor antagonists with planar chirality</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1680</span>– <span class="NLM_lpage">1684</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.01.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.bmc.2013.01.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=23428965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislyltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=1680-1684&author=F.+Sannaauthor=B.+Ortnerauthor=H.+H%C3%BCbnerauthor=S.+L%C3%B6berauthor=N.+Tschammerauthor=P.+Gmeiner&title=Discovery+of+dopamine+D4+receptor+antagonists+with+planar+chirality&doi=10.1016%2Fj.bmc.2013.01.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of dopamine D4 receptor antagonists with planar chirality</span></div><div class="casAuthors">Sanna, Fabrizio; Ortner, Birgit; Huebner, Harald; Loeber, Stefan; Tschammer, Nuska; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1680-1684</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Employing the D4 selective phenylpiperazine 2 as a lead compd., planar chiral analogs with paracyclophane substructure were synthesized and evaluated for their ability to bind and activate dopamine receptors.  The study revealed that the introduction of a [2.2]paracyclophane moiety is tolerated by dopamine receptors of the D2 family.  Subtype selectivity for D4 and ligand efficacy depend on the abs. configuration of the test compds.  Whereas the achiral single-layered lead 2 and the double-layered paracyclophane (R)-3 showed partial agonist properties, the enantiomer (S)-3 behaved as a neutral antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBnXwSYTwOirVg90H21EOLACvtfcHk0lhyynwy7N994A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislyltbg%253D&md5=24a9e18e9d12e93710b1a0111ac0b1d0</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.01.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.01.065%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DF.%26aulast%3DOrtner%26aufirst%3DB.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520dopamine%2520D4%2520receptor%2520antagonists%2520with%2520planar%2520chirality%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D1680%26epage%3D1684%26doi%3D10.1016%2Fj.bmc.2013.01.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">1,1′-Disubstituted Ferrocenes as Molecular Hinges in Mono- and Bivalent Dopamine Receptor Ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6860</span>– <span class="NLM_lpage">6870</span>, <span class="refDoi"> DOI: 10.1021/jm901120h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901120h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1artbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6860-6870&author=D.+Huberauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=1%2C1%E2%80%B2-Disubstituted+Ferrocenes+as+Molecular+Hinges+in+Mono-+and+Bivalent+Dopamine+Receptor+Ligands&doi=10.1021%2Fjm901120h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">1,1'-Disubstituted Ferrocenes as Molecular Hinges in Mono- and Bivalent Dopamine Receptor Ligands</span></div><div class="casAuthors">Huber, Daniela; Hubner, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6860-6870</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of previous work on dopaminergic partial agonists, disubstituted ferrocenes are presented as valuable arene bioisosteres.  Because substituents at the distal cyclopentadienyl ring are able to adjust the relative disposition that is required for ligand binding, disubstituted ferrocenes can act as mol. hinges.  Taking advantage of click chem., the regioselective construction and functionalization of the target mols. is reported.  Thus triazole derived appendages were used for the fine-tuning of biol. activity and for the attachment of linker units generating bivalent GPCR ligands.  Receptor binding was evaluated by radioligand displacement expts., revealing superaffinity with sub- to single-digit nanomolar Ki values for particular test compds.  As a neutral antagonist at the dopamine receptors D3 and D4 and a potent partial agonist at the D2 subtype (intrinsic activity = 57%, EC50 = 2.5 nM), the bifunctional ferrocene 10b (shown as I) revealed a novel and unique activity profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodgaMgslFywrVg90H21EOLACvtfcHk0lhyynwy7N994A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1artbfK&md5=3af6a44ffa1d85de28d68a15e1a9e3f7</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm901120h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901120h%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DD.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3D1%252C1%25E2%2580%25B2-Disubstituted%2520Ferrocenes%2520as%2520Molecular%2520Hinges%2520in%2520Mono-%2520and%2520Bivalent%2520Dopamine%2520Receptor%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6860%26epage%3D6870%26doi%3D10.1021%2Fjm901120h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sampson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyunni, S. V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etukala, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ofori, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricker, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamango, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ablordeppey, S. Y.</span></span> <span> </span><span class="NLM_article-title">Identification of a new selective dopamine D<sub>4</sub> receptor ligand</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3105</span>– <span class="NLM_lpage">3114</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.bmc.2014.04.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=24800940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsVWqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=3105-3114&author=D.+Sampsonauthor=X.+Y.+Zhuauthor=S.+V.+K.+Eyunniauthor=J.+R.+Etukalaauthor=E.+Oforiauthor=B.+Brickerauthor=N.+S.+Lamangoauthor=V.+Setolaauthor=B.+L.+Rothauthor=S.+Y.+Ablordeppey&title=Identification+of+a+new+selective+dopamine+D4+receptor+ligand&doi=10.1016%2Fj.bmc.2014.04.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a new selective dopamine D4 receptor ligand</span></div><div class="casAuthors">Sampson, Dinithia; Zhu, Xue Y.; Eyunni, Suresh V. K.; Etukala, Jagan R.; Ofori, Edward; Bricker, Barbara; Lamango, Nazarius S.; Setola, Vincent; Roth, Bryan L.; Ablordeppey, Seth Y.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3105-3114</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The dopamine D4 receptor has been shown to play key roles in certain CNS pathologies including addiction to cigarette smoking.  Thus, selective D4 ligands may be useful in treating some of these conditions.  Previous studies in the authors' lab. have indicated that the piperazine analog of haloperidol exhibits selective and increased affinity to the DAD4 receptor subtype, in comparison to its piperidine analog.  This led to further exploration of the piperazine moiety to identify new agents that are selective at the D4 receptor.  Compd. (I) (KiD4 = 0.84 nM) was the most potent of the compds. tested.  However, it only had moderate selectivity for the D4 receptor.  2-(3-(4-(Pyrimidin-2-yl)piperazin-1yl)propyl)benzo[d]thiazole trihydrobromide (KiD4 = 3.9 nM) while not as potent, was more discriminatory for the D4 receptor subtype.  In fact, 2-(3-(4-(pyrimidin-2-yl)piperazin-1yl)propyl)benzo[d]thiazole trihydrobromide has little or no binding affinity to any of the other four DA receptor subtypes.  In addn., of the 23 CNS receptors evaluated, only two, 5HT1AR and 5HT2BR, have binding affinity consts. better than 100 nM (Ki <100 nM).  2-(3-(4-(Pyrimidin-2-yl)piperazin-1yl)propyl)benzo[d]thiazole trihydrobromide is a potentially useful D4-selective ligand for probing disease treatments involving the D4 receptor, such as assisting smoking cessation, reversing cognitive deficits in schizophrenia and treating erectile dysfunction.  Thus, further optimization, functional characterization and evaluation in animal models may be warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXRZKJRLbzEbVg90H21EOLACvtfcHk0lhjrXI3Nh5WLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsVWqtrg%253D&md5=ed55b3f8dc194764069f9cbf8330d91c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DSampson%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%2BY.%26aulast%3DEyunni%26aufirst%3DS.%2BV.%2BK.%26aulast%3DEtukala%26aufirst%3DJ.%2BR.%26aulast%3DOfori%26aufirst%3DE.%26aulast%3DBricker%26aufirst%3DB.%26aulast%3DLamango%26aufirst%3DN.%2BS.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DAblordeppey%26aufirst%3DS.%2BY.%26atitle%3DIdentification%2520of%2520a%2520new%2520selective%2520dopamine%2520D4%2520receptor%2520ligand%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D3105%26epage%3D3114%26doi%3D10.1016%2Fj.bmc.2014.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">D<sub>4</sub> dopamine receptor high-resolution structures enable the discovery of selective agonists</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1126/science.aan5468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1126%2Fscience.aan5468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=29051383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Kns73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2017&pages=381-386&author=S.+Wangauthor=D.+Wackerauthor=A.+Levitauthor=T.+Cheauthor=R.+M.+Betzauthor=J.+D.+McCorvyauthor=A.+J.+Venkatakrishnanauthor=X.-P.+Huangauthor=R.+O.+Drorauthor=B.+K.+Rothauthor=B.+L.+Roth&title=D4+dopamine+receptor+high-resolution+structures+enable+the+discovery+of+selective+agonists&doi=10.1126%2Fscience.aan5468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">D4 dopamine receptor high-resolution structures enable the discovery of selective agonists</span></div><div class="casAuthors">Wang, Sheng; Wacker, Daniel; Levit, Anat; Che, Tao; Betz, Robin M.; McCorvy, John D.; Venkatakrishnan, A. J.; Huang, Xi-Ping; Dror, Ron O.; Shoichet, Brian K.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">6361</span>),
    <span class="NLM_cas:pages">381-386</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Dopamine receptors are implicated in the pathogenesis and treatment of nearly every neuropsychiatric disorder.  Although thousands of drugs interact with these receptors, our mol. understanding of dopaminergic drug selectivity and design remains clouded.  To illuminate dopamine receptor structure, function, and ligand recognition, we detd. crystal structures of the D4 dopamine receptor in its inactive state bound to the antipsychotic drug nemonapride, with resolns. up to 1.95 angstroms.  These structures suggest a mechanism for the control of constitutive signaling, and their unusually high resoln. enabled a structure-based campaign for new agonists of the D4 dopamine receptor.  The ability to efficiently exploit structure for specific probe discovery-rapidly moving from elucidating receptor structure to discovering previously unrecognized, selective agonists-testifies to the power of structure-based approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8NDKhkv_ILbVg90H21EOLACvtfcHk0lhjrXI3Nh5WLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Kns73I&md5=0bbb93e6bcb33577f9d9b7459273d896</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1126%2Fscience.aan5468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aan5468%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DBetz%26aufirst%3DR.%2BM.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DVenkatakrishnan%26aufirst%3DA.%2BJ.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DRoth%26aufirst%3DB.%2BK.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DD4%2520dopamine%2520receptor%2520high-resolution%2520structures%2520enable%2520the%2520discovery%2520of%2520selective%2520agonists%26jtitle%3DScience%26date%3D2017%26volume%3D358%26spage%3D381%26epage%3D386%26doi%3D10.1126%2Fscience.aan5468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lasch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M. R.</span></span> <span> </span><span class="NLM_article-title">Zinc-mediated allylation and benzylation of phenylazocarboxylic esters</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">10412</span>– <span class="NLM_lpage">10420</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.5b01978</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.5b01978" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFGltbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2015&pages=10412-10420&author=R.+Laschauthor=M.+R.+Heinrich&title=Zinc-mediated+allylation+and+benzylation+of+phenylazocarboxylic+esters&doi=10.1021%2Facs.joc.5b01978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Zinc-Mediated Allylation and Benzylation of Phenylazocarboxylic Esters</span></div><div class="casAuthors">Lasch, Roman; Heinrich, Markus R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">10412-10420</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Allylation and benzylation of phenylazocarboxylic tert-Bu esters have been achieved under Barbier-type reaction conditions and in very short reactions times using the corresponding allyl and benzyl bromides or iodides in combination with zinc powder.  Whereas all reactions occurred exclusively at the β-nitrogen atom of the azocarboxylic esters, the linkage of allyl units was shown to depend on the substitution pattern at the double bond of the allyl halide.  The hydrazines obtained are useful precursors for indoles and indazoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbUy99qgTKA7Vg90H21EOLACvtfcHk0ljIDJTXwIzEEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFGltbzM&md5=3d8fd2f41d8802047e44320ee32e54dd</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.5b01978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.5b01978%26sid%3Dliteratum%253Aachs%26aulast%3DLasch%26aufirst%3DR.%26aulast%3DHeinrich%26aufirst%3DM.%2BR.%26atitle%3DZinc-mediated%2520allylation%2520and%2520benzylation%2520of%2520phenylazocarboxylic%2520esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2015%26volume%3D80%26spage%3D10412%26epage%3D10420%26doi%3D10.1021%2Facs.joc.5b01978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sabio Buzo, G.</span>; <span class="NLM_string-name">Tomas Loba, A.</span>; <span class="NLM_string-name">Martinez, A.</span>; <span class="NLM_string-name">Gil Ayuso-Gontan, C.</span>; <span class="NLM_string-name">Gonzalez Teran, B.</span>; <span class="NLM_string-name">Manieri, E.</span></span> <span> </span><span class="NLM_article-title">P38 MAPK inhibitors for the treatment and prophylaxis of liver cancer</span>. PCT Int. Appl., <span class="NLM_patent">WO 2016198698 A2</span> 20161215, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=G.+Sabio+Buzo&author=A.+Tomas+Loba&author=A.+Martinez&author=C.+Gil+Ayuso-Gontan&author=B.+Gonzalez+Teran&author=E.+Manieri&title=P38+MAPK+inhibitors+for+the+treatment+and+prophylaxis+of+liver+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSabio%2BBuzo%26aufirst%3DG.%26atitle%3DP38%2520MAPK%2520inhibitors%2520for%2520the%2520treatment%2520and%2520prophylaxis%2520of%2520liver%2520cancer%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biediger, R. J.</span>; <span class="NLM_string-name">Chen, Q.</span>; <span class="NLM_string-name">Decker, E. R.</span>; <span class="NLM_string-name">Holland, G. W.</span>; <span class="NLM_string-name">Kassir, J. M.</span>; <span class="NLM_string-name">Li, W.</span>; <span class="NLM_string-name">Market, R. V.</span>; <span class="NLM_string-name">Scott, I. L.</span>; <span class="NLM_string-name">Wu, C.</span>; <span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Preparation of carboxylic acid derivatives that inhibit the binding of integrins to their receptors</span>. U.S. Patent <span class="NLM_patent">20,040,063,955 A1</span> 20040401, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=R.+J.+Biediger&author=Q.+Chen&author=E.+R.+Decker&author=G.+W.+Holland&author=J.+M.+Kassir&author=W.+Li&author=R.+V.+Market&author=I.+L.+Scott&author=C.+Wu&author=J.+Li&title=Preparation+of+carboxylic+acid+derivatives+that+inhibit+the+binding+of+integrins+to+their+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBiediger%26aufirst%3DR.%2BJ.%26atitle%3DPreparation%2520of%2520carboxylic%2520acid%2520derivatives%2520that%2520inhibit%2520the%2520binding%2520of%2520integrins%2520to%2520their%2520receptors%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mederski, W.</span>; <span class="NLM_string-name">Tsaklakidi, C.</span>; <span class="NLM_string-name">Cezanne, B.</span>; <span class="NLM_string-name">Dorsch, D.</span>; <span class="NLM_string-name">Barnes, C.</span>; <span class="NLM_string-name">Gleitz, J.</span></span> <span> </span><span class="NLM_article-title">Preparation of semicarbazides as inhibitors of blood-coagulation factor Xa and VIIa</span>. Ger. Offen., DE <span class="NLM_patent">10220048 A1</span> 20031113, <span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=W.+Mederski&author=C.+Tsaklakidi&author=B.+Cezanne&author=D.+Dorsch&author=C.+Barnes&author=J.+Gleitz&title=Preparation+of+semicarbazides+as+inhibitors+of+blood-coagulation+factor+Xa+and+VIIa"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMederski%26aufirst%3DW.%26atitle%3DPreparation%2520of%2520semicarbazides%2520as%2520inhibitors%2520of%2520blood-coagulation%2520factor%2520Xa%2520and%2520VIIa%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fehler, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maschauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höfling, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartuschat, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschammer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prante, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M. R.</span></span> <span> </span><span class="NLM_article-title">Fast and efficient <sup>18</sup>F-labeling by [<sup>18</sup>F]fluorophenylazo-carboxylic esters</span>. <i>Chem.—Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">370</span>– <span class="NLM_lpage">375</span>, <span class="refDoi"> DOI: 10.1002/chem.201303409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1002%2Fchem.201303409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=24339325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSkurjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=370-375&author=S.+K.+Fehlerauthor=S.+Maschauerauthor=S.+B.+H%C3%B6flingauthor=A.+L.+Bartuschatauthor=N.+Tschammerauthor=H.+H%C3%BCbnerauthor=P.+Gmeinerauthor=O.+Pranteauthor=M.+R.+Heinrich&title=Fast+and+efficient+18F-labeling+by+%5B18F%5Dfluorophenylazo-carboxylic+esters&doi=10.1002%2Fchem.201303409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Fast and Efficient 18F-Labeling by [18F|Fluorophenylazocarboxylic Esters</span></div><div class="casAuthors">Fehler, Stefanie K.; Maschauer, Simone; Hoefling, Sarah B.; Bartuschat, Amelie L.; Tschammer, Nuska; Huebner, Harald; Gmeiner, Peter; Prante, Olaf; Heinrich, Markus R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">370-375</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The introduction of a [18F]fluoride ion into the arom. core of phenyl(azo)carboxylic esters was achieved in only 30 s, with radiochem. yields of up to 95%-to-85%.  For labeling purposes, the resulting 18F-substituted azo ester can be further converted in a radical-arylation reaction to give biaryls or in a substitution reaction at its carbonyl unit to produce azo carboxamide derivs.  The title compds. thus formed included 2-[[18F]-4-fluorophenyl]-N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]diazenecarboxamide (I).  I was used as positron-emission tomog. imaging agent (PET imaging) for imaging D3 dopamine receptors (without interference of D2 dopamine receptors).  Biaryl compds. included 4-(fluoro-18F)-1,1'-biphenyl, [4-(fluoro-18F)phenyl]furan derivs., etc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8jHvUXb-2FbVg90H21EOLACvtfcHk0lgm5NjyEtmpsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSkurjP&md5=844f27428d3d55a8e682b8d7fda495e3</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fchem.201303409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201303409%26sid%3Dliteratum%253Aachs%26aulast%3DFehler%26aufirst%3DS.%2BK.%26aulast%3DMaschauer%26aufirst%3DS.%26aulast%3DH%25C3%25B6fling%26aufirst%3DS.%2BB.%26aulast%3DBartuschat%26aufirst%3DA.%2BL.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DPrante%26aufirst%3DO.%26aulast%3DHeinrich%26aufirst%3DM.%2BR.%26atitle%3DFast%2520and%2520efficient%252018F-labeling%2520by%2520%255B18F%255Dfluorophenylazo-carboxylic%2520esters%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D2014%26volume%3D20%26spage%3D370%26epage%3D375%26doi%3D10.1002%2Fchem.201303409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B. T.</span></span> <span> </span><span class="NLM_article-title">The competitive and noncompetitive antagonism of receptor-mediated drug actions in the presence of spare receptors</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/1056-8719(93)90055-j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2F1056-8719%2893%2990055-j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=8318718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK3sXlsFWmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1993&pages=85-91&author=B.+T.+Zhu&title=The+competitive+and+noncompetitive+antagonism+of+receptor-mediated+drug+actions+in+the+presence+of+spare+receptors&doi=10.1016%2F1056-8719%2893%2990055-j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The competitive and noncompetitive antagonism of receptor-mediated drug actions in the presence of spare receptors</span></div><div class="casAuthors">Zhu, Bao Ting</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-91</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">A review with 10 refs.  According to the original receptor occupancy theory proposed by Clark in the 1930s, the percent occupancy of total available receptors by an agonist is linearly related to the response (or effect).  However, the first recognition of "receptor reserve" or "spare receptors" mainly by Furchgott and Stephenson in sep. studies about two decades ago has profoundly modified the original receptor occupancy theory, i.e., the receptor occupancy is not directly proportional to the responses, and the ED50 (or EC50) could be much lower than the equil. dissocn. const. (Kd).  To date, the receptor reserve phenomenon has been characterized in an increasing no. of receptor systems.  In theory, spare receptors may influence the profile of dose-response (D-R) relationship as well as that of the competitive or noncompetitive antagonism of receptor-mediated drug actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcQNyZPlOsebVg90H21EOLACvtfcHk0lgm5NjyEtmpsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlsFWmsro%253D&md5=decc28468eb5c2714b2dfcf9a0734328</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2F1056-8719%2893%2990055-j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1056-8719%252893%252990055-j%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DB.%2BT.%26atitle%3DThe%2520competitive%2520and%2520noncompetitive%2520antagonism%2520of%2520receptor-mediated%2520drug%2520actions%2520in%2520the%2520presence%2520of%2520spare%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D1993%26volume%3D29%26spage%3D85%26epage%3D91%26doi%3D10.1016%2F1056-8719%2893%2990055-j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Black, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leff, P.</span></span> <span> </span><span class="NLM_article-title">Operational models of pharmacological agonism</span>. <i>Proc. R. Soc. London, Ser. B</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>220</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1098/rspb.1983.0093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1098%2Frspb.1983.0093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=6141562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaL2cXmtFaqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=1983&pages=141-162&author=J.+W.+Blackauthor=P.+Leff&title=Operational+models+of+pharmacological+agonism&doi=10.1098%2Frspb.1983.0093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Operational models of pharmacological agonism</span></div><div class="casAuthors">Black, J. W.; Leff, P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Royal Society of London, Series B:  Biological Sciences</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">220</span>
        (<span class="NLM_cas:issue">1219</span>),
    <span class="NLM_cas:pages">141-62</span>CODEN:
                <span class="NLM_cas:coden">PRLBA4</span>;
        ISSN:<span class="NLM_cas:issn">0080-4649</span>.
    </div><div class="casAbstract">A general, operational model is presented which explicitly describes pharmacol. agonism in terms of 3 parameters: an agonist-receptor dissocn. const., the total receptor concn. [Ro], and a parameter (KE) which defines the transduction of the agonist-receptor complex into pharmacol. effect.  The ratio RO/KE, the transducer ratio (τ), is a logical definition for the efficacy of an agonist in a system.  The model provides a chem. definition of intrinsic efficacy, making this parameter exptl. accessible in principle.  Alternate models are compared and contrasted with regard to their practical and conceptual utilities in exptl. pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonpXVldFQ_nbVg90H21EOLACvtfcHk0lgr8kvMOgPg7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmtFaqtA%253D%253D&md5=a0421df9c56495d48d076010acf44b65</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1098%2Frspb.1983.0093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frspb.1983.0093%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DJ.%2BW.%26aulast%3DLeff%26aufirst%3DP.%26atitle%3DOperational%2520models%2520of%2520pharmacological%2520agonism%26jtitle%3DProc.%2520R.%2520Soc.%2520London%252C%2520Ser.%2520B%26date%3D1983%26volume%3D220%26spage%3D141%26epage%3D162%26doi%3D10.1098%2Frspb.1983.0093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Namkung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radresa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devost, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beautrait, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Gouill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laporte, S. A.</span></span> <span> </span><span class="NLM_article-title">Quantifying biased signaling in GPCRs using BRET-based biosensors</span>. <i>Methods</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1016/j.ymeth.2015.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.ymeth.2015.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=25890247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslehsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2016&pages=5-10&author=Y.+Namkungauthor=O.+Radresaauthor=S.+Armandoauthor=D.+Devostauthor=A.+Beautraitauthor=C.+Le+Gouillauthor=S.+A.+Laporte&title=Quantifying+biased+signaling+in+GPCRs+using+BRET-based+biosensors&doi=10.1016%2Fj.ymeth.2015.04.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Quantifying biased signaling in GPCRs using BRET-based biosensors</span></div><div class="casAuthors">Namkung, Yoon; Radresa, Olivier; Armando, Sylvain; Devost, Dominic; Beautrait, Alexandre; Le Gouill, Christian; Laporte, Stephane A.</div><div class="citationInfo"><span class="NLM_cas:title">Methods (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5-10</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There has been a growing appreciation that G protein-coupled receptor (GPCR) functional selectivity (viz. biased signaling), in particular between G protein- and β-arrestin-dependent signaling, can be achieved with specific ligands, and that such directed signaling represents a promising avenue for improving drug efficacy and therapy.  Thus, for any given GPCRs it is important to define means to pharmacol. characterize and classify drugs for their propensity to bias signaling.  Here we describe an exptl. protocol and step-by-step approach to assess functional selectivity between Gαq and β-arrestin-dependent responses using the prototypical angiotensin II (AngII) type 1 receptor (AT1R) expressed in HEK 293 cells.  The protocol describes the expression of Bioluminescence Resonance Energy Transfer (BRET) sensors for either Gαq or β-arrestin with AT1R, and the use of the operational model of pharmacol. agonism to quantify ligand bias.  Such methods are equally applicable to other GPCRs and their downstream signaling effectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoisQm2sSQfUbVg90H21EOLACvtfcHk0lgr8kvMOgPg7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslehsLo%253D&md5=3734d70788ffaa1faeb348d608d2c126</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2015.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2015.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DNamkung%26aufirst%3DY.%26aulast%3DRadresa%26aufirst%3DO.%26aulast%3DArmando%26aufirst%3DS.%26aulast%3DDevost%26aufirst%3DD.%26aulast%3DBeautrait%26aufirst%3DA.%26aulast%3DLe%2BGouill%26aufirst%3DC.%26aulast%3DLaporte%26aufirst%3DS.%2BA.%26atitle%3DQuantifying%2520biased%2520signaling%2520in%2520GPCRs%2520using%2520BRET-based%2520biosensors%26jtitle%3DMethods%26date%3D2016%26volume%3D92%26spage%3D5%26epage%3D10%26doi%3D10.1016%2Fj.ymeth.2015.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Westhuizen, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, M.</span></span> <span> </span><span class="NLM_article-title">Quantification of ligand bias for clinically relevant β<sub>2</sub>-adrenergic receptor ligands: implications for drug taxonomy</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">509</span>, <span class="refDoi"> DOI: 10.1124/mol.113.088880</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1124%2Fmol.113.088880" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=24366668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVylu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=492-509&author=E.+T.+van%0Ader+Westhuizenauthor=B.+Bretonauthor=A.+Christopoulosauthor=M.+Bouvier&title=Quantification+of+ligand+bias+for+clinically+relevant+%CE%B22-adrenergic+receptor+ligands%3A+implications+for+drug+taxonomy&doi=10.1124%2Fmol.113.088880"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of ligand bias for clinically relevant β2-adrenergic receptor ligands: implications for drug taxonomy</span></div><div class="casAuthors">van der Westhuizen, Emma T.; Breton, Billy; Christopoulos, Arthur; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">492-509, 33 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The concepts of functional selectivity and ligand bias are becoming increasingly appreciated in modern drug discovery programs, necessitating more informed approaches to compd. classification and, ultimately, therapeutic candidate selection.  Using the β2-adrenergic receptor as a model, we present a proof of concept study that assessed the bias of 19 β-adrenergic ligands, including many clin. used compds., across four pathways [cAMP prodn., extracellular signal-regulated kinase 1/2 (ERK1/2) activation, calcium mobilization and receptor endocytosis] in the same cell background (human embryonic kidney 293S cells).  Efficacy-based clustering placed the ligands into five distinct groups with respect to signaling signatures.  In some cases, apparent functional selectivity originated from off-target effects on other endogenously expressed adrenergic receptors, highlighting the importance of thoroughly assessing selectivity of the responses before concluding receptor-specific ligand-biased signaling.  Eliminating the nonselective compds. did not change the clustering of the 10 remaining compds.  Some ligands exhibited large differences in potency for the different pathways, suggesting that the nature of the receptor-effector complexes influences the relative affinity of the compds. for specific receptor conformations.  Calcn. of relative effectiveness (within pathway) and bias factors (between pathways) for each of the compds., using an operational model of agonism, revealed a global signaling signature for all of the compds. relative to isoproterenol.  Most compds. were biased toward ERK1/2 activation over the other pathways, consistent with the notion that many proximal effectors converge on this pathway.  Overall, we demonstrate a higher level of ligand texture than previously anticipated, opening perspectives for the establishment of pluridimensional correlations between signaling profiles, drug classification, therapeutic efficacy and safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_6gTmfSSaXLVg90H21EOLACvtfcHk0lgr8kvMOgPg7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVylu74%253D&md5=b3c934fb87abb58d08ef15f435a6a331</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.088880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.088880%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BWesthuizen%26aufirst%3DE.%2BT.%26aulast%3DBreton%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DQuantification%2520of%2520ligand%2520bias%2520for%2520clinically%2520relevant%2520%25CE%25B22-adrenergic%2520receptor%2520ligands%253A%2520implications%2520for%2520drug%2520taxonomy%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26spage%3D492%26epage%3D509%26doi%3D10.1124%2Fmol.113.088880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solanki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirsath, V. S.</span></span> <span> </span><span class="NLM_article-title">Comparative in-vitro intrinsic clearance of Imipramine in multiple species liver microsomes: human, rat, mouse and dog</span>. <i>J. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">126</span>, <span class="refDoi"> DOI: 10.4172/2157-7609.1000126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.4172%2F2157-7609.1000126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Whur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=126&author=J.+K.+Singhauthor=A.+Solankiauthor=V.+S.+Shirsath&title=Comparative+in-vitro+intrinsic+clearance+of+Imipramine+in+multiple+species+liver+microsomes%3A+human%2C+rat%2C+mouse+and+dog&doi=10.4172%2F2157-7609.1000126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative in-vitro intrinsic clearance of Imipramine in multiple species liver microsomes: human, rat, mouse and dog</span></div><div class="casAuthors">Singh, Jitendra Kumar; Solanki, Anant; Shirsath, Vikas S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">126</span>CODEN:
                <span class="NLM_cas:coden">JDMTAZ</span>;
        ISSN:<span class="NLM_cas:issn">2157-7609</span>.
    
            (<span class="NLM_cas:orgname">OMICS Publishing Group</span>)
        </div><div class="casAbstract">Imipramine is a renowned tricyclic anti-depressant mol.  It is known to be highly potent and efficient as compared to any other antidepressants available.  There are numerous literature reports which elucidate the metabolic pathways of Imipramine.  There are also various reports showing the effect of substrate and time on metab. of Imipramine.  Most of the anal. methods used in these studies were HPLC and or LC-MS.  These studies have also been extended to identification of specific isoforms of cytochrome P 450 family responsible for the metab. of Imipramine as is outlined.  Further, LC-MS based studies have also been reported on the metab. of Imipramine in in-vitro systems including human liver microsomes and its extrapolation on human oral bioavailability data.  However, till date, there has been no published report on the systematic metabolic stability of this mol. in pooled mouse and dog liver microsomes.  The present study was undertaken with the aim to understand the metabolic stability of Imipramine in liver microsomes of different species including human, wistar rat, CD1 mouse and male beagle dog.  We have also attempted to outline the differences between the metabolic stability in these four species.  The reaction samples were scanned for specific m/z values corresponding to reported metabolites, which in turn confirms microsomal metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHooAolbA_2LVg90H21EOLACvtfcHk0liQO9f67ZpZgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Whur7M&md5=cb62284b946dbc862f35d630b651b989</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.4172%2F2157-7609.1000126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F2157-7609.1000126%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%2BK.%26aulast%3DSolanki%26aufirst%3DA.%26aulast%3DShirsath%26aufirst%3DV.%2BS.%26atitle%3DComparative%2520in-vitro%2520intrinsic%2520clearance%2520of%2520Imipramine%2520in%2520multiple%2520species%2520liver%2520microsomes%253A%2520human%252C%2520rat%252C%2520mouse%2520and%2520dog%26jtitle%3DJ.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2012%26volume%3D3%26spage%3D126%26doi%3D10.4172%2F2157-7609.1000126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinemann, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Functionally selective dopamine D<sub>2</sub>/D<sub>3</sub> receptor agonists comprising an enyne moiety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5130</span>– <span class="NLM_lpage">5141</span>, <span class="refDoi"> DOI: 10.1021/jm400520c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400520c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslSqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5130-5141&author=C.+Hillerauthor=R.+C.+Klingauthor=F.+W.+Heinemannauthor=K.+Meyerauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Functionally+selective+dopamine+D2%2FD3+receptor+agonists+comprising+an+enyne+moiety&doi=10.1021%2Fjm400520c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Functionally Selective Dopamine D2/D3 Receptor Agonists Comprising an Enyne Moiety</span></div><div class="casAuthors">Hiller, Christine; Kling, Ralf C.; Heinemann, Frank W.; Meyer, Karsten; Huebner, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5130-5141</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonracemic ethynylcyclohexynylamines I and ent-I {R = 1,1'-biphenyl-4-yl, pyrazolo[1,5-a]pyridin-2-yl, pyrazolo[1,5-a]pyridin-3-yl, 4-[3-(1-butyl-1,2,3-triazol-4-yloxy)propoxy]-3-methoxyphenyl, benzo[b]thiophene-2-yl, ferrocenyl} were prepd. as dopamine receptor agonists with atypical catechol isosteres; their selectivities for dopamine receptors and for activating receptors through G-protein subunits Go and Gi and the metabolic stability of rac-I (R = 4-PhC6H4) were detd.  The ethynylcyclohexynylamines bound to D2-like receptors with high affinities.  Ent-I (R = pyrazolo[1,5-a]pyridin-2-yl) selectively activated D2slow-promoted Go activation over Gi coupling; the most significant functional bias obsd. was for ent-I {R = 4-[3-(1-butyl-1,2,3-triazol-4-yloxy)propoxy]-3-methoxyphenyl} which selectively activated Go over Gi coupling at D2long receptors.  Functional selectivity for β-arrestin recruitment over Gi activation was obsd. for I (R = 1,1'-biphenyl-4-yl) and ent-I (R = benzothiophene-2-yl), while ent-I (R = pyrazolo[1,5-a]pyridin-2-yl) preferred β-arrestin recruitment compared to Go coupling.  The structure of a nonracemic N-(ethynylcyclohexenyl)dinitrobenzamide was detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXn2SrS-IBCrVg90H21EOLACvtfcHk0liQO9f67ZpZgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslSqtr4%253D&md5=3855de949f505a83ed3aa561ca182e75</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm400520c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400520c%26sid%3Dliteratum%253Aachs%26aulast%3DHiller%26aufirst%3DC.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DHeinemann%26aufirst%3DF.%2BW.%26aulast%3DMeyer%26aufirst%3DK.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DFunctionally%2520selective%2520dopamine%2520D2%252FD3%2520receptor%2520agonists%2520comprising%2520an%2520enyne%2520moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5130%26epage%3D5141%26doi%3D10.1021%2Fjm400520c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span> Avogadro, “An
open-source molecular builder and visualization tool. Version 1.2.0”:<span class="NLM_contrib-group"><span class="NLM_string-name">Hanwell, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonie, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandermeersch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zurek, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchison, G. R.</span></span> <span> </span><span class="NLM_article-title">Avogadro: an advanced semantic chemical editor, visualization, and analysis platform</span>. <i>J. Cheminf.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">17</span>, <span class="refDoi"> DOI: 10.1186/1758-2946-4-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1186%2F1758-2946-4-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVGksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=17&author=M.+D.+Hanwellauthor=D.+E.+Curtisauthor=D.+C.+Lonieauthor=T.+Vandermeerschauthor=E.+Zurekauthor=G.+R.+Hutchison&title=Avogadro%3A+an+advanced+semantic+chemical+editor%2C+visualization%2C+and+analysis+platform&doi=10.1186%2F1758-2946-4-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Avogadro: an advanced semantic chemical editor, visualization, and analysis platform</span></div><div class="casAuthors">Hanwell, Marcus D.; Curtis, Donald E.; Lonie, David C.; Vandermeersch, Tim; Zurek, Eva; Hutchison, Geoffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cheminformatics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17</span>CODEN:
                <span class="NLM_cas:coden">JCOHB3</span>;
        ISSN:<span class="NLM_cas:issn">1758-2946</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Background: The Avogadro project has developed an advanced mol. editor and visualizer designed for cross-platform use in computational chem., mol. modeling, bioinformatics, materials science, and related areas.  It offers flexible, high quality rendering, and a powerful plugin architecture.  Typical uses include building mol. structures, formatting input files, and analyzing output of a wide variety of computational chem. packages.  By using the CML file format as its native document type, Avogadro seeks to enhance the semantic accessibility of chem. data types.  Results: The work presented here details the Avogadro library, which is a framework providing a code library and application programming interface (API) with three-dimensional visualization capabilities; and has direct applications to research and education in the fields of chem., physics, materials science, and biol.  The Avogadro application provides a rich graphical interface using dynamically loaded plugins through the library itself.  The application and library can each be extended by implementing a plugin module in C++ or Python to explore different visualization techniques, build/manipulate mol. structures, and interact with other programs.  We describe some example extensions, one which uses a genetic algorithm to find stable crystal structures, and one which interfaces with the PackMol program to create packed, solvated structures for mol. dynamics simulations.  The 1.0 release series of Avogadro is the main focus of the results discussed here.  Conclusions: Avogadro offers a semantic chem. builder and platform for visualization and anal.  For users, it offers an easy-to-use builder, integrated support for downloading from common databases such as PubChem and the Protein Data Bank, extg. chem. data from a wide variety of formats, including computational chem. output, and native, semantic support for the CML file format.  For developers, it can be easily extended via a powerful plugin mechanism to support new features in org. chem., inorg. complexes, drug design, materials, biomols., and simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryQMK72CZkerVg90H21EOLACvtfcHk0liQO9f67ZpZgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVGksLg%253D&md5=f10400f51db314afa780e99403ca748a</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1186%2F1758-2946-4-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1758-2946-4-17%26sid%3Dliteratum%253Aachs%26aulast%3DHanwell%26aufirst%3DM.%2BD.%26aulast%3DCurtis%26aufirst%3DD.%2BE.%26aulast%3DLonie%26aufirst%3DD.%2BC.%26aulast%3DVandermeersch%26aufirst%3DT.%26aulast%3DZurek%26aufirst%3DE.%26aulast%3DHutchison%26aufirst%3DG.%2BR.%26atitle%3DAvogadro%253A%2520an%2520advanced%2520semantic%2520chemical%2520editor%252C%2520visualization%252C%2520and%2520analysis%2520platform%26jtitle%3DJ.%2520Cheminf.%26date%3D2012%26volume%3D4%26spage%3D17%26doi%3D10.1186%2F1758-2946-4-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span> AutoDock Tools, version
1.5.6:<span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span> <span> </span><span class="NLM_article-title">Python: A Programming Language for Software Integration and Development</span>. <i>J. Mol. Graphics Mod.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/S1093-3263(99)99999-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2FS1093-3263%2899%2999999-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10660911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=57-61&author=M.+F.+Sanner&title=Python%3A+A+Programming+Language+for+Software+Integration+and+Development&doi=10.1016%2FS1093-3263%2899%2999999-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Python: a programming language for software integration and development</span></div><div class="casAuthors">Sanner, M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-61</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The use of interpreted languages in biocomputing has been investigated to create a programmable, dynamic environment in which components can be tied together at a high level.  This work has demonstrated the benefits of such an approach and the features of the interpreted language that are key to successful component integration.  This involved Python, an interpreted, interactive, object-oriented programming language.  It provides high-level data structures such as list and associative arrays, dynamic typing and dynamic binding, modules, classes, exceptions, automatic memory management and others.  Python has been found to be instrumental in the mol. modeling research environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaCFXA1JC8X7Vg90H21EOLACvtfcHk0liLjrEn3XuTDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D&md5=3bf94934548080055dda54f68468c656</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS1093-3263%2899%2999999-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1093-3263%252899%252999999-0%26sid%3Dliteratum%253Aachs%26aulast%3DSanner%26aufirst%3DM.%2BF.%26atitle%3DPython%253A%2520A%2520Programming%2520Language%2520for%2520Software%2520Integration%2520and%2520Development%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Mod.%26date%3D1999%26volume%3D17%26spage%3D57%26epage%3D61%26doi%3D10.1016%2FS1093-3263%2899%2999999-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit60a"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+docking+with+selective+receptor+flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60aR"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0liLjrEn3XuTDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit60a&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520docking%2520with%2520selective%2520receptor%2520flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trott, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+Improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0liLjrEn3XuTDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520Improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Structure of the D<sub>2</sub> dopamine receptor bound to the atypical antipsychotic drug risperidone</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>555</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1038/nature25758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1038%2Fnature25758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=29466326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFKqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=555&publication_year=2018&pages=269-273&author=S.+Wangauthor=T.+Cheauthor=A.+Levitauthor=B.+K.+Shoichetauthor=D.+Wackerauthor=B.+L.+Roth&title=Structure+of+the+D2+dopamine+receptor+bound+to+the+atypical+antipsychotic+drug+risperidone&doi=10.1038%2Fnature25758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone</span></div><div class="casAuthors">Wang, Sheng; Che, Tao; Levit, Anat; Shoichet, Brian K.; Wacker, Daniel; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">555</span>
        (<span class="NLM_cas:issue">7695</span>),
    <span class="NLM_cas:pages">269-273</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Dopamine is a neurotransmitter that has been implicated in processes as diverse as reward, addiction, control of coordinated movement, metab. and hormonal secretion.  Correspondingly, dysregulation of the dopaminergic system has been implicated in diseases such as schizophrenia, Parkinson's disease, depression, attention deficit hyperactivity disorder, and nausea and vomiting.  The actions of dopamine are mediated by a family of five G-protein-coupled receptors.  The D2 dopamine receptor (DRD2) is the primary target for both typical and atypical antipsychotic drugs, and for drugs used to treat Parkinson's disease.  Unfortunately, many drugs that target DRD2 cause serious and potentially life-threatening side effects due to promiscuous activities against related receptors.  Accordingly, a mol. understanding of the structure and function of DRD2 could provide a template for the design of safer and more effective medications.  Here we report the crystal structure of DRD2 in complex with the widely prescribed atypical antipsychotic drug risperidone.  The DRD2-risperidone structure reveals an unexpected mode of antipsychotic drug binding to dopamine receptors, and highlights structural determinants that are essential for the actions of risperidone and related drugs at DRD2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeo4Ov49kft7Vg90H21EOLACvtfcHk0liLjrEn3XuTDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFKqt7c%253D&md5=2842adc1893293ea8dbf98ae3270a1b2</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnature25758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25758%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructure%2520of%2520the%2520D2%2520dopamine%2520receptor%2520bound%2520to%2520the%2520atypical%2520antipsychotic%2520drug%2520risperidone%26jtitle%3DNature%26date%3D2018%26volume%3D555%26spage%3D269%26epage%3D273%26doi%3D10.1038%2Fnature25758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, E. Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the human dopamine D<sub>3</sub> receptor in complex with a D<sub>2</sub>/D<sub>3</sub> selective antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">1091</span>– <span class="NLM_lpage">1095</span>, <span class="refDoi"> DOI: 10.1126/science.1197410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1126%2Fscience.1197410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=21097933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1091-1095&author=E.+Y.+T.+Chienauthor=W.+Liuauthor=Q.+Zhaoauthor=V.+Katritchauthor=G.+Won+Hanauthor=M.+A.+Hansonauthor=L.+Shiauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+human+dopamine+D3+receptor+in+complex+with+a+D2%2FD3+selective+antagonist&doi=10.1126%2Fscience.1197410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist</span></div><div class="casAuthors">Chien, Ellen Y. T.; Liu, Wei; Zhao, Qiang; Katritch, Vsevolod; Won Han, Gye; Hanson, Michael A.; Shi, Lei; Newman, Amy Hauck; Javitch, Jonathan A.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6007</span>),
    <span class="NLM_cas:pages">1091-1095</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Dopamine modulates movement, cognition, and emotion through activation of dopamine G protein-coupled receptors in the brain.  The crystal structure of the human dopamine D3 receptor (D3R) in complex with the small mol. D2R/D3R-specific antagonist eticlopride reveals important features of the ligand binding pocket and extracellular loops.  On the intracellular side of the receptor, a locked conformation of the ionic lock and two distinctly different conformations of intracellular loop 2 are obsd.  Docking of R-22, a D3R-selective antagonist, reveals an extracellular extension of the eticlopride binding site that comprises a second binding pocket for the aryl amide of R-22, which differs between the highly homologous D2R and D3R.  This difference provides direction to the design of D3R-selective agents for treating drug abuse and other neuropsychiatric indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOEcfSdjMm-7Vg90H21EOLACvtfcHk0lgVrXqf1-fveA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM&md5=12c6f343daea9fb14ca605a092f28533</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1126%2Fscience.1197410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1197410%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DE.%2BY.%2BT.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DWon%2BHan%26aufirst%3DG.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520human%2520dopamine%2520D3%2520receptor%2520in%2520complex%2520with%2520a%2520D2%252FD3%2520selective%2520antagonist%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1091%26epage%3D1095%26doi%3D10.1126%2Fscience.1197410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, D. A.</span></span> <span> </span><span class="NLM_article-title">The Cation−π Interaction</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">1303</span>– <span class="NLM_lpage">1324</span>, <span class="refDoi"> DOI: 10.1021/cr9603744</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr9603744" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK2sXksV2kurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1997&pages=1303-1324&author=J.+C.+Maauthor=D.+A.+Dougherty&title=The+Cation%E2%88%92%CF%80+Interaction&doi=10.1021%2Fcr9603744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The Cation-π Interaction</span></div><div class="casAuthors">Ma, Jennifer C.; Dougherty, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1303-1324</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 293 refs. concerning the title interaction with emphasis on side chain interactions in proteins and protein-ligand interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGfJ_HZ_O2qLVg90H21EOLACvtfcHk0lgVrXqf1-fveA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksV2kurk%253D&md5=e9b3feef32db1495484b4adcd941b138</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fcr9603744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9603744%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DJ.%2BC.%26aulast%3DDougherty%26aufirst%3DD.%2BA.%26atitle%3DThe%2520Cation%25E2%2588%2592%25CF%2580%2520Interaction%26jtitle%3DChem.%2520Rev.%26date%3D1997%26volume%3D97%26spage%3D1303%26epage%3D1324%26doi%3D10.1021%2Fcr9603744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span> <span> </span><span class="NLM_article-title">Biased ligands of G protein-coupled receptors (GPCRs): structure-functional selectivity relationships (SFSRs) and therapeutic potential</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9841</span>– <span class="NLM_lpage">9878</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00435</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00435" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9841-9878&author=L.+Tanauthor=W.+Yanauthor=J.+D.+McCorvyauthor=J.+Cheng&title=Biased+ligands+of+G+protein-coupled+receptors+%28GPCRs%29%3A+structure-functional+selectivity+relationships+%28SFSRs%29+and+therapeutic+potential&doi=10.1021%2Facs.jmedchem.8b00435"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential</span></div><div class="casAuthors">Tan, Liang; Yan, Wenzhong; McCorvy, John D.; Cheng, Jianjun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9841-9878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) signal through both G-protein-dependent and G-protein-independent pathways, and β-arrestin recruitment is the most recognized one of the latter.  Biased ligands selective for either pathway are expected to regulate biol. functions of GPCRs in a more precise way, therefore providing new drug mols. with superior efficacy and/or reduced side effects.  During the past decade, biased ligands have been discovered and developed for many GPCRs, such as the μ opioid receptor, the angiotensin II receptor type 1, the dopamine D2 receptor, and many others.  In this Perspective, recent advances in this field are reviewed by discussing the structure-functional selectivity relationships (SFSRs) of GPCR biased ligands and the therapeutic potential of these mols.  Further understanding of the biol. functions assocd. with each signaling pathway and structural basis for biased signaling will facilitate future drug design in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNFjkAvar29LVg90H21EOLACvtfcHk0lgVrXqf1-fveA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73N&md5=a7bd605b82666357f5a0a209002225e5</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00435%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DCheng%26aufirst%3DJ.%26atitle%3DBiased%2520ligands%2520of%2520G%2520protein-coupled%2520receptors%2520%2528GPCRs%2529%253A%2520structure-functional%2520selectivity%2520relationships%2520%2528SFSRs%2529%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9841%26epage%3D9878%26doi%3D10.1021%2Facs.jmedchem.8b00435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Fattah, M. A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span> <span> </span><span class="NLM_article-title">An interactive SAR approach to discover novel hybrid thieno probes as ligands for D<sub>2</sub>-like receptors with affinities in the subnanomolar range</span>. <i>Chem. Biodiversity</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2247</span>– <span class="NLM_lpage">2266</span>, <span class="refDoi"> DOI: 10.1002/cbdv.201300204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1002%2Fcbdv.201300204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=24327445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFaltbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=2247-2266&author=M.+A.+O.+Abdel-Fattahauthor=J.+Lehmannauthor=A.+H.+Abadi&title=An+interactive+SAR+approach+to+discover+novel+hybrid+thieno+probes+as+ligands+for+D2-like+receptors+with+affinities+in+the+subnanomolar+range&doi=10.1002%2Fcbdv.201300204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">An Interactive SAR Approach to Discover Novel Hybrid Thieno Probes as Ligands for D2-Like Receptors with Affinities in the Subnanomolar Range</span></div><div class="casAuthors">Abdel-Fattah, Mohamed A. O.; Lehmann, Jochen; Abadi, Ashraf H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2247-2266</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">Arylpiperazinylalkyl phthalimides I [R = 2-EtOC6H4, 2,3-Cl2C6H3, 2-FC6H4, 2-ClC6H4, 2-HOC6H4, 4-FC6H4, 4-ClC6H4, 3,4-Cl2C6H3, 4-HOC6H4, Ph; X = (CH2)n; n = 1, 2] and arylpiperazinylalkyl benzamides and thiophenecarboxamides II [R = 2-EtOC6H4, 2,3-Cl2C6H3, 2-FC6H4, 2-ClC6H4, 2-HOC6H4, 4-FC6H4, 4-ClC6H4, 3,4-Cl2C6H3, 4-HOC6H4, Ph; R1 = Ph, 2-thienyl; X = (CH2)n; n = 1, 2] were prepd. as selective ligands for dopamine D3 and D4 (D2-like) receptors.  Of the arylpiperazinylalkyl phthalimides prepd., I (R = 2-EtOC6H4; n = 2) showed the highest affinity towards D4 and D3 receptors with Ki values in the low nanomolar range, and D2/D4- and D2/D3-selectivity indexes of 72 and 20, resp.  Further optimization led to the D4-selective ligand II (R1 = 2-thienyl; n = 1) with a Ki(D4) value of 0.62 nM, and to II (R1 = 2-thienyl; n = 2) with Ki(D4) and Ki(D3) values of 0.03 and 0.26 nM, resp.  Mol. docking expts. revealed the importance of the unique D4 residue Arg186 in manipulating the D4-subtype-receptor selectivity of the ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsgZBlwDG4MbVg90H21EOLACvtfcHk0ljWVHYRpSmgVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFaltbzO&md5=1934cb1116cfe22c350668ff1969d076</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.201300204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.201300204%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Fattah%26aufirst%3DM.%2BA.%2BO.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26atitle%3DAn%2520interactive%2520SAR%2520approach%2520to%2520discover%2520novel%2520hybrid%2520thieno%2520probes%2520as%2520ligands%2520for%2520D2-like%2520receptors%2520with%2520affinities%2520in%2520the%2520subnanomolar%2520range%26jtitle%3DChem.%2520Biodiversity%26date%3D2013%26volume%3D10%26spage%3D2247%26epage%3D2266%26doi%3D10.1002%2Fcbdv.201300204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saponaro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aghazadeh Tabrizi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosconati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincenzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Novel 2-((2-(4-(Substituted)phenylpiperazin-1-yl)ethyl)amino)-5′-N-ethylcarboxamidoadenosines as Potent and Selective Agonists of the A2A Adenosine Receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3253</span>– <span class="NLM_lpage">3267</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00215</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00215" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVOrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3253-3267&author=D.+Pretiauthor=P.+G.+Baraldiauthor=G.+Saponaroauthor=R.+Romagnoliauthor=M.+Aghazadeh+Tabriziauthor=S.+Baraldiauthor=S.+Cosconatiauthor=A.+Brunoauthor=E.+Novellinoauthor=F.+Vincenziauthor=A.+Ravaniauthor=P.+A.+Boreaauthor=K.+Varani&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Novel+2-%28%282-%284-%28Substituted%29phenylpiperazin-1-yl%29ethyl%29amino%29-5%E2%80%B2-N-ethylcarboxamidoadenosines+as+Potent+and+Selective+Agonists+of+the+A2A+Adenosine+Receptor&doi=10.1021%2Facs.jmedchem.5b00215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel 2-((2-(4-(Substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamido-adenosines as Potent and Selective Agonists of the A2A Adenosine Receptor</span></div><div class="casAuthors">Preti, Delia; Baraldi, Pier Giovanni; Saponaro, Giulia; Romagnoli, Romeo; Aghazadeh Tabrizi, Mojgan; Baraldi, Stefania; Cosconati, Sandro; Bruno, Agostino; Novellino, Ettore; Vincenzi, Fabrizio; Ravani, Annalisa; Borea, Pier Andrea; Varani, Katia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3253-3267</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stimulation of A2A adenosine receptors (AR) promotes anti-inflammatory responses in animal models of allergic rhinitis, asthma, chronic obstructive pulmonary disease, and rheumatic diseases.  Herein we describe the results of a research program aimed at identifying potent and selective agonists of the A2AAR as potential anti-inflammatory agents.  The recent crystallog. anal. of A2AAR agonists and antagonists in complex with the receptor provided key information on the structural determinants leading to receptor activation or blocking.  In light of this, we designed a new series of 2-((4-aryl(alkyl)piperazin-1-yl)alkylamino)-5'-N-ethylcarboxamido-adenosines, e.g. I, with high A2AAR affinity, activation potency and selectivity obtained by merging distinctive structural elements of known agonists and antagonists of the investigated target.  Docking-based SAR optimization allowed us to identify compd. I as one of the most potent and selective A2A agonist discovered so far (Ki hA2AAR = 4.8 nM, EC50 hA2AAR = 4.9 nM, Ki hA1AR > 10 000 nM, Ki hA3AR = 1487 nM, EC50 hA2BAR > 10 000 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-oIoiqp7btLVg90H21EOLACvtfcHk0ljWVHYRpSmgVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVOrtrg%253D&md5=bd2e0d3960b94b43b21cafb2327a62dd</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00215%26sid%3Dliteratum%253Aachs%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DSaponaro%26aufirst%3DG.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DAghazadeh%2BTabrizi%26aufirst%3DM.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DBruno%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DRavani%26aufirst%3DA.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DVarani%26aufirst%3DK.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Novel%25202-%2528%25282-%25284-%2528Substituted%2529phenylpiperazin-1-yl%2529ethyl%2529amino%2529-5%25E2%2580%25B2-N-ethylcarboxamidoadenosines%2520as%2520Potent%2520and%2520Selective%2520Agonists%2520of%2520the%2520A2A%2520Adenosine%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3253%26epage%3D3267%26doi%3D10.1021%2Facs.jmedchem.5b00215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">García, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alajarín, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Álvarez-Builla, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-García, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bascuñana-Almarcha, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peña-Salcedo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozo, M. A.</span></span> <span> </span><span class="NLM_article-title">N-(4-[18F]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HT1A receptors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">795</span>– <span class="NLM_lpage">806</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.ejmech.2014.07.096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=25171752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GktLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=795-806&author=G.+Garc%C3%ADaauthor=V.+Abetauthor=R.+Alajar%C3%ADnauthor=J.+%C3%81lvarez-Buillaauthor=M.+Delgadoauthor=L.+Garc%C3%ADa-Garc%C3%ADaauthor=P.+Bascu%C3%B1ana-Almarchaauthor=C.+Pe%C3%B1a-Salcedoauthor=J.+Kellyauthor=M.+A.+Pozo&title=N-%284-%5B18F%5D-fluoropyridin-2-yl%29-N-%7B2-%5B4-%282-methoxyphenyl%29piperazin-1-yl%5Dethyl%7Dcarboxamides+as+analogs+of+WAY100635.+New+PET+tracers+of+serotonin+5-HT1A+receptors&doi=10.1016%2Fj.ejmech.2014.07.096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">N-(4-[18F]-fluoro-2-pyridinyl)-N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HT1A receptors</span></div><div class="casAuthors">Garcia, Gonzalo; Abet, Valentina; Alajarin, Ramon; Alvarez-Builla, Julio; Delgado, Mercedes; Garcia-Garcia, Luis; Bascunana-Almarcha, Pablo; Pena-Salcedo, Carmen; Kelly, James; Pozo, Miguel A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">795-806</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">N-(4-[18F]-Fluoro-2-pyridinyl)-N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]carboxamide derivs. were prepd. by labeling their 4-nitro-2-pyridinyl precursors through nitro substitution by the 18F anion.  In vitro and in vivo tests showed that the cyclohexanecarboxamide deriv. is a reversible, selective and high affinity 5-HT1A receptor antagonist (IC50 = 0.29 nM, ki = 0.18 nM) with high brain uptake, slow brain clearance and stability to defluorination when compared with conventional stds.  This PET radioligand is a promising candidate for an improved in vivo quantification of 5-HT1A receptors in neuropsychiatric disorders.  The synthesis of the target compds. was achieved by a reaction of N-(4-nitro-2-pyridinyl)-N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]amide derivs. with (Kryptofix-2.2.2)potassium fluoride[18F].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroKvtKmBtIf7Vg90H21EOLACvtfcHk0ljWVHYRpSmgVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GktLfM&md5=2309d16675ae8165b073193e1175bcde</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.096%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa%26aufirst%3DG.%26aulast%3DAbet%26aufirst%3DV.%26aulast%3DAlajar%25C3%25ADn%26aufirst%3DR.%26aulast%3D%25C3%2581lvarez-Builla%26aufirst%3DJ.%26aulast%3DDelgado%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Garc%25C3%25ADa%26aufirst%3DL.%26aulast%3DBascu%25C3%25B1ana-Almarcha%26aufirst%3DP.%26aulast%3DPe%25C3%25B1a-Salcedo%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DJ.%26aulast%3DPozo%26aufirst%3DM.%2BA.%26atitle%3DN-%25284-%255B18F%255D-fluoropyridin-2-yl%2529-N-%257B2-%255B4-%25282-methoxyphenyl%2529piperazin-1-yl%255Dethyl%257Dcarboxamides%2520as%2520analogs%2520of%2520WAY100635.%2520New%2520PET%2520tracers%2520of%2520serotonin%25205-HT1A%2520receptors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D85%26spage%3D795%26epage%3D806%26doi%3D10.1016%2Fj.ejmech.2014.07.096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vermeulen, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Smeden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprouse, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikström, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grol, C. J.</span></span> <span> </span><span class="NLM_article-title">Novel 5-HT7Receptor Inverse Agonists. Synthesis and Molecular Modeling of Arylpiperazine- and 1,2,3,4-Tetrahydroisoquinoline-Based Arylsulfonamides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5451</span>– <span class="NLM_lpage">5466</span>, <span class="refDoi"> DOI: 10.1021/jm049743b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049743b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsleisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5451-5466&author=E.+S.+Vermeulenauthor=M.+van+Smedenauthor=A.+W.+Schmidtauthor=J.+S.+Sprouseauthor=H.+V.+Wikstr%C3%B6mauthor=C.+J.+Grol&title=Novel+5-HT7Receptor+Inverse+Agonists.+Synthesis+and+Molecular+Modeling+of+Arylpiperazine-+and+1%2C2%2C3%2C4-Tetrahydroisoquinoline-Based+Arylsulfonamides&doi=10.1021%2Fjm049743b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 5-HT7 Receptor Inverse Agonists. Synthesis and Molecular Modeling of Arylpiperazine- and 1,2,3,4-Tetrahydroisoquinoline-Based Arylsulfonamides</span></div><div class="casAuthors">Vermeulen, Erik S.; Van Smeden, Marjan; Schmidt, Anne W.; Sprouse, Jeffrey S.; Wikstroem, Haakan V.; Grol, Cor J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5451-5466</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of arylpiperazine- and 1,2,3,4-tetrahydroisoquinoline-based arylsulfonamides was synthesized and evaluated for their interactions with the constitutively active 5-HT7 receptor.  Effects on basal adenylate cyclase activity were measured using HEK-293 cells expressing the rat 5-HT7.  All ligands produced a decrease of adenylate cyclase activity, indicative of their inverse agonism.  Addnl., computational studies with a set of 22 inverse agonists, including these novel inverse agonists and inverse agonists known from literature, resulted in a pharmacophore model and a CoMFA model (R2 = 0.97, SE = 0.18).  Docking of inverse agonists at the binding site of a model of the helical parts of the 5-HT7 receptor, based on the α carbon template for 7-TM GPCRs, revealed interesting mol. interactions and a possible explanation for obsd. structure-activity relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqboqchHGBr97Vg90H21EOLACvtfcHk0ljSjjl5_WkZVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsleisL8%253D&md5=6fcdfd93be91c6fc8507b40b7b0dd6ee</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm049743b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049743b%26sid%3Dliteratum%253Aachs%26aulast%3DVermeulen%26aufirst%3DE.%2BS.%26aulast%3Dvan%2BSmeden%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DSprouse%26aufirst%3DJ.%2BS.%26aulast%3DWikstr%25C3%25B6m%26aufirst%3DH.%2BV.%26aulast%3DGrol%26aufirst%3DC.%2BJ.%26atitle%3DNovel%25205-HT7Receptor%2520Inverse%2520Agonists.%2520Synthesis%2520and%2520Molecular%2520Modeling%2520of%2520Arylpiperazine-%2520and%25201%252C2%252C3%252C4-Tetrahydroisoquinoline-Based%2520Arylsulfonamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5451%26epage%3D5466%26doi%3D10.1021%2Fjm049743b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lasch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M. R.</span></span> <span> </span><span class="NLM_article-title">Cycloaddition reactions of glycine imine anions to phenylazocarboxylic esters - a new access to 1,3,5-trisubstituted 1,2,4-triazoles</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">4282</span>– <span class="NLM_lpage">4295</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2015.04.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.tet.2015.04.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFCgsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=4282-4295&author=R.+Laschauthor=M.+R.+Heinrich&title=Cycloaddition+reactions+of+glycine+imine+anions+to+phenylazocarboxylic+esters+-+a+new+access+to+1%2C3%2C5-trisubstituted+1%2C2%2C4-triazoles&doi=10.1016%2Fj.tet.2015.04.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Cycloaddition reactions of glycine imine anions to phenylazocarboxylic esters - a new access to 1,3,5-trisubstituted 1,2,4-triazoles</span></div><div class="casAuthors">Lasch, Roman; Heinrich, Markus R.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4282-4295</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Phenylazocarboxylic tert-Bu esters have recently been shown to be highly versatile building blocks due to their ability to undergo nucleophilic arom. substitutions under mild conditions, particularly well with [18F]fluoride, and to act as precursors for aryl radicals.  The authors now report first examples for cycloaddn. reactions to phenylazocarboxylates.  In a one-pot reaction with readily accessible glycine imines, a variety of highly substituted 1,2,4-triazoles could be obtained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqcjtE1nHos7Vg90H21EOLACvtfcHk0ljSjjl5_WkZVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFCgsLs%253D&md5=952cde1d6944a70843af59427b3d81ee</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2015.04.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2015.04.078%26sid%3Dliteratum%253Aachs%26aulast%3DLasch%26aufirst%3DR.%26aulast%3DHeinrich%26aufirst%3DM.%2BR.%26atitle%3DCycloaddition%2520reactions%2520of%2520glycine%2520imine%2520anions%2520to%2520phenylazocarboxylic%2520esters%2520-%2520a%2520new%2520access%2520to%25201%252C3%252C5-trisubstituted%25201%252C2%252C4-triazoles%26jtitle%3DTetrahedron%26date%3D2015%26volume%3D71%26spage%3D4282%26epage%3D4295%26doi%3D10.1016%2Fj.tet.2015.04.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kisseljova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tšubrik, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sillard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mäeorg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mäeorg, U.</span></span> <span> </span><span class="NLM_article-title">Addition of arylboronic acids to symmetrical and unsymmetrical azo compounds</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1021/ol052403f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol052403f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12rtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=43-45&author=K.+Kisseljovaauthor=O.+T%C5%A1ubrikauthor=R.+Sillardauthor=S.+M%C3%A4eorgauthor=U.+M%C3%A4eorg&title=Addition+of+arylboronic+acids+to+symmetrical+and+unsymmetrical+azo+compounds&doi=10.1021%2Fol052403f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Addition of Arylboronic Acids to Symmetrical and Unsymmetrical Azo Compounds</span></div><div class="casAuthors">Kisseljova, Ksenija; Tsubrik, Olga; Sillard, Rannar; Maeeorg, Sirje; Maeeorg, Uno</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-45</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The addn. of aryl- and heteroarylboronic acids to azo compds. is described.  E.g., Cu(OAc)2 catalyzed the addn. of PhB(OH)2 to PhN:NBoc to give 100% Ph2NNHBoc.  Copper salt catalysis was necessary to perform the reaction under mild conditions and high yields.  Excellent regioselectivity was obsd. in addn. to unsym. azo compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriElhAZDsNt7Vg90H21EOLACvtfcHk0ljSjjl5_WkZVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12rtbfE&md5=7f89fd300b6dadfff996aeda25524b21</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fol052403f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol052403f%26sid%3Dliteratum%253Aachs%26aulast%3DKisseljova%26aufirst%3DK.%26aulast%3DT%25C5%25A1ubrik%26aufirst%3DO.%26aulast%3DSillard%26aufirst%3DR.%26aulast%3DM%25C3%25A4eorg%26aufirst%3DS.%26aulast%3DM%25C3%25A4eorg%26aufirst%3DU.%26atitle%3DAddition%2520of%2520arylboronic%2520acids%2520to%2520symmetrical%2520and%2520unsymmetrical%2520azo%2520compounds%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D43%26epage%3D45%26doi%3D10.1021%2Fol052403f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krüll, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prante, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M. R.</span></span> <span> </span><span class="NLM_article-title">Microwave-Assisted Rapid One-Pot Synthesis of Fused and Non-Fused Indoles and 5-[18 F]Fluoroindoles from Phenylazocarboxylates</span>. <i>Chem.—Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">16174</span>– <span class="NLM_lpage">16178</span>, <span class="refDoi"> DOI: 10.1002/chem.201703890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1002%2Fchem.201703890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=28940808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs12lsbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=16174-16178&author=J.+Kr%C3%BCllauthor=A.+Hubertauthor=N.+Nebelauthor=O.+Pranteauthor=M.+R.+Heinrich&title=Microwave-Assisted+Rapid+One-Pot+Synthesis+of+Fused+and+Non-Fused+Indoles+and+5-%5B18+F%5DFluoroindoles+from+Phenylazocarboxylates&doi=10.1002%2Fchem.201703890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Microwave-Assisted Rapid One-Pot Synthesis of Fused and Non-Fused Indoles and 5-[18F]Fluoroindoles from Phenylazocarboxylates</span></div><div class="casAuthors">Kruell, Jasmin; Hubert, Anja; Nebel, Natascha; Prante, Olaf; Heinrich, Markus R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">64</span>),
    <span class="NLM_cas:pages">16174-16178</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Substituted indoles can be prepd. from phenylazocarboxylates through a rapid one-pot sequence featuring a microwave-assisted Fischer indole synthesis as a key step.  Considering that the phenylazocarboxylates may beforehand be modified by mild nucleophilic arom. substitution, including the introduction of [18F]fluoride, the overall strategy offers an attractive new access to 5-[18F]fluoroindoles, e.g., I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb3kVy8oooL7Vg90H21EOLACvtfcHk0lgC8fissRcItQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs12lsbfF&md5=3e6309b5f8f5c746d6620e9aa1fe915e</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2Fchem.201703890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201703890%26sid%3Dliteratum%253Aachs%26aulast%3DKr%25C3%25BCll%26aufirst%3DJ.%26aulast%3DHubert%26aufirst%3DA.%26aulast%3DNebel%26aufirst%3DN.%26aulast%3DPrante%26aufirst%3DO.%26aulast%3DHeinrich%26aufirst%3DM.%2BR.%26atitle%3DMicrowave-Assisted%2520Rapid%2520One-Pot%2520Synthesis%2520of%2520Fused%2520and%2520Non-Fused%2520Indoles%2520and%25205-%255B18%2520F%255DFluoroindoles%2520from%2520Phenylazocarboxylates%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D16174%26epage%3D16178%26doi%3D10.1002%2Fchem.201703890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fehler, S.</span></span> <span> </span><span class="NLM_article-title">Neue Reaktionen von Phenylazocarbonsäureestern mit Anwendungen in der Wirkstoffsynthese</span>. Ph.D. Thesis, <span class="NLM_publisher-name">FAU Erlangen-Nürnberg</span>, <span class="NLM_publisher-loc">Erlangen</span>, May 31, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Fehler&title=Neue+Reaktionen+von+Phenylazocarbons%C3%A4ureestern+mit+Anwendungen+in+der+Wirkstoffsynthese"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFehler%26aufirst%3DS.%26atitle%3DNeue%2520Reaktionen%2520von%2520Phenylazocarbons%25C3%25A4ureestern%2520mit%2520Anwendungen%2520in%2520der%2520Wirkstoffsynthese%26pub%3DFAU%2520Erlangen-N%25C3%25BCrnberg%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haubmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Conjugated enynes as nonaromatic catechol bioisosteres: synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D<sub>3</sub> subtype</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">756</span>– <span class="NLM_lpage">762</span>, <span class="refDoi"> DOI: 10.1021/jm991098z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm991098z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvV2ntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=756-762&author=H.+H%C3%BCbnerauthor=C.+Haubmannauthor=W.+Utzauthor=P.+Gmeiner&title=Conjugated+enynes+as+nonaromatic+catechol+bioisosteres%3A+synthesis%2C+binding+experiments%2C+and+computational+studies+of+novel+dopamine+receptor+agonists+recognizing+preferentially+the+D3+subtype&doi=10.1021%2Fjm991098z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugated Enynes as Nonaromatic Catechol Bioisosteres: Synthesis, Binding Experiments, and Computational Studies of Novel Dopamine Receptor Agonists Recognizing Preferentially the D3 Subtype</span></div><div class="casAuthors">Huebner, Harald; Haubmann, Christian; Utz, Wolfgang; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">756-762</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To evaluate nonarom. catechol bioisosteres, the conformationally restrained enynes and enediynes were synthesized via palladium-catalyzed coupling as the key reaction step.  Subsequent receptor binding studies at the dopamine receptor subtypes D1, D2 long, D2 short, D3, and D4 showed highly interesting binding profiles for the enynes when compared to dopamine.  At the guanine nucleotide-sensitive high-affinity binding site of the D3 receptor, the target compd. (Ki = 5.2 nM) was 10-fold more potent than dopamine but less potent at the D2 and D4 subtypes.  In contrast to dopamine the agonists enynes showed strong selectivity for the receptors of the D2 family (D2-D4).  As far as we know, this study represents the first report on nonarom. dopamine agonists.  Comparison of mol. electrostatic potentials, derived from semiempirical MO calcns., and lipophilicity maps was performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWheANs3NXRLVg90H21EOLACvtfcHk0lgC8fissRcItQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvV2ntQ%253D%253D&md5=affc96571dd02832d40f990d29786a3a</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm991098z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991098z%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DHaubmann%26aufirst%3DC.%26aulast%3DUtz%26aufirst%3DW.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DConjugated%2520enynes%2520as%2520nonaromatic%2520catechol%2520bioisosteres%253A%2520synthesis%252C%2520binding%2520experiments%252C%2520and%2520computational%2520studies%2520of%2520novel%2520dopamine%2520receptor%2520agonists%2520recognizing%2520preferentially%2520the%2520D3%2520subtype%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D756%26epage%3D762%26doi%3D10.1021%2Fjm991098z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biden, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selbie, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shine, J.</span></span> <span> </span><span class="NLM_article-title">Structural subtypes of the dopamine D<sub>2</sub> receptor are functionally distinct: expression of the cloned D2A and D2B subtypes in a heterologous cell line</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">920</span>– <span class="NLM_lpage">926</span>, <span class="refDoi"> DOI: 10.1210/me.6.6.920</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1210%2Fme.6.6.920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1323056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK38Xks1emsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1992&pages=920-926&author=G.+Hayesauthor=T.+J.+Bidenauthor=L.+A.+Selbieauthor=J.+Shine&title=Structural+subtypes+of+the+dopamine+D2+receptor+are+functionally+distinct%3A+expression+of+the+cloned+D2A+and+D2B+subtypes+in+a+heterologous+cell+line&doi=10.1210%2Fme.6.6.920"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Structural subtypes of the dopamine D2 receptor are functionally distinct:  expression of the cloned D2A and D2B subtypes in a heterologous cell line</span></div><div class="casAuthors">Hayes, Gillian; Biden, Trevor J.; Selbie, Lisa A.; Shine, John</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">920-6</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    </div><div class="casAbstract">Two subtypes of the human dopamine D2 receptor are generated by alternate splicing of the RNA transcript of a single gene.  These 2 forms, termed D2A (long) and D2B (short), differ by the insertion of 29 amino acids within the putative 3rd cytoplasmic loop, an intracellular domain thought to have a role in coupling this class of receptors to particular 2nd messenger systems.  The D2A and D2B structural subtypes were also shown to be functionally distinct.  Expression of the 2 subtypes in a fibroblast cell line revealed that although occupations of both receptors lead to an increase in cytosolic free Ca concn., they differ in their capacity to inhibit cAMP prodn.  At physiol. dopamine concns., the D2β-mediated inhibition of CGRP-stimulated cAMP accumulation is almost double the response mediated by the D2A subtype.  Thus, the D2A and D2B subtypes constitute functionally distinct forms of the dopamine receptor that can couple to multiple intracellular signalling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBM-8vF3erjLVg90H21EOLACvtfcHk0li1xxO13TkGPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xks1emsrk%253D&md5=16cd2d9d673f866fd6a5c5dd9f9db730</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1210%2Fme.6.6.920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.6.6.920%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DG.%26aulast%3DBiden%26aufirst%3DT.%2BJ.%26aulast%3DSelbie%26aufirst%3DL.%2BA.%26aulast%3DShine%26aufirst%3DJ.%26atitle%3DStructural%2520subtypes%2520of%2520the%2520dopamine%2520D2%2520receptor%2520are%2520functionally%2520distinct%253A%2520expression%2520of%2520the%2520cloned%2520D2A%2520and%2520D2B%2520subtypes%2520in%2520a%2520heterologous%2520cell%2520line%26jtitle%3DMol.%2520Endocrinol.%26date%3D1992%26volume%3D6%26spage%3D920%26epage%3D926%26doi%3D10.1210%2Fme.6.6.920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sokoloff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giros, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martres, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouthenet, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J.-C.</span></span> <span> </span><span class="NLM_article-title">Molecular cloning and characterization of a novel dopamine receptor (D<sub>3</sub>) as a target for neuroleptics</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1038/347146a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1038%2F347146a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1975644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK3MXhsFyjtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=1990&pages=146-151&author=P.+Sokoloffauthor=B.+Girosauthor=M.-P.+Martresauthor=M.-L.+Bouthenetauthor=J.-C.+Schwartz&title=Molecular+cloning+and+characterization+of+a+novel+dopamine+receptor+%28D3%29+as+a+target+for+neuroleptics&doi=10.1038%2F347146a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics</span></div><div class="casAuthors">Sokoloff, Pierre; Giros, Bruno; Martres, Marie Pascale; Bouthenet, Marie Louise; Schwartz, Jean Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6289</span>),
    <span class="NLM_cas:pages">146-51</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">A dopamine receptor has been characterized which differs in its pharmacol. and signalling system from the D1 or D2 receptor and represents both an autoreceptor and a postsynaptic receptor.  The D3 receptor is localized to limbic areas of the brain, which are assocd. with cognitive, emotional, and endocrine functions.  It seems to mediate some of the effects of antipsychotic drugs and drugs used against Parkinson's disease, that were previously thought to interact only with D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYcwXGdNb1ILVg90H21EOLACvtfcHk0li1xxO13TkGPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsFyjtrg%253D&md5=0ea4d33964b478c51de32e96345811f6</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2F347146a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F347146a0%26sid%3Dliteratum%253Aachs%26aulast%3DSokoloff%26aufirst%3DP.%26aulast%3DGiros%26aufirst%3DB.%26aulast%3DMartres%26aufirst%3DM.-P.%26aulast%3DBouthenet%26aufirst%3DM.-L.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26atitle%3DMolecular%2520cloning%2520and%2520characterization%2520of%2520a%2520novel%2520dopamine%2520receptor%2520%2528D3%2529%2520as%2520a%2520target%2520for%2520neuroleptics%26jtitle%3DNature%26date%3D1990%26volume%3D347%26spage%3D146%26epage%3D151%26doi%3D10.1038%2F347146a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asghari, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwaldt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tol, H. H. M.</span></span> <span> </span><span class="NLM_article-title">Modulation of intracellular cyclic AMP levels by different human dopamine D<sub>4</sub> receptor variants</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1165</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.1995.65031157.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1046%2Fj.1471-4159.1995.65031157.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2002&pages=1157-1165&author=V.+Asghariauthor=S.+Sanyalauthor=S.+Buchwaldtauthor=A.+Patersonauthor=V.+Jovanovicauthor=H.+H.+M.+Van+Tol&title=Modulation+of+intracellular+cyclic+AMP+levels+by+different+human+dopamine+D4+receptor+variants&doi=10.1046%2Fj.1471-4159.1995.65031157.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1995.65031157.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1995.65031157.x%26sid%3Dliteratum%253Aachs%26aulast%3DAsghari%26aufirst%3DV.%26aulast%3DSanyal%26aufirst%3DS.%26aulast%3DBuchwaldt%26aufirst%3DS.%26aulast%3DPaterson%26aufirst%3DA.%26aulast%3DJovanovic%26aufirst%3DV.%26aulast%3DVan%2BTol%26aufirst%3DH.%2BH.%2BM.%26atitle%3DModulation%2520of%2520intracellular%2520cyclic%2520AMP%2520levels%2520by%2520different%2520human%2520dopamine%2520D4%2520receptor%2520variants%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D65%26spage%3D1157%26epage%3D1165%26doi%3D10.1046%2Fj.1471-4159.1995.65031157.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lowry, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosebrough, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farr, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randall, R. J.</span></span> <span> </span><span class="NLM_article-title">Protein measurement with the Folin phenol reagent</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1951</span>,  <span class="NLM_volume"><i>193</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2FS0021-9258%2819%2952451-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=14907713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaG38XhsVyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=1951&pages=265-275&author=O.+H.+Lowryauthor=N.+J.+Rosebroughauthor=A.+L.+Farrauthor=R.+J.+Randall&title=Protein+measurement+with+the+Folin+phenol+reagent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Protein measurement with the Folin phenol reagent</span></div><div class="casAuthors">Lowry, Oliver H.; Rosebrough, Nira J.; Farr, A. Lewis; Randall, Rose J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1951</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-75</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">cf. C.A. 41, 1271h.  Proteins were detd. with the Folin phenol reagent after alk. Cu treatment.  The method is as sensitive as with Nessler reagent, yet requires no digestion.  It is 10-20 times more sensitive than detn. of the ultraviolet absorption at λ = 280 mμ and is more specific.  It is several fold more sensitive than the ninhydrin reaction and 100 times more sensitive than the biuret reaction.  Two major disadvantages are: the amt. of color varies with different proteins; the color is not strictly proportional to concn.  Few substances cause serious interference.  Uric acid, guanine, and xanthine react with Folin reagent.  The method is useful for following enzyme fractionation, detg. mixed tissue proteins, detn. of very small amts. of protein, or detg. highly dild. protein, or protein in colored solns. or in the presence of N-contg. material.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHNRKGd34F8LVg90H21EOLACvtfcHk0lhekXp8CgRZPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38XhsVyrsw%253D%253D&md5=19d36395fad7dd87661caa3d2b97640d</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2819%2952451-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252819%252952451-6%26sid%3Dliteratum%253Aachs%26aulast%3DLowry%26aufirst%3DO.%2BH.%26aulast%3DRosebrough%26aufirst%3DN.%2BJ.%26aulast%3DFarr%26aufirst%3DA.%2BL.%26aulast%3DRandall%26aufirst%3DR.%2BJ.%26atitle%3DProtein%2520measurement%2520with%2520the%2520Folin%2520phenol%2520reagent%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1951%26volume%3D193%26spage%3D265%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fish, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stößel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eitel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albold, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huebner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunahara, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Structure-based design and discovery of new M2 receptor agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9239</span>– <span class="NLM_lpage">9250</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01113</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01113" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGnu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9239-9250&author=I.+Fishauthor=A.+St%C3%B6%C3%9Felauthor=K.+Eitelauthor=C.+Valantauthor=S.+Alboldauthor=H.+Huebnerauthor=D.+M%C3%B6llerauthor=M.+J.+Clarkauthor=R.+K.+Sunaharaauthor=A.+Christopoulosauthor=B.+K.+Shoichetauthor=P.+Gmeiner&title=Structure-based+design+and+discovery+of+new+M2+receptor+agonists&doi=10.1021%2Facs.jmedchem.7b01113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design and Discovery of New M2 Receptor Agonists</span></div><div class="casAuthors">Fish, Inbar; Stossel, Anne; Eitel, Katrin; Valant, Celine; Albold, Sabine; Huebner, Harald; Moller, Dorothee; Clark, Mary J.; Sunahara, Roger K.; Christopoulos, Arthur; Shoichet, Brian K.; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9239-9250</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Muscarinic receptor agonists are characterized by apparently strict restraints on their tertiary or quaternary amine and their distance to an ester or related center.  On the basis of the active state crystal structure of the muscarinic M2 receptor in complex with iperoxo, the authors explored potential agonists that lacked the highly conserved functionalities of previously known ligands.  Using structure-guided pharmacophore design followed by docking, the authors found two agonists (compds. 3 (2-(3-methoxyphenyl)-N,N,N-trimethylethan-1-aminium formate) and 17 (2-(benzofuran-6-yl)-N,N,N-trimethylethan-1-aminium formate)), out of 19 docked and synthesized compds., that fit the receptor well and were predicted to form a hydrogen-bond conserved among known agonists.  Structural optimization led to compd. 28 (2-(2,3-dihydrobenzofuran-6-yl)-N,N,N-trimethylethan-1-aminium formate), which was 4-fold more potent than its parent 3.  Fortified by the discovery of this new scaffold, the authors sought a broader range of chemotypes by docking 2.2 million fragments, which revealed another three micromolar agonists unrelated either to 28 or known muscarinics.  Even pockets as tightly defined and as deeply studied as that of the muscarinic reveal opportunities for the structure-based design and the discovery of new chemotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Yk4WSO0I3LVg90H21EOLACvtfcHk0lhekXp8CgRZPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGnu7nN&md5=113c2c9b16bc816ddde88634a129da09</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01113%26sid%3Dliteratum%253Aachs%26aulast%3DFish%26aufirst%3DI.%26aulast%3DSt%25C3%25B6%25C3%259Fel%26aufirst%3DA.%26aulast%3DEitel%26aufirst%3DK.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DAlbold%26aufirst%3DS.%26aulast%3DHuebner%26aufirst%3DH.%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DClark%26aufirst%3DM.%2BJ.%26aulast%3DSunahara%26aufirst%3DR.%2BK.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DStructure-based%2520design%2520and%2520discovery%2520of%2520new%2520M2%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9239%26epage%3D9250%26doi%3D10.1021%2Facs.jmedchem.7b01113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uzuneser, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skultety, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzheimer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedland, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of G protein-biased dopaminergics with a pyrazolo[1,5-a]pyridine substructure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2908</span>– <span class="NLM_lpage">2929</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01857</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01857" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A280%3ADC%252BC1czhs1Ojsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2908-2929&author=D.+M%C3%B6llerauthor=A.+Banerjeeauthor=T.+C.+Uzuneserauthor=M.+Skultetyauthor=T.+Huthauthor=B.+Plouffeauthor=H.+H%C3%BCbnerauthor=C.+Alzheimerauthor=K.+Friedlandauthor=C.+P.+M%C3%BCllerauthor=M.+Bouvierauthor=P.+Gmeiner&title=Discovery+of+G+protein-biased+dopaminergics+with+a+pyrazolo%5B1%2C5-a%5Dpyridine+substructure&doi=10.1021%2Facs.jmedchem.6b01857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure</span></div><div class="casAuthors">Moller Dorothee; Banerjee Ashutosh; Skultety Marika; Hubner Harald; Gmeiner Peter; Uzuneser Taygun C; Muller Christian P; Huth Tobias; Alzheimer Christian; Plouffe Bianca; Bouvier Michel; Friedland Kristina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2908-2929</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">1,4-Disubstituted aromatic piperazines are privileged structural motifs recognized by aminergic G protein-coupled receptors.  Connection of a lipophilic moiety to the arylpiperazine core by an appropriate linker represents a promising concept to increase binding affinity and to fine-tune functional properties.  In particular, incorporation of a pyrazolo[1,5-a]pyridine heterocyclic appendage led to a series of high-affinity dopamine receptor partial agonists.  Comprehensive pharmacological characterization involving BRET biosensors, binding studies, electrophysiology, and complementation-based assays revealed compounds favoring activation of G proteins (preferably Go) over β-arrestin recruitment at dopamine D2 receptors.  The feasibility to design G protein-biased partial agonists as putative novel therapeutics was demonstrated for the representative 2-methoxyphenylpiperazine 16c, which unequivocally displayed antipsychotic activity in vivo.  Moreover, combination of the pyrazolo[1,5-a]pyridine appendage with a 5-hydroxy-N-propyl-2-aminotetraline unit led to balanced or G protein-biased dopaminergic ligands depending on the stereochemistry of the headgroup, illustrating the complex structure-functional selectivity relationships at dopamine D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSsvEaQplNsM25P7XSLhESfW6udTcc2ebflGWtyE3gerntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czhs1Ojsw%253D%253D&md5=208855de29fed6b821fd6e4a5bfb412f</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01857%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DUzuneser%26aufirst%3DT.%2BC.%26aulast%3DSkultety%26aufirst%3DM.%26aulast%3DHuth%26aufirst%3DT.%26aulast%3DPlouffe%26aufirst%3DB.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DAlzheimer%26aufirst%3DC.%26aulast%3DFriedland%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BP.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520G%2520protein-biased%2520dopaminergics%2520with%2520a%2520pyrazolo%255B1%252C5-a%255Dpyridine%2520substructure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2908%26epage%3D2929%26doi%3D10.1021%2Facs.jmedchem.6b01857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung-Chi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (<i>K</i><sub>i</sub>) and the concentration of inhibitor which causes 50 per cent inhibition (I<sub>50</sub>) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=4202581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=C.+Yung-Chiauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28Ki%29+and+the+concentration+of+inhibitor+which+causes+50+per+cent+inhibition+%28I50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DYung-Chi%26aufirst%3DC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528Ki%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2520per%2520cent%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schellhorn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gienger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaab, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaindl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeb, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Structure-guided development of heterodimer-selective GPCR ligands</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12298</span>, <span class="refDoi"> DOI: 10.1038/ncomms12298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1038%2Fncomms12298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=27457610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12gu7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12298&author=H.+H%C3%BCbnerauthor=T.+Schellhornauthor=M.+Giengerauthor=C.+Schaabauthor=J.+Kaindlauthor=L.+Leebauthor=T.+Clarkauthor=D.+M%C3%B6llerauthor=P.+Gmeiner&title=Structure-guided+development+of+heterodimer-selective+GPCR+ligands&doi=10.1038%2Fncomms12298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided development of heterodimer-selective GPCR ligands</span></div><div class="casAuthors">Huebner, Harald; Schellhorn, Tamara; Gienger, Marie; Schaab, Carolin; Kaindl, Jonas; Leeb, Laurin; Clark, Timothy; Moeller, Dorothee; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12298</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Crystal structures of G protein-coupled receptor (GPCR) ligand complexes allow a rational design of novel mol. probes and drugs.  Here we report the structure-guided design, chem. synthesis and biol. investigations of bivalent ligands for dopamine D2 receptor/neurotensin NTS1 receptor (D2R/NTS1R) heterodimers.  The compds. of types 1-3 consist of three different D2R pharmacophores bound to an affinity-generating lipophilic appendage, a polyethylene glycol-based linker and the NTS1R agonist NT(8-13).  The bivalent ligands show binding affinity in the picomolar range for cells coexpressing both GPCRs and unprecedented selectivity (up to three orders of magnitude), compared with cells that only express D2Rs.  A functional switch is obsd. for the bivalent ligands 3b,c inhibiting cAMP formation in cells singly expressing D2Rs but stimulating cAMP accumulation in D2R/NTS1R-coexpressing cells.  Moreover, the newly synthesized bivalent ligands show a strong, predominantly NTS1R-mediated β-arrestin-2 recruitment at the D2R/NTS1R-coexpressing cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphGLuLYNRHcbVg90H21EOLACvtfcHk0lg8hGMVoz446w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12gu7bI&md5=eedc7c7eead43116f8f1a092faea7c62</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fncomms12298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12298%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DSchellhorn%26aufirst%3DT.%26aulast%3DGienger%26aufirst%3DM.%26aulast%3DSchaab%26aufirst%3DC.%26aulast%3DKaindl%26aufirst%3DJ.%26aulast%3DLeeb%26aufirst%3DL.%26aulast%3DClark%26aufirst%3DT.%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DStructure-guided%2520development%2520of%2520heterodimer-selective%2520GPCR%2520ligands%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12298%26doi%3D10.1038%2Fncomms12298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Broach, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorner, J.</span></span> <span> </span><span class="NLM_article-title">High-throughput screening for drug discovery</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>384</i></span>,  <span class="NLM_fpage">14</span>, <span class="refDoi"> DOI: 10.1038/384014a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1038%2F384014a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=8895594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK28Xmsl2rsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=1996&pages=14&author=J.+R.+Broachauthor=J.+Thorner&title=High-throughput+screening+for+drug+discovery&doi=10.1038%2F384014a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening for drug discovery</span></div><div class="casAuthors">Broach, James R.; Thorner, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">6604, Suppl.</span>),
    <span class="NLM_cas:pages">14-16</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">A review with 23 refs.  There are now a large no. of known proteins available as potential targets for drug treatment.  Concurrently, new approaches have increased the no. of compds. that can be tested for activity against these targets.  Together, these trends have stimulated the adoption of high-throughput screening as a primary tool for early-stage drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHliuK3qN3urVg90H21EOLACvtfcHk0lg8hGMVoz446w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xmsl2rsr4%253D&md5=356ca2edc709ece1a0c80f560ddd893d</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2F384014a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F384014a0%26sid%3Dliteratum%253Aachs%26aulast%3DBroach%26aufirst%3DJ.%2BR.%26aulast%3DThorner%26aufirst%3DJ.%26atitle%3DHigh-throughput%2520screening%2520for%2520drug%2520discovery%26jtitle%3DNature%26date%3D1996%26volume%3D384%26spage%3D14%26doi%3D10.1038%2F384014a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fish, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaake, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eitel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartuschat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaindl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampp, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunahara, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Structure-guided development of selective M<sub>3</sub> muscarinic acetylcholine receptor antagonists</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">12046</span>– <span class="NLM_lpage">12050</span>, <span class="refDoi"> DOI: 10.1073/pnas.1813988115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1073%2Fpnas.1813988115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=30404914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFanu7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=12046-12050&author=H.+Liuauthor=J.+Hofmannauthor=I.+Fishauthor=B.+Schaakeauthor=K.+Eitelauthor=A.+Bartuschatauthor=J.+Kaindlauthor=H.+Ramppauthor=A.+Banerjeeauthor=H.+H%C3%BCbnerauthor=M.+J.+Clarkauthor=S.+G.+Vincentauthor=J.+T.+Fisherauthor=M.+R.+Heinrichauthor=K.+Hirataauthor=X.+Liuauthor=R.+K.+Sunaharaauthor=B.+K.+Shoichetauthor=B.+K.+Kobilkaauthor=P.+Gmeiner&title=Structure-guided+development+of+selective+M3+muscarinic+acetylcholine+receptor+antagonists&doi=10.1073%2Fpnas.1813988115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists</span></div><div class="casAuthors">Liu, Hongtao; Hofmann, Josefa; Fish, Inbar; Schaake, Benjamin; Eitel, Katrin; Bartuschat, Amelie; Kaindl, Jonas; Rampp, Hannelore; Banerjee, Ashutosh; HA1/4bner, Harald; Clark, Mary J.; Vincent, Sandra G.; Fisher, John T.; Heinrich, Markus R.; Hirata, Kunio; Liu, Xiangyu; Sunahara, Roger K.; Shoichet, Brian K.; Kobilka, Brian K.; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">12046-12050</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Drugs that treat chronic obstructive pulmonary disease by antagonizing the M3 muscarinic acetylcholine receptor (M3R) have had a significant effect on health, but can suffer from their lack of selectivity against the M2R subtype, which modulates heart rate.  Beginning with the crystal structures of M2R and M3R, we exploited a single amino acid difference in their orthosteric binding pockets using mol. docking and structure-based design.  The resulting M3R antagonists had up to 100-fold selectivity over M2R in affinity and over 1,000-fold selectivity in vivo.  The crystal structure of the M3R-selective antagonist in complex with M3R corresponded closely to the docking-predicted geometry, providing a template for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdR9T0wReSnbVg90H21EOLACvtfcHk0lg8hGMVoz446w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFanu7nE&md5=69c76953444dfbde4a3559507b4f8f4a</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1813988115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1813988115%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHofmann%26aufirst%3DJ.%26aulast%3DFish%26aufirst%3DI.%26aulast%3DSchaake%26aufirst%3DB.%26aulast%3DEitel%26aufirst%3DK.%26aulast%3DBartuschat%26aufirst%3DA.%26aulast%3DKaindl%26aufirst%3DJ.%26aulast%3DRampp%26aufirst%3DH.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DClark%26aufirst%3DM.%2BJ.%26aulast%3DVincent%26aufirst%3DS.%2BG.%26aulast%3DFisher%26aufirst%3DJ.%2BT.%26aulast%3DHeinrich%26aufirst%3DM.%2BR.%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSunahara%26aufirst%3DR.%2BK.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DStructure-guided%2520development%2520of%2520selective%2520M3%2520muscarinic%2520acetylcholine%2520receptor%2520antagonists%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2018%26volume%3D115%26spage%3D12046%26epage%3D12050%26doi%3D10.1073%2Fpnas.1813988115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0ljiOj-JQCiqbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sterling, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span> <span> </span><span class="NLM_article-title">ZINC 15 - Ligand Discovery for Everyone</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2324</span>– <span class="NLM_lpage">2337</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.5b00559</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.5b00559" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1OhurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=2324-2337&author=T.+Sterlingauthor=J.+J.+Irwin&title=ZINC+15+-+Ligand+Discovery+for+Everyone&doi=10.1021%2Facs.jcim.5b00559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">ZINC 15 - Ligand Discovery for Everyone</span></div><div class="casAuthors">Sterling, Teague; Irwin, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2324-2337</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Many questions about the biol. activity and availability of small mols. remain inaccessible to investigators who could most benefit from their answers.  To narrow the gap between chemoinformatics and biol., we have developed a suite of ligand annotation, purchasability, target, and biol. assocn. tools, incorporated into ZINC and meant for investigators who are not computer specialists.  The new version contains over 120 million purchasable "drug-like" compds. - effectively all org. mols. that are for sale - a quarter of which are available for immediate delivery.  ZINC connects purchasable compds. to high-value ones such as metabolites, drugs, natural products, and annotated compds. from the literature.  Compds. may be accessed by the genes for which they are annotated as well as the major and minor target classes to which those genes belong.  It offers new anal. tools that are easy for nonspecialists yet with few limitations for experts.  ZINC retains its original 3D roots - all mols. are available in biol. relevant, ready-to-dock formats.  ZINC is freely available at http://zinc15.docking.org.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWfkDnal3D3bVg90H21EOLACvtfcHk0ljiOj-JQCiqbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1OhurbF&md5=e767c26c1d0aff7432c403c59a5d2b8b</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.5b00559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.5b00559%26sid%3Dliteratum%253Aachs%26aulast%3DSterling%26aufirst%3DT.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26atitle%3DZINC%252015%2520-%2520Ligand%2520Discovery%2520for%2520Everyone%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26spage%3D2324%26epage%3D2337%26doi%3D10.1021%2Facs.jcim.5b00559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60','cit60a'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victor  Babin</span>, <span class="hlFld-ContribAuthor ">Antoine  Sallustrau</span>, <span class="hlFld-ContribAuthor ">Olivier  Loreau</span>, <span class="hlFld-ContribAuthor ">Fabien  Caillé</span>, <span class="hlFld-ContribAuthor ">Amélie  Goudet</span>, <span class="hlFld-ContribAuthor ">Héloïse  Cahuzac</span>, <span class="hlFld-ContribAuthor ">Antonio  Del Vecchio</span>, <span class="hlFld-ContribAuthor ">Frédéric  Taran</span>, <span class="hlFld-ContribAuthor ">Davide  Audisio</span>. </span><span class="cited-content_cbyCitation_article-title">A general procedure for carbon isotope labeling of linear urea derivatives with carbon dioxide. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (54)
                                     , 6680-6683. <a href="https://doi.org/10.1039/D1CC02665H" title="DOI URL">https://doi.org/10.1039/D1CC02665H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CC02665H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CC02665H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DA%252Bgeneral%252Bprocedure%252Bfor%252Bcarbon%252Bisotope%252Blabeling%252Bof%252Blinear%252Burea%252Bderivatives%252Bwith%252Bcarbon%252Bdioxide%26aulast%3DBabin%26aufirst%3DVictor%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D54%26spage%3D6680%26epage%3D6683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Milica  Elek</span>, <span class="hlFld-ContribAuthor ">Nemanja  Djokovic</span>, <span class="hlFld-ContribAuthor ">Annika  Frank</span>, <span class="hlFld-ContribAuthor ">Slavica  Oljacic</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Zivkovic</span>, <span class="hlFld-ContribAuthor ">Katarina  Nikolic</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, in silico, and in vitro studies of novel dopamine D
              2
              and D
              3
              receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2021,</strong> <em>354 </em>
                                    (6)
                                     , 2000486. <a href="https://doi.org/10.1002/ardp.202000486" title="DOI URL">https://doi.org/10.1002/ardp.202000486</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.202000486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.202000486%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%25252C%252Bin%252Bsilico%25252C%252Band%252Bin%252Bvitro%252Bstudies%252Bof%252Bnovel%252Bdopamine%252BD%252B2%252Band%252BD%252B3%252Breceptor%252Bligands%26aulast%3DElek%26aufirst%3DMilica%26date%3D2021%26date%3D2021%26volume%3D354%26issue%3D6%26spage%3D2000486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianfabio  Giorgioni</span>, <span class="hlFld-ContribAuthor ">Fabio  Del Bello</span>, <span class="hlFld-ContribAuthor ">Pegi  Pavletić</span>, <span class="hlFld-ContribAuthor ">Wilma  Quaglia</span>, <span class="hlFld-ContribAuthor ">Luca  Botticelli</span>, <span class="hlFld-ContribAuthor ">Carlo  Cifani</span>, <span class="hlFld-ContribAuthor ">Emanuela  Micioni Di Bonaventura</span>, <span class="hlFld-ContribAuthor ">Maria Vittoria  Micioni Di Bonaventura</span>, <span class="hlFld-ContribAuthor ">Alessandro  Piergentili</span>. </span><span class="cited-content_cbyCitation_article-title">Recent findings leading to the discovery of selective dopamine D4 receptor ligands for the treatment of widespread diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113141. <a href="https://doi.org/10.1016/j.ejmech.2020.113141" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113141%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bfindings%252Bleading%252Bto%252Bthe%252Bdiscovery%252Bof%252Bselective%252Bdopamine%252BD4%252Breceptor%252Bligands%252Bfor%252Bthe%252Btreatment%252Bof%252Bwidespread%252Bdiseases%26aulast%3DGiorgioni%26aufirst%3DGianfabio%26date%3D2021%26volume%3D212%26spage%3D113141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Highly subtype-selective dopamine D<sub>4</sub> receptor ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Target Compounds <b>12a–c</b> and <b>14–47</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) arylpiperazine hydrochloride <b>7a–e</b> (1.0 equiv), bromoalkylphthalimide <b>8a–c</b> (2.0 equiv), K<sub>2</sub>CO<sub>3</sub> (4.0 equiv), acetone, reflux, 20 h 40–100%; (ii) N<sub>2</sub>H<sub>4</sub> (10.0 equiv), ethanol, reflux, 1 h, 65–88%; (iii) <i>tert</i>-butyl phenylazocarboxylate <b>11a–f</b> (1.1 equiv), K<sub>2</sub>CO<sub>3</sub> (4.0 equiv), ethanol, argon atmosphere, 40 °C, 24–99%; (iv) benzyl- or allyl bromide <b>13a–i</b> (2.5–5.0 equiv), zinc powder (2.5–10 equiv), THF, NH<sub>4</sub>Cl, 30 s, 18–99%.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Dose–response curves for the most potent compounds <b>15</b>, <b>17</b>, <b>18</b>, and the reference quinpirole measuring G protein or arrestin-mediated D<sub>4</sub> receptor signaling. (A) IP-One assay measuring G protein-mediated signaling in HEK cells co-expressing the D<sub>4</sub>R and the G protein hybrid Gα<sub>qi</sub>. (B) Arrestin recruitment measuring partial agonist properties as well as partial antagonism of 300 nM quinpirole employing the PathHunter complementation assay in HEK cells expressing D<sub>4</sub>R-PKA and (EA)-β-arrestin-2. Both graphs show pooled curves from six individual experiments each done in duplicates (agonist effect), antagonist properties are displayed as mean curves derived from three to four experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Oxidative metabolism of APH199 (<b>17</b>) and imipramine upon exposure to male rat liver microsomes. Results from LC–MS analysis are depicted in percentage of non-metabolized APH199 (<b>17</b>) and imipramine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Calculated binding pose of ligand APH199 (<b>17</b>) (green) to the dopamine D<sub>4</sub> receptor (PDB-D<sub>4</sub>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WIU">5WIU</a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> View from the extracellular side on the phenyl and benzyl units occupying the EBP (left) and view on the semicarbazide unit (center).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Subtype selectivity of ligand <b>17</b> (green). Docking into the D<sub>4</sub> subtype (left) compared with an overlay of the D<sub>2</sub> (purple) and D<sub>3</sub> (turquoise) subtype (right) (PDB-D<sub>4</sub>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WIU">5WIU</a>; PDB-D<sub>2</sub>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CM4">6CM4</a>; PDB-D<sub>3</sub>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBL">3PBL</a>).<a onclick="showRef(event, 'ref47 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref47 ref62 ref63">(47,62,63)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Docking of the known D<sub>4</sub> selective ligands <b>1b</b> and 9-6-24 (<b>5</b>) into the D<sub>4</sub> subtype (PDB-D<sub>4</sub>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WIU">5WIU</a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/medium/jm9b01085_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Summary of structure–activity relationships and structure-functional selectivity relationships for the novel semicarbazide ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01085/20191108/images/large/jm9b01085_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01085&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i97">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70747" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70747" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 86 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vallone, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picetti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrelli, E.</span></span> <span> </span><span class="NLM_article-title">Structure and function of dopamine receptors</span>. <i>Neurosci. Biobehav. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/s0149-7634(99)00063-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fs0149-7634%2899%2900063-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10654668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtVylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2000&pages=125-132&author=D.+Valloneauthor=R.+Picettiauthor=E.+Borrelli&title=Structure+and+function+of+dopamine+receptors&doi=10.1016%2Fs0149-7634%2899%2900063-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of dopamine receptors</span></div><div class="casAuthors">Vallone, D.; Picetti, R.; Borrelli, E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience and Biobehavioral Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">NBREDE</span>;
        ISSN:<span class="NLM_cas:issn">0149-7634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">This review with 87 refs. focuses on the pharmacol. and biochem. features shared by the dopamine receptors.  Dopamine (DA) is the most abundant catecholamine in the brain.  The involvement and importance of DA as a neurotransmitter in the regulation of different physiol. functions in the central nervous system (CNS) is well known.  Deregulation of the dopaminergic system was linked with Parkinson's disease, Tourette's syndrome, schizophrenia, attention deficit hyperactive disorder (ADHD), and generation of pituitary tumors.  The authors address their coupling to secondary messenger pathways and their physiol. function based upon studies using pharmacol. tools, specific brain lesions and, more recently, genetically modified animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoosy1SXDXa7Vg90H21EOLACvtfcHk0li6gfIsBkvQNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtVylug%253D%253D&md5=0fa459e1055a9542eebfc06834ad7a72</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fs0149-7634%2899%2900063-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0149-7634%252899%252900063-9%26sid%3Dliteratum%253Aachs%26aulast%3DVallone%26aufirst%3DD.%26aulast%3DPicetti%26aufirst%3DR.%26aulast%3DBorrelli%26aufirst%3DE.%26atitle%3DStructure%2520and%2520function%2520of%2520dopamine%2520receptors%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2000%26volume%3D24%26spage%3D125%26epage%3D132%26doi%3D10.1016%2Fs0149-7634%2899%2900063-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Missale, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">Dopamine receptors: from structure to function</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1152/physrev.1998.78.1.189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1152%2Fphysrev.1998.78.1.189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=9457173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK1cXptlOjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1998&pages=189-225&author=C.+Missaleauthor=S.+R.+Nashauthor=S.+W.+Robinsonauthor=M.+Jaberauthor=M.+G.+Caron&title=Dopamine+receptors%3A+from+structure+to+function&doi=10.1152%2Fphysrev.1998.78.1.189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine receptors: from structure to function</span></div><div class="casAuthors">Missale, Cristina; Nash, S. Russel; Robinson, Susan W.; Jaber, Mohamed; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">189-225</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 481 refs.  The diverse physiol. actions of dopamine are mediated by at least five distinct G protein-coupled receptor subtypes.  Two D1-like receptor subtypes (D1 and D5) couple to the G protein Gs and activate adenylyl cyclase.  The other receptor subtypes belong to the D2-like subfamily (D2, D3, and D4) and are prototypic of G protein-coupled receptors that inhibit adenylyl cyclase and activate K+ channels.  The genes for the D1 and D5 receptors are intron-less, but pseudogenes of the D5 exist.  The D2 and D3 receptors vary in certain tissues and species as a result of alternative splicing, and the human D4 receptor gene exhibits extensive polymorphic variation.  In the central nervous system, dopamine receptors are widely expressed because they are involved in the control of locomotion, cognition, emotion, and affect as well as neuroendocrine secretion.  In the periphery, dopamine receptors are present more prominently in kidney, vasculature, and pituitary, where they affect mainly sodium homeostasis, vascular tone, and hormone secretion.  Numerous genetic linkage anal. studies have failed so far to reveal unequivocal evidence for the involvement of one of these receptors in the etiol. of various central nervous system disorders.  However, targeted deletion of several of these dopamine receptor genes in mice should provide valuable information about their physiol. functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaajNmBxnkYbVg90H21EOLACvtfcHk0ljANl_ix8WbXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXptlOjtg%253D%253D&md5=a505d0e2c640ca205d4470ad69f607ff</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.1998.78.1.189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.1998.78.1.189%26sid%3Dliteratum%253Aachs%26aulast%3DMissale%26aufirst%3DC.%26aulast%3DNash%26aufirst%3DS.%2BR.%26aulast%3DRobinson%26aufirst%3DS.%2BW.%26aulast%3DJaber%26aufirst%3DM.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DDopamine%2520receptors%253A%2520from%2520structure%2520to%2520function%26jtitle%3DPhysiol.%2520Rev.%26date%3D1998%26volume%3D78%26spage%3D189%26epage%3D225%26doi%3D10.1152%2Fphysrev.1998.78.1.189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span> <span> </span><span class="NLM_article-title">The physiology, signaling, and pharmacology of dopamine receptors</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1124/pr.110.002642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1124%2Fpr.110.002642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=21303898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=182-217&author=J.-M.+Beaulieuauthor=R.+R.+Gainetdinov&title=The+physiology%2C+signaling%2C+and+pharmacology+of+dopamine+receptors&doi=10.1124%2Fpr.110.002642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The physiology, signaling, and pharmacology of dopamine receptors</span></div><div class="casAuthors">Beaulieu, Jean-Martin; Gainetdinov, Raul R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-217</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiol. functions of the catecholaminergic neurotransmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension.  Pharmacol. agents targeting dopaminergic neurotransmission have been clin. used in the management of several neurol. and psychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder, Huntington's disease, attention deficit hyperactivity disorder (ADHD1), and Tourette's syndrome.  Numerous advances have occurred in understanding the general structural, biochem., and functional properties of dopamine receptors that have led to the development of multiple pharmacol. active compds. that directly target dopamine receptors, such as antiparkinson drugs and antipsychotics.  Recent progress in understanding the complex biol. of dopamine receptor-related signal transduction mechanisms has revealed that, in addn. to their primary action on cAMP-mediated signaling, dopamine receptors can act through diverse signaling mechanisms that involve alternative G protein coupling or through G protein-independent mechanisms via interactions with ion channels or proteins that are characteristically implicated in receptor desensitization, such as β-arrestins.  One of the future directions in managing dopamine-related pathol. conditions may involve a transition from the approaches that directly affect receptor function to a precise targeting of postreceptor intracellular signaling modalities either directly or through ligand-biased signaling pharmacol.  In this comprehensive review, we discuss dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms.  In addn., we discuss the abnormalities of dopamine receptor expression, function, and signaling that are documented in human disorders and the current pharmacol. and emerging trends in the development of novel therapeutic agents that act at dopamine receptors and/or on related signaling events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplp84qmbSbA7Vg90H21EOLACvtfcHk0ljANl_ix8WbXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D&md5=53e6841062c98abe60c732692109e498</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.002642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.002642%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.-M.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26atitle%3DThe%2520physiology%252C%2520signaling%252C%2520and%2520pharmacology%2520of%2520dopamine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D182%26epage%3D217%26doi%3D10.1124%2Fpr.110.002642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Löber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschammer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2010.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.tips.2010.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=21232805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A280%3ADC%252BC3M3ktVWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=148-157&author=S.+L%C3%B6berauthor=H.+H%C3%BCbnerauthor=N.+Tschammerauthor=P.+Gmeiner&title=Recent+advances+in+the+search+for+D3-+and+D4-selective+drugs%3A+probes%2C+models+and+candidates&doi=10.1016%2Fj.tips.2010.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates</span></div><div class="casAuthors">Lober Stefan; Hubner Harald; Tschammer Nuska; Gmeiner Peter</div><div class="citationInfo"><span class="NLM_cas:title">Trends in pharmacological sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">148-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dopamine D(2)-like receptors (including D(2), D(3) and D(4)) belong to the 'rhodopsin-like' family of G protein-coupled receptors (GPCRs), which represent the largest group of targets for bioactive molecules.  Due to their high sequence similarity, the design of subtype-selective ligands requires rational and effective strategies.  The general formula of 1,4-disubstituted aromatic piperidines and piperazines (1,4-DAPs) was extracted from classical dopaminergic drugs.  The biological properties of this compound family are encoded by an aromatic head group that controls intrinsic activity, an amine moiety and a lipophilic appendage.  D(3)- and D(4)-selective molecular probes and drug candidates were generated from the general formula of 1,4-DAP.  Formal structural rearrangement led to investigational drugs beyond the 1,4-DAP structure.  The very recent publication of the X-ray crystal structure of D(3) should facilitate efficient discovery of unprecedented chemotypes.  However, the development of D(3)-selective agonists, functionally selective ligands and the exploitation of homo- and heteromers remain challenging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJYDidIFGFwMjl5L8hwNX0fW6udTcc2ebmhUYGs6gy-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3ktVWnsg%253D%253D&md5=9b688525eaa75c6d965b634617c16d70</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2010.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2010.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DRecent%2520advances%2520in%2520the%2520search%2520for%2520D3-%2520and%2520D4-selective%2520drugs%253A%2520probes%252C%2520models%2520and%2520candidates%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D148%26epage%3D157%26doi%3D10.1016%2Fj.tips.2010.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Tol, H. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunzow, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunahara, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niznik, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Civelli, O.</span></span> <span> </span><span class="NLM_article-title">Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">610</span>– <span class="NLM_lpage">614</span>, <span class="refDoi"> DOI: 10.1038/350610a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1038%2F350610a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1840645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK38XhsV2n" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1991&pages=610-614&author=H.+H.+M.+Van%0ATolauthor=J.+R.+Bunzowauthor=H.-C.+Guanauthor=R.+K.+Sunaharaauthor=P.+Seemanauthor=H.+B.+Niznikauthor=O.+Civelli&title=Cloning+of+the+gene+for+a+human+dopamine+D4+receptor+with+high+affinity+for+the+antipsychotic+clozapine&doi=10.1038%2F350610a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine</span></div><div class="casAuthors">Van Tol, Hubert H. M.; Bunzow, James R.; Guan, Hong Chang; Sunahara, Roger K.; Seeman, Philip; Niznik, Hyman B.; Civelli, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">6319</span>),
    <span class="NLM_cas:pages">610-14</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The cloning of a gene that encodes a clozapine-sensitive dopamine receptor, D4 is reported.  The D4 receptor gene has high homol. to the human dopamine D2 and D3 receptor genes.  The pharmacol. characteristics of this receptor resemble those of the D2 and D3 receptors, but its affinity for clozapine is one order of magnitude higher.  Recognition and characterization of this clozapine neuroleptic site may prove useful in the design of new types of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpneU9aH4jnoLVg90H21EOLACvtfcHk0ljtNod1bnfajg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsV2n&md5=de5f7ade54d85f54181c53d15d6af169</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F350610a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F350610a0%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BTol%26aufirst%3DH.%2BH.%2BM.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DGuan%26aufirst%3DH.-C.%26aulast%3DSunahara%26aufirst%3DR.%2BK.%26aulast%3DSeeman%26aufirst%3DP.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DCloning%2520of%2520the%2520gene%2520for%2520a%2520human%2520dopamine%2520D4%2520receptor%2520with%2520high%2520affinity%2520for%2520the%2520antipsychotic%2520clozapine%26jtitle%3DNature%26date%3D1991%26volume%3D350%26spage%3D610%26epage%3D614%26doi%3D10.1038%2F350610a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seeman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tol, H. H. M.</span></span> <span> </span><span class="NLM_article-title">Atypical neuroleptics have low affinity for dopamine D<sub>2</sub> receptors or are selective for D<sub>4</sub> receptors</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/s0893-133x(96)00187-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fs0893-133x%2896%2900187-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=9015795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK2sXhtFemsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=93-110&author=P.+Seemanauthor=R.+Corbettauthor=H.+H.+M.+Van+Tol&title=Atypical+neuroleptics+have+low+affinity+for+dopamine+D2+receptors+or+are+selective+for+D4+receptors&doi=10.1016%2Fs0893-133x%2896%2900187-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors</span></div><div class="casAuthors">Seeman, Philip; Corbett, Roy; Van Tol, Hubert H. M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">93-110</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with over 150 refs.  This review examines the possible receptor basis of the atypical action of those atypical antipsychotic drugs that elicit low levels of Parkinsonism.  Such an examn. requires consistent and accurate dissocn. consts. for the antipsychotic drugs at the relevant dopamine and serotonin receptors.  It has long been known, however, that the dissocn. const. of a given antipsychotic drug at the dopamine D2 receptor varies between labs.  Although such variation depends on several factors, it has recently been recognized that the radioligand used to measure the competition between the antipsychotic drug and the radioligand is an important variable.  The present review summarizes information on this radioligand dependence.  In general, a radioligand of low soly. in the membrane (i.e., low tissue:buffer partition) results in a low value for the antipsychotic dissocn. const. when the drug competes with the radioligand.  Hence, by first obtaining the antipsychotic dissocn. consts. using different radioligands of different soly. in the membrane, one can then extrapolate the data to low or "zero" ligand soly.  The extrapolated value represents the radioligand-independent dissocn. const. of the antipsychotic.  These values are here given for dopamine D2 and D4 receptors, as well as for serotonin 5-HT2A receptors.  These values, moreover, agree with the dissocn. const. directly obtained with the radioactive antipsychotic itself.  For example, clozapine revealed a radioligand-independent value of 1.6 nM at the dopamine D4 receptor, agreeing with the value directly measured with [3H]-clozapine at D4.  However, because clozapine competes with endogenous dopamine, the in vivo concn. of clozapine (to occupy dopamine D4 receptors) can be derived to be about 13 nM, agreeing with the value of 12 to 20 nM in the plasma water or spinal fluid obsd. in treated patients.  The atypical neuroleptics remoxipride clozapine, perlapine, seroquel and melperone had low affinity for the dopamine D2 receptor (radioligand-independent dissocn. consts. of 30 to 90 nM).  Such low affinity make these latter five drugs readily displaceable gy high level of endogenous dopamine in the caudate or putamen.  Most typical neuroleptics have radioligand-independent values of 0.3 to 5 nM at dopamine D2 receptors, making them more resistant to displacement by endogenous dopamine.  Finally, a relation was found between the neuroleptic doses for rat catalepsy and the D2:D4 ratio of the radioligand-independent K values for these two receptors.  Thus, the atypical neuroleptics appear to fall into two groups, those that have a low affinity for dopamine D2 receptors and those that are selective for dopamine D4 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt31KrJf3jQrVg90H21EOLACvtfcHk0ljtNod1bnfajg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtFemsbo%253D&md5=6c9c980ce2a7bde593d57abbd87f09bf</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fs0893-133x%2896%2900187-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0893-133x%252896%252900187-x%26sid%3Dliteratum%253Aachs%26aulast%3DSeeman%26aufirst%3DP.%26aulast%3DCorbett%26aufirst%3DR.%26aulast%3DVan%2BTol%26aufirst%3DH.%2BH.%2BM.%26atitle%3DAtypical%2520neuroleptics%2520have%2520low%2520affinity%2520for%2520dopamine%2520D2%2520receptors%2520or%2520are%2520selective%2520for%2520D4%2520receptors%26jtitle%3DNeuropsychopharmacology%26date%3D1997%26volume%3D16%26spage%3D93%26epage%3D110%26doi%3D10.1016%2Fs0893-133x%2896%2900187-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarazi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeghiayan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldessarini, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kula, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumeyer, J. L.</span></span> <span> </span><span class="NLM_article-title">Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D<sub>2</sub>-like and striatolimbic D<sub>4</sub>-like dopamine receptors</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1016/s0893-133x(97)00046-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fs0893-133x%2897%2900046-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=9272485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK2sXls1Oqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=186-196&author=F.+Taraziauthor=S.+K.+Yeghiayanauthor=R.+J.+Baldessariniauthor=N.+S.+Kulaauthor=J.+L.+Neumeyer&title=Long-term+effects+of+S%28%2B%29N-n-propylnorapomorphine+compared+with+typical+and+atypical+antipsychotics%3A+differential+increases+of+cerebrocortical+D2-like+and+striatolimbic+D4-like+dopamine+receptors&doi=10.1016%2Fs0893-133x%2897%2900046-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors</span></div><div class="casAuthors">Tarazi, Frank I.; Yeghiayan, Sylva K.; Baldessarini, Ross J.; Kula, Nora S.; Neumeyer, John L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">186-196</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Changes in D2-like dopamine (DA) receptor binding in rat brain regions were compared by quant. in vitro receptor autoradiog. after 21-d treatment with a typical (fluphenazine), atypical (clozapine), or candidate atypical antipsychotic (S[+]-N-n-propylnorapomorphine, [+]-NPA).  Fluphenazine treatment significantly increased binding of the D2,3,4 radioligands [3H]nemonapride and [3H]spiperone in caudate-putamen (CPu: 22%, 32%), nucleus accumbens (ACC: 67%, 52%), olfactory tubercle (OT: 53%, 43%), and medial prefrontal cerebral cortex (MPC: 46%, 47%) but not dorsolateral frontal cortex (DFC).  D2-like binding in MPC was also increased by (+)-NPA (49%, 39%) and clozapine (60%, 40%), but not in DFC, CPu, ACC, or OT.  Binding of D2,3-selective [3H]raclopride increased less after fluphenazine in ACC (27%) and CPu (16%) than with the nonselective radioligands, and not after clozapine or (+)-NPA.  D3-selective binding of [3H]R(+)-7-OH-DPAT was not changed with any treatment or region including islands of Calleja.  Binding of [3H]nemonapride or [3H]spiperone under D4-selective conditions (with 300 nM S[-]-raclopride and other masking agents, at sites occluded by D4 ligand L-745,870), was increased by fluphenazine, (+)-NPA, clozapine in ACC (120%, 76%, 70%, resp.), in CPu (54%, 37%, 35%), but not in OT, DFC or MPC.  These results support the hypothesis that cerebrocortical D2-like and striatolimbic D4-like receptors contribute to antipsychotic actions of both typical and atypical drugs and encourage further consideration of S(+)aporphines as potential atypical antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMx9XZ42KSxLVg90H21EOLACvtfcHk0lju8r4oDrhKGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXls1Oqsr4%253D&md5=d1790025d7ad2141c6318da40d39ad29</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fs0893-133x%2897%2900046-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0893-133x%252897%252900046-8%26sid%3Dliteratum%253Aachs%26aulast%3DTarazi%26aufirst%3DF.%26aulast%3DYeghiayan%26aufirst%3DS.%2BK.%26aulast%3DBaldessarini%26aufirst%3DR.%2BJ.%26aulast%3DKula%26aufirst%3DN.%2BS.%26aulast%3DNeumeyer%26aufirst%3DJ.%2BL.%26atitle%3DLong-term%2520effects%2520of%2520S%2528%252B%2529N-n-propylnorapomorphine%2520compared%2520with%2520typical%2520and%2520atypical%2520antipsychotics%253A%2520differential%2520increases%2520of%2520cerebrocortical%2520D2-like%2520and%2520striatolimbic%2520D4-like%2520dopamine%2520receptors%26jtitle%3DNeuropsychopharmacology%26date%3D1997%26volume%3D17%26spage%3D186%26epage%3D196%26doi%3D10.1016%2Fs0893-133x%2897%2900046-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Last, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reines, S. A.</span></span> <span> </span><span class="NLM_article-title">The effects of a selective D<sub>4</sub> dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia</span>. <i>Arch. Gen. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">567</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.1001/archpsyc.1997.01830180085011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1001%2Farchpsyc.1997.01830180085011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=9193198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK2sXksFWhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=567-572&author=M.+S.+Kramerauthor=B.+Lastauthor=A.+Getsonauthor=S.+A.+Reines&title=The+effects+of+a+selective+D4+dopamine+receptor+antagonist+%28L-745%2C870%29+in+acutely+psychotic+inpatients+with+schizophrenia&doi=10.1001%2Farchpsyc.1997.01830180085011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">the effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia</span></div><div class="casAuthors">Kramer, Mark S.; Last, Barbara; Getson, Albert; Reines, Scott A.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">567-572</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Based mainly on the selective antagonism of clozapine at D4 compared with D2 dopamine receptors, hopes have run high that a selective D4 dopamine receptor antagonist might improve the pharmacol. treatment of patients with schizophrenia.  We report, to our knowledge, the first multicenter study of the antipsychotic potential of a highly specific D4 dopamine receptor antagonist (ie, L-745,870) in patients with acute schizophrenia.  Thirty-eight acutely psychotic and neuroleptic responsive (by history) newly admitted inpatients with schizophrenia were randomized to 4 wk of double-blind treatment (2:1) with either L-745,870 (n = 26), 15 mg/d, or placebo (n = 12) after 3- to 5-day placebo run-in period.  Overall, a greater percentage of patients receiving L-745,870 compared with patients receiving placebo discontinued the study for insufficient therapeutic response (32% vs 16%).  At the end of 4 wk by last observation carried forward anal., the mean change from baseline to week 4 on the total Brief Psychiatric Rating Scale favored placebo (ie, -8 points [-15% change from baseline] vs -1 point [-2% change from baseline] from placebo vs L-745,870, P = 0.09).  Similar differences in favor of placebo in changes from baseline mean scores were obsd. for the not carried forward anal. on the total Brief Psychiatric Rating Scale (P < 0.03), for not carried forward and last observation carried forward analyses on the sum of selected pos. symptom items of the Brief Psychiatric Rating Scale, and for the Clin. Global Impression anal. (P = 0.03, last observation carried forward).  A greater percentage of patients receiving L-745,870 had scores indicative of some level of worsening (compared with baseline) on the total Brief Psychiatric Rating Scale and the Clin. Global Impressions' Severity of Illness Scale as well as pos. symptoms compared with those receiving placebo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOzPyP-d8vUrVg90H21EOLACvtfcHk0lju8r4oDrhKGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksFWhsLk%253D&md5=1491ce3ea914e3cf85cf4025dd2bd2ba</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1997.01830180085011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1997.01830180085011%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DM.%2BS.%26aulast%3DLast%26aufirst%3DB.%26aulast%3DGetson%26aufirst%3DA.%26aulast%3DReines%26aufirst%3DS.%2BA.%26atitle%3DThe%2520effects%2520of%2520a%2520selective%2520D4%2520dopamine%2520receptor%2520antagonist%2520%2528L-745%252C870%2529%2520in%2520acutely%2520psychotic%2520inpatients%2520with%2520schizophrenia%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1997%26volume%3D54%26spage%3D567%26epage%3D572%26doi%3D10.1001%2Farchpsyc.1997.01830180085011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ukai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsunaga, H.</span></span> <span> </span><span class="NLM_article-title">Involvement of dopamine D<sub>3</sub> and D<sub>4</sub> receptors in the discriminative stimulus properties of cocaine in the rat</span>. <i>Methods Find. Exp. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">649</span>, <span class="refDoi"> DOI: 10.1358/mf.2005.27.9.939341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1358%2Fmf.2005.27.9.939341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=16357950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvV2htg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=645-649&author=M.+Ukaiauthor=H.+Mitsunaga&title=Involvement+of+dopamine+D3+and+D4+receptors+in+the+discriminative+stimulus+properties+of+cocaine+in+the+rat&doi=10.1358%2Fmf.2005.27.9.939341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of dopamine D3 and D4 receptors in the discriminative stimulus properties of cocaine in the rats</span></div><div class="casAuthors">Ukai, M.; Mitsunaga, H.</div><div class="citationInfo"><span class="NLM_cas:title">Methods and Findings in Experimental and Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">645-649</span>CODEN:
                <span class="NLM_cas:coden">MFEPDX</span>;
        ISSN:<span class="NLM_cas:issn">0379-0355</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">The present study was carried out to det. the involvement of dopamine receptor subtypes D3 and D4, in the discriminative stimulus effects of cocaine in the rats trained to discriminate 10 mg/kg of cocaine from vehicle.  The discriminative stimulus effects of cocaine (1-10 mg/kg) were dose-dependent.  The dopamine D2 receptor agonist bromocriptine (1.25-20 mg/kg) and the dopamine D3 receptor agonist R(+)-7-OH-DPAT (0.0001-03 mg/kg) produced cocaine (10 mg/kg)-like discriminative stimulus effects.  Both the dopamine D3 receptor antagonist GR103691 (1 mg/kg) and the dopamine D4 receptor antagonist L745870 (1 mg/kg) partially antagonized the discriminative stimulus effects of cocaine (10 mg/kg) and the cocaine (10 mg/kg)-like discriminative stimulus effects of R(+)-7-OH-DPAT (0.3 mg/kg).  L745870 (0.001 mg/kg) inhibited the antagonistic effects of GR103691 (1 mg/kg) on the discriminative stimulus effects of cocaine (10 mg/kg), whereas the drug (0.001 mg/kg) enhanced the antagonistic effects of GR103691 (1 mg/kg) on the cocaine (10 mg/kg)-like discriminative stimulus effects of R(+)-7-OH-DPAT (0.3 mg/kg).  GR103691 (1 mg/kg) in combination with L745870 (0.001 mg/kg) did not markedly affect the cocaine (10 mg/kg)-like discriminative stimulus effects of bromocriptine (20 mg/kg).  These results suggest that the discriminative stimulus effects of cocaine are different from the cocaine-like discriminative stimulus effects of bromocriptine or R(+)-7-OH-DPAT, in terms of dopamine D3 and D4 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNBl7L98oQv7Vg90H21EOLACvtfcHk0lju8r4oDrhKGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvV2htg%253D%253D&md5=5050aaece272f8681109e673ce443981</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1358%2Fmf.2005.27.9.939341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fmf.2005.27.9.939341%26sid%3Dliteratum%253Aachs%26aulast%3DUkai%26aufirst%3DM.%26aulast%3DMitsunaga%26aufirst%3DH.%26atitle%3DInvolvement%2520of%2520dopamine%2520D3%2520and%2520D4%2520receptors%2520in%2520the%2520discriminative%2520stimulus%2520properties%2520of%2520cocaine%2520in%2520the%2520rat%26jtitle%3DMethods%2520Find.%2520Exp.%2520Clin.%2520Pharmacol.%26date%3D2005%26volume%3D27%26spage%3D645%26epage%3D649%26doi%3D10.1358%2Fmf.2005.27.9.939341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rheingold, C.</span></span> <span> </span><span class="NLM_article-title">Dopamine D Receptor Antagonists for the Treatment of Cocaine Use Disorders</span>. <i>CNS Neurol. Disord.: Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">707</span>– <span class="NLM_lpage">715</span>, <span class="refDoi"> DOI: 10.2174/1871527314666150529132723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.2174%2F1871527314666150529132723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=26022267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWls73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=707-715&author=J.+Bergmanauthor=C.+Rheingold&title=Dopamine+D+Receptor+Antagonists+for+the+Treatment+of+Cocaine+Use+Disorders&doi=10.2174%2F1871527314666150529132723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 Receptor Antagonists for the Treatment of Cocaine Use Disorders</span></div><div class="casAuthors">Bergman, Jack; Rheingold, Curtis G.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">707-715</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The identification of effective medications for the management of cocaine use disorders remains an unmet public health challenge.  In view of the prominent role of dopaminergic mechanisms in cocaine's abuse-related effects, research has focused on the development of subtype-selective dopamine D1-4 receptor antagonists.  Here, we briefly recap the current status of this research effort, with a focus on several aspects of D4 research that may be pertinent to the consideration of D4 ligands in the development of candidate medications.  Addnl., we present data from selfadministration studies in nonhuman primates showing that i.v. cocaine-maintained behavior is moderately, though non-significantly, decreased by doses of the D4-selective partial agonist Ro10-5824 and dramatically reduced by the D4- selective receptor antagonist NGD-94-1.  The effects of these D4 ligands on cocaine self-administration were consistent among subjects and occurred in the absence of comparable effects on food-maintained responding.  These data suggest that available D4 receptor antagonists should be investigated further as candidate medications for the management of cocaine use disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplh2B6VHhlkbVg90H21EOLACvtfcHk0liZb3FCg5aebA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWls73E&md5=4ceaa55f00813312bdacb0a3d5a6f36e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F1871527314666150529132723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871527314666150529132723%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%26aulast%3DRheingold%26aufirst%3DC.%26atitle%3DDopamine%2520D%2520Receptor%2520Antagonists%2520for%2520the%2520Treatment%2520of%2520Cocaine%2520Use%2520Disorders%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2015%26volume%3D14%26spage%3D707%26epage%3D715%26doi%3D10.2174%2F1871527314666150529132723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mamiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ukai, M.</span></span> <span> </span><span class="NLM_article-title">Effects of L-745,870, a dopamine D<sub>4</sub> receptor antagonist, on naloxone-induced morphine dependence in mice</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>1025</i></span>,  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1196/annals.1316.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1196%2Fannals.1316.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=15542745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVSnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1025&publication_year=2004&pages=424-429&author=T.+Mamiyaauthor=T.+Matsumuraauthor=M.+Ukai&title=Effects+of+L-745%2C870%2C+a+dopamine+D4+receptor+antagonist%2C+on+naloxone-induced+morphine+dependence+in+mice&doi=10.1196%2Fannals.1316.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of L-745,870, a dopamine D4 receptor antagonist, on naloxone-induced morphine dependence in mice</span></div><div class="casAuthors">Mamiya, T.; Matsumura, T.; Ukai, M.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1025</span>
        (<span class="NLM_cas:issue">Current Status of Drug Dependence/Abuse Studies</span>),
    <span class="NLM_cas:pages">424-429</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">We examd. whether dopamine D4 receptor is involved in morphine dependence in mice.  Mice pretreated with morphine (10 mg/kg, s.c.) twice a day for 5 days showed withdrawal syndromes such as jumping, rearing, and forepaw tremors after the administration of naloxone (2 mg/kg, i.p.) on the sixth day.  Such mice exhibited significant elevation of cAMP levels in the thalamus compared with the control mice.  L-745,870 (1 mg/kg, i.p.), a selective dopamine D4 receptor antagonist, pretreated with morphine on the sixth day, significantly attenuated the severity of withdrawal syndromes and the increase in cAMP levels after the administration of naloxone.  These results suggest that (1) the elevation of cAMP levels is involved in the expression of morphine-induced withdrawal syndromes, and (2) dopamine D4 receptor antagonists-inhibit the expression of morphine-induced withdrawal syndromes accompanied with biochem. changes in mice.  Furthermore, dopamine D4 receptor antagonists may be useful drugs for attenuating the expression of morphine dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDlwunPK4wBbVg90H21EOLACvtfcHk0liZb3FCg5aebA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVSnsw%253D%253D&md5=d12f6f44acfaa192c0c1abf175bcc7c0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1196%2Fannals.1316.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1316.052%26sid%3Dliteratum%253Aachs%26aulast%3DMamiya%26aufirst%3DT.%26aulast%3DMatsumura%26aufirst%3DT.%26aulast%3DUkai%26aufirst%3DM.%26atitle%3DEffects%2520of%2520L-745%252C870%252C%2520a%2520dopamine%2520D4%2520receptor%2520antagonist%252C%2520on%2520naloxone-induced%2520morphine%2520dependence%2520in%2520mice%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2004%26volume%3D1025%26spage%3D424%26epage%3D429%26doi%3D10.1196%2Fannals.1316.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabeshima, T.</span></span> <span> </span><span class="NLM_article-title">Nefiracetam attenuates methamphetamine-induced discriminative stimulus effects in rats</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>1025</i></span>,  <span class="NLM_fpage">274</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1196/annals.1316.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1196%2Fannals.1316.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=15542727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVSjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1025&publication_year=2004&pages=274-278&author=Y.+Yanauthor=T.+Mizunoauthor=A.+Nittaauthor=K.+Yamadaauthor=T.+Nabeshima&title=Nefiracetam+attenuates+methamphetamine-induced+discriminative+stimulus+effects+in+rats&doi=10.1196%2Fannals.1316.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nefiracetam attenuates methamphetamine-induced discriminative stimulus effects in rats</span></div><div class="casAuthors">Yan, Yijin; Mizuno, Tomoko; Nitta, Atsumi; Yamada, Kiyofumi; Nabeshima, Toshitaka</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1025</span>
        (<span class="NLM_cas:issue">Current Status of Drug Dependence/Abuse Studies</span>),
    <span class="NLM_cas:pages">274-278</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">Nefiracetam has been reported to increase intracellular cAMP levels and enhance calcium channel current.  Since the cAMP cascade is involved in the development of drug dependence, we investigated whether nefiracetam attenuates the methamphetamine (MAP)-induced discriminative responses in rats.  Nefiracetam (50 mg/kg) inhibited MAP-induced discriminative responses.  Furthermore, rolipram, raclopride, and L-745870, all of which can enhance cAMP activity, disrupted MAP-paired lever press of rats.  Nifedipine and neomycin, which are blockers of voltage-sensitive calcium channels (VSCCs), decreased MAP-induced discriminative responses.  However, pretreatment of these VSCC blockers failed to affect the inhibitory effects of nefiracetam on MAP-induced discriminative responses.  Our findings suggested that nefiracetam inhibits MAP-induced discriminative responses, which may be at least partly assocd. with the changes in intracellular cAMP levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQhuG4Dp6v_7Vg90H21EOLACvtfcHk0liZb3FCg5aebA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVSjuw%253D%253D&md5=4027698285c63b4b8f1474f5b0e1d2f4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1196%2Fannals.1316.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1316.034%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DY.%26aulast%3DMizuno%26aufirst%3DT.%26aulast%3DNitta%26aufirst%3DA.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DNabeshima%26aufirst%3DT.%26atitle%3DNefiracetam%2520attenuates%2520methamphetamine-induced%2520discriminative%2520stimulus%2520effects%2520in%2520rats%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2004%26volume%3D1025%26spage%3D274%26epage%3D278%26doi%3D10.1196%2Fannals.1316.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ciano, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandy, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Foll, B.</span></span> <span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> receptors in psychostimulant addiction</span>. <i>Adv. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1016/b978-0-12-420118-7.00008-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fb978-0-12-420118-7.00008-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=24484981" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=301-321&author=P.+D.+Cianoauthor=D.+K.+Grandyauthor=B.+Le+Foll&title=Dopamine+D4+receptors+in+psychostimulant+addiction&doi=10.1016%2Fb978-0-12-420118-7.00008-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fb978-0-12-420118-7.00008-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fb978-0-12-420118-7.00008-1%26sid%3Dliteratum%253Aachs%26aulast%3DCiano%26aufirst%3DP.%2BD.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DLe%2BFoll%26aufirst%3DB.%26atitle%3DDopamine%2520D4%2520receptors%2520in%2520psychostimulant%2520addiction%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2014%26volume%3D69%26spage%3D301%26epage%3D321%26doi%3D10.1016%2Fb978-0-12-420118-7.00008-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suárez-Boomgaard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshitake, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roales-Buján, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valderrama-Carvajal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilbao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina-Luque, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Díaz-Cabiale, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craenenbroeck, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroto-Escuela, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez
de Fonseca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santín, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Calle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuxe, K.</span></span> <span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> receptor stimulation prevents nigrostriatal dopamine pathway activation by morphine: relevance for drug addiction</span>. <i>Addict. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1232</span>– <span class="NLM_lpage">1245</span>, <span class="refDoi"> DOI: 10.1111/adb.12407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1111%2Fadb.12407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=27212105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtl2gs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1232-1245&author=A.+Riveraauthor=B.+Gagoauthor=D.+Su%C3%A1rez-Boomgaardauthor=T.+Yoshitakeauthor=R.+Roales-Buj%C3%A1nauthor=A.+Valderrama-Carvajalauthor=A.+Bilbaoauthor=J.+Medina-Luqueauthor=Z.+D%C3%ADaz-Cabialeauthor=K.+V.+Craenenbroeckauthor=D.+O.+Borroto-Escuelaauthor=J.+Kehrauthor=F.+Rodr%C3%ADguez%0Ade+Fonsecaauthor=L.+Sant%C3%ADnauthor=A.+de+la+Calleauthor=K.+Fuxe&title=Dopamine+D4+receptor+stimulation+prevents+nigrostriatal+dopamine+pathway+activation+by+morphine%3A+relevance+for+drug+addiction&doi=10.1111%2Fadb.12407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 receptor stimulation prevents nigrostriatal dopamine pathway activation by morphine: relevance for drug addiction</span></div><div class="casAuthors">Rivera, Alicia; Gago, Belen; Suarez-Boomgaard, Diana; Yoshitake, Takashi; Roales-Bujan, Ruth; Valderrama-Carvajal, Alejandra; Bilbao, Ainhoa; Medina-Luque, Jose; Diaz-Cabiale, Zaida; Van Craenenbroeck, Kathleen; Borroto-Escuela, Dasiel O.; Kehr, Jan; Rodriguez de Fonseca, Fernando; Santin, Luis; de la Calle, Adelaida; Fuxe, Kjell</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1232-1245</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-1600</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Morphine is one of the most effective drugs used for pain management, but it is also highly addictive.  Morphine elicits acute and long-term adaptive changes at cellular and mol. level in the brain, which play a crit. role in the development of tolerance, dependence and addiction.  Previous studies indicated that the dopamine D4 receptor (D4R) activation counteracts morphine-induced adaptive changes of the μ opioid receptor (MOR) signaling in the striosomes of the caudate putamen (CPu), as well as the induction of several Fos family transcription factors.  Thus, it has been suggested that D4R could play an important role avoiding some of the addictive effects of morphine.  Here, using different drugs administration paradigms, it is detd. that the D4R agonist PD168,077 prevents morphine-induced activation of the nigrostriatal dopamine pathway and morphol. changes of substantia nigra pars compacta (SNc) dopamine neurons, leading to a restoration of dopamine levels and metab. in the CPu.  Results from receptor autoradiog. indicate that D4R activation modulates MOR function in the substantia nigra pars reticulata (SNr) and the striosomes of the CPu, suggesting that these regions are critically involved in the modulation of SNc dopamine neuronal function through a functional D4R/MOR interaction.  In addn., D4R activation counteracts the rewarding effects of morphine, as well as the development of hyperlocomotion and phys. dependence without any effect on its analgesic properties.  These results provide a novel role of D4R agonist as a pharmacol. strategy to prevent the adverse effects of morphine in the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomhjVo9ElQhLVg90H21EOLACvtfcHk0lgB3I_VqHjidw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtl2gs7fI&md5=a93bd2a424ae18405a96d9dcbb1dbecd</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fadb.12407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fadb.12407%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DA.%26aulast%3DGago%26aufirst%3DB.%26aulast%3DSu%25C3%25A1rez-Boomgaard%26aufirst%3DD.%26aulast%3DYoshitake%26aufirst%3DT.%26aulast%3DRoales-Buj%25C3%25A1n%26aufirst%3DR.%26aulast%3DValderrama-Carvajal%26aufirst%3DA.%26aulast%3DBilbao%26aufirst%3DA.%26aulast%3DMedina-Luque%26aufirst%3DJ.%26aulast%3DD%25C3%25ADaz-Cabiale%26aufirst%3DZ.%26aulast%3DCraenenbroeck%26aufirst%3DK.%2BV.%26aulast%3DBorroto-Escuela%26aufirst%3DD.%2BO.%26aulast%3DKehr%26aufirst%3DJ.%26aulast%3DRodr%25C3%25ADguez%2Bde%2BFonseca%26aufirst%3DF.%26aulast%3DSant%25C3%25ADn%26aufirst%3DL.%26aulast%3Dde%2Bla%2BCalle%26aufirst%3DA.%26aulast%3DFuxe%26aufirst%3DK.%26atitle%3DDopamine%2520D4%2520receptor%2520stimulation%2520prevents%2520nigrostriatal%2520dopamine%2520pathway%2520activation%2520by%2520morphine%253A%2520relevance%2520for%2520drug%2520addiction%26jtitle%3DAddict.%2520Biol.%26date%3D2017%26volume%3D22%26spage%3D1232%26epage%3D1245%26doi%3D10.1111%2Fadb.12407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, S.</span></span> <span> </span><span class="NLM_article-title">Dopamine receptor D<sub>4</sub> promoter hypermethylation increases the risk of drug addiction</span>. <i>Exp. Ther. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2128</span>– <span class="NLM_lpage">2133</span>, <span class="refDoi"> DOI: 10.3892/etm.2017.5615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.3892%2Fetm.2017.5615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=29434815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFSgtbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=2128-2133&author=H.+Jiauthor=X.+Xuauthor=G.+Liuauthor=H.+Liuauthor=Q.+Wangauthor=W.+Shenauthor=L.+Liauthor=X.+Xieauthor=H.+Huauthor=L.+Xuauthor=W.+Zhouauthor=S.+Duan&title=Dopamine+receptor+D4+promoter+hypermethylation+increases+the+risk+of+drug+addiction&doi=10.3892%2Fetm.2017.5615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine receptor D4 promoter hypermethylation increases the risk of drug addiction</span></div><div class="casAuthors">Ji, Huihui; Xu, Xuting; Liu, Guili; Liu, Huifen; Wang, Qinwen; Shen, Wenwen; Li, Longhui; Xie, Xiaohu; Hu, Haochang; Xu, Lei; Zhou, Wenhua; Duan, Shiwei</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Therapeutic Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">2128-2133</span>CODEN:
                <span class="NLM_cas:coden">ETMXA2</span>;
        ISSN:<span class="NLM_cas:issn">1792-1015</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Heroin and methylamphetamine (METH) are two addictive drugs that cause serious problems for society.  Dopamine receptor D4 (DRD4), a key receptor in the dopaminergic system, may facilitate the development of drug addiction.  The aim of the present study was to investigate the assocn. between the promoter methylation level of DRD4 gene and drug addiction.  Bisulfite pyrosequencing technol. was used to measure the methylation levels of DRD4 promoter in 60 drug addicts and 52 matched controls.  Significantly higher levels of DRD4 CpG1 and CpG4 methylation were detected in METH and heroin drug addicts compared with controls (P<0.05).  Male METH addicts exhibited significantly higher DRD4 CpG1, CpG2 and CpG4 methylation levels compared with sex-matched controls (P<0.05).  In heroin addicts, a pos. correlation was obsd. between depression-dejection and DRD4 CpG5 methylation (r = 0.537, P = 0.039) whereas there was a neg. correlation between drug usage frequency and CpG1 methylation (r = -0.632, P = 0.011).  In METH addicts, methylation levels were not significantly assocd. with depression-dejection and drug usage frequency.  In addn., luciferase assays demonstrated that the target sequence of the DRD4 promoter upregulates gene expression.  The results of the present study suggest that DNA methylation of DRD4 may be responsible for the patho-physiol. of drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonhACVhG-3nrVg90H21EOLACvtfcHk0lgB3I_VqHjidw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFSgtbvN&md5=c2f55480bff3823ff222f36288aad5c6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3892%2Fetm.2017.5615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fetm.2017.5615%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DDuan%26aufirst%3DS.%26atitle%3DDopamine%2520receptor%2520D4%2520promoter%2520hypermethylation%2520increases%2520the%2520risk%2520of%2520drug%2520addiction%26jtitle%3DExp.%2520Ther.%2520Med.%26date%3D2018%26volume%3D15%26spage%3D2128%26epage%3D2133%26doi%3D10.3892%2Fetm.2017.5615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Negrete-Díaz, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shumilov, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Real, M. Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina-Luque, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valderrama-Carvajal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Moreno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, A.</span></span> <span> </span><span class="NLM_article-title">Pharmacological activation of dopamine D<sub>4</sub> receptor modulates morphine-induced changes in the expression of GAD65/67 and GABA<sub>B</sub> receptors in the basal ganglia</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2019.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.neuropharm.2019.01.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=30682345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFGmtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2019&pages=22-29&author=J.+V.+Negrete-D%C3%ADazauthor=K.+Shumilovauthor=M.+%C3%81.+Realauthor=J.+Medina-Luqueauthor=A.+Valderrama-Carvajalauthor=G.+Floresauthor=A.+Rodr%C3%ADguez-Morenoauthor=A.+Rivera&title=Pharmacological+activation+of+dopamine+D4+receptor+modulates+morphine-induced+changes+in+the+expression+of+GAD65%2F67+and+GABAB+receptors+in+the+basal+ganglia&doi=10.1016%2Fj.neuropharm.2019.01.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological activation of dopamine D4 receptor modulates morphine-induced changes in the expression of GAD65/67 and GABAB receptors in the basal ganglia</span></div><div class="casAuthors">Negrete-Diaz, Jose Vicente; Shumilov, Kirill; Real, M. Angeles; Medina-Luque, Jose; Valderrama-Carvajal, Alejandra; Flores, Gonzalo; Rodriguez-Moreno, Antonio; Rivera, Alicia</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-29</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dopamine D4 receptor (D4R) stimulation, in a putative D4R/μ opioid heteroreceptor (MOR) complex, counteracts the mol., cellular and behavioral actions of morphine which are assocd. with morphine addiction, without any effect on its analgesic properties.  In the present work, we have evaluated the role of D4R in modulating the effects of a continuous treatment with morphine on the GABAergic system in the basal ganglia.  It has been demonstrated that the co-administration of a D4R agonist together with morphine leads to a restoration of GABA signaling by preventing drug-induced changes in GAD65/67 expression in the caudate putamen, globus palidus and substantia nigra.  Results from GABABR1 and GABABR2 expression suggest a role of D4R in modulation of the GABAB heteroreceptor complexes along the basal ganglia, esp. in the functional divisions of the caudate putamen.  These results provide a new proof of the functional interaction between D4R and MOR and we postulate this putative heteroreceptor complex as a key target for the development of a new strategy to prevent the addictive effects of morphine in the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMJ8ahLCSi6rVg90H21EOLACvtfcHk0lh71jgCdhNGww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFGmtLc%253D&md5=ee391c642703584c792b58b29c6ff80b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2019.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2019.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DNegrete-D%25C3%25ADaz%26aufirst%3DJ.%2BV.%26aulast%3DShumilov%26aufirst%3DK.%26aulast%3DReal%26aufirst%3DM.%2B%25C3%2581.%26aulast%3DMedina-Luque%26aufirst%3DJ.%26aulast%3DValderrama-Carvajal%26aufirst%3DA.%26aulast%3DFlores%26aufirst%3DG.%26aulast%3DRodr%25C3%25ADguez-Moreno%26aufirst%3DA.%26aulast%3DRivera%26aufirst%3DA.%26atitle%3DPharmacological%2520activation%2520of%2520dopamine%2520D4%2520receptor%2520modulates%2520morphine-induced%2520changes%2520in%2520the%2520expression%2520of%2520GAD65%252F67%2520and%2520GABAB%2520receptors%2520in%2520the%2520basal%2520ganglia%26jtitle%3DNeuropharmacology%26date%3D2019%26volume%3D152%26spage%3D22%26epage%3D29%26doi%3D10.1016%2Fj.neuropharm.2019.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pushparaj, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Strat, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamaleddin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Justinova, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Foll, B.</span></span> <span> </span><span class="NLM_article-title">Blockade of dopamine D<sub>4</sub> receptors attenuates reinstatement of extinguished nicotine-seeking behavior in rats</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">696</span>, <span class="refDoi"> DOI: 10.1038/npp.2011.245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1038%2Fnpp.2011.245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=22030716" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2011&pages=685-696&author=Y.+Yanauthor=A.+Pushparajauthor=Y.+Le+Stratauthor=I.+Gamaleddinauthor=C.+Barnesauthor=Z.+Justinovaauthor=S.+R.+Goldbergauthor=B.+Le+Foll&title=Blockade+of+dopamine+D4+receptors+attenuates+reinstatement+of+extinguished+nicotine-seeking+behavior+in+rats&doi=10.1038%2Fnpp.2011.245"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.245%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DY.%26aulast%3DPushparaj%26aufirst%3DA.%26aulast%3DLe%2BStrat%26aufirst%3DY.%26aulast%3DGamaleddin%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DC.%26aulast%3DJustinova%26aufirst%3DZ.%26aulast%3DGoldberg%26aufirst%3DS.%2BR.%26aulast%3DLe%2BFoll%26aufirst%3DB.%26atitle%3DBlockade%2520of%2520dopamine%2520D4%2520receptors%2520attenuates%2520reinstatement%2520of%2520extinguished%2520nicotine-seeking%2520behavior%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2011%26volume%3D37%26spage%3D685%26epage%3D696%26doi%3D10.1038%2Fnpp.2011.245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bachner-Melman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zohar, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elizur, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemanov, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gritsenko, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebstein, R. P.</span></span> <span> </span><span class="NLM_article-title">Anorexia nervosa, perfectionism, and dopamine D<sub>4</sub> receptor (DRD4)</span>. <i>Am. J. Med. Genet., Part B</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">748</span>– <span class="NLM_lpage">756</span>, <span class="refDoi"> DOI: 10.1002/ajmg.b.30505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1002%2Fajmg.b.30505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFamsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2007&pages=748-756&author=R.+Bachner-Melmanauthor=E.+Lererauthor=A.+H.+Zoharauthor=I.+Kremerauthor=Y.+Elizurauthor=L.+Nemanovauthor=M.+Golanauthor=S.+Blankauthor=I.+Gritsenkoauthor=R.+P.+Ebstein&title=Anorexia+nervosa%2C+perfectionism%2C+and+dopamine+D4+receptor+%28DRD4%29&doi=10.1002%2Fajmg.b.30505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Anorexia nervosa, perfectionism, and dopamine D4 receptor (DRD4)</span></div><div class="casAuthors">Bachner-Melman, Rachel; Lerer, Elad; Zohar, Ada H.; Kremer, Ilana; Elizur, Yoel; Nemanov, Lubov; Golan, Moria; Blank, Shulamit; Gritsenko, Inga; Ebstein, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">144B</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">748-756</span>CODEN:
                <span class="NLM_cas:coden">AJMGC9</span>;
        ISSN:<span class="NLM_cas:issn">1552-4841</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The dopamine D4 receptor (DRD4), a well-characterized, polymorphic gene, is an attractive candidate for contributing risk to disordered eating and anorexia nervosa (AN).  We tested assocn. using UNPHASED for 5 DRD4 polymorphic loci, 3 promoter region SNPs (C-521T, C-616G, A-809G), the 120 bp promoter region tandem duplication and the exon III repeat, in 202 AN trios and 418 control families.  Since perfectionism characterizes AN, we tested these five loci for assocn. with the Child and Adolescent Perfectionism Scale (CAPS) in the AN and control groups.  Single locus anal. showed significant assocn. between the 'C' C-521T allele and AN.  Haplotype anal. also showed significant assocn., particularly a 4-locus haplotype (exon III&120 bp repeat&C-521T&A-809G).  Assocn. was also obsd. between DRD4 and CAPS scores both for AN and control subjects.  The insulin-like growth factor 2 (IGF2) and the arginine vasopressin 1a receptor (AVPR1a), previously shown to be assocd. with disordered eating, were also assocd. with CAPS scores.  Three genes assocd. with AN were also assocd. with perfectionism.  Personality traits are potential endophenotypes for understanding the etiol. of eating disorders and one of the several pathways to eating pathol. may be mediated by the impact of DNA sequences on perfectionism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU7UtVSmIpUbVg90H21EOLACvtfcHk0liP-zHCgI9d1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFamsrrO&md5=75b47b7108110a6ef07cf6b1a672d330</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fajmg.b.30505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fajmg.b.30505%26sid%3Dliteratum%253Aachs%26aulast%3DBachner-Melman%26aufirst%3DR.%26aulast%3DLerer%26aufirst%3DE.%26aulast%3DZohar%26aufirst%3DA.%2BH.%26aulast%3DKremer%26aufirst%3DI.%26aulast%3DElizur%26aufirst%3DY.%26aulast%3DNemanov%26aufirst%3DL.%26aulast%3DGolan%26aufirst%3DM.%26aulast%3DBlank%26aufirst%3DS.%26aulast%3DGritsenko%26aufirst%3DI.%26aulast%3DEbstein%26aufirst%3DR.%2BP.%26atitle%3DAnorexia%2520nervosa%252C%2520perfectionism%252C%2520and%2520dopamine%2520D4%2520receptor%2520%2528DRD4%2529%26jtitle%3DAm.%2520J.%2520Med.%2520Genet.%252C%2520Part%2520B%26date%3D2007%26volume%3D144%26spage%3D748%26epage%3D756%26doi%3D10.1002%2Fajmg.b.30505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gervasini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordillo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Herráiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, J. A.</span></span> <span> </span><span class="NLM_article-title">Influence of dopamine polymorphisms on the risk for anorexia nervosa and associated psychopathological features</span>. <i>J. Clin. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">555</span>, <span class="refDoi"> DOI: 10.1097/jcp.0b013e3182970469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1097%2Fjcp.0b013e3182970469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=23775054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVGktrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=551-555&author=G.+Gervasiniauthor=I.+Gordilloauthor=A.+Garc%C3%ADa-Herr%C3%A1izauthor=I.+Floresauthor=M.+Jim%C3%A9nezauthor=M.+Mongeauthor=J.+A.+Carrillo&title=Influence+of+dopamine+polymorphisms+on+the+risk+for+anorexia+nervosa+and+associated+psychopathological+features&doi=10.1097%2Fjcp.0b013e3182970469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of Dopamine Polymorphisms on the Risk for Anorexia Nervosa and Associated Psychopathological Features</span></div><div class="casAuthors">Gervasini, Guillermo; Gordillo, Inmaculada; Garcia-Herraiz, Angustias; Flores, Isalud; Jimenez, Mercedes; Monge, Melchora; Carrillo, Juan Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">551-555</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Dopamine neuronal functions make polymorphisms in dopaminergic pathways good candidates for playing a relevant role in anorexia nervosa (AN) and related psychopathol. features.  We have analyzed the effect of 8 polymorphisms in genes coding for dopamine receptors (DRD2, DRD3, and DRD4), transporters (DAT1) and metabolizing enzymes (COMT) in 78 women with AN and 186 control subjects.  Assocd. psychopathol. characteristics in patients with AN were assessed by the Eating Disorders Inventory Test-2 and SCL-90R self-reported questionnaires.  The DRD4 variable no. of tandem repeats (VNTR) 7R/7R and DRD4 -616CC genotypes were significantly assocd. with a greater risk for AN (odds ratio, 3.83; confidence interval, 1.05-13.98; P = 0.04; and odds ratio, 1.74; confidence interval, 1.01-2.97; P = 0.03, resp.).  The anal. of physiol. parameters in the patients with AN revealed that the short allele of a 120-base pair tandem repeat in the promoter region of the DRD4 gene was assocd. with higher wt. (48.35 ± 6.79 vs 43.95 ± 5.78 kg; Bonferroni, P < 0.05), whereas the DRD4 -521TT genotype was assocd. with significantly higher body mass index (17.29 ± 2.25 vs 18.13 ± 2.41 kg/m; Bonferroni, P < 0.05).  The DRD4 C-616G and DAT1 VNTR polymorphisms correlated with several psychopathol. features in patients with AN.  Carriers of the mutant homozygous genotypes scored higher in all but one of the Eating Disorders Inventory Test-2 subscales.  After correction for multiple testing, differences in Asceticism scores between DAT1 VNTR genotypes, as well as differences in Drive for Thinness and Body Dissatisfaction between C-616G genotypes remained significant (P < 0.05).  The results show that certain genetic alterations in the dopamine pathways are able to modify the risk for AN as well as modulate psychopathol. features that are often coupled to this disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcDz_oQEKGy7Vg90H21EOLACvtfcHk0liP-zHCgI9d1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVGktrzN&md5=6b60b589993020c31a1033cd790ba3ef</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1097%2Fjcp.0b013e3182970469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fjcp.0b013e3182970469%26sid%3Dliteratum%253Aachs%26aulast%3DGervasini%26aufirst%3DG.%26aulast%3DGordillo%26aufirst%3DI.%26aulast%3DGarc%25C3%25ADa-Herr%25C3%25A1iz%26aufirst%3DA.%26aulast%3DFlores%26aufirst%3DI.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DM.%26aulast%3DMonge%26aufirst%3DM.%26aulast%3DCarrillo%26aufirst%3DJ.%2BA.%26atitle%3DInfluence%2520of%2520dopamine%2520polymorphisms%2520on%2520the%2520risk%2520for%2520anorexia%2520nervosa%2520and%2520associated%2520psychopathological%2520features%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2013%26volume%3D33%26spage%3D551%26epage%3D555%26doi%3D10.1097%2Fjcp.0b013e3182970469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gervasini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamero-Villarroel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mota-Zamorano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Herráiz, A.</span></span> <span> </span><span class="NLM_article-title">Effect of dopamine receptor D<sub>4</sub> (DRD4) haplotypes on general psychopathology in patients with eating disorders</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>654</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.gene.2018.02.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.gene.2018.02.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=29455021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivVymtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=654&publication_year=2018&pages=43-48&author=G.+Gervasiniauthor=L.+M.+Gonz%C3%A1lezauthor=C.+Gamero-Villarroelauthor=S.+Mota-Zamoranoauthor=J.+A.+Carrilloauthor=I.+Floresauthor=A.+Garc%C3%ADa-Herr%C3%A1iz&title=Effect+of+dopamine+receptor+D4+%28DRD4%29+haplotypes+on+general+psychopathology+in+patients+with+eating+disorders&doi=10.1016%2Fj.gene.2018.02.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of dopamine receptor D4 (DRD4) haplotypes on general psychopathology in patients with eating disorders</span></div><div class="casAuthors">Gervasini, Guillermo; Gonzalez, Luz M.; Gamero-Villarroel, Carmen; Mota-Zamorano, Sonia; Carrillo, Juan Antonio; Flores, Isalud; Garcia-Herraiz, Angustias</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">654</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">43-48</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Among the many candidate genes analyzed in eating disorder (ED) patients, those involved in dopaminergic functions may be of special relevance, as dopamine is known to play a significant role in feeding behavior, the distortion of body image, hyperactivity and reward and reinforcement processes.  We aimed to det. the effect of functional polymorphisms and haplotypes in the Dopamine Receptor D4 (DRD4) gene on general psychopathol. symptoms in ED patients.  Two-hundred-and-seventy-three ED patients [199 with Anorexia Nervosa (AN) and 74 with Bulimia Nervosa (BN)] completed the SCL-90R inventory and were genotyped for four functional, clin. relevant DRD4 polymorphisms: three variants in the promoter region [120-bp tandem repeat (TR, long vs. short allele), C-616G and C-521T] and a variable no. of tandem repeats (VNTR) in exon 3 (7R vs. non-7R allele).  After correcting for multiple testing, none of the assayed polymorphisms were individually assocd. with SCL-90R results.  Four DRD4 haplotypes (*1-*4) were detected in the patients with a frequency>0.1.  In the BN group, haplotype *2 (non7R-TR long-C-C) was assocd. with higher scores in the three global SCL-90R indexes (GSI, PSDI and PST) after Bonferroni correction (p≤0.01 in all instances).  Furthermore, carriers of this haplotype displayed higher scores (worst symptomatol.) in Somatization, Obsessive-Compulsive, Anxiety, Phobic anxiety, Paranoid ideation and the test addnl. items (p-values for the differences between carriers vs. non-carriers ranging from 0.0001 to 0.0110).  Certain combinations of DRD4 variants may contribute to psychopathol. features in BN patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorYqAwTKTOWbVg90H21EOLACvtfcHk0liP-zHCgI9d1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivVymtrs%253D&md5=4525c216cfce672ee4c4782633badc5f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.gene.2018.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gene.2018.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DGervasini%26aufirst%3DG.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DL.%2BM.%26aulast%3DGamero-Villarroel%26aufirst%3DC.%26aulast%3DMota-Zamorano%26aufirst%3DS.%26aulast%3DCarrillo%26aufirst%3DJ.%2BA.%26aulast%3DFlores%26aufirst%3DI.%26aulast%3DGarc%25C3%25ADa-Herr%25C3%25A1iz%26aufirst%3DA.%26atitle%3DEffect%2520of%2520dopamine%2520receptor%2520D4%2520%2528DRD4%2529%2520haplotypes%2520on%2520general%2520psychopathology%2520in%2520patients%2520with%2520eating%2520disorders%26jtitle%3DGene%26date%3D2018%26volume%3D654%26spage%3D43%26epage%3D48%26doi%3D10.1016%2Fj.gene.2018.02.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LaHoste, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigal, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glabe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. L.</span></span> <span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> receptor gene polymorphism is associated with attention deficit hyperactivity disorder</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=9118321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A280%3ADyaK2s3jtlartg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1996&pages=121-124&author=G.+J.+LaHosteauthor=J.+M.+Swansonauthor=S.+B.+Wigalauthor=C.+Glabeauthor=T.+Wigalauthor=N.+Kingauthor=J.+L.+Kennedy&title=Dopamine+D4+receptor+gene+polymorphism+is+associated+with+attention+deficit+hyperactivity+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder</span></div><div class="casAuthors">LaHoste G J; Swanson J M; Wigal S B; Glabe C; Wigal T; King N; Kennedy J L</div><div class="citationInfo"><span class="NLM_cas:title">Molecular psychiatry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-4</span>
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    </div><div class="casAbstract">Dopamine is believed to play a major role in the manifestation of attention deficit hyperactivity disorder (ADHD), which affects 3-6% of school-age children and shows evidence of familiarity.  The dopamine D4 receptor, which is preferentially distributed in cortical and limbic regions of the brain, is currently of major interest because of the high degree of functionally relevant variability in its gene (DRD4), and the association of this gene with Novelty Seeking behavior.  We examined the variability in the length of a region of DRD4 that contains a 48-bp repeat sequence in children with ADHD and controls matched for ethnicity.  ADHD children differed from controls in that the 7-fold repeat form of DRD4 occurred significantly more frequently than in the control sample.  This form of the receptor has previously been shown to mediate a blunted intracellular response to dopamine.  Although ADHD is likely to be multifactorial in its etiology and its heritability is likely to be polygenetic, the present findings suggest that polymorphic variation in the gene encoding the D4 dopamine receptor may be a contributing factor in the expression of symptoms associated with ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRN_l8s_261K2lSCSgBhwJFfW6udTcc2eYlC0k6sVOH_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s3jtlartg%253D%253D&md5=ce39ec8adf6503bb18524d566f891988</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaHoste%26aufirst%3DG.%2BJ.%26aulast%3DSwanson%26aufirst%3DJ.%2BM.%26aulast%3DWigal%26aufirst%3DS.%2BB.%26aulast%3DGlabe%26aufirst%3DC.%26aulast%3DWigal%26aufirst%3DT.%26aulast%3DKing%26aufirst%3DN.%26aulast%3DKennedy%26aufirst%3DJ.%2BL.%26atitle%3DDopamine%2520D4%2520receptor%2520gene%2520polymorphism%2520is%2520associated%2520with%2520attention%2520deficit%2520hyperactivity%2520disorder%26jtitle%3DMol.%2520Psychiatry%26date%3D1996%26volume%3D1%26spage%3D121%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smalley, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantwell, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGough, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del’Homme, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asarnow, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, S. F.</span></span> <span> </span><span class="NLM_article-title">Evidence that the dopamine D<sub>4</sub> receptor is a susceptibility gene in attention deficit hyperactivity disorder</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1038/sj.mp.4000457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1038%2Fsj.mp.4000457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=9774776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXls12ntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1998&pages=427-430&author=S.+L.+Smalleyauthor=J.+N.+Baileyauthor=C.+G.+Palmerauthor=D.+P.+Cantwellauthor=J.+J.+McGoughauthor=M.+A.+Del%E2%80%99Hommeauthor=J.+R.+Asarnowauthor=J.+A.+Woodwardauthor=C.+Ramseyauthor=S.+F.+Nelson&title=Evidence+that+the+dopamine+D4+receptor+is+a+susceptibility+gene+in+attention+deficit+hyperactivity+disorder&doi=10.1038%2Fsj.mp.4000457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder</span></div><div class="casAuthors">Smalley, S. L.; Bailey, J. N.; Palmer, C. G.; Cantwell, D. P.; McGough, J. J.; Del'Homme, M. A.; Asarnow, J. R.; Woodward, J. A.; Ramsey, C.; Nelson, S. F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">427-430</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">Attention deficit hyperactivity disorder (ADHD) is a common neurobehavioral problem afflicting 5-10% of children and adolescents and persisting into adulthood in 30-50% or more of cases.  Family, twin, and adoption studies suggest genetic factors contribute to ADHD and symptoms of inattention, impulsivity, and hyperactivity.  Because stimulant intervention is effective in reducing ADHD symptoms in about 70-80% of cases, mol. genetic investigations of genes involved in dopamine regulation are currently underway by many groups.  In a case control study of the dopamine D4 receptor gene (DRD4) and ADHD, La Hoste and colleagues (1996) found an increase of a 7-repeat variant of a 48-bp VNTR in exon 310 among ADHD subjects compared to controls.  Swanson and colleagues (1998) replicated this finding in a sample of 52 ADHD probands and their biol. parents using a haplotype relative risk anal.  Here, the authors describe linkage investigations of the VNTR and ADHD in affected sibling pair (ASP) families and singleton families using both the transmission disequil. test (TDT) and a mean test of identity-by-descent (IBD) sharing.  Using the TDT in the total sample, the 7 allele is differentially transmitted to ADHD children (P = 0.03) while the mean test revealed no evidence of increased IBD sharing among ASPs.  In the current sample, the 7 allele attributes a 1.5-fold risk for developing ADHD over non-carriers of the allele estd. under a model described by Risch and Merikangas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomy7yvc-tXBrVg90H21EOLACvtfcHk0ljtQ5mWVyByyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXls12ntr0%253D&md5=cee23ac900d1b77217b666acba5839d5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4000457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4000457%26sid%3Dliteratum%253Aachs%26aulast%3DSmalley%26aufirst%3DS.%2BL.%26aulast%3DBailey%26aufirst%3DJ.%2BN.%26aulast%3DPalmer%26aufirst%3DC.%2BG.%26aulast%3DCantwell%26aufirst%3DD.%2BP.%26aulast%3DMcGough%26aufirst%3DJ.%2BJ.%26aulast%3DDel%25E2%2580%2599Homme%26aufirst%3DM.%2BA.%26aulast%3DAsarnow%26aufirst%3DJ.%2BR.%26aulast%3DWoodward%26aufirst%3DJ.%2BA.%26aulast%3DRamsey%26aufirst%3DC.%26aulast%3DNelson%26aufirst%3DS.%2BF.%26atitle%3DEvidence%2520that%2520the%2520dopamine%2520D4%2520receptor%2520is%2520a%2520susceptibility%2520gene%2520in%2520attention%2520deficit%2520hyperactivity%2520disorder%26jtitle%3DMol.%2520Psychiatry%26date%3D1998%26volume%3D3%26spage%3D427%26epage%3D430%26doi%3D10.1038%2Fsj.mp.4000457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarazi, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldessarini, R. J.</span></span> <span> </span><span class="NLM_article-title">Role of dopamine D<sub>4</sub> receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">624</span>– <span class="NLM_lpage">632</span>, <span class="refDoi"> DOI: 10.1016/s0893-133x(01)00262-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fs0893-133x%2801%2900262-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=11682245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnslCjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2001&pages=624-632&author=K.+Zhangauthor=F.+I.+Taraziauthor=R.+J.+Baldessarini&title=Role+of+dopamine+D4+receptors+in+motor+hyperactivity+induced+by+neonatal+6-hydroxydopamine+lesions+in+rats&doi=10.1016%2Fs0893-133x%2801%2900262-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Dopamine D4 Receptors in Motor Hyperactivity Induced by Neonatal 6-Hydroxydopamine Lesions in Rats</span></div><div class="casAuthors">Zhang, Kehong; Tarazi, Frank I.; Baldessarini, Ross J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">624-632</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The role of dopamine D4 receptors in behavioral hyperactivity was investigated by assessing D4 receptor expression in brain regions and behavioral effects of D4 receptor-selective ligands in juvenile rats with neonatal 6-hydroxydopamine lesions, a lab. model for attention deficit-hyperactivity disorder (ADHD).  Autoradiog. anal. indicated that motor hyperactivity in lesioned rats was closely correlated with increases in D4 but not D2 receptor levels in caudate-putamen.  D4-selective antagonist CP-293,019 dose-dependently reversed lesion-induced hyperactivity, and D4-agonist CP-226,269 increased it.  These results indicate a physiol. role of dopamine D4 receptors in motor behavior, and may suggest much-needed innovative treatments for ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLwJLfQQgg3bVg90H21EOLACvtfcHk0lg1mdgbmzRPXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnslCjsLY%253D&md5=22ce93f3b654bee58d47552e6057bd1c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fs0893-133x%2801%2900262-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0893-133x%252801%252900262-7%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DTarazi%26aufirst%3DF.%2BI.%26aulast%3DBaldessarini%26aufirst%3DR.%2BJ.%26atitle%3DRole%2520of%2520dopamine%2520D4%2520receptors%2520in%2520motor%2520hyperactivity%2520induced%2520by%2520neonatal%25206-hydroxydopamine%2520lesions%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2001%26volume%3D25%26spage%3D624%26epage%3D632%26doi%3D10.1016%2Fs0893-133x%2801%2900262-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span> <span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> receptor gene associated with the frontal-striatal-cerebellar loop in children with ADHD: a resting-state fMRI study</span>. <i>Neurosci. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1007/s12264-018-0217-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1007%2Fs12264-018-0217-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=29564731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltlWjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2018&pages=497-506&author=A.+Qianauthor=X.+Wangauthor=H.+Liuauthor=J.+Taoauthor=J.+Zhouauthor=Q.+Yeauthor=J.+Liauthor=C.+Yangauthor=J.+Chengauthor=K.+Zhaoauthor=M.+Wang&title=Dopamine+D4+receptor+gene+associated+with+the+frontal-striatal-cerebellar+loop+in+children+with+ADHD%3A+a+resting-state+fMRI+study&doi=10.1007%2Fs12264-018-0217-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 Receptor Gene Associated with the Frontal-Striatal-Cerebellar Loop in Children with ADHD: A Resting-State fMRI Study</span></div><div class="casAuthors">Qian, Andan; Wang, Xin; Liu, Huiru; Tao, Jiejie; Zhou, Jiejie; Ye, Qiong; Li, Jiance; Yang, Chuang; Cheng, Jingliang; Zhao, Ke; Wang, Meihao</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Bulletin</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">497-506</span>CODEN:
                <span class="NLM_cas:coden">NBEUAS</span>;
        ISSN:<span class="NLM_cas:issn">1995-8218</span>.
    
            (<span class="NLM_cas:orgname">Shanghai Institutes for Biological Sciences</span>)
        </div><div class="casAbstract">Attention deficit hyperactivity disorder (ADHD) is a common childhood neuropsychiatric disorder that has been linked to the dopaminergic system.  This study aimed to investigate the effects of regulation of the dopamine D4 receptor (DRD4) on functional brain activity during the resting state in ADHD children using the methods of regional homogeneity (ReHo) and functional connectivity (FC).  Resting-state functional magnetic resonance imaging data were analyzed in 49 children with ADHD.  All participants were classified as either carriers of the DRD4 4-repeat/4-repeat (4R/4R) allele (n = 30) or the DRD4 2-repeat (2R) allele (n = 19).  The results showed that participants with the DRD4 2R allele had decreased ReHo bilaterally in the posterior lobes of the cerebellum, while ReHo was increased in the left angular gyrus.  Compared with participants carrying the DRD4 4R/4R allele, those with the DRD4 2R allele showed decreased FC to the left angular gyrus in the left striatum, right inferior frontal gyrus, and bilateral lobes of the cerebellum.  The increased FC regions included the left superior frontal gyrus, medial frontal gyrus, and rectus gyrus.  These data suggest that the DRD4 polymorphisms are assocd. with localized brain activity and specific functional connections, including abnormality in the frontal-striatal-cerebellar loop.  Our study not only enhances the understanding of the correlation between the cerebellar lobes and ADHD, but also provides an imaging basis for explaining the neural mechanisms underlying ADHD in children.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOihwD8Emw3bVg90H21EOLACvtfcHk0lg1mdgbmzRPXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltlWjs78%253D&md5=09313b88aa334b4e91535e641d697f74</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2Fs12264-018-0217-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12264-018-0217-7%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DTao%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DM.%26atitle%3DDopamine%2520D4%2520receptor%2520gene%2520associated%2520with%2520the%2520frontal-striatal-cerebellar%2520loop%2520in%2520children%2520with%2520ADHD%253A%2520a%2520resting-state%2520fMRI%2520study%26jtitle%3DNeurosci.%2520Bull.%26date%3D2018%26volume%3D34%26spage%3D497%26epage%3D506%26doi%3D10.1007%2Fs12264-018-0217-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brioni, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreland, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedlund, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly-Roberts, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolasa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polakowski, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, K.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, J. P.</span></span> <span> </span><span class="NLM_article-title">Activation of dopamine D<sub>4</sub> receptors by ABT-724 induces penile erection in rats</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">6758</span>– <span class="NLM_lpage">6763</span>, <span class="refDoi"> DOI: 10.1073/pnas.0308292101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1073%2Fpnas.0308292101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=15087502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVyhs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=6758-6763&author=J.+D.+Brioniauthor=R.+B.+Morelandauthor=M.+Cowartauthor=G.+C.+Hsiehauthor=A.+O.+Stewartauthor=P.+Hedlundauthor=D.+L.+Donnelly-Robertsauthor=M.+Nakaneauthor=J.+J.+Lynchauthor=T.+Kolasaauthor=J.+S.+Polakowskiauthor=M.+A.+Osinskiauthor=K.+Marshauthor=K.-E.+Anderssonauthor=J.+P.+Sullivan&title=Activation+of+dopamine+D4+receptors+by+ABT-724+induces+penile+erection+in+rats&doi=10.1073%2Fpnas.0308292101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats</span></div><div class="casAuthors">Brioni, Jorge D.; Moreland, Robert B.; Cowart, Marlon; Hsieh, Gin C.; Stewart, Andrew O.; Hedlund, Petter; Donnelly-Roberts, Diana L.; Nakane, Masaki; Lynch, James J., III; Kolasa, Teodozyi; Polakowski, James S.; Osinski, Mark A.; Marsh, Kennan; Andersson, Karl-Erik; Sullivan, James P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6758-6763</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Apomorphine, a nonselective dopamine receptor agonist, facilitates penile erection and is effective in patients suffering from erectile dysfunction.  The specific dopamine receptor subtype(s) responsible for its erectogenic effect is not known.  Here we report that the dopamine D4 receptor plays a role in the regulation of penile function.  ABT-724 is a selective dopamine D4 receptor agonist that activates human dopamine D4 receptors with an EC50 of 12.4 nM and 61% efficacy, with no effect on dopamine D1, D2, D3, or D5 receptors.  ABT-724 dose-dependently facilitates penile erection when given s.c. to conscious rats, an effect that is blocked by haloperidol and clozapine but not by domperidone.  A proerectile effect is obsd. after intracerebroventricular but not intrathecal administration, suggesting a supraspinal site of action.  S.c. injections of ABT-724 increase intracavernosal pressure in awake freely moving rats.  In the presence of sildenafil, a potentiation of the proerectile effect of ABT-724 is obsd. in conscious rats.  The ability of ABT-724 to facilitate penile erection together with the favorable side-effect profile indicates that ABT-724 could be useful for the treatment of erectile dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_CPLyHqtzJ7Vg90H21EOLACvtfcHk0lg1mdgbmzRPXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVyhs7g%253D&md5=b37690221970ae889a6589e9177cf321</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0308292101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0308292101%26sid%3Dliteratum%253Aachs%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DMoreland%26aufirst%3DR.%2BB.%26aulast%3DCowart%26aufirst%3DM.%26aulast%3DHsieh%26aufirst%3DG.%2BC.%26aulast%3DStewart%26aufirst%3DA.%2BO.%26aulast%3DHedlund%26aufirst%3DP.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DNakane%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DKolasa%26aufirst%3DT.%26aulast%3DPolakowski%26aufirst%3DJ.%2BS.%26aulast%3DOsinski%26aufirst%3DM.%2BA.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DAndersson%26aufirst%3DK.-E.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26atitle%3DActivation%2520of%2520dopamine%2520D4%2520receptors%2520by%2520ABT-724%2520induces%2520penile%2520erection%2520in%2520rats%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D6758%26epage%3D6763%26doi%3D10.1073%2Fpnas.0308292101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolasa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulenko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hakeem, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowart, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchic, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terranova, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kouhen, O. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly-Roberts, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namovic, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingsworth, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martino, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetter, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darbyshire, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gintant, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreland, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brioni, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. O.</span></span> <span> </span><span class="NLM_article-title">Discovery of 3-Methyl-N-(1-oxy-3′,4′,5′,6′-tetrahydro-2′H-[2,4′-bipyridine]-1′-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D<sub>4</sub> agonist for the treatment of erectile dysfunction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">7450</span>– <span class="NLM_lpage">7465</span>, <span class="refDoi"> DOI: 10.1021/jm060662k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060662k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFykurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7450-7465&author=M.+V.+Patelauthor=T.+Kolasaauthor=K.+Mortellauthor=M.+A.+Matulenkoauthor=A.+A.+Hakeemauthor=J.+J.+Rohdeauthor=S.+L.+Nelsonauthor=M.+D.+Cowartauthor=M.+Nakaneauthor=L.+N.+Millerauthor=M.+E.+Uchicauthor=M.+A.+Terranovaauthor=O.+F.+El-Kouhenauthor=D.+L.+Donnelly-Robertsauthor=M.+T.+Namovicauthor=P.+R.+Hollingsworthauthor=R.+Changauthor=B.+R.+Martinoauthor=J.+M.+Wetterauthor=K.+C.+Marshauthor=R.+Martinauthor=J.+F.+Darbyshireauthor=G.+Gintantauthor=G.+C.+Hsiehauthor=R.+B.+Morelandauthor=J.+P.+Sullivanauthor=J.+D.+Brioniauthor=A.+O.+Stewart&title=Discovery+of+3-Methyl-N-%281-oxy-3%E2%80%B2%2C4%E2%80%B2%2C5%E2%80%B2%2C6%E2%80%B2-tetrahydro-2%E2%80%B2H-%5B2%2C4%E2%80%B2-bipyridine%5D-1%E2%80%B2-ylmethyl%29benzamide+%28ABT-670%29%2C+an+orally+bioavailable+dopamine+D4+agonist+for+the+treatment+of+erectile+dysfunction&doi=10.1021%2Fjm060662k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3-Methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an Orally Bioavailable Dopamine D4 Agonist for the Treatment of Erectile Dysfunction</span></div><div class="casAuthors">Patel, Meena V.; Kolasa, Teodozyj; Mortell, Kathleen; Matulenko, Mark A.; Hakeem, Ahmed A.; Rohde, Jeffrey J.; Nelson, Sherry L.; Cowart, Marlon D.; Nakane, Masaki; Miller, Loan N.; Uchic, Marie E.; Terranova, Marc A.; El-Kouhen, Odile F.; Donnelly-Roberts, Diana L.; Namovic, Marian T.; Hollingsworth, Peter R.; Chang, Renjie; Martino, Brenda R.; Wetter, Jill M.; Marsh, Kennan C.; Martin, Ruth; Darbyshire, John F.; Gintant, Gary; Hsieh, Gin C.; Moreland, Robert B.; Sullivan, James P.; Brioni, Jorge D.; Stewart, Andrew O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">7450-7465</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The goal of this study was to identify a structurally distinct D4-selective agonist with superior oral bioavailability to our first-generation clin. candidate 1a (ABT-724) for the potential treatment of erectile dysfunction.  Arylpiperazines such as (heteroarylmethyl)piperazine 1a, benzamide 2, and acetamides such as 3a,b exhibit poor oral bioavailability.  Structure-activity relationship (SAR) studies with the arylpiperidine template provided potent partial agonists such as 4d and 5k that demonstrated no improvement in oral bioavailability.  Further optimization with the (N-oxy-2-pyridinyl)piperidine template led to the discovery of compd. 6b (ABT-670), which exhibited excellent oral bioavailability in rat, dog, and monkey (68%, 85%, and 91%, resp.) with comparable efficacy, safety, and tolerability to 1a.  The N-oxy-2-pyridinyl moiety not only provided the structural motif required for agonist function but also reduced metab. rates.  The SAR study leading to the discovery of 6b is described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3nDe7tEoJO7Vg90H21EOLACvtfcHk0lhqrJAjT1-atQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFykurrM&md5=a036941dfd27f9a36e8e87aa177d8298</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm060662k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060662k%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%2BV.%26aulast%3DKolasa%26aufirst%3DT.%26aulast%3DMortell%26aufirst%3DK.%26aulast%3DMatulenko%26aufirst%3DM.%2BA.%26aulast%3DHakeem%26aufirst%3DA.%2BA.%26aulast%3DRohde%26aufirst%3DJ.%2BJ.%26aulast%3DNelson%26aufirst%3DS.%2BL.%26aulast%3DCowart%26aufirst%3DM.%2BD.%26aulast%3DNakane%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DL.%2BN.%26aulast%3DUchic%26aufirst%3DM.%2BE.%26aulast%3DTerranova%26aufirst%3DM.%2BA.%26aulast%3DEl-Kouhen%26aufirst%3DO.%2BF.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DNamovic%26aufirst%3DM.%2BT.%26aulast%3DHollingsworth%26aufirst%3DP.%2BR.%26aulast%3DChang%26aufirst%3DR.%26aulast%3DMartino%26aufirst%3DB.%2BR.%26aulast%3DWetter%26aufirst%3DJ.%2BM.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DDarbyshire%26aufirst%3DJ.%2BF.%26aulast%3DGintant%26aufirst%3DG.%26aulast%3DHsieh%26aufirst%3DG.%2BC.%26aulast%3DMoreland%26aufirst%3DR.%2BB.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DStewart%26aufirst%3DA.%2BO.%26atitle%3DDiscovery%2520of%25203-Methyl-N-%25281-oxy-3%25E2%2580%25B2%252C4%25E2%2580%25B2%252C5%25E2%2580%25B2%252C6%25E2%2580%25B2-tetrahydro-2%25E2%2580%25B2H-%255B2%252C4%25E2%2580%25B2-bipyridine%255D-1%25E2%2580%25B2-ylmethyl%2529benzamide%2520%2528ABT-670%2529%252C%2520an%2520orally%2520bioavailable%2520dopamine%2520D4%2520agonist%2520for%2520the%2520treatment%2520of%2520erectile%2520dysfunction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7450%26epage%3D7465%26doi%3D10.1021%2Fjm060662k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corda, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melis, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piludu, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Löber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argiolas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgi, O.</span></span> <span> </span><span class="NLM_article-title">Dopamine agonist-induced penile erection and yawning: A comparative study in outbred Roman high- and low-avoidance rats</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/j.pbb.2013.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.pbb.2013.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=23664901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFOmsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2013&pages=59-66&author=F.+Sannaauthor=M.+G.+Cordaauthor=M.+R.+Melisauthor=M.+A.+Piluduauthor=S.+L%C3%B6berauthor=H.+H%C3%BCbnerauthor=P.+Gmeinerauthor=A.+Argiolasauthor=O.+Giorgi&title=Dopamine+agonist-induced+penile+erection+and+yawning%3A+A+comparative+study+in+outbred+Roman+high-+and+low-avoidance+rats&doi=10.1016%2Fj.pbb.2013.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine agonist-induced penile erection and yawning: A comparative study in outbred Roman high- and low-avoidance rats</span></div><div class="casAuthors">Sanna, Fabrizio; Corda, Maria Giuseppa; Melis, Maria Rosaria; Piludu, Maria Antonietta; Lober, Stefan; Hubner, Harald; Gmeiner, Peter; Argiolas, Antonio; Giorgi, Osvaldo</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-66</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The effects on penile erection and yawning of s.c. (SC) injections of the mixed dopamine D1/D2-like agonist apomorphine (0.02-0.2 mg/kg) were studied in outbred Roman high- (RHA) and low-avoidance (RLA) male rats, 2 lines selectively bred for their resp. rapid vs. poor acquisition of the active avoidance response in the shuttle-box, and compared with the effects obsd. in male Sprague-Dawley (SD) rats.  Apomorphine dose-response curves were bell-shaped in all rat lines/strains.  Notably, more penile erections and yawns were recorded mainly in the ascending part of these curves (e.g., apomorphine 0.02-0.08 mg/kg) in both RLA and RHA rats compared to SD rats, with RLA rats showing the higher response (esp. for yawning) with respect to RHA rats.  Similar results were found with PD-168,077 (0.02-0.2 mg/kg SC), a D4 receptor agonist, which induced penile erection but not yawning.  In all rat lines/strains, apomorphine responses were markedly reduced by the D2 antagonist L-741,626, but not by the D3 antagonist, SB277011A, whereas the D4 antagonists L-745,870 and FAUC213 elicited a partial, yet statistically significant, inhibitory effect.  In contrast, the pro-erectile effect of PD-168,077 was completely abolished by L-745,870 and FAUC213, as expected.  The present study confirms and extends previously reported differences in dopamine transmission between RLA and RHA rats and between the SD strain and the Roman lines.  Moreover, it confirms previous studies supporting the view that dopamine receptors of the D2 subtype play a predominant role in the pro-yawning and pro-erectile effect of apomorphine, and that the selective stimulation of D4 receptors induces penile erection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo27Y_IyA8S5LVg90H21EOLACvtfcHk0lh-UW9UCAK7xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFOmsrs%253D&md5=832f1e2297aa19e088faf9c41dcf6b2e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2013.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2013.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DF.%26aulast%3DCorda%26aufirst%3DM.%2BG.%26aulast%3DMelis%26aufirst%3DM.%2BR.%26aulast%3DPiludu%26aufirst%3DM.%2BA.%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DArgiolas%26aufirst%3DA.%26aulast%3DGiorgi%26aufirst%3DO.%26atitle%3DDopamine%2520agonist-induced%2520penile%2520erection%2520and%2520yawning%253A%2520A%2520comparative%2520study%2520in%2520outbred%2520Roman%2520high-%2520and%2520low-avoidance%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2013%26volume%3D109%26spage%3D59%26epage%3D66%26doi%3D10.1016%2Fj.pbb.2013.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sood, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idris, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neill, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A. M.</span></span> <span> </span><span class="NLM_article-title">PD168077, a D<sub>4</sub> receptor agonist, reverses object recognition deficits in rats: potential role for D<sub>4</sub> receptor mechanisms in improving cognitive dysfunction in schizophrenia</span>. <i>J. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">792</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1177/0269881110387840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1177%2F0269881110387840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=21088042" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=792-800&author=P.+Soodauthor=N.+F.+Idrisauthor=S.+Coleauthor=B.+Graysonauthor=J.+C.+Neillauthor=A.+M.+Young&title=PD168077%2C+a+D4+receptor+agonist%2C+reverses+object+recognition+deficits+in+rats%3A+potential+role+for+D4+receptor+mechanisms+in+improving+cognitive+dysfunction+in+schizophrenia&doi=10.1177%2F0269881110387840"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1177%2F0269881110387840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881110387840%26sid%3Dliteratum%253Aachs%26aulast%3DSood%26aufirst%3DP.%26aulast%3DIdris%26aufirst%3DN.%2BF.%26aulast%3DCole%26aufirst%3DS.%26aulast%3DGrayson%26aufirst%3DB.%26aulast%3DNeill%26aufirst%3DJ.%2BC.%26aulast%3DYoung%26aufirst%3DA.%2BM.%26atitle%3DPD168077%252C%2520a%2520D4%2520receptor%2520agonist%252C%2520reverses%2520object%2520recognition%2520deficits%2520in%2520rats%253A%2520potential%2520role%2520for%2520D4%2520receptor%2520mechanisms%2520in%2520improving%2520cognitive%2520dysfunction%2520in%2520schizophrenia%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2010%26volume%3D25%26spage%3D792%26epage%3D800%26doi%3D10.1177%2F0269881110387840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keck, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Free, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddaluna, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fountain, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stang, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhardt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenberger, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boateng, C. A.</span></span> <span> </span><span class="NLM_article-title">Dopamine D<sub>4</sub> receptor-selective compounds reveal structure–activity relationships that engender agonist efficacy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3722</span>– <span class="NLM_lpage">3740</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltFCiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3722-3740&author=T.+M.+Keckauthor=R.+B.+Freeauthor=M.+M.+Dayauthor=S.+L.+Brownauthor=M.+S.+Maddalunaauthor=G.+Fountainauthor=C.+Cooperauthor=B.+Fallonauthor=M.+Holmesauthor=C.+T.+Stangauthor=R.+Burkhardtauthor=A.+Bonifaziauthor=M.+P.+Ellenbergerauthor=A.+H.+Newmanauthor=D.+R.+Sibleyauthor=C.+Wuauthor=C.+A.+Boateng&title=Dopamine+D4+receptor-selective+compounds+reveal+structure%E2%80%93activity+relationships+that+engender+agonist+efficacy&doi=10.1021%2Facs.jmedchem.9b00231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D4 Receptor-Selective Compounds Reveal Structure-Activity Relationships that Engender Agonist Efficacy</span></div><div class="casAuthors">Keck, Thomas M.; Free, R. Benjamin; Day, Marilyn M.; Brown, Sonvia L.; Maddaluna, Michele S.; Fountain, Griffin; Cooper, Charles; Fallon, Brooke; Holmes, Matthew; Stang, Christopher T.; Burkhardt, Russell; Bonifazi, Alessandro; Ellenberger, Michael P.; Newman, Amy H.; Sibley, David R.; Wu, Chun; Boateng, Comfort A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3722-3740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D4 receptor (D4R) plays important roles in cognition, attention, and decision making.  Novel D4R-selective ligands have promise in medication development for neuropsychiatric conditions, including Alzheimer's disease and substance use disorders.  To identify new D4R-selective ligands, and to understand the mol. determinants of agonist efficacy at D4R, we report a series of eighteen novel ligands based on the classical D4R agonist A-412997 (1, 2-(4-(pyridin-2-yl)piperidin-1-yl)-N-(m-tolyl)acetamide).  Compds. were profiled using radioligand binding displacement assays, β-arrestin recruitment assays, cAMP inhibition assays, and mol. dynamics computational modeling.  We identified several novel D4R-selective (Ki ≤ 4.3 nM and >100-fold vs other D2-like receptors) compds. with diverse partial agonist and antagonist profiles, falling into three structural groups.  These compds. highlight receptor-ligand interactions that control efficacy at D2-like receptors and may provide insights into targeted drug discovery, leading to a better understanding of the role of D4Rs in neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmtBRYg7sp8rVg90H21EOLACvtfcHk0lh-UW9UCAK7xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltFCiuro%253D&md5=f3f03df2f50a91030295d32d6b692f1c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00231%26sid%3Dliteratum%253Aachs%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DFree%26aufirst%3DR.%2BB.%26aulast%3DDay%26aufirst%3DM.%2BM.%26aulast%3DBrown%26aufirst%3DS.%2BL.%26aulast%3DMaddaluna%26aufirst%3DM.%2BS.%26aulast%3DFountain%26aufirst%3DG.%26aulast%3DCooper%26aufirst%3DC.%26aulast%3DFallon%26aufirst%3DB.%26aulast%3DHolmes%26aufirst%3DM.%26aulast%3DStang%26aufirst%3DC.%2BT.%26aulast%3DBurkhardt%26aufirst%3DR.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DEllenberger%26aufirst%3DM.%2BP.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DBoateng%26aufirst%3DC.%2BA.%26atitle%3DDopamine%2520D4%2520receptor-selective%2520compounds%2520reveal%2520structure%25E2%2580%2593activity%2520relationships%2520that%2520engender%2520agonist%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3722%26epage%3D3740%26doi%3D10.1021%2Facs.jmedchem.9b00231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balius, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroz, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Meara, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Algaa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolmachova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolmachev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span> <span> </span><span class="NLM_article-title">Ultra-large library docking for discovering new chemotypes</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>566</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-0917-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1038%2Fs41586-019-0917-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=30728502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmt1yns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=566&publication_year=2019&pages=224-229&author=J.+Lyuauthor=S.+Wangauthor=T.+E.+Baliusauthor=I.+Singhauthor=A.+Levitauthor=Y.+S.+Morozauthor=M.+J.+O%E2%80%99Mearaauthor=T.+Cheauthor=E.+Algaaauthor=K.+Tolmachovaauthor=A.+A.+Tolmachevauthor=B.+K.+Shoichetauthor=B.+L.+Rothauthor=J.+J.+Irwin&title=Ultra-large+library+docking+for+discovering+new+chemotypes&doi=10.1038%2Fs41586-019-0917-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Ultra-large library docking for discovering new chemotypes</span></div><div class="casAuthors">Lyu, Jiankun; Wang, Sheng; Balius, Trent E.; Singh, Isha; Levit, Anat; Moroz, Yurii S.; O'Meara, Matthew J.; Che, Tao; Algaa, Enkhjargal; Tolmachova, Kateryna; Tolmachev, Andrey A.; Shoichet, Brian K.; Roth, Bryan L.; Irwin, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">566</span>
        (<span class="NLM_cas:issue">7743</span>),
    <span class="NLM_cas:pages">224-229</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Despite intense interest in expanding chem. space, libraries contg. hundreds-of-millions to billions of diverse mols. have remained inaccessible.  Here we investigate structure-based docking of 170 million make-on-demand compds. from 130 well-characterized reactions.  The resulting library is diverse, representing over 10.7 million scaffolds that are otherwise unavailable.  For each compd. in the library, docking against AmpC β-lactamase (AmpC) and the D4 dopamine receptor were simulated.  From the top-ranking mols., 44 and 549 compds. were synthesized and tested for interactions with AmpC and the D4 dopamine receptor, resp.  We found a phenolate inhibitor of AmpC, which revealed a group of inhibitors without known precedent.  This mol. was optimized to 77 nM, which places it among the most potent non-covalent AmpC inhibitors known.  Crystal structures of this and other AmpC inhibitors confirmed the docking predictions.  Against the D4 dopamine receptor, hit rates fell almost monotonically with docking score, and a hit-rate vs. score curve predicted that the library contained 453,000 ligands for the D4 dopamine receptor.  Of 81 new chemotypes discovered, 30 showed submicromolar activity, including a 180-pM subtype-selective agonist of the D4 dopamine receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc_Nuo9pc-Z7Vg90H21EOLACvtfcHk0lhmimWeE1n97g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmt1yns70%253D&md5=589fb81ef11f9cbec645b9a3818648d1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-0917-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-0917-9%26sid%3Dliteratum%253Aachs%26aulast%3DLyu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DBalius%26aufirst%3DT.%2BE.%26aulast%3DSingh%26aufirst%3DI.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DMoroz%26aufirst%3DY.%2BS.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DM.%2BJ.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DAlgaa%26aufirst%3DE.%26aulast%3DTolmachova%26aufirst%3DK.%26aulast%3DTolmachev%26aufirst%3DA.%2BA.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26atitle%3DUltra-large%2520library%2520docking%2520for%2520discovering%2520new%2520chemotypes%26jtitle%3DNature%26date%3D2019%26volume%3D566%26spage%3D224%26epage%3D229%26doi%3D10.1038%2Fs41586-019-0917-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschammer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettinetti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Härterich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanig, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Dopamine D<sub>2</sub>, D<sub>3</sub>, and D<sub>4</sub> selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4923</span>– <span class="NLM_lpage">4935</span>, <span class="refDoi"> DOI: 10.1021/jm900690y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900690y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1ehtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4923-4935&author=K.+Ehrlichauthor=A.+G%C3%B6tzauthor=S.+Bollingerauthor=N.+Tschammerauthor=L.+Bettinettiauthor=S.+H%C3%A4rterichauthor=H.+H%C3%BCbnerauthor=H.+Lanigauthor=P.+Gmeiner&title=Dopamine+D2%2C+D3%2C+and+D4+selective+phenylpiperazines+as+molecular+probes+to+explore+the+origins+of+subtype+specific+receptor+binding&doi=10.1021%2Fjm900690y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D2, D3, and D4 Selective Phenylpiperazines as Molecular Probes To Explore the Origins of Subtype Specific Receptor Binding</span></div><div class="casAuthors">Ehrlich, Katharina; Gotz, Angela; Bollinger, Stefan; Tschammer, Nuska; Bettinetti, Laura; Harterich, Steffen; Hubner, Harald; Lanig, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4923-4935</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Assembling phenylpiperazines with 7a-azaindole via different spacer elements, we developed subtype selective dopamine receptor ligands, e.g. I, preferentially interacting with D4, D2, and D3, resp.  To complete this set, the methylthio analogs exceeding the affinity of methoxy derivs. by one order of magnitude and a structural intermediate II were synthesized.  These chem. similar but biol. divergent target compds. served as mol. probes for radioligand displacement expts., mutagenesis, and docking studies on homol. models based on the recent crystal structure of the β2-adrenergic receptor.  Specific interactions with the highly conserved amino acids Asp3.32 and His6.55 and less conserved residues at positions 2.61, 2.64, 3.28, and 3.29 were identified.  Inclusion of a carefully modeled extracellular loop 2 displayed two nonconserved residues in EL2 that differently contribute to ligand binding.  Obviously, subtype selectivity is caused by nonconserved but frequently mediated by conserved amino acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX2fsUqpFTIbVg90H21EOLACvtfcHk0lhmimWeE1n97g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1ehtLk%253D&md5=99880da2621063e269f8b7f765e09d55</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm900690y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900690y%26sid%3Dliteratum%253Aachs%26aulast%3DEhrlich%26aufirst%3DK.%26aulast%3DG%25C3%25B6tz%26aufirst%3DA.%26aulast%3DBollinger%26aufirst%3DS.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DBettinetti%26aufirst%3DL.%26aulast%3DH%25C3%25A4rterich%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DLanig%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDopamine%2520D2%252C%2520D3%252C%2520and%2520D4%2520selective%2520phenylpiperazines%2520as%2520molecular%2520probes%2520to%2520explore%2520the%2520origins%2520of%2520subtype%2520specific%2520receptor%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4923%26epage%3D4935%26doi%3D10.1021%2Fjm900690y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bettinetti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlotter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Interactive SAR studies:  rational discovery of super-potent and highly selective dopamine D<sub>3</sub> receptor antagonists and partial agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4594</span>– <span class="NLM_lpage">4597</span>, <span class="refDoi"> DOI: 10.1021/jm025558r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm025558r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms12rurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4594-4597&author=L.+Bettinettiauthor=K.+Schlotterauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Interactive+SAR+studies%3A%E2%80%89+rational+discovery+of+super-potent+and+highly+selective+dopamine+D3+receptor+antagonists+and+partial+agonists&doi=10.1021%2Fjm025558r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Interactive SAR Studies: Rational Discovery of Super-Potent and Highly Selective Dopamine D3 Receptor Antagonists and Partial Agonists</span></div><div class="casAuthors">Bettinetti, Laura; Schlotter, Karin; Huebner, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4594-4597</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Starting from dopamine receptor ligand BP897, an interactive drug discovery process leading to heterocyclic bioisosteres is demonstrated.  The four step strategy involved a careful optimization of geometric and electronic properties by systematic modification of the attachment points and heteroatoms, resp.  Efficacy tuning by modification of the Ph substituents led to both D3 partial agonists and full antagonists.  The benzothiophenes FAUC346 and FAUC365 revealed outstanding D3 affinity and subtype selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLmRgFhLa3yrVg90H21EOLACvtfcHk0lhmimWeE1n97g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms12rurg%253D&md5=c7ec92cd899fdcc79e918baf23ca826b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm025558r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm025558r%26sid%3Dliteratum%253Aachs%26aulast%3DBettinetti%26aufirst%3DL.%26aulast%3DSchlotter%26aufirst%3DK.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DInteractive%2520SAR%2520studies%253A%25E2%2580%2589%2520rational%2520discovery%2520of%2520super-potent%2520and%2520highly%2520selective%2520dopamine%2520D3%2520receptor%2520antagonists%2520and%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4594%26epage%3D4597%26doi%3D10.1021%2Fjm025558r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A.
H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cyriac, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deschamps, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, R. R.</span></span> <span> </span><span class="NLM_article-title">N-(4-(4-(2,3-Dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D<sub>3</sub> receptor antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2559</span>– <span class="NLM_lpage">2570</span>, <span class="refDoi"> DOI: 10.1021/jm900095y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900095y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktFGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2559-2570&author=A.%0AH.+Newmanauthor=P.+Cyriacauthor=J.+R.+Deschampsauthor=M.+Taylorauthor=R.+Kumarauthor=D.+Hoauthor=R.+R.+Luedtkeauthor=R.+R.+Luedtke&title=N-%284-%284-%282%2C3-Dichloro-+or+2-methoxyphenyl%29piperazin-1-yl%29butyl%29heterobiarylcarboxamides+with+functionalized+linking+chains+as+high+affinity+and+enantioselective+D3+receptor+antagonists&doi=10.1021%2Fjm900095y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">N-(4-(4-(2,3-Dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with Functionalized Linking Chains as High Affinity and Enantioselective D3 Receptor Antagonists</span></div><div class="casAuthors">Newman, Amy Hauck; Grundt, Peter; Cyriac, George; Deschamps, Jeffrey R.; Taylor, Michelle; Kumar, Rakesh; Ho, David; Luedtke, Robert R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2559-2570</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the present report, the D3 receptor pharmacophore is modified in the 2,3-diCl- and 2-OCH3-phenylpiperazine class of compds. with the goal to improve D3 receptor affinity and selectivity.  This extension of structure-activity relationships (SAR) has resulted in the identification of the first enantioselective D3 antagonists (R- and S-22) to be reported, wherein enantioselectivity is more pronounced at D3 than at D2, and that a binding region on the second extracellular loop (E2) may play a role in both enantioselectivity and D3 receptor selectivity.  Moreover, we have discovered some of the most D3-selective compds. reported to date that show high affinity (Ki = 1 nM) for D3 and ∼400-fold selectivity over the D2 receptor subtype.  Several of these analogs showed exquisite selectivity for D3 receptors over >60 other receptors, further underscoring their value as in vivo research tools.  These lead compds. also have appropriate phys. characteristics for in vivo exploration and therefore will be useful in detg. how intrinsic activity at D3 receptors tested in vitro is related to behaviors in animal models of addiction and other neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprbxvbF2dNX7Vg90H21EOLACvtfcHk0lhIVtR7nXvfFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktFGrt7s%253D&md5=665731381e379cec45ef058cd6c45d0e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm900095y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900095y%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DCyriac%26aufirst%3DP.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DHo%26aufirst%3DD.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DN-%25284-%25284-%25282%252C3-Dichloro-%2520or%25202-methoxyphenyl%2529piperazin-1-yl%2529butyl%2529heterobiarylcarboxamides%2520with%2520functionalized%2520linking%2520chains%2520as%2520high%2520affinity%2520and%2520enantioselective%2520D3%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2559%26epage%3D2570%26doi%3D10.1021%2Fjm900095y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hackling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perachon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höltje, H.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermuth, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokoloff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">N-(ω-(4-(2-Methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D<sub>2</sub> and D<sub>3</sub> receptor ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3883</span>– <span class="NLM_lpage">3899</span>, <span class="refDoi"> DOI: 10.1021/jm030836n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030836n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVSjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3883-3899&author=A.+Hacklingauthor=R.+Ghoshauthor=S.+Perachonauthor=A.+Mannauthor=H.-D.+H%C3%B6ltjeauthor=C.+G.+Wermuthauthor=J.-C.+Schwartzauthor=W.+Sipplauthor=P.+Sokoloffauthor=H.+Stark&title=N-%28%CF%89-%284-%282-Methoxyphenyl%29piperazin-1-yl%29alkyl%29carboxamides+as+dopamine+D2+and+D3+receptor+ligands&doi=10.1021%2Fjm030836n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">N-(ω-(4-(2-Methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as Dopamine D2 and D3 Receptor Ligands</span></div><div class="casAuthors">Hackling, Anneke; Ghosh, Robin; Perachon, Sylvie; Mann, Andre; Hoeltje, Hans-Dieter; Wermuth, Camille G.; Schwartz, Jean-Charles; Sippl, Wolfgang; Sokoloff, Pierre; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3883-3899</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D3 receptor is recognized as a potential therapeutic target for the treatment of various neurol. and psychiatric disorders.  Targetting high affinity and D3 vs. D2 receptor-preferring ligands, the partial agonist BP 897 was taken as a lead structure.  Variations in the spacer and the aryl moiety led to N-alkylated 1-(2-methyoxyphenyl)piperazines with markedly improved affinity and selectivity.  Mol. modeling studies supported the structural development.  Pharmacophore models for dopamine D2 and D3 receptor ligands were developed from their potentially bioactive conformation and were compared in order to get insight into mol. properties of importance for D2/D3 receptor selectivity.  For the 72 compds. presented here, an extended and more linear conformation in the aliph. or aryl spacers turned out to be crucial for dopamine D3 receptor selectivity.  Structural diversity in the aryl moiety (benzamides, heteroarylamides, arylimides) had a major influence on (sub)nanomolar D3 receptor affinity, which was optimized with more rigid aryl acrylamide derivs.  Compd. 38 (ST 280, (E)-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)cinnamoylamide)displayeda most promising pharmacol. profile (Ki (hD3) = 0.5 nM; Ki (hD2L) = 76.4 nM; selectivity ratio of 153), and above that, compd. 38 offered the prospect of a novel radioligand as a pharmacol. tool for various D3 receptor-related in vitro and in vivo investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9JKRnXLo6ELVg90H21EOLACvtfcHk0lgxQp38xbaOPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVSjsr0%253D&md5=ced853199c82b9663d84a47365e680de</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm030836n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030836n%26sid%3Dliteratum%253Aachs%26aulast%3DHackling%26aufirst%3DA.%26aulast%3DGhosh%26aufirst%3DR.%26aulast%3DPerachon%26aufirst%3DS.%26aulast%3DMann%26aufirst%3DA.%26aulast%3DH%25C3%25B6ltje%26aufirst%3DH.-D.%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DSokoloff%26aufirst%3DP.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DN-%2528%25CF%2589-%25284-%25282-Methoxyphenyl%2529piperazin-1-yl%2529alkyl%2529carboxamides%2520as%2520dopamine%2520D2%2520and%2520D3%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3883%26epage%3D3899%26doi%3D10.1021%2Fjm030836n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kulagowski, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broughton, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mawer, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridgill, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emms, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragan, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine: an antagonist with high affinity and selectivity for the human dopamine D<sub>4</sub> receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1941</span>– <span class="NLM_lpage">1942</span>, <span class="refDoi"> DOI: 10.1021/jm9600712</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9600712" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK28XisFClu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1941-1942&author=J.+J.+Kulagowskiauthor=H.+B.+Broughtonauthor=N.+R.+Curtisauthor=I.+M.+Mawerauthor=M.+P.+Ridgillauthor=R.+Bakerauthor=F.+Emmsauthor=S.+B.+Freedmanauthor=R.+Marwoodauthor=S.+Patelauthor=S.+Patelauthor=C.+I.+Raganauthor=P.+D.+Leeson&title=3-%5B%5B4-%284-Chlorophenyl%29piperazin-1-yl%5Dmethyl%5D-1H-pyrrolo%5B2%2C3-b%5Dpyridine%3A+an+antagonist+with+high+affinity+and+selectivity+for+the+human+dopamine+D4+receptor&doi=10.1021%2Fjm9600712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine: An Antagonist with High Affinity and Selectivity for the Human Dopamine D4 Receptor</span></div><div class="casAuthors">Kulagowski, Janusz J.; Broughton, Howard B.; Curtis, Neil R.; Mawer, Ian M.; Ridgill, Mark P.; Baker, Raymond; Emms, Frances; Freedman, Stephen B.; Marwood, Rosemarie; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1941-2</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A topol. similarity search of the Merck sample collection using known dopamine agonists and antagonists as probe structures identified indole I as having modest binding selectivity for cloned human dopamine D4 receptors over D2 and D3 subtypes.  Optimization of the amino side chain and introduction of a nitrogen atom into the indole nucleus resulted in L-745,870 (II), having high D4 affinity (Ki 0.43 nM) with 2200 and >5000-fold selectivity over D2 and D3 receptors, resp.  Also identified in the course of this work was the piperidinol III which demonstrated the opposite selectivity, being 100-fold binding selective for the D2 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb-2eP0UEXCrVg90H21EOLACvtfcHk0lgxQp38xbaOPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisFClu74%253D&md5=f67e836d1a4017fb08307cc1b9aabed9</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm9600712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9600712%26sid%3Dliteratum%253Aachs%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DBroughton%26aufirst%3DH.%2BB.%26aulast%3DCurtis%26aufirst%3DN.%2BR.%26aulast%3DMawer%26aufirst%3DI.%2BM.%26aulast%3DRidgill%26aufirst%3DM.%2BP.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DEmms%26aufirst%3DF.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DMarwood%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRagan%26aufirst%3DC.%2BI.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3D3-%255B%255B4-%25284-Chlorophenyl%2529piperazin-1-yl%255Dmethyl%255D-1H-pyrrolo%255B2%252C3-b%255Dpyridine%253A%2520an%2520antagonist%2520with%2520high%2520affinity%2520and%2520selectivity%2520for%2520the%2520human%2520dopamine%2520D4%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1941%26epage%3D1942%26doi%3D10.1021%2Fjm9600712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Löber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Rationally based efficacy tuning of selective dopamine D<sub>4</sub> receptor ligands leading to the complete antagonist 2-[4-(4-chlorophenyl)piperazin-1- ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 213)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">2691</span>– <span class="NLM_lpage">2694</span>, <span class="refDoi"> DOI: 10.1021/jm015522j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm015522j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A280%3ADC%252BD3MvltVaqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2691-2694&author=S.+L%C3%B6berauthor=H.+H%C3%BCbnerauthor=W.+Utzauthor=P.+Gmeiner&title=Rationally+based+efficacy+tuning+of+selective+dopamine+D4+receptor+ligands+leading+to+the+complete+antagonist+2-%5B4-%284-chlorophenyl%29piperazin-1-+ylmethyl%5Dpyrazolo%5B1%2C5-a%5Dpyridine+%28FAUC+213%29&doi=10.1021%2Fjm015522j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Rationally based efficacy tuning of selective dopamine d4 receptor ligands leading to the complete antagonist 2-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 213)</span></div><div class="casAuthors">Lober S; Hubner H; Utz W; Gmeiner P</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2691-4</span>
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Structure dependent efficacy studies in the field of selective D4 ligands led to the 2-aminomethyl substituted azaindole 2 (FAUC 213) that displayed strong D4 binding, high subtype selectivity, and complete antagonist properties in ligand-induced mitogenesis experiments.  According to our schematic molecular model, the intrinsic activity of the regioisomers investigated is controlled by the ability of the heterocyclic unit to interact with both elements of the D4 binding-site crevice, the aromatic microdomain in TM6, and a serine residue in TM5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTeUrGfCRgTjwpJitSxOdIlfW6udTcc2eaOvF5jBQnJIbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MvltVaqtQ%253D%253D&md5=fff842f3c039a8eb23722e3dc080b387</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm015522j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm015522j%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DUtz%26aufirst%3DW.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DRationally%2520based%2520efficacy%2520tuning%2520of%2520selective%2520dopamine%2520D4%2520receptor%2520ligands%2520leading%2520to%2520the%2520complete%2520antagonist%25202-%255B4-%25284-chlorophenyl%2529piperazin-1-%2520ylmethyl%255Dpyrazolo%255B1%252C5-a%255Dpyridine%2520%2528FAUC%2520213%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2691%26epage%3D2694%26doi%3D10.1021%2Fjm015522j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Löber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschammer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melis, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argiolas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">The azulene framework as a novel arene bioisostere: design of potent dopamine D<sub>4</sub> receptor ligands inducing penile erection</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200800395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1002%2Fcmdc.200800395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=19185034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A280%3ADC%252BD1M3htVyjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=325-328&author=S.+L%C3%B6berauthor=N.+Tschammerauthor=H.+H%C3%BCbnerauthor=M.+R.+Melisauthor=A.+Argiolasauthor=P.+Gmeiner&title=The+azulene+framework+as+a+novel+arene+bioisostere%3A+design+of+potent+dopamine+D4+receptor+ligands+inducing+penile+erection&doi=10.1002%2Fcmdc.200800395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The azulene framework as a novel arene bioisostere: design of potent dopamine D4 receptor ligands inducing penile erection</span></div><div class="casAuthors">Lober Stefan; Tschammer Nuska; Hubner Harald; Melis Maria Rosaria; Argiolas Antonio; Gmeiner Peter</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">325-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Blue makes it happen: The non-uniform charge distribution of the blue colored azulene framework is highly suitable for the bioisosteric replacement of bicyclic heteroarene moieties.  Showing an analogous binding mode as heterocyclic dopamine D4 receptor-selective lead compounds, the induction of penile erection in rats over a greater range of doses indicates a putative advantage of the rationally developed azulene derivative 2 b over apomorphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1W2Z6Jw6xMGyYR5VtavbzfW6udTcc2eaOvF5jBQnJIbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3htVyjtA%253D%253D&md5=c8e4a83af09476777109df320e6cb2b3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200800395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200800395%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DMelis%26aufirst%3DM.%2BR.%26aulast%3DArgiolas%26aufirst%3DA.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DThe%2520azulene%2520framework%2520as%2520a%2520novel%2520arene%2520bioisostere%253A%2520design%2520of%2520potent%2520dopamine%2520D4%2520receptor%2520ligands%2520inducing%2520penile%2520erection%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D325%26epage%3D328%26doi%3D10.1002%2Fcmdc.200800395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraxner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Cyanoindole derivatives as highly selective dopamine D<sub>4</sub> receptor partial agonists: solid-phase synthesis, binding assays, and functional experiments</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">4563</span>– <span class="NLM_lpage">4569</span>, <span class="refDoi"> DOI: 10.1021/jm0009989</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0009989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVamurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4563-4569&author=H.+H%C3%BCbnerauthor=J.+Kraxnerauthor=P.+Gmeiner&title=Cyanoindole+derivatives+as+highly+selective+dopamine+D4+receptor+partial+agonists%3A+solid-phase+synthesis%2C+binding+assays%2C+and+functional+experiments&doi=10.1021%2Fjm0009989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Cyanoindole Derivatives as Highly Selective Dopamine D4 Receptor Partial Agonists: Solid-Phase Synthesis, Binding Assays, and Functional Experiments</span></div><div class="casAuthors">Huebner, Harald; Kraxner, Johannes; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4563-4569</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Traceless linking of diethoxymethyl (DEM)-protected 5- and 6-cyanoindoles and subsequent incorporation of phenylpiperazine derivs. led to 2- and 3-piperazinylmethyl-substituted cyanoindoles.  Dopamine receptor binding studies on these products clearly indicated strong and selective recognition of the D4 subtype which is known as a promising target for the treatment of neuropsychiatric disorders.  The most interesting binding properties were obsd. for the 2-aminomethyl-5-cyanoindoles FAUC 299 and FAUC 316 (Ki = 0.52 and 1.0 nM, resp.) and a fluoro deriv. had extraordinary selectivity over D1, D2long, D2short, and D3 (>8600).  To det. ligand efficacy, mitogenesis expts. were performed indicating partial agonist effects for the test compds. (35% and 30%, when compared to the full agonist quinpirole).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSfyeNh-KUQLVg90H21EOLACvtfcHk0ljRs1RdDV5S9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVamurc%253D&md5=31d091ddfbf43674ff5a991bd946ce81</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm0009989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0009989%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DKraxner%26aufirst%3DJ.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DCyanoindole%2520derivatives%2520as%2520highly%2520selective%2520dopamine%2520D4%2520receptor%2520partial%2520agonists%253A%2520solid-phase%2520synthesis%252C%2520binding%2520assays%252C%2520and%2520functional%2520experiments%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4563%26epage%3D4569%26doi%3D10.1021%2Fjm0009989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glase, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akunne, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgic, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffner, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manley, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugsley, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wise, L. D.</span></span> <span> </span><span class="NLM_article-title">Substituted [(4-phenylpiperazinyl)- methyl]benzamides: selective dopamine D<sub>4</sub> agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1771</span>– <span class="NLM_lpage">1772</span>, <span class="refDoi"> DOI: 10.1021/jm970021c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970021c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK2sXjtFyhurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1771-1772&author=S.+A.+Glaseauthor=H.+C.+Akunneauthor=L.+M.+Georgicauthor=T.+G.+Heffnerauthor=R.+G.+MacKenzieauthor=P.+J.+Manleyauthor=T.+A.+Pugsleyauthor=L.+D.+Wise&title=Substituted+%5B%284-phenylpiperazinyl%29-+methyl%5Dbenzamides%3A+selective+dopamine+D4+agonists&doi=10.1021%2Fjm970021c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted [(4-Phenylpiperazinyl)- methyl]benzamides: Selective Dopamine D4 Agonists</span></div><div class="casAuthors">Glase, Shelly A.; Akunne, Hyacinth C.; Georgic, Lynn M.; Heffner, Thomas G.; MacKenzie, Robert G.; Manley, Peter J.; Pugsley, Thomas A.; Wise, Lawrence D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1771-1772</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">4-Phenylpiperazinylmethyl benzamides were identified as having modest binding affinity and selectivity for the dopamine (DA) D4 receptors.  These compds. also showed partial agonist activity as demonstrated by activation of mitogenesis in D4-transfected CHO p-5 cells.  Optimization of these properties by substituent modification on the two aryl rings resulted in compd. I, an agonist with 8.7 nM affinity for the DA D4 receptor with >300-fold selectivity over D3 and >400-fold selectivity over D2.  The DA antagonists haloperidol and L-745870 were shown to block the agonist effect of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQmKuGFfqQNLVg90H21EOLACvtfcHk0ljRs1RdDV5S9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtFyhurs%253D&md5=f5cee04dc26c4c57eb5ed1b6ad2d2385</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm970021c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970021c%26sid%3Dliteratum%253Aachs%26aulast%3DGlase%26aufirst%3DS.%2BA.%26aulast%3DAkunne%26aufirst%3DH.%2BC.%26aulast%3DGeorgic%26aufirst%3DL.%2BM.%26aulast%3DHeffner%26aufirst%3DT.%2BG.%26aulast%3DMacKenzie%26aufirst%3DR.%2BG.%26aulast%3DManley%26aufirst%3DP.%2BJ.%26aulast%3DPugsley%26aufirst%3DT.%2BA.%26aulast%3DWise%26aufirst%3DL.%2BD.%26atitle%3DSubstituted%2520%255B%25284-phenylpiperazinyl%2529-%2520methyl%255Dbenzamides%253A%2520selective%2520dopamine%2520D4%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1771%26epage%3D1772%26doi%3D10.1021%2Fjm970021c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raviña, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masaguer, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Areias, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selent, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D<sub>3</sub> receptor ligands</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1773</span>– <span class="NLM_lpage">1778</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.01.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.bmcl.2009.01.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=19217777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1773-1778&author=R.+Ortegaauthor=E.+Ravi%C3%B1aauthor=C.+F.+Masaguerauthor=F.+Areiasauthor=J.+Breaauthor=M.+I.+Lozaauthor=L.+L%C3%B3pezauthor=J.+Selentauthor=M.+Pastorauthor=F.+Sanz&title=Synthesis%2C+binding+affinity+and+SAR+of+new+benzolactam+derivatives+as+dopamine+D3+receptor+ligands&doi=10.1016%2Fj.bmcl.2009.01.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands</span></div><div class="casAuthors">Ortega, Raquel; Ravina, Enrique; Masaguer, Christian F.; Areias, Filipe; Brea, Jose; Loza, Maria I.; Lopez, Laura; Selent, Jana; Pastor, Manuel; Sanz, Ferran</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1773-1778</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of new benzolactam derivs. was synthesized and the derivs. were evaluated for their affinities at the dopamine D1, D2, and D3 receptors.  Some of these compds. showed high D2 and/or D3 affinity and selectivity over the D1 receptor.  The SAR study of these compds. revealed structural characteristics that decisively influenced their D2 and D3 affinities.  Structural models of the complexes between some of the most representative compds. of this series and the D2 and D3 receptors were obtained with the aim of rationalizing the obsd. exptl. results.  Moreover, selected compds. showed moderate binding affinity on 5-HT2A which could contribute to reducing the occurrence of extrapyramidal side effects as potential antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrYQNuzEqh47Vg90H21EOLACvtfcHk0ljY_Q4yeimVkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSltLk%253D&md5=128aaff8165c04095fee2270f2459868</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.067%26sid%3Dliteratum%253Aachs%26aulast%3DOrtega%26aufirst%3DR.%26aulast%3DRavi%25C3%25B1a%26aufirst%3DE.%26aulast%3DMasaguer%26aufirst%3DC.%2BF.%26aulast%3DAreias%26aufirst%3DF.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DSelent%26aufirst%3DJ.%26aulast%3DPastor%26aufirst%3DM.%26aulast%3DSanz%26aufirst%3DF.%26atitle%3DSynthesis%252C%2520binding%2520affinity%2520and%2520SAR%2520of%2520new%2520benzolactam%2520derivatives%2520as%2520dopamine%2520D3%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1773%26epage%3D1778%26doi%3D10.1016%2Fj.bmcl.2009.01.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Löber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological investigations of dopaminergic partial agonists preferentially recognizing the D<sub>4</sub> receptor subtype</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2955</span>– <span class="NLM_lpage">2959</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.02.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.bmcl.2006.02.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=16563764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A280%3ADC%252BD283osFyjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2955-2959&author=S.+L%C3%B6berauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Synthesis+and+biological+investigations+of+dopaminergic+partial+agonists+preferentially+recognizing+the+D4+receptor+subtype&doi=10.1016%2Fj.bmcl.2006.02.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological investigations of dopaminergic partial agonists preferentially recognizing the D4 receptor subtype</span></div><div class="casAuthors">Lober Stefan; Hubner Harald; Gmeiner Peter</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2955-9</span>
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    </div><div class="casAbstract">Aminomethyl-substituted biaryls bearing a pyrazole or triazole moiety were synthesized and investigated for dopamine and serotonin receptor binding.  The N-arylpyrazoles 3b,f,g and 4 revealed Ki values in the subnanomolar range (0.28-0.70 nM) for the dopamine D4 receptor subtype.  Employing both mitogenesis and GTPgammaS assays, ligand efficacy was evaluated indicating partial agonist properties.  Interestingly, the tetrahydropyrimidine 4 (FAUC 2020) displayed significant intrinsic selectivity for D2(long) over D2(short).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQDBGjugch2s8-crCu0nI_sfW6udTcc2ebJwWHfEfcUo7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD283osFyjuw%253D%253D&md5=34c01cba25a1234f964d85d04bfa1310</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.02.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.02.075%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520biological%2520investigations%2520of%2520dopaminergic%2520partial%2520agonists%2520preferentially%2520recognizing%2520the%2520D4%2520receptor%2520subtype%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2955%26epage%3D2959%26doi%3D10.1016%2Fj.bmcl.2006.02.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okuyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawashima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funakoshi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, S.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumagai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagamine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomisawa, K.</span></span> <span> </span><span class="NLM_article-title">A selective dopamine D<sub>4</sub> receptor antagonist, NRA0160: A preclinical neuropharmacological profile</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">2109</span>– <span class="NLM_lpage">2125</span>, <span class="refDoi"> DOI: 10.1016/s0024-3205(99)00476-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fs0024-3205%2899%2900476-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10579464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFegtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1999&pages=2109-2125&author=S.+Okuyamaauthor=N.+Kawashimaauthor=S.+Chakiauthor=R.+Yoshikawaauthor=T.+Funakoshiauthor=S.-i.+Ogawaauthor=Y.+Suzukiauthor=Y.+Ikedaauthor=T.+Kumagaiauthor=A.+Nakazatoauthor=M.+Nagamineauthor=K.+Tomisawa&title=A+selective+dopamine+D4+receptor+antagonist%2C+NRA0160%3A+A+preclinical+neuropharmacological+profile&doi=10.1016%2Fs0024-3205%2899%2900476-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A selective dopamine D4 receptor antagonist, NRA0160: A preclinical neuropharmacological profile</span></div><div class="casAuthors">Okuyama, Shigeru; Kawashima, Naoya; Chaki, Shigeyuki; Yoshikawa, Ryoko; Funakoshi, Takeo; Ogawa, Shin-Ichi; Suzuki, Yoshiko; Ikeda, Yoko; Kumagai, Toshihito; Nakazato, Atsuro; Nagamine, Masashi; Tomisawa, Kazuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2109-2125</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">NRA0160, 5-[2-(4-(3-fluorobenzylidene) piperidin-1-yl)ethyl]-4-(4-fluorophenyl)thiazole-2-carboxamide, has a high affinity for human cloned dopamine D4.2, D4.4 and D4.7 receptors, with Ki values of 0.5, 0.9 and 2.7 nM, resp.  NRA0160 is over 20,000-fold more potent at the dopamine D4.2 receptor compared with the human cloned dopamine D2L receptor.  NRA0160 has negligible affinity for the human cloned dopamine D3 receptor (Ki=39 nM), rat serotonin (5-HT)2A receptors (Ki=180 nM) and rat α1 adrenoceptor (Ki=237 nM).  NRA0160 and clozapine antagonized locomotor hyperactivity induced by methamphetamine (MAP) in mice.  NRA0160 and clozapine antagonized MAP-induced stereotyped behavior in mice, although their effects did not exceed 50% inhibition, even at the highest dose given.  NRA0160 and clozapine significantly induced catalepsy in rats, although their effects did not exceed 50% induction even at the highest dose given.  NRA0160 and clozapine significantly reversed the disruption of prepulse inhibition (PPI) in rats produced by apomorphine.  NRA0160 and clozapine significantly shortened the phencyclidine (PCP)-induced prolonged swimming latency in rats in a water maze task.  These findings suggest that NRA0160 may have unique antipsychotic activities without the liability of motor side effects typical of classical antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1yx7gnQ9hUrVg90H21EOLACvtfcHk0ljY_Q4yeimVkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFegtbs%253D&md5=d3377a91a770321c4aa5d443e3fe8080</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fs0024-3205%2899%2900476-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0024-3205%252899%252900476-2%26sid%3Dliteratum%253Aachs%26aulast%3DOkuyama%26aufirst%3DS.%26aulast%3DKawashima%26aufirst%3DN.%26aulast%3DChaki%26aufirst%3DS.%26aulast%3DYoshikawa%26aufirst%3DR.%26aulast%3DFunakoshi%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DS.-i.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DY.%26aulast%3DKumagai%26aufirst%3DT.%26aulast%3DNakazato%26aufirst%3DA.%26aulast%3DNagamine%26aufirst%3DM.%26aulast%3DTomisawa%26aufirst%3DK.%26atitle%3DA%2520selective%2520dopamine%2520D4%2520receptor%2520antagonist%252C%2520NRA0160%253A%2520A%2520preclinical%2520neuropharmacological%2520profile%26jtitle%3DLife%2520Sci.%26date%3D1999%26volume%3D65%26spage%3D2109%26epage%3D2125%26doi%3D10.1016%2Fs0024-3205%2899%2900476-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broughton, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emms, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragan, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">5-(4-Chlorophenyl)-4-methyl-3-(1-(2- phenylethyl)piperidin-4-yl)isoxazole: A Potent, Selective Antagonist at Human Cloned Dopamine D4 Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1943</span>– <span class="NLM_lpage">1945</span>, <span class="refDoi"> DOI: 10.1021/jm960072u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960072u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK28XisFClu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1943-1945&author=M.+Rowleyauthor=H.+B.+Broughtonauthor=I.+Collinsauthor=R.+Bakerauthor=F.+Emmsauthor=R.+Marwoodauthor=S.+Patelauthor=S.+Patelauthor=C.+I.+Raganauthor=S.+B.+Freedmanauthor=P.+D.+Leeson&title=5-%284-Chlorophenyl%29-4-methyl-3-%281-%282-+phenylethyl%29piperidin-4-yl%29isoxazole%3A+A+Potent%2C+Selective+Antagonist+at+Human+Cloned+Dopamine+D4+Receptors&doi=10.1021%2Fjm960072u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">5-(4-Chlorophenyl)-4-methyl-3-(1-(2- phenylethyl)piperidin-4-yl)isoxazole: A Potent, Selective Antagonist at Human Cloned Dopamine D4 Receptors</span></div><div class="casAuthors">Rowley, Michael; Broughton, Howard B.; Collins, Ian; Baker, Raymond; Emms, Frances; Marwood, Rosemarie; Patel, Shil; Patel, Smita; Ragan, C. Ian; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1943-5</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Based on the structure of the classical neuroleptic haloperidol, the Merck sample collection was screened using the topol. similarity probe method for compds. that might have affinity for human cloned dopamine D4 receptors, and in the hope that they might show selectivity over other subtypes.  This led to 5-(4-chlorophenyl)-3-(1-(4-chlorobenzyl)piperidin-4-yl)pyrazole with a Ki of 61 nM at D4, and 4-fold selectivity over D2.  A medicinal chem. program was initiated to improve the affinity and selectivity.  Alteration of the basic nitrogen substituent gave increased affinity, while changes to the pyrazole moiety improved selectivity.  The isoxazole 5-(4-chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole is an antagonist with high D4 affinity and selectivity over the other human cloned dopamine receptor subtypes (Ki: hD4 3.5 nM, hD2 > 1700 nM, hD3 770 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLxE0hed6E4LVg90H21EOLACvtfcHk0lhzCGyH2yMNcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisFClu78%253D&md5=3521fcd79cb3b3ca262337f2c9dbf3d1</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm960072u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960072u%26sid%3Dliteratum%253Aachs%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DBroughton%26aufirst%3DH.%2BB.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DEmms%26aufirst%3DF.%26aulast%3DMarwood%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRagan%26aufirst%3DC.%2BI.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3D5-%25284-Chlorophenyl%2529-4-methyl-3-%25281-%25282-%2520phenylethyl%2529piperidin-4-yl%2529isoxazole%253A%2520A%2520Potent%252C%2520Selective%2520Antagonist%2520at%2520Human%2520Cloned%2520Dopamine%2520D4%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1943%26epage%3D1945%26doi%3D10.1021%2Fjm960072u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Löber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschammer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of dopamine D4 receptor antagonists with planar chirality</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1680</span>– <span class="NLM_lpage">1684</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.01.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.bmc.2013.01.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=23428965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislyltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=1680-1684&author=F.+Sannaauthor=B.+Ortnerauthor=H.+H%C3%BCbnerauthor=S.+L%C3%B6berauthor=N.+Tschammerauthor=P.+Gmeiner&title=Discovery+of+dopamine+D4+receptor+antagonists+with+planar+chirality&doi=10.1016%2Fj.bmc.2013.01.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of dopamine D4 receptor antagonists with planar chirality</span></div><div class="casAuthors">Sanna, Fabrizio; Ortner, Birgit; Huebner, Harald; Loeber, Stefan; Tschammer, Nuska; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1680-1684</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Employing the D4 selective phenylpiperazine 2 as a lead compd., planar chiral analogs with paracyclophane substructure were synthesized and evaluated for their ability to bind and activate dopamine receptors.  The study revealed that the introduction of a [2.2]paracyclophane moiety is tolerated by dopamine receptors of the D2 family.  Subtype selectivity for D4 and ligand efficacy depend on the abs. configuration of the test compds.  Whereas the achiral single-layered lead 2 and the double-layered paracyclophane (R)-3 showed partial agonist properties, the enantiomer (S)-3 behaved as a neutral antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBnXwSYTwOirVg90H21EOLACvtfcHk0lhzCGyH2yMNcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislyltbg%253D&md5=24a9e18e9d12e93710b1a0111ac0b1d0</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.01.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.01.065%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DF.%26aulast%3DOrtner%26aufirst%3DB.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520dopamine%2520D4%2520receptor%2520antagonists%2520with%2520planar%2520chirality%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D1680%26epage%3D1684%26doi%3D10.1016%2Fj.bmc.2013.01.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">1,1′-Disubstituted Ferrocenes as Molecular Hinges in Mono- and Bivalent Dopamine Receptor Ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6860</span>– <span class="NLM_lpage">6870</span>, <span class="refDoi"> DOI: 10.1021/jm901120h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901120h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1artbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6860-6870&author=D.+Huberauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=1%2C1%E2%80%B2-Disubstituted+Ferrocenes+as+Molecular+Hinges+in+Mono-+and+Bivalent+Dopamine+Receptor+Ligands&doi=10.1021%2Fjm901120h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">1,1'-Disubstituted Ferrocenes as Molecular Hinges in Mono- and Bivalent Dopamine Receptor Ligands</span></div><div class="casAuthors">Huber, Daniela; Hubner, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6860-6870</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of previous work on dopaminergic partial agonists, disubstituted ferrocenes are presented as valuable arene bioisosteres.  Because substituents at the distal cyclopentadienyl ring are able to adjust the relative disposition that is required for ligand binding, disubstituted ferrocenes can act as mol. hinges.  Taking advantage of click chem., the regioselective construction and functionalization of the target mols. is reported.  Thus triazole derived appendages were used for the fine-tuning of biol. activity and for the attachment of linker units generating bivalent GPCR ligands.  Receptor binding was evaluated by radioligand displacement expts., revealing superaffinity with sub- to single-digit nanomolar Ki values for particular test compds.  As a neutral antagonist at the dopamine receptors D3 and D4 and a potent partial agonist at the D2 subtype (intrinsic activity = 57%, EC50 = 2.5 nM), the bifunctional ferrocene 10b (shown as I) revealed a novel and unique activity profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodgaMgslFywrVg90H21EOLACvtfcHk0ljcKo5lsQStYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1artbfK&md5=3af6a44ffa1d85de28d68a15e1a9e3f7</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm901120h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901120h%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DD.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3D1%252C1%25E2%2580%25B2-Disubstituted%2520Ferrocenes%2520as%2520Molecular%2520Hinges%2520in%2520Mono-%2520and%2520Bivalent%2520Dopamine%2520Receptor%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6860%26epage%3D6870%26doi%3D10.1021%2Fjm901120h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sampson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyunni, S. V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etukala, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ofori, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricker, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamango, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ablordeppey, S. Y.</span></span> <span> </span><span class="NLM_article-title">Identification of a new selective dopamine D<sub>4</sub> receptor ligand</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3105</span>– <span class="NLM_lpage">3114</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.bmc.2014.04.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=24800940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsVWqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=3105-3114&author=D.+Sampsonauthor=X.+Y.+Zhuauthor=S.+V.+K.+Eyunniauthor=J.+R.+Etukalaauthor=E.+Oforiauthor=B.+Brickerauthor=N.+S.+Lamangoauthor=V.+Setolaauthor=B.+L.+Rothauthor=S.+Y.+Ablordeppey&title=Identification+of+a+new+selective+dopamine+D4+receptor+ligand&doi=10.1016%2Fj.bmc.2014.04.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a new selective dopamine D4 receptor ligand</span></div><div class="casAuthors">Sampson, Dinithia; Zhu, Xue Y.; Eyunni, Suresh V. K.; Etukala, Jagan R.; Ofori, Edward; Bricker, Barbara; Lamango, Nazarius S.; Setola, Vincent; Roth, Bryan L.; Ablordeppey, Seth Y.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3105-3114</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The dopamine D4 receptor has been shown to play key roles in certain CNS pathologies including addiction to cigarette smoking.  Thus, selective D4 ligands may be useful in treating some of these conditions.  Previous studies in the authors' lab. have indicated that the piperazine analog of haloperidol exhibits selective and increased affinity to the DAD4 receptor subtype, in comparison to its piperidine analog.  This led to further exploration of the piperazine moiety to identify new agents that are selective at the D4 receptor.  Compd. (I) (KiD4 = 0.84 nM) was the most potent of the compds. tested.  However, it only had moderate selectivity for the D4 receptor.  2-(3-(4-(Pyrimidin-2-yl)piperazin-1yl)propyl)benzo[d]thiazole trihydrobromide (KiD4 = 3.9 nM) while not as potent, was more discriminatory for the D4 receptor subtype.  In fact, 2-(3-(4-(pyrimidin-2-yl)piperazin-1yl)propyl)benzo[d]thiazole trihydrobromide has little or no binding affinity to any of the other four DA receptor subtypes.  In addn., of the 23 CNS receptors evaluated, only two, 5HT1AR and 5HT2BR, have binding affinity consts. better than 100 nM (Ki <100 nM).  2-(3-(4-(Pyrimidin-2-yl)piperazin-1yl)propyl)benzo[d]thiazole trihydrobromide is a potentially useful D4-selective ligand for probing disease treatments involving the D4 receptor, such as assisting smoking cessation, reversing cognitive deficits in schizophrenia and treating erectile dysfunction.  Thus, further optimization, functional characterization and evaluation in animal models may be warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXRZKJRLbzEbVg90H21EOLACvtfcHk0ljcKo5lsQStYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsVWqtrg%253D&md5=ed55b3f8dc194764069f9cbf8330d91c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DSampson%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%2BY.%26aulast%3DEyunni%26aufirst%3DS.%2BV.%2BK.%26aulast%3DEtukala%26aufirst%3DJ.%2BR.%26aulast%3DOfori%26aufirst%3DE.%26aulast%3DBricker%26aufirst%3DB.%26aulast%3DLamango%26aufirst%3DN.%2BS.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DAblordeppey%26aufirst%3DS.%2BY.%26atitle%3DIdentification%2520of%2520a%2520new%2520selective%2520dopamine%2520D4%2520receptor%2520ligand%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D3105%26epage%3D3114%26doi%3D10.1016%2Fj.bmc.2014.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">D<sub>4</sub> dopamine receptor high-resolution structures enable the discovery of selective agonists</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1126/science.aan5468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1126%2Fscience.aan5468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=29051383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Kns73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2017&pages=381-386&author=S.+Wangauthor=D.+Wackerauthor=A.+Levitauthor=T.+Cheauthor=R.+M.+Betzauthor=J.+D.+McCorvyauthor=A.+J.+Venkatakrishnanauthor=X.-P.+Huangauthor=R.+O.+Drorauthor=B.+K.+Rothauthor=B.+L.+Roth&title=D4+dopamine+receptor+high-resolution+structures+enable+the+discovery+of+selective+agonists&doi=10.1126%2Fscience.aan5468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">D4 dopamine receptor high-resolution structures enable the discovery of selective agonists</span></div><div class="casAuthors">Wang, Sheng; Wacker, Daniel; Levit, Anat; Che, Tao; Betz, Robin M.; McCorvy, John D.; Venkatakrishnan, A. J.; Huang, Xi-Ping; Dror, Ron O.; Shoichet, Brian K.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">6361</span>),
    <span class="NLM_cas:pages">381-386</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Dopamine receptors are implicated in the pathogenesis and treatment of nearly every neuropsychiatric disorder.  Although thousands of drugs interact with these receptors, our mol. understanding of dopaminergic drug selectivity and design remains clouded.  To illuminate dopamine receptor structure, function, and ligand recognition, we detd. crystal structures of the D4 dopamine receptor in its inactive state bound to the antipsychotic drug nemonapride, with resolns. up to 1.95 angstroms.  These structures suggest a mechanism for the control of constitutive signaling, and their unusually high resoln. enabled a structure-based campaign for new agonists of the D4 dopamine receptor.  The ability to efficiently exploit structure for specific probe discovery-rapidly moving from elucidating receptor structure to discovering previously unrecognized, selective agonists-testifies to the power of structure-based approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8NDKhkv_ILbVg90H21EOLACvtfcHk0lju1B2p1NcyaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Kns73I&md5=0bbb93e6bcb33577f9d9b7459273d896</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1126%2Fscience.aan5468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aan5468%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DBetz%26aufirst%3DR.%2BM.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DVenkatakrishnan%26aufirst%3DA.%2BJ.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DRoth%26aufirst%3DB.%2BK.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DD4%2520dopamine%2520receptor%2520high-resolution%2520structures%2520enable%2520the%2520discovery%2520of%2520selective%2520agonists%26jtitle%3DScience%26date%3D2017%26volume%3D358%26spage%3D381%26epage%3D386%26doi%3D10.1126%2Fscience.aan5468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lasch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M. R.</span></span> <span> </span><span class="NLM_article-title">Zinc-mediated allylation and benzylation of phenylazocarboxylic esters</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">10412</span>– <span class="NLM_lpage">10420</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.5b01978</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.5b01978" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFGltbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2015&pages=10412-10420&author=R.+Laschauthor=M.+R.+Heinrich&title=Zinc-mediated+allylation+and+benzylation+of+phenylazocarboxylic+esters&doi=10.1021%2Facs.joc.5b01978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Zinc-Mediated Allylation and Benzylation of Phenylazocarboxylic Esters</span></div><div class="casAuthors">Lasch, Roman; Heinrich, Markus R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">10412-10420</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Allylation and benzylation of phenylazocarboxylic tert-Bu esters have been achieved under Barbier-type reaction conditions and in very short reactions times using the corresponding allyl and benzyl bromides or iodides in combination with zinc powder.  Whereas all reactions occurred exclusively at the β-nitrogen atom of the azocarboxylic esters, the linkage of allyl units was shown to depend on the substitution pattern at the double bond of the allyl halide.  The hydrazines obtained are useful precursors for indoles and indazoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbUy99qgTKA7Vg90H21EOLACvtfcHk0lju1B2p1NcyaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFGltbzM&md5=3d8fd2f41d8802047e44320ee32e54dd</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.5b01978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.5b01978%26sid%3Dliteratum%253Aachs%26aulast%3DLasch%26aufirst%3DR.%26aulast%3DHeinrich%26aufirst%3DM.%2BR.%26atitle%3DZinc-mediated%2520allylation%2520and%2520benzylation%2520of%2520phenylazocarboxylic%2520esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2015%26volume%3D80%26spage%3D10412%26epage%3D10420%26doi%3D10.1021%2Facs.joc.5b01978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sabio Buzo, G.</span>; <span class="NLM_string-name">Tomas Loba, A.</span>; <span class="NLM_string-name">Martinez, A.</span>; <span class="NLM_string-name">Gil Ayuso-Gontan, C.</span>; <span class="NLM_string-name">Gonzalez Teran, B.</span>; <span class="NLM_string-name">Manieri, E.</span></span> <span> </span><span class="NLM_article-title">P38 MAPK inhibitors for the treatment and prophylaxis of liver cancer</span>. PCT Int. Appl., <span class="NLM_patent">WO 2016198698 A2</span> 20161215, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=G.+Sabio+Buzo&author=A.+Tomas+Loba&author=A.+Martinez&author=C.+Gil+Ayuso-Gontan&author=B.+Gonzalez+Teran&author=E.+Manieri&title=P38+MAPK+inhibitors+for+the+treatment+and+prophylaxis+of+liver+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSabio%2BBuzo%26aufirst%3DG.%26atitle%3DP38%2520MAPK%2520inhibitors%2520for%2520the%2520treatment%2520and%2520prophylaxis%2520of%2520liver%2520cancer%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biediger, R. J.</span>; <span class="NLM_string-name">Chen, Q.</span>; <span class="NLM_string-name">Decker, E. R.</span>; <span class="NLM_string-name">Holland, G. W.</span>; <span class="NLM_string-name">Kassir, J. M.</span>; <span class="NLM_string-name">Li, W.</span>; <span class="NLM_string-name">Market, R. V.</span>; <span class="NLM_string-name">Scott, I. L.</span>; <span class="NLM_string-name">Wu, C.</span>; <span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Preparation of carboxylic acid derivatives that inhibit the binding of integrins to their receptors</span>. U.S. Patent <span class="NLM_patent">20,040,063,955 A1</span> 20040401, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=R.+J.+Biediger&author=Q.+Chen&author=E.+R.+Decker&author=G.+W.+Holland&author=J.+M.+Kassir&author=W.+Li&author=R.+V.+Market&author=I.+L.+Scott&author=C.+Wu&author=J.+Li&title=Preparation+of+carboxylic+acid+derivatives+that+inhibit+the+binding+of+integrins+to+their+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBiediger%26aufirst%3DR.%2BJ.%26atitle%3DPreparation%2520of%2520carboxylic%2520acid%2520derivatives%2520that%2520inhibit%2520the%2520binding%2520of%2520integrins%2520to%2520their%2520receptors%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mederski, W.</span>; <span class="NLM_string-name">Tsaklakidi, C.</span>; <span class="NLM_string-name">Cezanne, B.</span>; <span class="NLM_string-name">Dorsch, D.</span>; <span class="NLM_string-name">Barnes, C.</span>; <span class="NLM_string-name">Gleitz, J.</span></span> <span> </span><span class="NLM_article-title">Preparation of semicarbazides as inhibitors of blood-coagulation factor Xa and VIIa</span>. Ger. Offen., DE <span class="NLM_patent">10220048 A1</span> 20031113, <span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=W.+Mederski&author=C.+Tsaklakidi&author=B.+Cezanne&author=D.+Dorsch&author=C.+Barnes&author=J.+Gleitz&title=Preparation+of+semicarbazides+as+inhibitors+of+blood-coagulation+factor+Xa+and+VIIa"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMederski%26aufirst%3DW.%26atitle%3DPreparation%2520of%2520semicarbazides%2520as%2520inhibitors%2520of%2520blood-coagulation%2520factor%2520Xa%2520and%2520VIIa%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fehler, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maschauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höfling, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartuschat, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschammer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prante, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M. R.</span></span> <span> </span><span class="NLM_article-title">Fast and efficient <sup>18</sup>F-labeling by [<sup>18</sup>F]fluorophenylazo-carboxylic esters</span>. <i>Chem.—Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">370</span>– <span class="NLM_lpage">375</span>, <span class="refDoi"> DOI: 10.1002/chem.201303409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1002%2Fchem.201303409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=24339325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSkurjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=370-375&author=S.+K.+Fehlerauthor=S.+Maschauerauthor=S.+B.+H%C3%B6flingauthor=A.+L.+Bartuschatauthor=N.+Tschammerauthor=H.+H%C3%BCbnerauthor=P.+Gmeinerauthor=O.+Pranteauthor=M.+R.+Heinrich&title=Fast+and+efficient+18F-labeling+by+%5B18F%5Dfluorophenylazo-carboxylic+esters&doi=10.1002%2Fchem.201303409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Fast and Efficient 18F-Labeling by [18F|Fluorophenylazocarboxylic Esters</span></div><div class="casAuthors">Fehler, Stefanie K.; Maschauer, Simone; Hoefling, Sarah B.; Bartuschat, Amelie L.; Tschammer, Nuska; Huebner, Harald; Gmeiner, Peter; Prante, Olaf; Heinrich, Markus R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">370-375</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The introduction of a [18F]fluoride ion into the arom. core of phenyl(azo)carboxylic esters was achieved in only 30 s, with radiochem. yields of up to 95%-to-85%.  For labeling purposes, the resulting 18F-substituted azo ester can be further converted in a radical-arylation reaction to give biaryls or in a substitution reaction at its carbonyl unit to produce azo carboxamide derivs.  The title compds. thus formed included 2-[[18F]-4-fluorophenyl]-N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]diazenecarboxamide (I).  I was used as positron-emission tomog. imaging agent (PET imaging) for imaging D3 dopamine receptors (without interference of D2 dopamine receptors).  Biaryl compds. included 4-(fluoro-18F)-1,1'-biphenyl, [4-(fluoro-18F)phenyl]furan derivs., etc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8jHvUXb-2FbVg90H21EOLACvtfcHk0ljrAGexbSaCGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSkurjP&md5=844f27428d3d55a8e682b8d7fda495e3</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fchem.201303409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201303409%26sid%3Dliteratum%253Aachs%26aulast%3DFehler%26aufirst%3DS.%2BK.%26aulast%3DMaschauer%26aufirst%3DS.%26aulast%3DH%25C3%25B6fling%26aufirst%3DS.%2BB.%26aulast%3DBartuschat%26aufirst%3DA.%2BL.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DPrante%26aufirst%3DO.%26aulast%3DHeinrich%26aufirst%3DM.%2BR.%26atitle%3DFast%2520and%2520efficient%252018F-labeling%2520by%2520%255B18F%255Dfluorophenylazo-carboxylic%2520esters%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D2014%26volume%3D20%26spage%3D370%26epage%3D375%26doi%3D10.1002%2Fchem.201303409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B. T.</span></span> <span> </span><span class="NLM_article-title">The competitive and noncompetitive antagonism of receptor-mediated drug actions in the presence of spare receptors</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/1056-8719(93)90055-j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2F1056-8719%2893%2990055-j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=8318718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK3sXlsFWmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1993&pages=85-91&author=B.+T.+Zhu&title=The+competitive+and+noncompetitive+antagonism+of+receptor-mediated+drug+actions+in+the+presence+of+spare+receptors&doi=10.1016%2F1056-8719%2893%2990055-j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The competitive and noncompetitive antagonism of receptor-mediated drug actions in the presence of spare receptors</span></div><div class="casAuthors">Zhu, Bao Ting</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-91</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">A review with 10 refs.  According to the original receptor occupancy theory proposed by Clark in the 1930s, the percent occupancy of total available receptors by an agonist is linearly related to the response (or effect).  However, the first recognition of "receptor reserve" or "spare receptors" mainly by Furchgott and Stephenson in sep. studies about two decades ago has profoundly modified the original receptor occupancy theory, i.e., the receptor occupancy is not directly proportional to the responses, and the ED50 (or EC50) could be much lower than the equil. dissocn. const. (Kd).  To date, the receptor reserve phenomenon has been characterized in an increasing no. of receptor systems.  In theory, spare receptors may influence the profile of dose-response (D-R) relationship as well as that of the competitive or noncompetitive antagonism of receptor-mediated drug actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcQNyZPlOsebVg90H21EOLACvtfcHk0ljrAGexbSaCGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlsFWmsro%253D&md5=decc28468eb5c2714b2dfcf9a0734328</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2F1056-8719%2893%2990055-j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1056-8719%252893%252990055-j%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DB.%2BT.%26atitle%3DThe%2520competitive%2520and%2520noncompetitive%2520antagonism%2520of%2520receptor-mediated%2520drug%2520actions%2520in%2520the%2520presence%2520of%2520spare%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D1993%26volume%3D29%26spage%3D85%26epage%3D91%26doi%3D10.1016%2F1056-8719%2893%2990055-j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Black, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leff, P.</span></span> <span> </span><span class="NLM_article-title">Operational models of pharmacological agonism</span>. <i>Proc. R. Soc. London, Ser. B</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>220</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1098/rspb.1983.0093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1098%2Frspb.1983.0093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=6141562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaL2cXmtFaqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=1983&pages=141-162&author=J.+W.+Blackauthor=P.+Leff&title=Operational+models+of+pharmacological+agonism&doi=10.1098%2Frspb.1983.0093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Operational models of pharmacological agonism</span></div><div class="casAuthors">Black, J. W.; Leff, P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Royal Society of London, Series B:  Biological Sciences</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">220</span>
        (<span class="NLM_cas:issue">1219</span>),
    <span class="NLM_cas:pages">141-62</span>CODEN:
                <span class="NLM_cas:coden">PRLBA4</span>;
        ISSN:<span class="NLM_cas:issn">0080-4649</span>.
    </div><div class="casAbstract">A general, operational model is presented which explicitly describes pharmacol. agonism in terms of 3 parameters: an agonist-receptor dissocn. const., the total receptor concn. [Ro], and a parameter (KE) which defines the transduction of the agonist-receptor complex into pharmacol. effect.  The ratio RO/KE, the transducer ratio (τ), is a logical definition for the efficacy of an agonist in a system.  The model provides a chem. definition of intrinsic efficacy, making this parameter exptl. accessible in principle.  Alternate models are compared and contrasted with regard to their practical and conceptual utilities in exptl. pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonpXVldFQ_nbVg90H21EOLACvtfcHk0lhV_8CTEYncBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmtFaqtA%253D%253D&md5=a0421df9c56495d48d076010acf44b65</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1098%2Frspb.1983.0093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frspb.1983.0093%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DJ.%2BW.%26aulast%3DLeff%26aufirst%3DP.%26atitle%3DOperational%2520models%2520of%2520pharmacological%2520agonism%26jtitle%3DProc.%2520R.%2520Soc.%2520London%252C%2520Ser.%2520B%26date%3D1983%26volume%3D220%26spage%3D141%26epage%3D162%26doi%3D10.1098%2Frspb.1983.0093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Namkung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radresa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devost, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beautrait, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Gouill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laporte, S. A.</span></span> <span> </span><span class="NLM_article-title">Quantifying biased signaling in GPCRs using BRET-based biosensors</span>. <i>Methods</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1016/j.ymeth.2015.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.ymeth.2015.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=25890247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslehsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2016&pages=5-10&author=Y.+Namkungauthor=O.+Radresaauthor=S.+Armandoauthor=D.+Devostauthor=A.+Beautraitauthor=C.+Le+Gouillauthor=S.+A.+Laporte&title=Quantifying+biased+signaling+in+GPCRs+using+BRET-based+biosensors&doi=10.1016%2Fj.ymeth.2015.04.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Quantifying biased signaling in GPCRs using BRET-based biosensors</span></div><div class="casAuthors">Namkung, Yoon; Radresa, Olivier; Armando, Sylvain; Devost, Dominic; Beautrait, Alexandre; Le Gouill, Christian; Laporte, Stephane A.</div><div class="citationInfo"><span class="NLM_cas:title">Methods (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5-10</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There has been a growing appreciation that G protein-coupled receptor (GPCR) functional selectivity (viz. biased signaling), in particular between G protein- and β-arrestin-dependent signaling, can be achieved with specific ligands, and that such directed signaling represents a promising avenue for improving drug efficacy and therapy.  Thus, for any given GPCRs it is important to define means to pharmacol. characterize and classify drugs for their propensity to bias signaling.  Here we describe an exptl. protocol and step-by-step approach to assess functional selectivity between Gαq and β-arrestin-dependent responses using the prototypical angiotensin II (AngII) type 1 receptor (AT1R) expressed in HEK 293 cells.  The protocol describes the expression of Bioluminescence Resonance Energy Transfer (BRET) sensors for either Gαq or β-arrestin with AT1R, and the use of the operational model of pharmacol. agonism to quantify ligand bias.  Such methods are equally applicable to other GPCRs and their downstream signaling effectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoisQm2sSQfUbVg90H21EOLACvtfcHk0lhV_8CTEYncBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslehsLo%253D&md5=3734d70788ffaa1faeb348d608d2c126</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2015.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2015.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DNamkung%26aufirst%3DY.%26aulast%3DRadresa%26aufirst%3DO.%26aulast%3DArmando%26aufirst%3DS.%26aulast%3DDevost%26aufirst%3DD.%26aulast%3DBeautrait%26aufirst%3DA.%26aulast%3DLe%2BGouill%26aufirst%3DC.%26aulast%3DLaporte%26aufirst%3DS.%2BA.%26atitle%3DQuantifying%2520biased%2520signaling%2520in%2520GPCRs%2520using%2520BRET-based%2520biosensors%26jtitle%3DMethods%26date%3D2016%26volume%3D92%26spage%3D5%26epage%3D10%26doi%3D10.1016%2Fj.ymeth.2015.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Westhuizen, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, M.</span></span> <span> </span><span class="NLM_article-title">Quantification of ligand bias for clinically relevant β<sub>2</sub>-adrenergic receptor ligands: implications for drug taxonomy</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">509</span>, <span class="refDoi"> DOI: 10.1124/mol.113.088880</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1124%2Fmol.113.088880" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=24366668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVylu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=492-509&author=E.+T.+van%0Ader+Westhuizenauthor=B.+Bretonauthor=A.+Christopoulosauthor=M.+Bouvier&title=Quantification+of+ligand+bias+for+clinically+relevant+%CE%B22-adrenergic+receptor+ligands%3A+implications+for+drug+taxonomy&doi=10.1124%2Fmol.113.088880"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of ligand bias for clinically relevant β2-adrenergic receptor ligands: implications for drug taxonomy</span></div><div class="casAuthors">van der Westhuizen, Emma T.; Breton, Billy; Christopoulos, Arthur; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">492-509, 33 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The concepts of functional selectivity and ligand bias are becoming increasingly appreciated in modern drug discovery programs, necessitating more informed approaches to compd. classification and, ultimately, therapeutic candidate selection.  Using the β2-adrenergic receptor as a model, we present a proof of concept study that assessed the bias of 19 β-adrenergic ligands, including many clin. used compds., across four pathways [cAMP prodn., extracellular signal-regulated kinase 1/2 (ERK1/2) activation, calcium mobilization and receptor endocytosis] in the same cell background (human embryonic kidney 293S cells).  Efficacy-based clustering placed the ligands into five distinct groups with respect to signaling signatures.  In some cases, apparent functional selectivity originated from off-target effects on other endogenously expressed adrenergic receptors, highlighting the importance of thoroughly assessing selectivity of the responses before concluding receptor-specific ligand-biased signaling.  Eliminating the nonselective compds. did not change the clustering of the 10 remaining compds.  Some ligands exhibited large differences in potency for the different pathways, suggesting that the nature of the receptor-effector complexes influences the relative affinity of the compds. for specific receptor conformations.  Calcn. of relative effectiveness (within pathway) and bias factors (between pathways) for each of the compds., using an operational model of agonism, revealed a global signaling signature for all of the compds. relative to isoproterenol.  Most compds. were biased toward ERK1/2 activation over the other pathways, consistent with the notion that many proximal effectors converge on this pathway.  Overall, we demonstrate a higher level of ligand texture than previously anticipated, opening perspectives for the establishment of pluridimensional correlations between signaling profiles, drug classification, therapeutic efficacy and safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_6gTmfSSaXLVg90H21EOLACvtfcHk0lhV_8CTEYncBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVylu74%253D&md5=b3c934fb87abb58d08ef15f435a6a331</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.088880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.088880%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BWesthuizen%26aufirst%3DE.%2BT.%26aulast%3DBreton%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DQuantification%2520of%2520ligand%2520bias%2520for%2520clinically%2520relevant%2520%25CE%25B22-adrenergic%2520receptor%2520ligands%253A%2520implications%2520for%2520drug%2520taxonomy%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26spage%3D492%26epage%3D509%26doi%3D10.1124%2Fmol.113.088880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solanki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirsath, V. S.</span></span> <span> </span><span class="NLM_article-title">Comparative in-vitro intrinsic clearance of Imipramine in multiple species liver microsomes: human, rat, mouse and dog</span>. <i>J. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">126</span>, <span class="refDoi"> DOI: 10.4172/2157-7609.1000126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.4172%2F2157-7609.1000126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Whur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=126&author=J.+K.+Singhauthor=A.+Solankiauthor=V.+S.+Shirsath&title=Comparative+in-vitro+intrinsic+clearance+of+Imipramine+in+multiple+species+liver+microsomes%3A+human%2C+rat%2C+mouse+and+dog&doi=10.4172%2F2157-7609.1000126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative in-vitro intrinsic clearance of Imipramine in multiple species liver microsomes: human, rat, mouse and dog</span></div><div class="casAuthors">Singh, Jitendra Kumar; Solanki, Anant; Shirsath, Vikas S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">126</span>CODEN:
                <span class="NLM_cas:coden">JDMTAZ</span>;
        ISSN:<span class="NLM_cas:issn">2157-7609</span>.
    
            (<span class="NLM_cas:orgname">OMICS Publishing Group</span>)
        </div><div class="casAbstract">Imipramine is a renowned tricyclic anti-depressant mol.  It is known to be highly potent and efficient as compared to any other antidepressants available.  There are numerous literature reports which elucidate the metabolic pathways of Imipramine.  There are also various reports showing the effect of substrate and time on metab. of Imipramine.  Most of the anal. methods used in these studies were HPLC and or LC-MS.  These studies have also been extended to identification of specific isoforms of cytochrome P 450 family responsible for the metab. of Imipramine as is outlined.  Further, LC-MS based studies have also been reported on the metab. of Imipramine in in-vitro systems including human liver microsomes and its extrapolation on human oral bioavailability data.  However, till date, there has been no published report on the systematic metabolic stability of this mol. in pooled mouse and dog liver microsomes.  The present study was undertaken with the aim to understand the metabolic stability of Imipramine in liver microsomes of different species including human, wistar rat, CD1 mouse and male beagle dog.  We have also attempted to outline the differences between the metabolic stability in these four species.  The reaction samples were scanned for specific m/z values corresponding to reported metabolites, which in turn confirms microsomal metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHooAolbA_2LVg90H21EOLACvtfcHk0lieyto4lx091A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Whur7M&md5=cb62284b946dbc862f35d630b651b989</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.4172%2F2157-7609.1000126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F2157-7609.1000126%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%2BK.%26aulast%3DSolanki%26aufirst%3DA.%26aulast%3DShirsath%26aufirst%3DV.%2BS.%26atitle%3DComparative%2520in-vitro%2520intrinsic%2520clearance%2520of%2520Imipramine%2520in%2520multiple%2520species%2520liver%2520microsomes%253A%2520human%252C%2520rat%252C%2520mouse%2520and%2520dog%26jtitle%3DJ.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2012%26volume%3D3%26spage%3D126%26doi%3D10.4172%2F2157-7609.1000126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinemann, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Functionally selective dopamine D<sub>2</sub>/D<sub>3</sub> receptor agonists comprising an enyne moiety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5130</span>– <span class="NLM_lpage">5141</span>, <span class="refDoi"> DOI: 10.1021/jm400520c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400520c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslSqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5130-5141&author=C.+Hillerauthor=R.+C.+Klingauthor=F.+W.+Heinemannauthor=K.+Meyerauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Functionally+selective+dopamine+D2%2FD3+receptor+agonists+comprising+an+enyne+moiety&doi=10.1021%2Fjm400520c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Functionally Selective Dopamine D2/D3 Receptor Agonists Comprising an Enyne Moiety</span></div><div class="casAuthors">Hiller, Christine; Kling, Ralf C.; Heinemann, Frank W.; Meyer, Karsten; Huebner, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5130-5141</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonracemic ethynylcyclohexynylamines I and ent-I {R = 1,1'-biphenyl-4-yl, pyrazolo[1,5-a]pyridin-2-yl, pyrazolo[1,5-a]pyridin-3-yl, 4-[3-(1-butyl-1,2,3-triazol-4-yloxy)propoxy]-3-methoxyphenyl, benzo[b]thiophene-2-yl, ferrocenyl} were prepd. as dopamine receptor agonists with atypical catechol isosteres; their selectivities for dopamine receptors and for activating receptors through G-protein subunits Go and Gi and the metabolic stability of rac-I (R = 4-PhC6H4) were detd.  The ethynylcyclohexynylamines bound to D2-like receptors with high affinities.  Ent-I (R = pyrazolo[1,5-a]pyridin-2-yl) selectively activated D2slow-promoted Go activation over Gi coupling; the most significant functional bias obsd. was for ent-I {R = 4-[3-(1-butyl-1,2,3-triazol-4-yloxy)propoxy]-3-methoxyphenyl} which selectively activated Go over Gi coupling at D2long receptors.  Functional selectivity for β-arrestin recruitment over Gi activation was obsd. for I (R = 1,1'-biphenyl-4-yl) and ent-I (R = benzothiophene-2-yl), while ent-I (R = pyrazolo[1,5-a]pyridin-2-yl) preferred β-arrestin recruitment compared to Go coupling.  The structure of a nonracemic N-(ethynylcyclohexenyl)dinitrobenzamide was detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXn2SrS-IBCrVg90H21EOLACvtfcHk0lieyto4lx091A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslSqtr4%253D&md5=3855de949f505a83ed3aa561ca182e75</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm400520c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400520c%26sid%3Dliteratum%253Aachs%26aulast%3DHiller%26aufirst%3DC.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DHeinemann%26aufirst%3DF.%2BW.%26aulast%3DMeyer%26aufirst%3DK.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DFunctionally%2520selective%2520dopamine%2520D2%252FD3%2520receptor%2520agonists%2520comprising%2520an%2520enyne%2520moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5130%26epage%3D5141%26doi%3D10.1021%2Fjm400520c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span> Avogadro, “An
open-source molecular builder and visualization tool. Version 1.2.0”:<span class="NLM_contrib-group"><span class="NLM_string-name">Hanwell, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonie, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandermeersch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zurek, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchison, G. R.</span></span> <span> </span><span class="NLM_article-title">Avogadro: an advanced semantic chemical editor, visualization, and analysis platform</span>. <i>J. Cheminf.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">17</span>, <span class="refDoi"> DOI: 10.1186/1758-2946-4-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1186%2F1758-2946-4-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVGksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=17&author=M.+D.+Hanwellauthor=D.+E.+Curtisauthor=D.+C.+Lonieauthor=T.+Vandermeerschauthor=E.+Zurekauthor=G.+R.+Hutchison&title=Avogadro%3A+an+advanced+semantic+chemical+editor%2C+visualization%2C+and+analysis+platform&doi=10.1186%2F1758-2946-4-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Avogadro: an advanced semantic chemical editor, visualization, and analysis platform</span></div><div class="casAuthors">Hanwell, Marcus D.; Curtis, Donald E.; Lonie, David C.; Vandermeersch, Tim; Zurek, Eva; Hutchison, Geoffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cheminformatics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17</span>CODEN:
                <span class="NLM_cas:coden">JCOHB3</span>;
        ISSN:<span class="NLM_cas:issn">1758-2946</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Background: The Avogadro project has developed an advanced mol. editor and visualizer designed for cross-platform use in computational chem., mol. modeling, bioinformatics, materials science, and related areas.  It offers flexible, high quality rendering, and a powerful plugin architecture.  Typical uses include building mol. structures, formatting input files, and analyzing output of a wide variety of computational chem. packages.  By using the CML file format as its native document type, Avogadro seeks to enhance the semantic accessibility of chem. data types.  Results: The work presented here details the Avogadro library, which is a framework providing a code library and application programming interface (API) with three-dimensional visualization capabilities; and has direct applications to research and education in the fields of chem., physics, materials science, and biol.  The Avogadro application provides a rich graphical interface using dynamically loaded plugins through the library itself.  The application and library can each be extended by implementing a plugin module in C++ or Python to explore different visualization techniques, build/manipulate mol. structures, and interact with other programs.  We describe some example extensions, one which uses a genetic algorithm to find stable crystal structures, and one which interfaces with the PackMol program to create packed, solvated structures for mol. dynamics simulations.  The 1.0 release series of Avogadro is the main focus of the results discussed here.  Conclusions: Avogadro offers a semantic chem. builder and platform for visualization and anal.  For users, it offers an easy-to-use builder, integrated support for downloading from common databases such as PubChem and the Protein Data Bank, extg. chem. data from a wide variety of formats, including computational chem. output, and native, semantic support for the CML file format.  For developers, it can be easily extended via a powerful plugin mechanism to support new features in org. chem., inorg. complexes, drug design, materials, biomols., and simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryQMK72CZkerVg90H21EOLACvtfcHk0lgAJCPWQyL6Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVGksLg%253D&md5=f10400f51db314afa780e99403ca748a</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1186%2F1758-2946-4-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1758-2946-4-17%26sid%3Dliteratum%253Aachs%26aulast%3DHanwell%26aufirst%3DM.%2BD.%26aulast%3DCurtis%26aufirst%3DD.%2BE.%26aulast%3DLonie%26aufirst%3DD.%2BC.%26aulast%3DVandermeersch%26aufirst%3DT.%26aulast%3DZurek%26aufirst%3DE.%26aulast%3DHutchison%26aufirst%3DG.%2BR.%26atitle%3DAvogadro%253A%2520an%2520advanced%2520semantic%2520chemical%2520editor%252C%2520visualization%252C%2520and%2520analysis%2520platform%26jtitle%3DJ.%2520Cheminf.%26date%3D2012%26volume%3D4%26spage%3D17%26doi%3D10.1186%2F1758-2946-4-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span> AutoDock Tools, version
1.5.6:<span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span> <span> </span><span class="NLM_article-title">Python: A Programming Language for Software Integration and Development</span>. <i>J. Mol. Graphics Mod.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/S1093-3263(99)99999-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2FS1093-3263%2899%2999999-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10660911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=57-61&author=M.+F.+Sanner&title=Python%3A+A+Programming+Language+for+Software+Integration+and+Development&doi=10.1016%2FS1093-3263%2899%2999999-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Python: a programming language for software integration and development</span></div><div class="casAuthors">Sanner, M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-61</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The use of interpreted languages in biocomputing has been investigated to create a programmable, dynamic environment in which components can be tied together at a high level.  This work has demonstrated the benefits of such an approach and the features of the interpreted language that are key to successful component integration.  This involved Python, an interpreted, interactive, object-oriented programming language.  It provides high-level data structures such as list and associative arrays, dynamic typing and dynamic binding, modules, classes, exceptions, automatic memory management and others.  Python has been found to be instrumental in the mol. modeling research environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaCFXA1JC8X7Vg90H21EOLACvtfcHk0lgAJCPWQyL6Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D&md5=3bf94934548080055dda54f68468c656</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS1093-3263%2899%2999999-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1093-3263%252899%252999999-0%26sid%3Dliteratum%253Aachs%26aulast%3DSanner%26aufirst%3DM.%2BF.%26atitle%3DPython%253A%2520A%2520Programming%2520Language%2520for%2520Software%2520Integration%2520and%2520Development%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Mod.%26date%3D1999%26volume%3D17%26spage%3D57%26epage%3D61%26doi%3D10.1016%2FS1093-3263%2899%2999999-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit60a"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+docking+with+selective+receptor+flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60aR"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0lhZd7iaq9XtAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit60a&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520docking%2520with%2520selective%2520receptor%2520flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trott, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+Improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0lhZd7iaq9XtAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520Improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Structure of the D<sub>2</sub> dopamine receptor bound to the atypical antipsychotic drug risperidone</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>555</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1038/nature25758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1038%2Fnature25758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=29466326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFKqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=555&publication_year=2018&pages=269-273&author=S.+Wangauthor=T.+Cheauthor=A.+Levitauthor=B.+K.+Shoichetauthor=D.+Wackerauthor=B.+L.+Roth&title=Structure+of+the+D2+dopamine+receptor+bound+to+the+atypical+antipsychotic+drug+risperidone&doi=10.1038%2Fnature25758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone</span></div><div class="casAuthors">Wang, Sheng; Che, Tao; Levit, Anat; Shoichet, Brian K.; Wacker, Daniel; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">555</span>
        (<span class="NLM_cas:issue">7695</span>),
    <span class="NLM_cas:pages">269-273</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Dopamine is a neurotransmitter that has been implicated in processes as diverse as reward, addiction, control of coordinated movement, metab. and hormonal secretion.  Correspondingly, dysregulation of the dopaminergic system has been implicated in diseases such as schizophrenia, Parkinson's disease, depression, attention deficit hyperactivity disorder, and nausea and vomiting.  The actions of dopamine are mediated by a family of five G-protein-coupled receptors.  The D2 dopamine receptor (DRD2) is the primary target for both typical and atypical antipsychotic drugs, and for drugs used to treat Parkinson's disease.  Unfortunately, many drugs that target DRD2 cause serious and potentially life-threatening side effects due to promiscuous activities against related receptors.  Accordingly, a mol. understanding of the structure and function of DRD2 could provide a template for the design of safer and more effective medications.  Here we report the crystal structure of DRD2 in complex with the widely prescribed atypical antipsychotic drug risperidone.  The DRD2-risperidone structure reveals an unexpected mode of antipsychotic drug binding to dopamine receptors, and highlights structural determinants that are essential for the actions of risperidone and related drugs at DRD2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeo4Ov49kft7Vg90H21EOLACvtfcHk0ljiAB-t2Ifhnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFKqt7c%253D&md5=2842adc1893293ea8dbf98ae3270a1b2</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnature25758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25758%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructure%2520of%2520the%2520D2%2520dopamine%2520receptor%2520bound%2520to%2520the%2520atypical%2520antipsychotic%2520drug%2520risperidone%26jtitle%3DNature%26date%3D2018%26volume%3D555%26spage%3D269%26epage%3D273%26doi%3D10.1038%2Fnature25758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, E. Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the human dopamine D<sub>3</sub> receptor in complex with a D<sub>2</sub>/D<sub>3</sub> selective antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">1091</span>– <span class="NLM_lpage">1095</span>, <span class="refDoi"> DOI: 10.1126/science.1197410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1126%2Fscience.1197410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=21097933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1091-1095&author=E.+Y.+T.+Chienauthor=W.+Liuauthor=Q.+Zhaoauthor=V.+Katritchauthor=G.+Won+Hanauthor=M.+A.+Hansonauthor=L.+Shiauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+human+dopamine+D3+receptor+in+complex+with+a+D2%2FD3+selective+antagonist&doi=10.1126%2Fscience.1197410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist</span></div><div class="casAuthors">Chien, Ellen Y. T.; Liu, Wei; Zhao, Qiang; Katritch, Vsevolod; Won Han, Gye; Hanson, Michael A.; Shi, Lei; Newman, Amy Hauck; Javitch, Jonathan A.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6007</span>),
    <span class="NLM_cas:pages">1091-1095</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Dopamine modulates movement, cognition, and emotion through activation of dopamine G protein-coupled receptors in the brain.  The crystal structure of the human dopamine D3 receptor (D3R) in complex with the small mol. D2R/D3R-specific antagonist eticlopride reveals important features of the ligand binding pocket and extracellular loops.  On the intracellular side of the receptor, a locked conformation of the ionic lock and two distinctly different conformations of intracellular loop 2 are obsd.  Docking of R-22, a D3R-selective antagonist, reveals an extracellular extension of the eticlopride binding site that comprises a second binding pocket for the aryl amide of R-22, which differs between the highly homologous D2R and D3R.  This difference provides direction to the design of D3R-selective agents for treating drug abuse and other neuropsychiatric indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOEcfSdjMm-7Vg90H21EOLACvtfcHk0ljl3S-JmpJwWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM&md5=12c6f343daea9fb14ca605a092f28533</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1126%2Fscience.1197410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1197410%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DE.%2BY.%2BT.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DWon%2BHan%26aufirst%3DG.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520human%2520dopamine%2520D3%2520receptor%2520in%2520complex%2520with%2520a%2520D2%252FD3%2520selective%2520antagonist%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1091%26epage%3D1095%26doi%3D10.1126%2Fscience.1197410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, D. A.</span></span> <span> </span><span class="NLM_article-title">The Cation−π Interaction</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">1303</span>– <span class="NLM_lpage">1324</span>, <span class="refDoi"> DOI: 10.1021/cr9603744</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr9603744" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK2sXksV2kurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1997&pages=1303-1324&author=J.+C.+Maauthor=D.+A.+Dougherty&title=The+Cation%E2%88%92%CF%80+Interaction&doi=10.1021%2Fcr9603744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The Cation-π Interaction</span></div><div class="casAuthors">Ma, Jennifer C.; Dougherty, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1303-1324</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 293 refs. concerning the title interaction with emphasis on side chain interactions in proteins and protein-ligand interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGfJ_HZ_O2qLVg90H21EOLACvtfcHk0ljl3S-JmpJwWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksV2kurk%253D&md5=e9b3feef32db1495484b4adcd941b138</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fcr9603744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9603744%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DJ.%2BC.%26aulast%3DDougherty%26aufirst%3DD.%2BA.%26atitle%3DThe%2520Cation%25E2%2588%2592%25CF%2580%2520Interaction%26jtitle%3DChem.%2520Rev.%26date%3D1997%26volume%3D97%26spage%3D1303%26epage%3D1324%26doi%3D10.1021%2Fcr9603744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span> <span> </span><span class="NLM_article-title">Biased ligands of G protein-coupled receptors (GPCRs): structure-functional selectivity relationships (SFSRs) and therapeutic potential</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9841</span>– <span class="NLM_lpage">9878</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00435</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00435" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9841-9878&author=L.+Tanauthor=W.+Yanauthor=J.+D.+McCorvyauthor=J.+Cheng&title=Biased+ligands+of+G+protein-coupled+receptors+%28GPCRs%29%3A+structure-functional+selectivity+relationships+%28SFSRs%29+and+therapeutic+potential&doi=10.1021%2Facs.jmedchem.8b00435"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential</span></div><div class="casAuthors">Tan, Liang; Yan, Wenzhong; McCorvy, John D.; Cheng, Jianjun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9841-9878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) signal through both G-protein-dependent and G-protein-independent pathways, and β-arrestin recruitment is the most recognized one of the latter.  Biased ligands selective for either pathway are expected to regulate biol. functions of GPCRs in a more precise way, therefore providing new drug mols. with superior efficacy and/or reduced side effects.  During the past decade, biased ligands have been discovered and developed for many GPCRs, such as the μ opioid receptor, the angiotensin II receptor type 1, the dopamine D2 receptor, and many others.  In this Perspective, recent advances in this field are reviewed by discussing the structure-functional selectivity relationships (SFSRs) of GPCR biased ligands and the therapeutic potential of these mols.  Further understanding of the biol. functions assocd. with each signaling pathway and structural basis for biased signaling will facilitate future drug design in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNFjkAvar29LVg90H21EOLACvtfcHk0liksC5L4pPrzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73N&md5=a7bd605b82666357f5a0a209002225e5</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00435%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DCheng%26aufirst%3DJ.%26atitle%3DBiased%2520ligands%2520of%2520G%2520protein-coupled%2520receptors%2520%2528GPCRs%2529%253A%2520structure-functional%2520selectivity%2520relationships%2520%2528SFSRs%2529%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9841%26epage%3D9878%26doi%3D10.1021%2Facs.jmedchem.8b00435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Fattah, M. A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span> <span> </span><span class="NLM_article-title">An interactive SAR approach to discover novel hybrid thieno probes as ligands for D<sub>2</sub>-like receptors with affinities in the subnanomolar range</span>. <i>Chem. Biodiversity</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2247</span>– <span class="NLM_lpage">2266</span>, <span class="refDoi"> DOI: 10.1002/cbdv.201300204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1002%2Fcbdv.201300204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=24327445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFaltbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=2247-2266&author=M.+A.+O.+Abdel-Fattahauthor=J.+Lehmannauthor=A.+H.+Abadi&title=An+interactive+SAR+approach+to+discover+novel+hybrid+thieno+probes+as+ligands+for+D2-like+receptors+with+affinities+in+the+subnanomolar+range&doi=10.1002%2Fcbdv.201300204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">An Interactive SAR Approach to Discover Novel Hybrid Thieno Probes as Ligands for D2-Like Receptors with Affinities in the Subnanomolar Range</span></div><div class="casAuthors">Abdel-Fattah, Mohamed A. O.; Lehmann, Jochen; Abadi, Ashraf H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2247-2266</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">Arylpiperazinylalkyl phthalimides I [R = 2-EtOC6H4, 2,3-Cl2C6H3, 2-FC6H4, 2-ClC6H4, 2-HOC6H4, 4-FC6H4, 4-ClC6H4, 3,4-Cl2C6H3, 4-HOC6H4, Ph; X = (CH2)n; n = 1, 2] and arylpiperazinylalkyl benzamides and thiophenecarboxamides II [R = 2-EtOC6H4, 2,3-Cl2C6H3, 2-FC6H4, 2-ClC6H4, 2-HOC6H4, 4-FC6H4, 4-ClC6H4, 3,4-Cl2C6H3, 4-HOC6H4, Ph; R1 = Ph, 2-thienyl; X = (CH2)n; n = 1, 2] were prepd. as selective ligands for dopamine D3 and D4 (D2-like) receptors.  Of the arylpiperazinylalkyl phthalimides prepd., I (R = 2-EtOC6H4; n = 2) showed the highest affinity towards D4 and D3 receptors with Ki values in the low nanomolar range, and D2/D4- and D2/D3-selectivity indexes of 72 and 20, resp.  Further optimization led to the D4-selective ligand II (R1 = 2-thienyl; n = 1) with a Ki(D4) value of 0.62 nM, and to II (R1 = 2-thienyl; n = 2) with Ki(D4) and Ki(D3) values of 0.03 and 0.26 nM, resp.  Mol. docking expts. revealed the importance of the unique D4 residue Arg186 in manipulating the D4-subtype-receptor selectivity of the ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsgZBlwDG4MbVg90H21EOLACvtfcHk0liksC5L4pPrzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFaltbzO&md5=1934cb1116cfe22c350668ff1969d076</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.201300204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.201300204%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Fattah%26aufirst%3DM.%2BA.%2BO.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26atitle%3DAn%2520interactive%2520SAR%2520approach%2520to%2520discover%2520novel%2520hybrid%2520thieno%2520probes%2520as%2520ligands%2520for%2520D2-like%2520receptors%2520with%2520affinities%2520in%2520the%2520subnanomolar%2520range%26jtitle%3DChem.%2520Biodiversity%26date%3D2013%26volume%3D10%26spage%3D2247%26epage%3D2266%26doi%3D10.1002%2Fcbdv.201300204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saponaro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aghazadeh Tabrizi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosconati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincenzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Novel 2-((2-(4-(Substituted)phenylpiperazin-1-yl)ethyl)amino)-5′-N-ethylcarboxamidoadenosines as Potent and Selective Agonists of the A2A Adenosine Receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3253</span>– <span class="NLM_lpage">3267</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00215</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00215" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVOrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3253-3267&author=D.+Pretiauthor=P.+G.+Baraldiauthor=G.+Saponaroauthor=R.+Romagnoliauthor=M.+Aghazadeh+Tabriziauthor=S.+Baraldiauthor=S.+Cosconatiauthor=A.+Brunoauthor=E.+Novellinoauthor=F.+Vincenziauthor=A.+Ravaniauthor=P.+A.+Boreaauthor=K.+Varani&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Novel+2-%28%282-%284-%28Substituted%29phenylpiperazin-1-yl%29ethyl%29amino%29-5%E2%80%B2-N-ethylcarboxamidoadenosines+as+Potent+and+Selective+Agonists+of+the+A2A+Adenosine+Receptor&doi=10.1021%2Facs.jmedchem.5b00215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel 2-((2-(4-(Substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamido-adenosines as Potent and Selective Agonists of the A2A Adenosine Receptor</span></div><div class="casAuthors">Preti, Delia; Baraldi, Pier Giovanni; Saponaro, Giulia; Romagnoli, Romeo; Aghazadeh Tabrizi, Mojgan; Baraldi, Stefania; Cosconati, Sandro; Bruno, Agostino; Novellino, Ettore; Vincenzi, Fabrizio; Ravani, Annalisa; Borea, Pier Andrea; Varani, Katia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3253-3267</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stimulation of A2A adenosine receptors (AR) promotes anti-inflammatory responses in animal models of allergic rhinitis, asthma, chronic obstructive pulmonary disease, and rheumatic diseases.  Herein we describe the results of a research program aimed at identifying potent and selective agonists of the A2AAR as potential anti-inflammatory agents.  The recent crystallog. anal. of A2AAR agonists and antagonists in complex with the receptor provided key information on the structural determinants leading to receptor activation or blocking.  In light of this, we designed a new series of 2-((4-aryl(alkyl)piperazin-1-yl)alkylamino)-5'-N-ethylcarboxamido-adenosines, e.g. I, with high A2AAR affinity, activation potency and selectivity obtained by merging distinctive structural elements of known agonists and antagonists of the investigated target.  Docking-based SAR optimization allowed us to identify compd. I as one of the most potent and selective A2A agonist discovered so far (Ki hA2AAR = 4.8 nM, EC50 hA2AAR = 4.9 nM, Ki hA1AR > 10 000 nM, Ki hA3AR = 1487 nM, EC50 hA2BAR > 10 000 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-oIoiqp7btLVg90H21EOLACvtfcHk0li4CKcX9WvpMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVOrtrg%253D&md5=bd2e0d3960b94b43b21cafb2327a62dd</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00215%26sid%3Dliteratum%253Aachs%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DSaponaro%26aufirst%3DG.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DAghazadeh%2BTabrizi%26aufirst%3DM.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DBruno%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DRavani%26aufirst%3DA.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DVarani%26aufirst%3DK.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Novel%25202-%2528%25282-%25284-%2528Substituted%2529phenylpiperazin-1-yl%2529ethyl%2529amino%2529-5%25E2%2580%25B2-N-ethylcarboxamidoadenosines%2520as%2520Potent%2520and%2520Selective%2520Agonists%2520of%2520the%2520A2A%2520Adenosine%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3253%26epage%3D3267%26doi%3D10.1021%2Facs.jmedchem.5b00215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">García, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alajarín, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Álvarez-Builla, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-García, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bascuñana-Almarcha, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peña-Salcedo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozo, M. A.</span></span> <span> </span><span class="NLM_article-title">N-(4-[18F]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HT1A receptors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">795</span>– <span class="NLM_lpage">806</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.ejmech.2014.07.096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=25171752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GktLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=795-806&author=G.+Garc%C3%ADaauthor=V.+Abetauthor=R.+Alajar%C3%ADnauthor=J.+%C3%81lvarez-Buillaauthor=M.+Delgadoauthor=L.+Garc%C3%ADa-Garc%C3%ADaauthor=P.+Bascu%C3%B1ana-Almarchaauthor=C.+Pe%C3%B1a-Salcedoauthor=J.+Kellyauthor=M.+A.+Pozo&title=N-%284-%5B18F%5D-fluoropyridin-2-yl%29-N-%7B2-%5B4-%282-methoxyphenyl%29piperazin-1-yl%5Dethyl%7Dcarboxamides+as+analogs+of+WAY100635.+New+PET+tracers+of+serotonin+5-HT1A+receptors&doi=10.1016%2Fj.ejmech.2014.07.096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">N-(4-[18F]-fluoro-2-pyridinyl)-N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HT1A receptors</span></div><div class="casAuthors">Garcia, Gonzalo; Abet, Valentina; Alajarin, Ramon; Alvarez-Builla, Julio; Delgado, Mercedes; Garcia-Garcia, Luis; Bascunana-Almarcha, Pablo; Pena-Salcedo, Carmen; Kelly, James; Pozo, Miguel A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">795-806</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">N-(4-[18F]-Fluoro-2-pyridinyl)-N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]carboxamide derivs. were prepd. by labeling their 4-nitro-2-pyridinyl precursors through nitro substitution by the 18F anion.  In vitro and in vivo tests showed that the cyclohexanecarboxamide deriv. is a reversible, selective and high affinity 5-HT1A receptor antagonist (IC50 = 0.29 nM, ki = 0.18 nM) with high brain uptake, slow brain clearance and stability to defluorination when compared with conventional stds.  This PET radioligand is a promising candidate for an improved in vivo quantification of 5-HT1A receptors in neuropsychiatric disorders.  The synthesis of the target compds. was achieved by a reaction of N-(4-nitro-2-pyridinyl)-N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]amide derivs. with (Kryptofix-2.2.2)potassium fluoride[18F].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroKvtKmBtIf7Vg90H21EOLACvtfcHk0lgwU8QW_s52Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GktLfM&md5=2309d16675ae8165b073193e1175bcde</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.096%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa%26aufirst%3DG.%26aulast%3DAbet%26aufirst%3DV.%26aulast%3DAlajar%25C3%25ADn%26aufirst%3DR.%26aulast%3D%25C3%2581lvarez-Builla%26aufirst%3DJ.%26aulast%3DDelgado%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Garc%25C3%25ADa%26aufirst%3DL.%26aulast%3DBascu%25C3%25B1ana-Almarcha%26aufirst%3DP.%26aulast%3DPe%25C3%25B1a-Salcedo%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DJ.%26aulast%3DPozo%26aufirst%3DM.%2BA.%26atitle%3DN-%25284-%255B18F%255D-fluoropyridin-2-yl%2529-N-%257B2-%255B4-%25282-methoxyphenyl%2529piperazin-1-yl%255Dethyl%257Dcarboxamides%2520as%2520analogs%2520of%2520WAY100635.%2520New%2520PET%2520tracers%2520of%2520serotonin%25205-HT1A%2520receptors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D85%26spage%3D795%26epage%3D806%26doi%3D10.1016%2Fj.ejmech.2014.07.096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vermeulen, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Smeden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprouse, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikström, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grol, C. J.</span></span> <span> </span><span class="NLM_article-title">Novel 5-HT7Receptor Inverse Agonists. Synthesis and Molecular Modeling of Arylpiperazine- and 1,2,3,4-Tetrahydroisoquinoline-Based Arylsulfonamides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5451</span>– <span class="NLM_lpage">5466</span>, <span class="refDoi"> DOI: 10.1021/jm049743b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049743b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsleisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5451-5466&author=E.+S.+Vermeulenauthor=M.+van+Smedenauthor=A.+W.+Schmidtauthor=J.+S.+Sprouseauthor=H.+V.+Wikstr%C3%B6mauthor=C.+J.+Grol&title=Novel+5-HT7Receptor+Inverse+Agonists.+Synthesis+and+Molecular+Modeling+of+Arylpiperazine-+and+1%2C2%2C3%2C4-Tetrahydroisoquinoline-Based+Arylsulfonamides&doi=10.1021%2Fjm049743b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 5-HT7 Receptor Inverse Agonists. Synthesis and Molecular Modeling of Arylpiperazine- and 1,2,3,4-Tetrahydroisoquinoline-Based Arylsulfonamides</span></div><div class="casAuthors">Vermeulen, Erik S.; Van Smeden, Marjan; Schmidt, Anne W.; Sprouse, Jeffrey S.; Wikstroem, Haakan V.; Grol, Cor J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5451-5466</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of arylpiperazine- and 1,2,3,4-tetrahydroisoquinoline-based arylsulfonamides was synthesized and evaluated for their interactions with the constitutively active 5-HT7 receptor.  Effects on basal adenylate cyclase activity were measured using HEK-293 cells expressing the rat 5-HT7.  All ligands produced a decrease of adenylate cyclase activity, indicative of their inverse agonism.  Addnl., computational studies with a set of 22 inverse agonists, including these novel inverse agonists and inverse agonists known from literature, resulted in a pharmacophore model and a CoMFA model (R2 = 0.97, SE = 0.18).  Docking of inverse agonists at the binding site of a model of the helical parts of the 5-HT7 receptor, based on the α carbon template for 7-TM GPCRs, revealed interesting mol. interactions and a possible explanation for obsd. structure-activity relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqboqchHGBr97Vg90H21EOLACvtfcHk0lgwU8QW_s52Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsleisL8%253D&md5=6fcdfd93be91c6fc8507b40b7b0dd6ee</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm049743b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049743b%26sid%3Dliteratum%253Aachs%26aulast%3DVermeulen%26aufirst%3DE.%2BS.%26aulast%3Dvan%2BSmeden%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DSprouse%26aufirst%3DJ.%2BS.%26aulast%3DWikstr%25C3%25B6m%26aufirst%3DH.%2BV.%26aulast%3DGrol%26aufirst%3DC.%2BJ.%26atitle%3DNovel%25205-HT7Receptor%2520Inverse%2520Agonists.%2520Synthesis%2520and%2520Molecular%2520Modeling%2520of%2520Arylpiperazine-%2520and%25201%252C2%252C3%252C4-Tetrahydroisoquinoline-Based%2520Arylsulfonamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5451%26epage%3D5466%26doi%3D10.1021%2Fjm049743b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lasch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M. R.</span></span> <span> </span><span class="NLM_article-title">Cycloaddition reactions of glycine imine anions to phenylazocarboxylic esters - a new access to 1,3,5-trisubstituted 1,2,4-triazoles</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">4282</span>– <span class="NLM_lpage">4295</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2015.04.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2Fj.tet.2015.04.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFCgsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=4282-4295&author=R.+Laschauthor=M.+R.+Heinrich&title=Cycloaddition+reactions+of+glycine+imine+anions+to+phenylazocarboxylic+esters+-+a+new+access+to+1%2C3%2C5-trisubstituted+1%2C2%2C4-triazoles&doi=10.1016%2Fj.tet.2015.04.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Cycloaddition reactions of glycine imine anions to phenylazocarboxylic esters - a new access to 1,3,5-trisubstituted 1,2,4-triazoles</span></div><div class="casAuthors">Lasch, Roman; Heinrich, Markus R.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4282-4295</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Phenylazocarboxylic tert-Bu esters have recently been shown to be highly versatile building blocks due to their ability to undergo nucleophilic arom. substitutions under mild conditions, particularly well with [18F]fluoride, and to act as precursors for aryl radicals.  The authors now report first examples for cycloaddn. reactions to phenylazocarboxylates.  In a one-pot reaction with readily accessible glycine imines, a variety of highly substituted 1,2,4-triazoles could be obtained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqcjtE1nHos7Vg90H21EOLACvtfcHk0lgwU8QW_s52Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFCgsLs%253D&md5=952cde1d6944a70843af59427b3d81ee</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2015.04.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2015.04.078%26sid%3Dliteratum%253Aachs%26aulast%3DLasch%26aufirst%3DR.%26aulast%3DHeinrich%26aufirst%3DM.%2BR.%26atitle%3DCycloaddition%2520reactions%2520of%2520glycine%2520imine%2520anions%2520to%2520phenylazocarboxylic%2520esters%2520-%2520a%2520new%2520access%2520to%25201%252C3%252C5-trisubstituted%25201%252C2%252C4-triazoles%26jtitle%3DTetrahedron%26date%3D2015%26volume%3D71%26spage%3D4282%26epage%3D4295%26doi%3D10.1016%2Fj.tet.2015.04.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kisseljova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tšubrik, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sillard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mäeorg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mäeorg, U.</span></span> <span> </span><span class="NLM_article-title">Addition of arylboronic acids to symmetrical and unsymmetrical azo compounds</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1021/ol052403f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol052403f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12rtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=43-45&author=K.+Kisseljovaauthor=O.+T%C5%A1ubrikauthor=R.+Sillardauthor=S.+M%C3%A4eorgauthor=U.+M%C3%A4eorg&title=Addition+of+arylboronic+acids+to+symmetrical+and+unsymmetrical+azo+compounds&doi=10.1021%2Fol052403f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Addition of Arylboronic Acids to Symmetrical and Unsymmetrical Azo Compounds</span></div><div class="casAuthors">Kisseljova, Ksenija; Tsubrik, Olga; Sillard, Rannar; Maeeorg, Sirje; Maeeorg, Uno</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-45</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The addn. of aryl- and heteroarylboronic acids to azo compds. is described.  E.g., Cu(OAc)2 catalyzed the addn. of PhB(OH)2 to PhN:NBoc to give 100% Ph2NNHBoc.  Copper salt catalysis was necessary to perform the reaction under mild conditions and high yields.  Excellent regioselectivity was obsd. in addn. to unsym. azo compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriElhAZDsNt7Vg90H21EOLACvtfcHk0ljvU_TPSQu4UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12rtbfE&md5=7f89fd300b6dadfff996aeda25524b21</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fol052403f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol052403f%26sid%3Dliteratum%253Aachs%26aulast%3DKisseljova%26aufirst%3DK.%26aulast%3DT%25C5%25A1ubrik%26aufirst%3DO.%26aulast%3DSillard%26aufirst%3DR.%26aulast%3DM%25C3%25A4eorg%26aufirst%3DS.%26aulast%3DM%25C3%25A4eorg%26aufirst%3DU.%26atitle%3DAddition%2520of%2520arylboronic%2520acids%2520to%2520symmetrical%2520and%2520unsymmetrical%2520azo%2520compounds%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D43%26epage%3D45%26doi%3D10.1021%2Fol052403f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krüll, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prante, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M. R.</span></span> <span> </span><span class="NLM_article-title">Microwave-Assisted Rapid One-Pot Synthesis of Fused and Non-Fused Indoles and 5-[18 F]Fluoroindoles from Phenylazocarboxylates</span>. <i>Chem.—Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">16174</span>– <span class="NLM_lpage">16178</span>, <span class="refDoi"> DOI: 10.1002/chem.201703890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1002%2Fchem.201703890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=28940808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs12lsbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=16174-16178&author=J.+Kr%C3%BCllauthor=A.+Hubertauthor=N.+Nebelauthor=O.+Pranteauthor=M.+R.+Heinrich&title=Microwave-Assisted+Rapid+One-Pot+Synthesis+of+Fused+and+Non-Fused+Indoles+and+5-%5B18+F%5DFluoroindoles+from+Phenylazocarboxylates&doi=10.1002%2Fchem.201703890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Microwave-Assisted Rapid One-Pot Synthesis of Fused and Non-Fused Indoles and 5-[18F]Fluoroindoles from Phenylazocarboxylates</span></div><div class="casAuthors">Kruell, Jasmin; Hubert, Anja; Nebel, Natascha; Prante, Olaf; Heinrich, Markus R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">64</span>),
    <span class="NLM_cas:pages">16174-16178</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Substituted indoles can be prepd. from phenylazocarboxylates through a rapid one-pot sequence featuring a microwave-assisted Fischer indole synthesis as a key step.  Considering that the phenylazocarboxylates may beforehand be modified by mild nucleophilic arom. substitution, including the introduction of [18F]fluoride, the overall strategy offers an attractive new access to 5-[18F]fluoroindoles, e.g., I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb3kVy8oooL7Vg90H21EOLACvtfcHk0ljvU_TPSQu4UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs12lsbfF&md5=3e6309b5f8f5c746d6620e9aa1fe915e</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2Fchem.201703890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201703890%26sid%3Dliteratum%253Aachs%26aulast%3DKr%25C3%25BCll%26aufirst%3DJ.%26aulast%3DHubert%26aufirst%3DA.%26aulast%3DNebel%26aufirst%3DN.%26aulast%3DPrante%26aufirst%3DO.%26aulast%3DHeinrich%26aufirst%3DM.%2BR.%26atitle%3DMicrowave-Assisted%2520Rapid%2520One-Pot%2520Synthesis%2520of%2520Fused%2520and%2520Non-Fused%2520Indoles%2520and%25205-%255B18%2520F%255DFluoroindoles%2520from%2520Phenylazocarboxylates%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D16174%26epage%3D16178%26doi%3D10.1002%2Fchem.201703890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fehler, S.</span></span> <span> </span><span class="NLM_article-title">Neue Reaktionen von Phenylazocarbonsäureestern mit Anwendungen in der Wirkstoffsynthese</span>. Ph.D. Thesis, <span class="NLM_publisher-name">FAU Erlangen-Nürnberg</span>, <span class="NLM_publisher-loc">Erlangen</span>, May 31, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Fehler&title=Neue+Reaktionen+von+Phenylazocarbons%C3%A4ureestern+mit+Anwendungen+in+der+Wirkstoffsynthese"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFehler%26aufirst%3DS.%26atitle%3DNeue%2520Reaktionen%2520von%2520Phenylazocarbons%25C3%25A4ureestern%2520mit%2520Anwendungen%2520in%2520der%2520Wirkstoffsynthese%26pub%3DFAU%2520Erlangen-N%25C3%25BCrnberg%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haubmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Conjugated enynes as nonaromatic catechol bioisosteres: synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D<sub>3</sub> subtype</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">756</span>– <span class="NLM_lpage">762</span>, <span class="refDoi"> DOI: 10.1021/jm991098z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm991098z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvV2ntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=756-762&author=H.+H%C3%BCbnerauthor=C.+Haubmannauthor=W.+Utzauthor=P.+Gmeiner&title=Conjugated+enynes+as+nonaromatic+catechol+bioisosteres%3A+synthesis%2C+binding+experiments%2C+and+computational+studies+of+novel+dopamine+receptor+agonists+recognizing+preferentially+the+D3+subtype&doi=10.1021%2Fjm991098z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugated Enynes as Nonaromatic Catechol Bioisosteres: Synthesis, Binding Experiments, and Computational Studies of Novel Dopamine Receptor Agonists Recognizing Preferentially the D3 Subtype</span></div><div class="casAuthors">Huebner, Harald; Haubmann, Christian; Utz, Wolfgang; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">756-762</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To evaluate nonarom. catechol bioisosteres, the conformationally restrained enynes and enediynes were synthesized via palladium-catalyzed coupling as the key reaction step.  Subsequent receptor binding studies at the dopamine receptor subtypes D1, D2 long, D2 short, D3, and D4 showed highly interesting binding profiles for the enynes when compared to dopamine.  At the guanine nucleotide-sensitive high-affinity binding site of the D3 receptor, the target compd. (Ki = 5.2 nM) was 10-fold more potent than dopamine but less potent at the D2 and D4 subtypes.  In contrast to dopamine the agonists enynes showed strong selectivity for the receptors of the D2 family (D2-D4).  As far as we know, this study represents the first report on nonarom. dopamine agonists.  Comparison of mol. electrostatic potentials, derived from semiempirical MO calcns., and lipophilicity maps was performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWheANs3NXRLVg90H21EOLACvtfcHk0ljEK0U1vkpBNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvV2ntQ%253D%253D&md5=affc96571dd02832d40f990d29786a3a</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm991098z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991098z%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DHaubmann%26aufirst%3DC.%26aulast%3DUtz%26aufirst%3DW.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DConjugated%2520enynes%2520as%2520nonaromatic%2520catechol%2520bioisosteres%253A%2520synthesis%252C%2520binding%2520experiments%252C%2520and%2520computational%2520studies%2520of%2520novel%2520dopamine%2520receptor%2520agonists%2520recognizing%2520preferentially%2520the%2520D3%2520subtype%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D756%26epage%3D762%26doi%3D10.1021%2Fjm991098z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biden, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selbie, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shine, J.</span></span> <span> </span><span class="NLM_article-title">Structural subtypes of the dopamine D<sub>2</sub> receptor are functionally distinct: expression of the cloned D2A and D2B subtypes in a heterologous cell line</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">920</span>– <span class="NLM_lpage">926</span>, <span class="refDoi"> DOI: 10.1210/me.6.6.920</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1210%2Fme.6.6.920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1323056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK38Xks1emsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1992&pages=920-926&author=G.+Hayesauthor=T.+J.+Bidenauthor=L.+A.+Selbieauthor=J.+Shine&title=Structural+subtypes+of+the+dopamine+D2+receptor+are+functionally+distinct%3A+expression+of+the+cloned+D2A+and+D2B+subtypes+in+a+heterologous+cell+line&doi=10.1210%2Fme.6.6.920"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Structural subtypes of the dopamine D2 receptor are functionally distinct:  expression of the cloned D2A and D2B subtypes in a heterologous cell line</span></div><div class="casAuthors">Hayes, Gillian; Biden, Trevor J.; Selbie, Lisa A.; Shine, John</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">920-6</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    </div><div class="casAbstract">Two subtypes of the human dopamine D2 receptor are generated by alternate splicing of the RNA transcript of a single gene.  These 2 forms, termed D2A (long) and D2B (short), differ by the insertion of 29 amino acids within the putative 3rd cytoplasmic loop, an intracellular domain thought to have a role in coupling this class of receptors to particular 2nd messenger systems.  The D2A and D2B structural subtypes were also shown to be functionally distinct.  Expression of the 2 subtypes in a fibroblast cell line revealed that although occupations of both receptors lead to an increase in cytosolic free Ca concn., they differ in their capacity to inhibit cAMP prodn.  At physiol. dopamine concns., the D2β-mediated inhibition of CGRP-stimulated cAMP accumulation is almost double the response mediated by the D2A subtype.  Thus, the D2A and D2B subtypes constitute functionally distinct forms of the dopamine receptor that can couple to multiple intracellular signalling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBM-8vF3erjLVg90H21EOLACvtfcHk0ljEK0U1vkpBNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xks1emsrk%253D&md5=16cd2d9d673f866fd6a5c5dd9f9db730</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1210%2Fme.6.6.920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.6.6.920%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DG.%26aulast%3DBiden%26aufirst%3DT.%2BJ.%26aulast%3DSelbie%26aufirst%3DL.%2BA.%26aulast%3DShine%26aufirst%3DJ.%26atitle%3DStructural%2520subtypes%2520of%2520the%2520dopamine%2520D2%2520receptor%2520are%2520functionally%2520distinct%253A%2520expression%2520of%2520the%2520cloned%2520D2A%2520and%2520D2B%2520subtypes%2520in%2520a%2520heterologous%2520cell%2520line%26jtitle%3DMol.%2520Endocrinol.%26date%3D1992%26volume%3D6%26spage%3D920%26epage%3D926%26doi%3D10.1210%2Fme.6.6.920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sokoloff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giros, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martres, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouthenet, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J.-C.</span></span> <span> </span><span class="NLM_article-title">Molecular cloning and characterization of a novel dopamine receptor (D<sub>3</sub>) as a target for neuroleptics</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1038/347146a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1038%2F347146a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1975644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK3MXhsFyjtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=1990&pages=146-151&author=P.+Sokoloffauthor=B.+Girosauthor=M.-P.+Martresauthor=M.-L.+Bouthenetauthor=J.-C.+Schwartz&title=Molecular+cloning+and+characterization+of+a+novel+dopamine+receptor+%28D3%29+as+a+target+for+neuroleptics&doi=10.1038%2F347146a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics</span></div><div class="casAuthors">Sokoloff, Pierre; Giros, Bruno; Martres, Marie Pascale; Bouthenet, Marie Louise; Schwartz, Jean Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6289</span>),
    <span class="NLM_cas:pages">146-51</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">A dopamine receptor has been characterized which differs in its pharmacol. and signalling system from the D1 or D2 receptor and represents both an autoreceptor and a postsynaptic receptor.  The D3 receptor is localized to limbic areas of the brain, which are assocd. with cognitive, emotional, and endocrine functions.  It seems to mediate some of the effects of antipsychotic drugs and drugs used against Parkinson's disease, that were previously thought to interact only with D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYcwXGdNb1ILVg90H21EOLACvtfcHk0ljEK0U1vkpBNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsFyjtrg%253D&md5=0ea4d33964b478c51de32e96345811f6</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2F347146a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F347146a0%26sid%3Dliteratum%253Aachs%26aulast%3DSokoloff%26aufirst%3DP.%26aulast%3DGiros%26aufirst%3DB.%26aulast%3DMartres%26aufirst%3DM.-P.%26aulast%3DBouthenet%26aufirst%3DM.-L.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26atitle%3DMolecular%2520cloning%2520and%2520characterization%2520of%2520a%2520novel%2520dopamine%2520receptor%2520%2528D3%2529%2520as%2520a%2520target%2520for%2520neuroleptics%26jtitle%3DNature%26date%3D1990%26volume%3D347%26spage%3D146%26epage%3D151%26doi%3D10.1038%2F347146a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asghari, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwaldt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tol, H. H. M.</span></span> <span> </span><span class="NLM_article-title">Modulation of intracellular cyclic AMP levels by different human dopamine D<sub>4</sub> receptor variants</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1165</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.1995.65031157.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1046%2Fj.1471-4159.1995.65031157.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2002&pages=1157-1165&author=V.+Asghariauthor=S.+Sanyalauthor=S.+Buchwaldtauthor=A.+Patersonauthor=V.+Jovanovicauthor=H.+H.+M.+Van+Tol&title=Modulation+of+intracellular+cyclic+AMP+levels+by+different+human+dopamine+D4+receptor+variants&doi=10.1046%2Fj.1471-4159.1995.65031157.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1995.65031157.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1995.65031157.x%26sid%3Dliteratum%253Aachs%26aulast%3DAsghari%26aufirst%3DV.%26aulast%3DSanyal%26aufirst%3DS.%26aulast%3DBuchwaldt%26aufirst%3DS.%26aulast%3DPaterson%26aufirst%3DA.%26aulast%3DJovanovic%26aufirst%3DV.%26aulast%3DVan%2BTol%26aufirst%3DH.%2BH.%2BM.%26atitle%3DModulation%2520of%2520intracellular%2520cyclic%2520AMP%2520levels%2520by%2520different%2520human%2520dopamine%2520D4%2520receptor%2520variants%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D65%26spage%3D1157%26epage%3D1165%26doi%3D10.1046%2Fj.1471-4159.1995.65031157.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lowry, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosebrough, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farr, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randall, R. J.</span></span> <span> </span><span class="NLM_article-title">Protein measurement with the Folin phenol reagent</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1951</span>,  <span class="NLM_volume"><i>193</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2FS0021-9258%2819%2952451-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=14907713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaG38XhsVyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=1951&pages=265-275&author=O.+H.+Lowryauthor=N.+J.+Rosebroughauthor=A.+L.+Farrauthor=R.+J.+Randall&title=Protein+measurement+with+the+Folin+phenol+reagent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Protein measurement with the Folin phenol reagent</span></div><div class="casAuthors">Lowry, Oliver H.; Rosebrough, Nira J.; Farr, A. Lewis; Randall, Rose J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1951</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-75</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">cf. C.A. 41, 1271h.  Proteins were detd. with the Folin phenol reagent after alk. Cu treatment.  The method is as sensitive as with Nessler reagent, yet requires no digestion.  It is 10-20 times more sensitive than detn. of the ultraviolet absorption at λ = 280 mμ and is more specific.  It is several fold more sensitive than the ninhydrin reaction and 100 times more sensitive than the biuret reaction.  Two major disadvantages are: the amt. of color varies with different proteins; the color is not strictly proportional to concn.  Few substances cause serious interference.  Uric acid, guanine, and xanthine react with Folin reagent.  The method is useful for following enzyme fractionation, detg. mixed tissue proteins, detn. of very small amts. of protein, or detg. highly dild. protein, or protein in colored solns. or in the presence of N-contg. material.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHNRKGd34F8LVg90H21EOLACvtfcHk0lj8-5UotPQ5_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38XhsVyrsw%253D%253D&md5=19d36395fad7dd87661caa3d2b97640d</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2819%2952451-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252819%252952451-6%26sid%3Dliteratum%253Aachs%26aulast%3DLowry%26aufirst%3DO.%2BH.%26aulast%3DRosebrough%26aufirst%3DN.%2BJ.%26aulast%3DFarr%26aufirst%3DA.%2BL.%26aulast%3DRandall%26aufirst%3DR.%2BJ.%26atitle%3DProtein%2520measurement%2520with%2520the%2520Folin%2520phenol%2520reagent%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1951%26volume%3D193%26spage%3D265%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fish, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stößel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eitel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albold, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huebner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunahara, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Structure-based design and discovery of new M2 receptor agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9239</span>– <span class="NLM_lpage">9250</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01113</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01113" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGnu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9239-9250&author=I.+Fishauthor=A.+St%C3%B6%C3%9Felauthor=K.+Eitelauthor=C.+Valantauthor=S.+Alboldauthor=H.+Huebnerauthor=D.+M%C3%B6llerauthor=M.+J.+Clarkauthor=R.+K.+Sunaharaauthor=A.+Christopoulosauthor=B.+K.+Shoichetauthor=P.+Gmeiner&title=Structure-based+design+and+discovery+of+new+M2+receptor+agonists&doi=10.1021%2Facs.jmedchem.7b01113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design and Discovery of New M2 Receptor Agonists</span></div><div class="casAuthors">Fish, Inbar; Stossel, Anne; Eitel, Katrin; Valant, Celine; Albold, Sabine; Huebner, Harald; Moller, Dorothee; Clark, Mary J.; Sunahara, Roger K.; Christopoulos, Arthur; Shoichet, Brian K.; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9239-9250</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Muscarinic receptor agonists are characterized by apparently strict restraints on their tertiary or quaternary amine and their distance to an ester or related center.  On the basis of the active state crystal structure of the muscarinic M2 receptor in complex with iperoxo, the authors explored potential agonists that lacked the highly conserved functionalities of previously known ligands.  Using structure-guided pharmacophore design followed by docking, the authors found two agonists (compds. 3 (2-(3-methoxyphenyl)-N,N,N-trimethylethan-1-aminium formate) and 17 (2-(benzofuran-6-yl)-N,N,N-trimethylethan-1-aminium formate)), out of 19 docked and synthesized compds., that fit the receptor well and were predicted to form a hydrogen-bond conserved among known agonists.  Structural optimization led to compd. 28 (2-(2,3-dihydrobenzofuran-6-yl)-N,N,N-trimethylethan-1-aminium formate), which was 4-fold more potent than its parent 3.  Fortified by the discovery of this new scaffold, the authors sought a broader range of chemotypes by docking 2.2 million fragments, which revealed another three micromolar agonists unrelated either to 28 or known muscarinics.  Even pockets as tightly defined and as deeply studied as that of the muscarinic reveal opportunities for the structure-based design and the discovery of new chemotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Yk4WSO0I3LVg90H21EOLACvtfcHk0lj8-5UotPQ5_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGnu7nN&md5=113c2c9b16bc816ddde88634a129da09</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01113%26sid%3Dliteratum%253Aachs%26aulast%3DFish%26aufirst%3DI.%26aulast%3DSt%25C3%25B6%25C3%259Fel%26aufirst%3DA.%26aulast%3DEitel%26aufirst%3DK.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DAlbold%26aufirst%3DS.%26aulast%3DHuebner%26aufirst%3DH.%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DClark%26aufirst%3DM.%2BJ.%26aulast%3DSunahara%26aufirst%3DR.%2BK.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DStructure-based%2520design%2520and%2520discovery%2520of%2520new%2520M2%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9239%26epage%3D9250%26doi%3D10.1021%2Facs.jmedchem.7b01113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uzuneser, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skultety, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzheimer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedland, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of G protein-biased dopaminergics with a pyrazolo[1,5-a]pyridine substructure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2908</span>– <span class="NLM_lpage">2929</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01857</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01857" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A280%3ADC%252BC1czhs1Ojsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2908-2929&author=D.+M%C3%B6llerauthor=A.+Banerjeeauthor=T.+C.+Uzuneserauthor=M.+Skultetyauthor=T.+Huthauthor=B.+Plouffeauthor=H.+H%C3%BCbnerauthor=C.+Alzheimerauthor=K.+Friedlandauthor=C.+P.+M%C3%BCllerauthor=M.+Bouvierauthor=P.+Gmeiner&title=Discovery+of+G+protein-biased+dopaminergics+with+a+pyrazolo%5B1%2C5-a%5Dpyridine+substructure&doi=10.1021%2Facs.jmedchem.6b01857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure</span></div><div class="casAuthors">Moller Dorothee; Banerjee Ashutosh; Skultety Marika; Hubner Harald; Gmeiner Peter; Uzuneser Taygun C; Muller Christian P; Huth Tobias; Alzheimer Christian; Plouffe Bianca; Bouvier Michel; Friedland Kristina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2908-2929</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">1,4-Disubstituted aromatic piperazines are privileged structural motifs recognized by aminergic G protein-coupled receptors.  Connection of a lipophilic moiety to the arylpiperazine core by an appropriate linker represents a promising concept to increase binding affinity and to fine-tune functional properties.  In particular, incorporation of a pyrazolo[1,5-a]pyridine heterocyclic appendage led to a series of high-affinity dopamine receptor partial agonists.  Comprehensive pharmacological characterization involving BRET biosensors, binding studies, electrophysiology, and complementation-based assays revealed compounds favoring activation of G proteins (preferably Go) over β-arrestin recruitment at dopamine D2 receptors.  The feasibility to design G protein-biased partial agonists as putative novel therapeutics was demonstrated for the representative 2-methoxyphenylpiperazine 16c, which unequivocally displayed antipsychotic activity in vivo.  Moreover, combination of the pyrazolo[1,5-a]pyridine appendage with a 5-hydroxy-N-propyl-2-aminotetraline unit led to balanced or G protein-biased dopaminergic ligands depending on the stereochemistry of the headgroup, illustrating the complex structure-functional selectivity relationships at dopamine D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSsvEaQplNsM25P7XSLhESfW6udTcc2eZs-3rW3bx6tLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czhs1Ojsw%253D%253D&md5=208855de29fed6b821fd6e4a5bfb412f</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01857%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DUzuneser%26aufirst%3DT.%2BC.%26aulast%3DSkultety%26aufirst%3DM.%26aulast%3DHuth%26aufirst%3DT.%26aulast%3DPlouffe%26aufirst%3DB.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DAlzheimer%26aufirst%3DC.%26aulast%3DFriedland%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BP.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520G%2520protein-biased%2520dopaminergics%2520with%2520a%2520pyrazolo%255B1%252C5-a%255Dpyridine%2520substructure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2908%26epage%3D2929%26doi%3D10.1021%2Facs.jmedchem.6b01857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung-Chi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (<i>K</i><sub>i</sub>) and the concentration of inhibitor which causes 50 per cent inhibition (I<sub>50</sub>) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=4202581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=C.+Yung-Chiauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28Ki%29+and+the+concentration+of+inhibitor+which+causes+50+per+cent+inhibition+%28I50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DYung-Chi%26aufirst%3DC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528Ki%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2520per%2520cent%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schellhorn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gienger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaab, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaindl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeb, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Structure-guided development of heterodimer-selective GPCR ligands</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12298</span>, <span class="refDoi"> DOI: 10.1038/ncomms12298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1038%2Fncomms12298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=27457610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12gu7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12298&author=H.+H%C3%BCbnerauthor=T.+Schellhornauthor=M.+Giengerauthor=C.+Schaabauthor=J.+Kaindlauthor=L.+Leebauthor=T.+Clarkauthor=D.+M%C3%B6llerauthor=P.+Gmeiner&title=Structure-guided+development+of+heterodimer-selective+GPCR+ligands&doi=10.1038%2Fncomms12298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided development of heterodimer-selective GPCR ligands</span></div><div class="casAuthors">Huebner, Harald; Schellhorn, Tamara; Gienger, Marie; Schaab, Carolin; Kaindl, Jonas; Leeb, Laurin; Clark, Timothy; Moeller, Dorothee; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12298</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Crystal structures of G protein-coupled receptor (GPCR) ligand complexes allow a rational design of novel mol. probes and drugs.  Here we report the structure-guided design, chem. synthesis and biol. investigations of bivalent ligands for dopamine D2 receptor/neurotensin NTS1 receptor (D2R/NTS1R) heterodimers.  The compds. of types 1-3 consist of three different D2R pharmacophores bound to an affinity-generating lipophilic appendage, a polyethylene glycol-based linker and the NTS1R agonist NT(8-13).  The bivalent ligands show binding affinity in the picomolar range for cells coexpressing both GPCRs and unprecedented selectivity (up to three orders of magnitude), compared with cells that only express D2Rs.  A functional switch is obsd. for the bivalent ligands 3b,c inhibiting cAMP formation in cells singly expressing D2Rs but stimulating cAMP accumulation in D2R/NTS1R-coexpressing cells.  Moreover, the newly synthesized bivalent ligands show a strong, predominantly NTS1R-mediated β-arrestin-2 recruitment at the D2R/NTS1R-coexpressing cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphGLuLYNRHcbVg90H21EOLACvtfcHk0li3Q8xBwEOUkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12gu7bI&md5=eedc7c7eead43116f8f1a092faea7c62</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fncomms12298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12298%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DSchellhorn%26aufirst%3DT.%26aulast%3DGienger%26aufirst%3DM.%26aulast%3DSchaab%26aufirst%3DC.%26aulast%3DKaindl%26aufirst%3DJ.%26aulast%3DLeeb%26aufirst%3DL.%26aulast%3DClark%26aufirst%3DT.%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DStructure-guided%2520development%2520of%2520heterodimer-selective%2520GPCR%2520ligands%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12298%26doi%3D10.1038%2Fncomms12298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Broach, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorner, J.</span></span> <span> </span><span class="NLM_article-title">High-throughput screening for drug discovery</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>384</i></span>,  <span class="NLM_fpage">14</span>, <span class="refDoi"> DOI: 10.1038/384014a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1038%2F384014a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=8895594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADyaK28Xmsl2rsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=1996&pages=14&author=J.+R.+Broachauthor=J.+Thorner&title=High-throughput+screening+for+drug+discovery&doi=10.1038%2F384014a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening for drug discovery</span></div><div class="casAuthors">Broach, James R.; Thorner, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">6604, Suppl.</span>),
    <span class="NLM_cas:pages">14-16</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">A review with 23 refs.  There are now a large no. of known proteins available as potential targets for drug treatment.  Concurrently, new approaches have increased the no. of compds. that can be tested for activity against these targets.  Together, these trends have stimulated the adoption of high-throughput screening as a primary tool for early-stage drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHliuK3qN3urVg90H21EOLACvtfcHk0li3Q8xBwEOUkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xmsl2rsr4%253D&md5=356ca2edc709ece1a0c80f560ddd893d</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2F384014a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F384014a0%26sid%3Dliteratum%253Aachs%26aulast%3DBroach%26aufirst%3DJ.%2BR.%26aulast%3DThorner%26aufirst%3DJ.%26atitle%3DHigh-throughput%2520screening%2520for%2520drug%2520discovery%26jtitle%3DNature%26date%3D1996%26volume%3D384%26spage%3D14%26doi%3D10.1038%2F384014a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fish, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaake, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eitel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartuschat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaindl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampp, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunahara, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Structure-guided development of selective M<sub>3</sub> muscarinic acetylcholine receptor antagonists</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">12046</span>– <span class="NLM_lpage">12050</span>, <span class="refDoi"> DOI: 10.1073/pnas.1813988115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=10.1073%2Fpnas.1813988115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=30404914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFanu7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=12046-12050&author=H.+Liuauthor=J.+Hofmannauthor=I.+Fishauthor=B.+Schaakeauthor=K.+Eitelauthor=A.+Bartuschatauthor=J.+Kaindlauthor=H.+Ramppauthor=A.+Banerjeeauthor=H.+H%C3%BCbnerauthor=M.+J.+Clarkauthor=S.+G.+Vincentauthor=J.+T.+Fisherauthor=M.+R.+Heinrichauthor=K.+Hirataauthor=X.+Liuauthor=R.+K.+Sunaharaauthor=B.+K.+Shoichetauthor=B.+K.+Kobilkaauthor=P.+Gmeiner&title=Structure-guided+development+of+selective+M3+muscarinic+acetylcholine+receptor+antagonists&doi=10.1073%2Fpnas.1813988115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists</span></div><div class="casAuthors">Liu, Hongtao; Hofmann, Josefa; Fish, Inbar; Schaake, Benjamin; Eitel, Katrin; Bartuschat, Amelie; Kaindl, Jonas; Rampp, Hannelore; Banerjee, Ashutosh; HA1/4bner, Harald; Clark, Mary J.; Vincent, Sandra G.; Fisher, John T.; Heinrich, Markus R.; Hirata, Kunio; Liu, Xiangyu; Sunahara, Roger K.; Shoichet, Brian K.; Kobilka, Brian K.; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">12046-12050</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Drugs that treat chronic obstructive pulmonary disease by antagonizing the M3 muscarinic acetylcholine receptor (M3R) have had a significant effect on health, but can suffer from their lack of selectivity against the M2R subtype, which modulates heart rate.  Beginning with the crystal structures of M2R and M3R, we exploited a single amino acid difference in their orthosteric binding pockets using mol. docking and structure-based design.  The resulting M3R antagonists had up to 100-fold selectivity over M2R in affinity and over 1,000-fold selectivity in vivo.  The crystal structure of the M3R-selective antagonist in complex with M3R corresponded closely to the docking-predicted geometry, providing a template for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdR9T0wReSnbVg90H21EOLACvtfcHk0li3Q8xBwEOUkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFanu7nE&md5=69c76953444dfbde4a3559507b4f8f4a</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1813988115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1813988115%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHofmann%26aufirst%3DJ.%26aulast%3DFish%26aufirst%3DI.%26aulast%3DSchaake%26aufirst%3DB.%26aulast%3DEitel%26aufirst%3DK.%26aulast%3DBartuschat%26aufirst%3DA.%26aulast%3DKaindl%26aufirst%3DJ.%26aulast%3DRampp%26aufirst%3DH.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DClark%26aufirst%3DM.%2BJ.%26aulast%3DVincent%26aufirst%3DS.%2BG.%26aulast%3DFisher%26aufirst%3DJ.%2BT.%26aulast%3DHeinrich%26aufirst%3DM.%2BR.%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSunahara%26aufirst%3DR.%2BK.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DStructure-guided%2520development%2520of%2520selective%2520M3%2520muscarinic%2520acetylcholine%2520receptor%2520antagonists%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2018%26volume%3D115%26spage%3D12046%26epage%3D12050%26doi%3D10.1073%2Fpnas.1813988115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lgQ3luBFw7zag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sterling, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span> <span> </span><span class="NLM_article-title">ZINC 15 - Ligand Discovery for Everyone</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2324</span>– <span class="NLM_lpage">2337</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.5b00559</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.5b00559" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1OhurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=2324-2337&author=T.+Sterlingauthor=J.+J.+Irwin&title=ZINC+15+-+Ligand+Discovery+for+Everyone&doi=10.1021%2Facs.jcim.5b00559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">ZINC 15 - Ligand Discovery for Everyone</span></div><div class="casAuthors">Sterling, Teague; Irwin, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2324-2337</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Many questions about the biol. activity and availability of small mols. remain inaccessible to investigators who could most benefit from their answers.  To narrow the gap between chemoinformatics and biol., we have developed a suite of ligand annotation, purchasability, target, and biol. assocn. tools, incorporated into ZINC and meant for investigators who are not computer specialists.  The new version contains over 120 million purchasable "drug-like" compds. - effectively all org. mols. that are for sale - a quarter of which are available for immediate delivery.  ZINC connects purchasable compds. to high-value ones such as metabolites, drugs, natural products, and annotated compds. from the literature.  Compds. may be accessed by the genes for which they are annotated as well as the major and minor target classes to which those genes belong.  It offers new anal. tools that are easy for nonspecialists yet with few limitations for experts.  ZINC retains its original 3D roots - all mols. are available in biol. relevant, ready-to-dock formats.  ZINC is freely available at http://zinc15.docking.org.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWfkDnal3D3bVg90H21EOLACvtfcHk0lgQ3luBFw7zag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1OhurbF&md5=e767c26c1d0aff7432c403c59a5d2b8b</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.5b00559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.5b00559%26sid%3Dliteratum%253Aachs%26aulast%3DSterling%26aufirst%3DT.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26atitle%3DZINC%252015%2520-%2520Ligand%2520Discovery%2520for%2520Everyone%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26spage%3D2324%26epage%3D2337%26doi%3D10.1021%2Facs.jcim.5b00559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WIU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WIU','PDB','5WIU'); return false;">PDB: 5WIU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CM4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CM4','PDB','6CM4'); return false;">PDB: 6CM4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBL','PDB','3PBL'); return false;">PDB: 3PBL</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i93"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01085">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_74847"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b01085">10.1021/acs.jmedchem.9b01085</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional docking poses; <sup>1</sup>H and <sup>13</sup>C NMR spectra of all target compounds <b>12a–c</b>, <b>14–47</b> and HPLC purity analysis data; calculation of bias factors; and PAINS screening results (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01085/suppl_file/jm9b01085_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01085/suppl_file/jm9b01085_si_002.csv">CSV</a>)</p></li><li><p class="inline">Additional compound information such as the compound ID, the related SMILES code and the biological data based on the binding studies (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01085/suppl_file/jm9b01085_si_003.xlsx">XLSX</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01085/suppl_file/jm9b01085_si_001.pdf">jm9b01085_si_001.pdf (10.58 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01085/suppl_file/jm9b01085_si_002.csv">jm9b01085_si_002.csv (8.66 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01085/suppl_file/jm9b01085_si_003.xlsx">jm9b01085_si_003.xlsx (15.97 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01085&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01085%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-21%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01085" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b64e3a86d1cb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
